"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties"
"CHEMBL3916358";"";"None";"405.46";"0";"2.15";"BDBM187780";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CC1";"IC50";"'='";"6.2";"nM";"8.21";"";"337465";"UO_0000065";"20.24";"0.37";"6.06";"6.37";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112445";"";"None";"452.53";"0";"3.59";"BDBM187418";"CC(C)CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.2";"nM";"8.49";"";"337154";"UO_0000065";"18.77";"0.35";"4.90";"7.33";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108001";"";"None";"543.00";"1";"3.60";"BDBM187809";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1Nc1cnn(C2CCOCC2)c1";"IC50";"'='";"6.5";"nM";"8.19";"";"337486";"UO_0000065";"15.08";"0.29";"4.59";"6.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115184";"";"None";"434.90";"0";"3.13";"BDBM187791";"CC(C)Nc1cc(-n2cnc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.0";"nM";"8.40";"";"337473";"UO_0000065";"19.31";"0.38";"5.27";"8.00";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112745";"";"None";"448.89";"0";"2.12";"BDBM187792";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1NC1COC1";"IC50";"'='";"10.0";"nM";"8.00";"";"337474";"UO_0000065";"17.82";"0.35";"5.88";"7.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109693";"";"None";"486.94";"0";"3.27";"BDBM187818";"CCn1cc(Nc2cc(-n3cnc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"2.9";"nM";"8.54";"";"337495";"UO_0000065";"17.53";"0.34";"5.27";"6.95";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109109";"";"None";"475.48";"0";"3.59";"BDBM187763";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)OC(F)F";"IC50";"'='";"13.7";"nM";"7.86";"";"337448";"UO_0000065";"16.54";"0.32";"4.27";"6.68";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3929809";"";"None";"457.54";"0";"3.04";"BDBM187487";"CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CC2)CC1";"IC50";"'='";"1.9";"nM";"8.72";"";"337222";"UO_0000065";"19.06";"0.35";"5.68";"6.99";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3953510";"";"None";"481.58";"0";"2.59";"BDBM187597";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](S(C)(=O)=O)CC1";"IC50";"'='";"6.8";"nM";"8.17";"";"337296";"UO_0000065";"16.96";"0.33";"5.58";"5.73";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115327";"";"None";"560.59";"2";"2.02";"BDBM187997";"COc1cnc(N2CC[C@@H](Nc3cc(-n4ncc5cc(C#N)cnc54)ncc3C(=O)NC[C@@H](F)C(C)(C)O)C2)nc1";"IC50";"'='";"8.1";"nM";"8.09";"";"337668";"UO_0000065";"14.43";"0.27";"6.07";"4.85";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114375";"";"None";"439.45";"0";"1.34";"BDBM188009";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1COC1";"IC50";"'='";"3.7";"nM";"8.43";"";"337678";"UO_0000065";"19.19";"0.36";"7.09";"6.11";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3911745";"";"None";"432.53";"0";"3.54";"BDBM187499";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](C)(O)CC1";"IC50";"'='";"4.6";"nM";"8.34";"";"337234";"UO_0000065";"19.28";"0.36";"4.80";"7.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3950081";"";"None";"351.41";"0";"2.46";"BDBM206153";"O=C(Nc1cc(CO)ccc1N1CCCCC1)c1cnn2cccnc12";"IC50";"'='";"199.0";"nM";"6.70";"";"364824";"UO_0000065";"19.07";"0.35";"4.24";"8.10";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3919786";"";"None";"533.61";"1";"3.00";"BDBM188099";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)c(N)nc43)cc2N[C@H]2CCCC[C@@H]2F)CC1";"IC50";"'='";"2.2";"nM";"8.66";"";"337762";"UO_0000065";"16.22";"0.30";"5.66";"5.29";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3894101";"";"None";"473.57";"0";"2.83";"BDBM187601";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCc2nc(N)sc2C1";"IC50";"'='";"9.1";"nM";"8.04";"";"337300";"UO_0000065";"16.98";"0.32";"5.21";"5.45";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106513";"";"None";"441.44";"0";"2.31";"BDBM187796";"CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1NC1COC1";"IC50";"'='";"13.5";"nM";"7.87";"";"337478";"UO_0000065";"17.83";"0.34";"5.56";"6.68";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107861";"";"None";"463.50";"0";"1.97";"BDBM187883";"C[N+]1=C(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)CC=N1";"IC50";"'='";"6.0";"nM";"8.22";"";"337558";"UO_0000065";"17.74";"0.33";"6.25";"6.27";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4452521";"";"None";"432.53";"0";"3.03";"5";"Cn1cc(Nc2nc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c3cc(C#N)ccc3n2)cn1";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"16.71";"0.31";"4.20";"6.96";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3919932";"";"None";"391.46";"0";"3.23";"BDBM206175";"O=C(Nc1cc2cccnc2cc1OC1CCNC1)c1csc2cncnc12";"IC50";"'='";"455.0";"nM";"6.34";"";"364846";"UO_0000065";"16.20";"0.31";"3.11";"7.12";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3952937";"";"None";"319.32";"0";"2.54";"BDBM206120";"COc1cc2ncccc2cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"43.0";"nM";"7.37";"";"364791";"UO_0000065";"23.07";"0.42";"4.83";"9.05";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3622517";"";"None";"472.57";"0";"0.31";"BDBM203491";"CN1CCN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"43.0";"nM";"7.37";"";"360951";"UO_0000065";"15.59";"0.30";"7.06";"5.34";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4070515";"";"None";"329.36";"0";"1.25";"30";"COc1cc2c(OC[C@H]3NC(=O)C[C@H]3C)nccc2cc1C(N)=O";"IC50";"'='";"52.3";"nM";"7.28";"";"";"UO_0000065";"22.11";"0.41";"6.03";"7.03";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4104133";"";"None";"229.28";"0";"2.73";"10";"CC(C)Oc1cc2ccccc2cc1C(N)=O";"IC50";"'='";"2087.0";"nM";"5.68";"";"";"UO_0000065";"24.78";"0.46";"2.95";"10.86";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4079243";"";"None";"359.38";"0";"0.87";"33";"COC[C@@H]1CC(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"IC50";"'='";"12.1";"nM";"7.92";"";"";"UO_0000065";"22.03";"0.42";"7.05";"7.02";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4071526";"";"None";"347.35";"0";"1.19";"39";"COc1cc2c(OC[C@H]3NC(=O)[C@H](F)[C@H]3C)nccc2cc1C(N)=O";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"25.11";"0.48";"7.53";"8.42";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4109321";"";"None";"523.64";"1";"3.63";"BDBM203637";"COc1ccc(N2CC3CC2CN3c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)cc1";"IC50";"'='";"757.0";"nM";"6.12";"";"361118";"UO_0000065";"11.69";"0.21";"2.49";"6.22";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3925654";"";"None";"549.77";"2";"6.29";"BDBM203289";"Cc1sc(-c2cnc(Nc3ccc4ncsc4c3)cc2NC(C)C)nc1C(=O)NCCCN1CCCCC1";"IC50";"'='";"2.7";"nM";"8.57";"";"360850";"UO_0000065";"15.59";"0.31";"2.28";"9.01";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4109337";"";"None";"471.54";"0";"0.40";"BDBM203476";"O=c1[nH]c(N2CC3(COC3)C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"8.9";"nM";"8.05";"";"360936";"UO_0000065";"17.07";"0.33";"7.65";"5.60";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4066705";"";"None";"361.37";"0";"1.58";"41";"CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@@H]1F";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"27.67";"0.53";"8.42";"9.66";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3981389";"";"None";"437.45";"0";"3.25";"BDBM188782";"CN1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(F)cc3F)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338637";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3944066";"";"None";"484.33";"0";"3.54";"BDBM188804";"O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(Br)cc1F)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338659";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL403433";"";"None";"295.35";"0";"1.79";"47";"COc1ccc2ncc(-c3cccc(NC4CNC4)n3)n2c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"27.61";"0.51";"6.36";"12.85";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL256733";"";"None";"364.45";"0";"2.26";"24";"CN(C)C(=O)c1ccc2ncc(-c3cccc(NC4CCNCC4)n3)n2c1";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"20.06";"0.37";"5.05";"9.80";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL256513";"";"None";"267.34";"0";"2.16";"32";"NCCCNc1cccc(-c2cnc3ccccn23)n1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"22.02";"0.40";"3.73";"8.63";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4225923";"";"None";"459.58";"0";"4.50";"16";"Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"13.97";"0.27";"1.92";"5.91";"0";"CHEMBL4222504";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219148";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";""
"CHEMBL4108325";"";"None";"438.51";"0";"3.61";"BDBM187893";"COC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"1.6";"nM";"8.80";"";"337568";"UO_0000065";"20.06";"0.38";"5.19";"8.39";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112293";"";"None";"523.61";"1";"3.27";"BDBM188072";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](C(C)(C)O)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"337738";"UO_0000065";"16.04";"0.30";"5.13";"5.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3590474";"";"None";"397.44";"0";"0.50";"14";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(N)=O)n1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"23.96";"0.45";"9.02";"6.02";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3590475";"";"None";"354.42";"0";"1.40";"15";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)cn1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"22.16";"0.41";"6.45";"6.82";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3908035";"";"None";"447.54";"0";"3.18";"BDBM187693";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)C1";"IC50";"'='";"6.3";"nM";"8.20";"";"337378";"UO_0000065";"18.32";"0.34";"5.02";"6.37";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115569";"";"None";"429.50";"0";"2.65";"BDBM187585";"CCC(O)(CC)[C@H](F)CNC(=O)c1cnc(-n2ncc3cncnc32)cc1NC(C)C";"IC50";"'='";"9.3";"nM";"8.03";"";"337284";"UO_0000065";"18.70";"0.35";"5.38";"6.82";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3931392";"";"None";"446.56";"0";"2.97";"BDBM187715";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1CCN(C)CC1";"IC50";"'='";"2.6";"nM";"8.59";"";"337400";"UO_0000065";"19.22";"0.36";"5.62";"7.68";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3933400";"";"None";"457.49";"0";"2.68";"BDBM187652";"CC(F)[C@H](C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.9";"nM";"8.41";"";"337338";"UO_0000065";"18.38";"0.35";"5.73";"6.53";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3634512";"";"None";"388.86";"0";"2.05";"42";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(Cl)n1";"IC50";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3950330";"";"None";"451.51";"0";"3.00";"BDBM187778";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(F)C1CCOCC1";"IC50";"'='";"4.9";"nM";"8.31";"";"337463";"UO_0000065";"18.40";"0.34";"5.31";"7.06";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111778";"";"None";"436.89";"0";"4.11";"BDBM187779";"CC(C)Nc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)F";"IC50";"'='";"4.3";"nM";"8.37";"";"337464";"UO_0000065";"19.15";"0.38";"4.26";"9.87";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3902784";"";"None";"483.52";"0";"3.57";"BDBM187728";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCC(F)(F)CC1";"IC50";"'='";"6.5";"nM";"8.19";"";"337413";"UO_0000065";"16.93";"0.32";"4.62";"6.36";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109159";"";"None";"487.54";"0";"3.45";"BDBM187882";"Cc1ccc(CNc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"18.4";"nM";"7.74";"";"337557";"UO_0000065";"15.87";"0.29";"4.29";"6.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112222";"";"None";"500.97";"1";"3.83";"BDBM187819";"CC(C)n1cc(Nc2cc(-n3cnc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"4.3";"nM";"8.37";"";"337496";"UO_0000065";"16.70";"0.33";"4.54";"6.81";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3971510";"";"None";"451.44";"0";"3.03";"BDBM187846";"CCCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"337523";"UO_0000065";"18.60";"0.35";"5.37";"6.65";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113759";"";"None";"472.91";"0";"2.78";"BDBM187855";"Cn1cc(Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"4.9";"nM";"8.31";"";"337532";"UO_0000065";"17.57";"0.34";"5.53";"6.77";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110921";"";"None";"493.64";"0";"2.66";"BDBM203775";"CC(=O)N1CCC2(CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)C2)C1";"IC50";"'='";"13.0";"nM";"7.89";"";"361249";"UO_0000065";"15.98";"0.31";"5.23";"7.42";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111625";"";"None";"541.73";"1";"4.31";"BDBM203776";"O=c1[nH]c(N2CCC3(CCN(Cc4ccccc4)C3)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"27.0";"nM";"7.57";"";"361250";"UO_0000065";"13.97";"0.27";"3.26";"8.49";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107435";"";"None";"478.67";"0";"4.33";"BDBM203680";"O=c1[nH]c(C2CCN(C3CCCC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"620.0";"nM";"6.21";"";"361154";"UO_0000065";"12.97";"0.25";"1.88";"7.22";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113480";"";"None";"479.51";"1";"1.77";"BDBM203472";"O=c1[nH]c(NC2CC(F)(F)C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"324.0";"nM";"6.49";"";"360932";"UO_0000065";"13.53";"0.27";"4.72";"4.53";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114411";"";"None";"561.66";"1";"4.08";"BDBM187971";"CC(C)Nc1cc(-n2ccc3cc(CNC(=O)NCc4ccccc4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"8.2";"nM";"8.09";"";"337646";"UO_0000065";"14.40";"0.27";"4.01";"6.07";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2018065";"";"None";"387.47";"0";"1.16";"7";"Cc1nc(N)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"1060.0";"nM";"5.97";"";"";"UO_0000065";"15.42";"0.30";"4.81";"4.35";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3403443";"";"None";"367.41";"0";"0.79";"24";"Nc1ncc(-c2ccc3ccccc3n2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"104.0";"nM";"6.98";"";"";"UO_0000065";"19.01";"0.35";"6.19";"5.08";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4089510";"";"None";"447.56";"0";"4.15";"15";"CN(C)C(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1";"IC50";"'='";"14600.0";"nM";"4.84";"";"";"UO_0000065";"10.80";"0.21";"0.69";"5.35";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4075955";"";"None";"449.54";"0";"3.30";"29";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"18.47";"0.35";"5.00";"6.95";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4075758";"";"None";"461.52";"0";"2.21";"32";"CNC(=O)c1cnc(Nc2ccc3c(c2)CC(=O)N3C)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"17.33";"0.32";"5.79";"6.31";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4081502";"";"None";"329.45";"0";"2.75";"19a";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOC4)c23)CC1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"21.01";"0.39";"4.17";"10.47";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3921461";"";"None";"421.84";"0";"3.90";"BDBM206261";"COc1cc(C(=O)Nc2ccccc2)c(Cl)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"7915.0";"nM";"5.10";"";"364932";"UO_0000065";"12.09";"0.23";"1.20";"5.23";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4061227";"";"None";"343.48";"0";"3.14";"20";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCOC4)c23)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"22.70";"0.43";"4.66";"11.80";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3353209";"";"None";"457.54";"0";"2.55";"BDBM50040809";"Cc1ccc(-n2nc(N3CCN(C4CCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338909";"UO_0000065";"";"";"";"";"1";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL482708";"";"None";"307.40";"0";"3.56";"8";"CN(c1nccc(-c2cnc3ccccn23)n1)C1CCCCC1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"20.81";"0.38";"2.84";"13.81";"0";"CHEMBL956501";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL3958433";"";"None";"559.45";"1";"2.77";"BDBM188924";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338779";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3895793";"";"None";"371.44";"0";"4.13";"BDBM206095";"O=C(Nc1cc2cccnc2cc1N1CCCCC1)c1cnn2ccccc12";"IC50";"'='";"8.0";"nM";"8.10";"";"364766";"UO_0000065";"21.80";"0.39";"3.97";"12.95";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3922358";"";"None";"539.59";"1";"2.99";"BDBM188797";"COc1ccc(-n2nc(C3CCN(S(=O)(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1";"IC50";"'<'";"100.0";"nM";"";"";"338652";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107242";"";"None";"427.53";"0";"1.75";"BDBM203542";"Cc1nccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc12";"IC50";"'='";"5.7";"nM";"8.24";"";"361022";"UO_0000065";"19.28";"0.38";"6.49";"7.63";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111047";"";"None";"455.54";"0";"1.15";"BDBM203796";"NC(=O)c1ccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc2c1";"IC50";"'='";"10.0";"nM";"8.00";"";"361270";"UO_0000065";"17.56";"0.34";"6.85";"5.79";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4293161";"";"None";"384.53";"0";"2.77";"25";"CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc([C@H]4CC[C@@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"7762.47";"nM";"5.11";"";"";"UO_0000065";"13.29";"0.25";"2.34";"5.77";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4110755";"";"None";"550.66";"3";"0.40";"BDBM203473";"CS(=O)(=O)N1CCC(Nc2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"545.0";"nM";"6.26";"";"360933";"UO_0000065";"11.37";"0.23";"5.86";"3.46";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4544284";"";"None";"458.53";"0";"2.75";"13";"O=C(Nc1cc2cnc(N3CCOCC3)nc2cc1N1CCCCC1)c1cnn2cccnc12";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"12.04";"0.22";"2.77";"5.48";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4554579";"";"None";"391.44";"0";"2.07";"15";"O=C(Nc1cc2[nH]cnc2cc1N1CCC(CO)CC1)c1cnn2cccnc12";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"16.56";"0.31";"4.41";"5.82";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4111327";"";"None";"415.49";"0";"0.65";"BDBM203498";"Cc1cccc(-c2c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)nc(N3CCCCC3)[nH]c2=O)n1";"IC50";"'='";"296.4";"nM";"6.53";"";"360958";"UO_0000065";"15.71";"0.30";"5.88";"4.85";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110006";"";"None";"472.57";"1";"0.72";"BDBM203502";"O=c1[nH]c(N[C@H]2CCCNC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"4260.0";"nM";"5.37";"";"360962";"UO_0000065";"11.36";"0.22";"4.65";"3.46";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4103497";"";"None";"357.41";"0";"2.03";"32";"CCC[C@@H]1CC(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"IC50";"'='";"28.4";"nM";"7.55";"";"";"UO_0000065";"21.11";"0.40";"5.52";"7.29";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4096446";"";"None";"353.45";"0";"3.66";"21";"N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCC(F)CC4)CC3)c2c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"24.11";"0.45";"4.86";"13.14";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4091329";"";"None";"330.43";"0";"2.93";"12";"COc1cc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2cc1OC";"IC50";"'='";"7400.0";"nM";"5.13";"";"";"UO_0000065";"15.53";"0.29";"2.20";"8.62";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4087705";"";"None";"299.42";"0";"2.73";"6";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]c4c(c23)CCC4)CC1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"21.33";"0.40";"3.66";"11.24";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3899446";"";"None";"493.57";"0";"3.97";"BDBM188879";"Cc1ccc(-n2nc(-c3ccc(CN4CCOCC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338734";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3950656";"";"None";"401.47";"0";"2.70";"BDBM206090";"NCC1CCN(c2cc3ncccc3cc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"364760";"UO_0000065";"21.67";"0.40";"6.00";"8.58";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3937613";"";"None";"402.45";"0";"3.82";"BDBM206142";"O=C(Nc1cc2ccccc2cc1OC1CCC(O)CC1)c1cnn2cccnc12";"IC50";"'='";"124.0";"nM";"6.91";"";"364813";"UO_0000065";"17.16";"0.31";"3.09";"7.78";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4113091";"";"None";"424.48";"0";"2.46";"BDBM188085";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(N2CCc3cc(C#N)cnc32)cc1NC1CC1";"IC50";"'='";"10.9";"nM";"7.96";"";"337748";"UO_0000065";"18.76";"0.35";"5.50";"6.97";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112091";"";"None";"565.73";"1";"2.94";"BDBM203598";"CS(=O)(=O)c1ccccc1N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"361079";"UO_0000065";"14.22";"0.28";"5.11";"6.52";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110923";"";"None";"467.60";"0";"2.32";"BDBM203782";"CC(=O)NC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"94.0";"nM";"7.03";"";"361256";"UO_0000065";"15.03";"0.29";"4.71";"6.11";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4283453";"";"None";"385.51";"0";"2.74";"27";"CN(C)[C@H]1CC[C@H](Oc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"676.08";"nM";"6.17";"";"";"UO_0000065";"16.00";"0.30";"3.43";"7.20";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3960714";"";"None";"497.59";"0";"1.17";"BDBM187762";"CNS(=O)(=O)N1CCC(NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"14.7";"nM";"7.83";"";"337447";"UO_0000065";"15.74";"0.31";"6.66";"4.96";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3901098";"";"None";"463.49";"0";"3.79";"BDBM188811";"O=C(Nc1cc(C2CCNCC2)nn1-c1c(F)cc(C2CC2)cc1F)c1cnn2cccnc12";"IC50";"'<'";"100.0";"nM";"";"";"338666";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3926498";"";"None";"403.45";"0";"2.14";"BDBM188813";"Cc1ccc(-n2nc(C3COCCN3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338668";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3956279";"";"None";"430.48";"0";"1.99";"BDBM187662";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCCc1ncn[nH]1";"IC50";"'='";"14.8";"nM";"7.83";"";"337347";"UO_0000065";"18.19";"0.33";"5.84";"5.22";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4439748";"";"None";"489.58";"0";"3.09";"7";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)cc34)CC2)CC1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"15.25";"0.28";"4.38";"6.01";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4439748";"";"None";"489.58";"0";"3.09";"7";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)cc34)CC2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"18.38";"0.34";"5.91";"7.24";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3945366";"";"None";"465.47";"0";"3.42";"BDBM187847";"CC(C)(C)NC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"17.0";"nM";"7.77";"";"337524";"UO_0000065";"16.69";"0.31";"4.35";"6.15";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3918080";"";"None";"549.59";"1";"3.95";"BDBM187853";"CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2Nc2cnn(CC(F)F)c2)CC1";"IC50";"'='";"8.6";"nM";"8.07";"";"337530";"UO_0000065";"14.68";"0.28";"4.12";"5.50";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107958";"";"None";"555.63";"1";"4.56";"BDBM203594";"O=c1[nH]c(N2CCN(c3cccc(C(F)(F)F)c3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"42.0";"nM";"7.38";"";"361075";"UO_0000065";"13.28";"0.26";"2.82";"8.27";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586484";"";"None";"424.46";"0";"4.15";"BDBM188865";"COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338720";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1929238";"";"None";"554.54";"2";"5.23";"27";"CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1932877";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1926590";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";""
"CHEMBL4115147";"";"None";"410.55";"0";"3.20";"BDBM203758";"O=c1[nH]c(N2CCCCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"71.0";"nM";"7.15";"";"361232";"UO_0000065";"17.41";"0.34";"3.95";"8.32";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115180";"";"None";"500.58";"1";"3.33";"BDBM187958";"CCOC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"5.4";"nM";"8.27";"";"337633";"UO_0000065";"16.52";"0.31";"4.94";"6.34";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107960";"";"None";"496.59";"0";"3.11";"BDBM187962";"CC(C)Nc1cc(-n2ccc3cc(CNC(=O)C4CC4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"13.5";"nM";"7.87";"";"337637";"UO_0000065";"15.85";"0.30";"4.76";"6.49";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110170";"";"None";"460.49";"0";"2.38";"BDBM188025";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCOCC1";"IC50";"'='";"12.5";"nM";"7.90";"";"337694";"UO_0000065";"17.16";"0.33";"5.52";"6.92";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3923081";"";"None";"403.41";"0";"0.95";"BDBM188032";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCc1nn[nH]n1";"IC50";"'='";"17.2";"nM";"7.76";"";"337698";"UO_0000065";"19.25";"0.35";"6.81";"4.76";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108032";"";"None";"490.57";"0";"2.05";"BDBM187736";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](NC(=O)[C@@H](C)O)CC1";"IC50";"'='";"8.2";"nM";"8.09";"";"337421";"UO_0000065";"16.48";"0.31";"6.04";"5.12";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3985063";"";"None";"404.48";"0";"2.62";"BDBM187748";"CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NCCC1CC1";"IC50";"'='";"6.3";"nM";"8.20";"";"337433";"UO_0000065";"20.27";"0.37";"5.58";"6.10";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112913";"";"None";"454.51";"0";"2.32";"BDBM187749";"CC[C@@H](C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.6";"nM";"8.80";"";"337434";"UO_0000065";"19.35";"0.36";"6.48";"5.68";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106539";"";"None";"448.57";"0";"2.75";"BDBM203626";"CC(C)(O)C1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1";"IC50";"'='";"42.0";"nM";"7.38";"";"361107";"UO_0000065";"16.45";"0.31";"4.63";"6.95";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107000";"";"None";"467.51";"2";"1.09";"BDBM203514";"O=c1[nH]c(Nc2cncnc2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"345.0";"nM";"6.46";"";"360974";"UO_0000065";"13.82";"0.27";"5.37";"3.82";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107488";"";"None";"439.52";"0";"0.96";"BDBM203657";"O=C1CCCN1c1cccc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)n1";"IC50";"'='";"258.0";"nM";"6.59";"";"361139";"UO_0000065";"14.99";"0.28";"5.63";"5.71";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586508";"";"None";"487.58";"0";"4.77";"BDBM188808";"CC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338663";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3932967";"";"None";"428.50";"0";"2.91";"BDBM188880";"O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(C2CC2)cn1)c1cnn2cccnc12";"IC50";"'<'";"100.0";"nM";"";"";"338735";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586504";"";"None";"523.59";"1";"3.32";"BDBM188807";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338662";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3953153";"";"None";"478.53";"0";"2.49";"BDBM187538";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2N[C@@H](C)CF)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"337257";"UO_0000065";"16.29";"0.30";"5.31";"5.66";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3905839";"";"None";"449.52";"0";"2.17";"BDBM187587";"CC(C)(O)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCOCC1";"IC50";"'='";"14.8";"nM";"7.83";"";"337286";"UO_0000065";"17.42";"0.32";"5.66";"5.67";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3946114";"";"None";"441.52";"0";"1.39";"BDBM187462";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCNS(C)(=O)=O";"IC50";"'='";"4.1";"nM";"8.39";"";"337198";"UO_0000065";"19.00";"0.37";"7.00";"5.91";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3970192";"";"None";"496.58";"0";"2.91";"BDBM187690";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(N2CCN(C)CC2)cn1";"IC50";"'='";"7.3";"nM";"8.14";"";"337375";"UO_0000065";"16.39";"0.30";"5.23";"6.36";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3957369";"";"None";"505.60";"1";"3.15";"BDBM188755";"Cc1cccc(-n2nc(C3CCN(S(=O)(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)c1";"IC50";"'<'";"1000.0";"nM";"";"";"338610";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107284";"";"None";"484.51";"0";"2.67";"BDBM187510";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCOCC1F";"IC50";"'='";"1.9";"nM";"8.72";"";"337241";"UO_0000065";"18.00";"0.34";"6.05";"6.97";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3634616";"";"None";"396.48";"0";"2.23";"49";"Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C#N)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"20.29";"0.39";"5.82";"5.98";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634514";"";"None";"387.88";"0";"2.66";"44";"Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(Cl)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"23.20";"0.46";"6.34";"8.80";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3909749";"";"None";"405.46";"0";"2.01";"BDBM187767";"C[C@@H](CO)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1CC1";"IC50";"'='";"7.9";"nM";"8.10";"";"337452";"UO_0000065";"19.98";"0.37";"6.09";"6.29";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3927743";"";"None";"448.89";"0";"2.12";"BDBM187707";"CC(C)Nc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NCC(F)C1(O)COC1";"IC50";"'='";"6.3";"nM";"8.20";"";"337392";"UO_0000065";"18.27";"0.36";"6.08";"7.18";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115348";"";"None";"495.64";"1";"2.39";"BDBM203605";"O=c1[nH]c(N2CCN(c3nncs3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"20.0";"nM";"7.70";"";"361086";"UO_0000065";"15.53";"0.31";"5.31";"6.70";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106994";"";"None";"406.49";"0";"1.72";"BDBM203609";"O=c1[nH]c(N2CCC(O)C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"20.0";"nM";"7.70";"";"361090";"UO_0000065";"18.94";"0.35";"5.98";"7.25";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107634";"";"None";"480.52";"0";"2.98";"BDBM203573";"O=c1[nH]c(N2CCOC(C(F)(F)F)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"201.0";"nM";"6.70";"";"361053";"UO_0000065";"13.94";"0.28";"3.72";"7.04";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3945694";"";"None";"513.65";"1";"3.53";"BDBM189013";"CCN1CCC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cn4)n3)CC2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338868";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111179";"";"None";"473.61";"0";"3.36";"BDBM203778";"Nc1ccc2c(c1)CN(c1nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]1)CC2";"IC50";"'='";"49.0";"nM";"7.31";"";"361252";"UO_0000065";"15.43";"0.29";"3.95";"6.53";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107356";"";"None";"466.62";"0";"2.23";"BDBM203563";"CN1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4c(C5CC5)nccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"30.0";"nM";"7.52";"";"361043";"UO_0000065";"16.12";"0.31";"5.29";"7.37";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4245507";"";"None";"437.57";"0";"3.06";"28";"O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4233340";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229420";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";""
"CHEMBL3939426";"";"None";"402.84";"0";"3.02";"BDBM206105";"O=C(Nc1cc(Cl)ccc1OC1CCC(O)CC1)c1cnn2cc(O)cnc12";"IC50";"'='";"23.0";"nM";"7.64";"";"364776";"UO_0000065";"18.96";"0.37";"4.62";"7.01";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3962393";"";"None";"426.46";"0";"4.59";"BDBM188834";"Cc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3F)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338689";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3929326";"";"None";"389.86";"0";"3.89";"BDBM206207";"O=C(Nc1cc(Cl)ccc1OC1CCC(O)C1)c1csc2cncnc12";"IC50";"'='";"1521.0";"nM";"5.82";"";"364878";"UO_0000065";"14.92";"0.31";"1.93";"6.90";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3981799";"";"None";"465.52";"0";"2.87";"BDBM189044";"Cc1ccc(-n2nc(C3CN(Cc4cncnc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338899";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3980732";"";"None";"510.58";"1";"4.39";"BDBM189026";"Cc1ccc(-n2nc(C3CCCN(Cc4ccc(F)cn4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338881";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3934792";"";"None";"512.64";"1";"4.87";"BDBM188951";"Cc1ccc(-n2nc(C3CCN(C(C)c4nccs4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338806";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586500";"";"None";"465.54";"0";"2.31";"22";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccccc3)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338609";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108668";"";"None";"406.47";"0";"3.78";"BDBM206102";"O=C(Nc1cc2cccnc2cc1O[C@@H]1CC[C@@H](O)C1)c1csc2cncnc12";"IC50";"'='";"15.0";"nM";"7.82";"";"364773";"UO_0000065";"19.25";"0.37";"4.04";"8.05";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3353203";"";"None";"430.51";"0";"2.00";"BDBM50040870";"O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CNCC[C@@H]2F)c1-c1nc2ccccc2s1";"IC50";"'='";"14.0";"nM";"7.85";"";"361136";"UO_0000065";"18.24";"0.36";"5.85";"8.25";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108289";"";"None";"428.52";"0";"1.08";"BDBM203658";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1csc(-n2cccn2)n1";"IC50";"'='";"82.0";"nM";"7.09";"";"361140";"UO_0000065";"16.54";"0.32";"6.01";"6.27";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3634383";"";"None";"421.48";"0";"3.30";"29";"Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)F)n1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"23.01";"0.46";"6.40";"8.76";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3586498";"";"None";"479.57";"0";"2.61";"BDBM188752";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338607";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586490";"";"None";"358.41";"0";"3.35";"BDBM188864";"Cc1ccc(-n2nc(C3CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338719";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3921423";"";"None";"523.62";"1";"1.98";"BDBM188895";"CNC(C)c1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"1000.0";"nM";"";"";"338750";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115266";"";"None";"542.67";"3";"0.38";"BDBM203816";"CN(N)/C=C(\N)C1CCN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"19.4";"nM";"7.71";"";"360996";"UO_0000065";"14.21";"0.28";"7.33";"4.06";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114035";"";"None";"473.56";"1";"1.15";"BDBM203471";"O=c1[nH]c(NC2CCOCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"575.0";"nM";"6.24";"";"360931";"UO_0000065";"13.18";"0.26";"5.09";"4.09";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4061890";"";"None";"315.33";"0";"1.00";"23";"COc1cc2c(OC[C@@H]3CCC(=O)N3)ccnc2cc1C(N)=O";"IC50";"'='";"5.9";"nM";"8.23";"";"";"UO_0000065";"26.10";"0.49";"7.23";"7.95";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3622184";"";"None";"388.45";"0";"0.87";"6";"Cc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"635.0";"nM";"6.20";"";"";"UO_0000065";"15.95";"0.31";"5.33";"4.72";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3353188";"";"None";"508.85";"0";"2.64";"21";"Cl.NC(=O)c1nn(-c2cccnc2)cc1NC(=O)c1coc(-c2ccnc(NCC(F)(F)F)c2)n1";"IC50";"'='";"0.36";"nM";"9.44";"";"";"UO_0000065";"19.99";"0.38";"6.80";"6.14";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4088523";"";"None";"358.41";"0";"3.41";"5";"NC(=O)c1cnc(Nc2ccc3[nH]ncc3c2)cc1NCc1ccccc1";"IC50";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"17.88";"0.32";"3.00";"5.89";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4104005";"";"None";"419.51";"0";"3.55";"9";"NC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"18.41";"0.35";"4.17";"6.82";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3944326";"";"None";"360.80";"0";"2.79";"BDBM206174";"O=C(Nc1cc(Cl)ccc1OCCCCO)c1cnn2cccnc12";"IC50";"'='";"437.0";"nM";"6.36";"";"364845";"UO_0000065";"17.63";"0.35";"3.57";"7.17";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4060511";"";"None";"440.57";"0";"2.33";"20";"N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCN(S(=O)(=O)C5CC5)CC4)CC3)c2c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.35";"0.38";"6.19";"8.34";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4087971";"";"None";"350.47";"0";"2.47";"18";"CN1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"22.17";"0.41";"5.30";"11.41";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4114127";"";"None";"513.55";"1";"2.41";"BDBM187894";"CC(C)NC(=O)[C@H](F)CNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"9.9";"nM";"8.00";"";"337569";"UO_0000065";"15.59";"0.30";"5.59";"5.52";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107677";"";"None";"491.53";"0";"3.12";"BDBM187863";"CC(C)c1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)[nH]n1";"IC50";"'='";"4.8";"nM";"8.32";"";"337540";"UO_0000065";"16.92";"0.32";"5.20";"5.28";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3953023";"";"None";"433.52";"0";"3.20";"BDBM187669";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1CCCCO1";"IC50";"'='";"6.5";"nM";"8.19";"";"337354";"UO_0000065";"18.89";"0.35";"4.99";"6.95";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113443";"";"None";"462.48";"0";"3.10";"BDBM188087";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(F)C1";"IC50";"'='";"3.4";"nM";"8.47";"";"337752";"UO_0000065";"18.31";"0.35";"5.37";"8.07";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4083650";"";"None";"295.39";"0";"2.79";"7";"CN(C)[C@H]1CC[C@H](Nc2ncnc3ccc(C#N)cc23)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"27.61";"0.51";"5.36";"12.58";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3403445";"";"None";"399.48";"0";"1.36";"26";"Nc1ncc(-c2nc(-c3ccccc3)cs2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"15.99";"0.31";"5.03";"4.65";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4447648";"";"None";"903.96";"2";"4.66";"Example 3";"O=C1CCC(N2C(=O)c3ccc(OCCOCCOCCN4CCN(Cc5ccc6c(c5)nc(NC(=O)c5cccc(C(F)(F)F)c5)n6[C@H]5CC[C@@H](CO)CC5)CC4)cc3C2=O)C(=O)N1";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4307631";"Inhibition of N-terminal GST-tagged human IRAK4 (2 to end residues) expressed in baculovirus infected Sf9 cells using Ser/Thr 7 peptide as substrate in presence of ATP after 1 hr by Z'-LYTE assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304808";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";""
"CHEMBL3980091";"";"None";"526.65";"1";"3.67";"BDBM188937";"CC(=O)N1CCC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338792";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3936754";"";"None";"473.56";"0";"4.35";"BDBM188793";"Cc1ccc(-n2nc(C3CCN(C4CCC4)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1";"IC50";"'<'";"100.0";"nM";"";"";"338648";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4088438";"";"None";"462.62";"0";"2.15";"26";"CS(=O)(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"14.82";"0.29";"4.70";"6.63";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4082572";"";"None";"267.34";"0";"2.18";"15";"N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N)CC3)c2c1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"28.03";"0.51";"5.31";"8.55";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4099061";"";"None";"312.46";"0";"4.04";"10";"CC(C)c1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"24.95";"0.46";"3.76";"18.99";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4111508";"";"None";"474.59";"0";"3.28";"BDBM203747";"O=c1[nH]c(N[C@H]2c3ccccc3C[C@H]2O)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"2500.0";"nM";"5.60";"";"361221";"UO_0000065";"11.80";"0.23";"2.32";"4.87";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106984";"";"None";"456.55";"0";"2.70";"BDBM203643";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccccc2F)cs1";"IC50";"'='";"60.0";"nM";"7.22";"";"361124";"UO_0000065";"15.82";"0.31";"4.52";"7.59";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL254546";"";"None";"379.49";"0";"3.21";"2l";"CN1CCN(c2ccc(NC(=O)c3csc(-c4cccnc4)n3)cc2)CC1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"16.22";"0.31";"2.94";"10.03";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4112749";"";"None";"393.47";"1";"0.37";"BDBM203486";"O=c1[nH]c(NC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1cscn1";"IC50";"'='";"1791.0";"nM";"5.75";"";"360946";"UO_0000065";"14.61";"0.29";"5.38";"4.01";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107129";"";"None";"591.76";"1";"3.50";"BDBM203777";"O=c1[nH]c(N2CCC3(CCN(S(=O)(=O)c4ccccc4)C3)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"23.0";"nM";"7.64";"";"361251";"UO_0000065";"12.91";"0.25";"4.14";"6.19";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1990583";"";"None";"405.39";"0";"3.35";"5g";"Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"15.96";"0.29";"3.12";"5.12";"0";"CHEMBL2064934";"Inhibition of Irak4 in presence of 10 uM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062488";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL4112492";"";"None";"426.55";"0";"2.44";"BDBM203569";"CC1CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1";"IC50";"'='";"97.0";"nM";"7.01";"";"361049";"UO_0000065";"16.44";"0.32";"4.57";"7.37";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113697";"";"None";"562.14";"1";"4.97";"BDBM203780";"O=c1[nH]c(N2CCC3(CCN(c4ccc(Cl)cc4)C3)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"47.0";"nM";"7.33";"";"361254";"UO_0000065";"13.04";"0.26";"2.36";"8.22";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3960645";"";"None";"426.55";"0";"2.44";"BDBM203697";"CC1(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CCCNC1";"IC50";"'='";"150.0";"nM";"6.82";"";"361171";"UO_0000065";"16.00";"0.31";"4.38";"7.17";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4581832";"";"None";"530.64";"2";"3.16";"16";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C5(C#N)CC5)nc34)CC2)CC1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"13.60";"0.25";"4.05";"5.26";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4108483";"";"None";"444.52";"1";"-0.06";"BDBM203499";"O=c1[nH]c(NC2CNC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"656.0";"nM";"6.18";"";"360959";"UO_0000065";"13.91";"0.27";"6.24";"3.98";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107784";"";"None";"501.62";"1";"3.58";"BDBM203752";"O=C1C[C@@H](Nc2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)Cc2ccccc2N1";"IC50";"'='";"5900.0";"nM";"5.23";"";"361226";"UO_0000065";"10.42";"0.20";"1.65";"4.22";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3403436";"";"None";"317.35";"0";"-0.36";"17";"Nc1ncc(-c2ccccn2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"830.0";"nM";"6.08";"";"";"UO_0000065";"19.16";"0.36";"6.44";"4.43";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3353202";"";"None";"488.62";"0";"2.93";"36";"O=c1[nH]c(N2CCN(c3cccnc3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"16.83";"0.32";"5.29";"8.06";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3902218";"";"None";"420.52";"0";"2.37";"BDBM203565";"C[C@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2ccc3ccccc3n2)CN1";"IC50";"'='";"541.0";"nM";"6.27";"";"361045";"UO_0000065";"14.90";"0.28";"3.90";"6.58";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3979957";"";"None";"420.52";"0";"2.37";"BDBM203550";"CC1CCC(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2ccc3ccccc3n2)CN1";"IC50";"'='";"91.0";"nM";"7.04";"";"361030";"UO_0000065";"16.74";"0.31";"4.67";"7.40";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3905639";"";"None";"521.72";"2";"5.59";"BDBM203295";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(=O)NCCCN2CCCC2)cs1";"IC50";"'='";"3.1";"nM";"8.51";"";"360857";"UO_0000065";"16.31";"0.32";"2.92";"8.95";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4115028";"";"None";"548.61";"2";"5.55";"BDBM203632";"O=c1[nH]c(N2CCC(c3ccccc3C(F)(F)F)CC2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"32.0";"nM";"7.50";"";"361113";"UO_0000065";"13.66";"0.26";"1.94";"8.72";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3968759";"";"None";"544.60";"1";"2.56";"BDBM188911";"Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)cc2NC(=O)c2ncn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338766";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110266";"";"None";"489.61";"0";"2.33";"BDBM203577";"O=c1[nH]c(N2CCN(c3cnccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"8.0";"nM";"8.10";"";"361057";"UO_0000065";"16.54";"0.32";"5.77";"7.04";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3590478";"";"None";"422.42";"0";"2.42";"1";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)(F)F)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"19.05";"0.37";"5.63";"6.99";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3586497";"";"None";"444.50";"0";"2.73";"BDBM188769";"Cc1ccc(-n2nc(C3CCN(C(N)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338624";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3983202";"";"None";"440.57";"0";"2.78";"BDBM203704";"CCN1CCCC1CNc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"2000.0";"nM";"5.70";"";"361178";"UO_0000065";"12.94";"0.25";"2.92";"6.60";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586488";"";"None";"395.43";"0";"3.54";"BDBM188857";"Cc1ccc(-n2nc(-c3cccnc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338712";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110843";"";"None";"461.55";"0";"2.95";"BDBM203716";"O=c1[nH]c(N2CCOCC2)nc(N[C@H]2c3ccccc3C[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"8300.0";"nM";"5.08";"";"361190";"UO_0000065";"11.01";"0.21";"2.13";"4.92";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3910622";"";"None";"455.49";"0";"1.71";"BDBM188054";"CC[C@@H](CO)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.4";"nM";"8.36";"";"337720";"UO_0000065";"18.35";"0.35";"6.65";"5.61";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114551";"";"None";"494.57";"0";"3.24";"BDBM187461";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@H]1CC[C@](C)(O)CC1";"IC50";"'='";"3.6";"nM";"8.44";"";"337197";"UO_0000065";"17.07";"0.32";"5.20";"6.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3958341";"";"None";"565.66";"1";"1.12";"BDBM187727";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(C(=O)C2CN(S(C)(=O)=O)C2)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"337716";"UO_0000065";"14.14";"0.27";"6.88";"4.81";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107733";"";"None";"500.97";"1";"3.66";"BDBM187839";"CCCn1cc(Nc2cc(-n3cnc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"2.5";"nM";"8.60";"";"337516";"UO_0000065";"17.17";"0.34";"4.94";"7.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3984250";"";"None";"446.56";"0";"3.78";"BDBM187954";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)C1";"IC50";"'='";"3.7";"nM";"8.43";"";"337629";"UO_0000065";"18.88";"0.35";"4.65";"7.28";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112863";"";"None";"602.65";"1";"3.82";"BDBM188103";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](NC(=O)c2ccccc2F)CC1";"IC50";"'='";"3.9";"nM";"8.41";"";"337766";"UO_0000065";"13.95";"0.26";"4.59";"5.33";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3973551";"";"None";"562.43";"1";"3.21";"BDBM188805";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(Br)cc3F)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338660";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3914414";"";"None";"457.58";"0";"4.45";"BDBM188943";"CCC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338798";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3353207";"";"None";"499.62";"0";"3.72";"BDBM50040866";"Cc1ccc(-n2nc(N3CCN(C4CCCCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338911";"UO_0000065";"";"";"";"";"1";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110840";"";"None";"469.50";"0";"2.83";"BDBM188094";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(F)C1";"IC50";"'='";"2.3";"nM";"8.64";"";"337759";"UO_0000065";"18.40";"0.35";"5.81";"6.71";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3917759";"";"None";"457.52";"0";"0.36";"BDBM187935";"C[C@@H](CO)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCNS(C)(=O)=O";"IC50";"'='";"4.7";"nM";"8.33";"";"337610";"UO_0000065";"18.20";"0.36";"7.97";"5.14";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3951642";"";"None";"391.88";"0";"4.14";"BDBM206204";"CC(C)(CCO)Oc1ccc(Cl)cc1NC(=O)c1csc2cncnc12";"IC50";"'='";"1459.0";"nM";"5.84";"";"364875";"UO_0000065";"14.89";"0.31";"1.70";"6.92";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3927810";"";"None";"369.86";"0";"4.02";"BDBM206206";"O=C(Nc1cc(Cl)ccc1N1CCCCCC1)c1cnn2cccnc12";"IC50";"'='";"1503.0";"nM";"5.82";"";"364877";"UO_0000065";"15.74";"0.31";"1.80";"9.31";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3972693";"";"None";"510.58";"1";"4.39";"BDBM189024";"Cc1ccc(-n2nc(C3CCCN(Cc4cccnc4F)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338879";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3983893";"";"None";"379.45";"0";"3.22";"BDBM206138";"NCCCOc1cc2ncccc2cc1NC(=O)c1csc2cncnc12";"IC50";"'='";"103.0";"nM";"6.99";"";"364809";"UO_0000065";"18.41";"0.35";"3.77";"6.78";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3941333";"";"None";"363.83";"0";"3.36";"BDBM206226";"O=C(Nc1cc(Cl)ccc1OCCCO)c1csc2cncnc12";"IC50";"'='";"2452.0";"nM";"5.61";"";"364897";"UO_0000065";"15.42";"0.32";"2.25";"6.65";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3980058";"";"None";"407.43";"0";"1.80";"BDBM187657";"COC(=O)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"10.3";"nM";"7.99";"";"337342";"UO_0000065";"19.60";"0.36";"6.19";"5.92";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3961753";"";"None";"498.57";"0";"4.08";"BDBM189067";"Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)C4CC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338925";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3919571";"";"None";"385.86";"0";"2.84";"BDBM206129";"O=C(Nc1cc(Cl)ccc1N1CCC(CO)CC1)c1cnn2cccnc12";"IC50";"'='";"72.0";"nM";"7.14";"";"364800";"UO_0000065";"18.51";"0.36";"4.30";"8.63";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3909398";"";"None";"550.65";"1";"4.25";"BDBM189111";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(C#N)cc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338969";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3914760";"";"None";"561.07";"1";"4.43";"BDBM189113";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(Cl)nc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338971";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3936302";"";"None";"552.61";"2";"5.17";"BDBM189005";"Cc1ccc(-n2nc(C3CCN(C4CCC(C(F)(F)F)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338860";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3890992";"";"None";"399.39";"0";"3.37";"BDBM188860";"O=C(Nc1cc(-c2ccncc2)nn1-c1ccc(F)cc1)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338715";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3969956";"";"None";"492.59";"0";"4.25";"BDBM188959";"Cc1ccc(-n2nc(C3CCN(Cc4cccnc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338814";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3975331";"";"None";"485.60";"0";"3.33";"BDBM189053";"Cc1ccc(-n2nc(N3CCN(C4CCCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338908";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111712";"";"None";"430.51";"0";"2.19";"BDBM203540";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cc(F)ccc2s1";"IC50";"'='";"8.4";"nM";"8.08";"";"361020";"UO_0000065";"18.76";"0.37";"5.89";"8.49";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3965756";"";"None";"485.49";"0";"3.50";"BDBM187658";"CCOP(=O)(CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C)OCC";"IC50";"'='";"16.0";"nM";"7.80";"";"337343";"UO_0000065";"16.06";"0.31";"4.30";"5.41";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3916291";"";"None";"296.33";"0";"2.55";"BDBM206253";"CCc1ccc(OC)c(NC(=O)c2cnn3cccnc23)c1";"IC50";"'='";"5885.0";"nM";"5.23";"";"364924";"UO_0000065";"17.65";"0.32";"2.68";"7.63";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3909014";"";"None";"607.56";"1";"4.68";"BDBM188848";"CCN(CC)CCC(=O)N1CCC(c2cc(NC(=O)c3cnn4cc(Br)cnc34)n(-c3ccc(C)cc3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338703";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4583622";"";"None";"384.48";"0";"2.44";"10";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C)nc34)CC2)CC1";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"15.80";"0.30";"3.64";"7.28";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3931124";"";"None";"564.49";"1";"4.60";"BDBM188844";"Cc1ccc(-n2nc(C3CCN(C4CCOCC4)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338699";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3895108";"";"None";"437.53";"0";"3.71";"BDBM206144";"COc1cc2ncccc2cc1NC(=O)c1csc2cnc(N(CCO)C(C)C)nc12";"IC50";"'='";"127.0";"nM";"6.90";"";"364815";"UO_0000065";"15.76";"0.30";"3.19";"6.86";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4108188";"";"None";"488.47";"0";"2.58";"BDBM187941";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1COCC1(F)F";"IC50";"'='";"8.7";"nM";"8.06";"";"337617";"UO_0000065";"16.50";"0.31";"5.48";"6.44";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3942465";"";"None";"558.46";"1";"3.38";"BDBM188853";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338708";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3936608";"";"None";"555.69";"1";"3.85";"BDBM188970";"Cc1ccc(-n2nc(C3CCN(C4CN(C(=O)NC(C)(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338825";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3926793";"";"None";"575.70";"2";"5.53";"BDBM189108";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc5ccccc5c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338966";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3900598";"";"None";"560.68";"1";"2.83";"BDBM188979";"Cc1ccc(-n2nc(C3CCN(C4CN(S(=O)(=O)C5CC5)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338834";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3936244";"";"None";"552.64";"1";"2.60";"BDBM188981";"Cc1ccc(-n2nc(C3CCN(C4CN(S(=O)(=O)CF)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338836";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL408383";"";"None";"347.35";"0";"4.06";"2f";"O=C(Nc1ccccc1OC(F)F)c1csc(-c2cccnc2)n1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"17.27";"0.34";"1.94";"9.36";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL402361";"";"None";"400.49";"0";"3.63";"18";"COc1ccc(-c2ccc3ncc(-c4cccc(NC5CCNCC5)n4)n3c2)cn1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"20.22";"0.37";"4.47";"10.60";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL402629";"";"None";"323.40";"0";"2.57";"13";"COc1ccc2ncc(-c3cccc(NC4CCNCC4)n3)n2c1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"25.42";"0.47";"5.65";"12.95";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL3980194";"";"None";"471.61";"0";"4.84";"BDBM188944";"CCCC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338799";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3898449";"";"None";"524.60";"1";"4.95";"BDBM188946";"Cc1ccc(-n2nc(C3CCN(C(C)c4ncccc4F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338801";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3971655";"";"None";"425.45";"0";"2.84";"BDBM189068";"Cc1ccc(-n2nc(-c3ccc(=O)n(C)c3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338926";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3899862";"";"None";"425.47";"0";"2.27";"BDBM206134";"COc1cc2ncccc2cc1NC(=O)c1csc2cnc(NCC(O)CO)nc12";"IC50";"'='";"82.0";"nM";"7.09";"";"364805";"UO_0000065";"16.65";"0.32";"4.82";"5.47";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3967389";"";"None";"498.62";"0";"4.31";"BDBM189022";"Cc1ccc(-n2nc(C3CCCN(Cc4cscn4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338877";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL258233";"";"None";"290.33";"0";"2.87";"29";"Cn1nccc1Nc1cccc(-c2cnc3ccccn23)n1";"IC50";"'='";"1134.0";"nM";"5.95";"";"";"UO_0000065";"20.48";"0.37";"3.08";"9.90";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL402080";"";"None";"291.36";"0";"1.95";"ABS-40";"c1cc(-c2cnc3ccccn23)nc(N2C[C@H]3C[C@@H]2CN3)c1";"IC50";"'='";"126.0";"nM";"6.90";"";"";"UO_0000065";"23.68";"0.43";"4.95";"15.18";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL258004";"";"None";"293.37";"0";"2.56";"2";"c1cc(NC2CCNCC2)nc(-c2cnc3ccccn23)c1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"25.41";"0.46";"4.90";"13.74";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL402104";"";"None";"310.74";"0";"3.44";"3c";"O=C(Nc1ccccc1Cl)c1cccc(-c2cncnc2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL257127";"";"None";"409.52";"0";"3.22";"2r";"COc1cc(N2CCN(C)CC2)ccc1NC(=O)c1csc(-c2cccnc2)n1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"15.76";"0.30";"3.24";"9.15";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL404514";"";"None";"341.39";"0";"3.47";"2p";"COc1ccc(NC(=O)c2csc(-c3cccnc3)n2)c(OC)c1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"17.34";"0.34";"2.45";"8.07";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL256504";"";"None";"293.37";"0";"2.56";"ABS-39";"c1cc(N[C@H]2CCCNC2)nc(-c2cnc3ccccn23)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"26.32";"0.48";"5.16";"14.23";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL436653";"";"None";"327.82";"0";"3.24";"7";"Clc1ccc2ncn(-c3cccc(NC4CCNCC4)n3)c2c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"26.00";"0.51";"5.28";"15.56";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL255935";"";"None";"323.40";"0";"2.59";"5";"COc1ccc2c(c1)ncn2-c1cccc(NC2CCNCC2)n1";"IC50";"'='";"208.0";"nM";"6.68";"";"";"UO_0000065";"20.66";"0.38";"4.09";"10.44";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL404142";"";"None";"293.37";"0";"2.32";"rac-42";"NC1CCCN(c2cccc(-c3cnc4ccccn34)n2)C1";"IC50";"'='";"535.0";"nM";"6.27";"";"";"UO_0000065";"21.38";"0.39";"3.95";"10.55";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL3942983";"";"None";"377.86";"0";"2.98";"BDBM206140";"COc1ccc(Cl)cc1NC(=O)c1csc2cnc(NCCN)nc12";"IC50";"'='";"107.0";"nM";"6.97";"";"364811";"UO_0000065";"18.45";"0.38";"3.99";"6.82";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3975753";"";"None";"406.47";"0";"3.78";"BDBM206141";"O=C(Nc1cc2cccnc2cc1O[C@@H]1CC[C@H](O)C1)c1csc2cncnc12";"IC50";"'='";"122.0";"nM";"6.91";"";"364812";"UO_0000065";"17.01";"0.33";"3.13";"7.11";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3921515";"";"None";"498.62";"0";"4.31";"BDBM189032";"Cc1ccc(-n2nc(C3CCCN(Cc4nccs4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338887";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3980126";"";"None";"578.47";"1";"3.86";"BDBM188850";"Cc1ccc(-n2nc(C3CCN(C(=O)C4(O)CCC4)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338705";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3896014";"";"None";"369.38";"0";"1.10";"BDBM206192";"COc1cc(C(=O)NCCCO)ccc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"640.0";"nM";"6.19";"";"364863";"UO_0000065";"16.77";"0.31";"5.09";"5.26";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3953542";"";"None";"429.86";"0";"2.42";"BDBM206139";"NC(=O)c1cnc2c(C(=O)Nc3cc(Cl)ccc3OC3CCC(O)CC3)cnn2c1";"IC50";"'='";"107.0";"nM";"6.97";"";"364810";"UO_0000065";"16.22";"0.32";"4.55";"5.29";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3941034";"";"None";"403.89";"0";"4.28";"BDBM206149";"O=C(Nc1cc(Cl)ccc1O[C@H]1CC[C@@H](O)CC1)c1csc2cncnc12";"IC50";"'='";"149.0";"nM";"6.83";"";"364820";"UO_0000065";"16.90";"0.35";"2.55";"8.09";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3974716";"";"None";"495.59";"0";"4.07";"BDBM187623";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](O)(c2ccncc2)CC1";"IC50";"'='";"2.8";"nM";"8.55";"";"337314";"UO_0000065";"17.26";"0.32";"4.48";"6.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111162";"";"None";"415.47";"0";"2.06";"BDBM187632";"CC(C)Nc1cc(-n2ccc3cnc(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.3";"nM";"8.89";"";"337321";"UO_0000065";"21.39";"0.40";"6.83";"6.78";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111587";"";"None";"422.46";"0";"2.71";"BDBM187401";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CC1";"IC50";"'='";"1.6";"nM";"8.80";"";"337137";"UO_0000065";"20.82";"0.39";"6.09";"7.59";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110079";"";"None";"455.49";"0";"1.71";"BDBM187683";"CC(C)(CO)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.7";"nM";"8.33";"";"337368";"UO_0000065";"18.28";"0.34";"6.62";"5.59";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110250";"";"None";"423.45";"0";"2.10";"BDBM187575";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CC1";"IC50";"'='";"3.8";"nM";"8.42";"";"337470";"UO_0000065";"19.88";"0.37";"6.32";"6.54";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110814";"";"None";"499.51";"0";"4.02";"BDBM187880";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc2ncoc2c1";"IC50";"'='";"1.9";"nM";"8.72";"";"337555";"UO_0000065";"17.46";"0.32";"4.70";"6.15";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108627";"";"None";"501.50";"1";"3.89";"BDBM187889";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(C#N)c1F";"IC50";"'='";"2.1";"nM";"8.68";"";"337564";"UO_0000065";"17.30";"0.32";"4.79";"6.21";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3958341";"";"None";"565.66";"1";"1.12";"BDBM187727";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(C(=O)C2CN(S(C)(=O)=O)C2)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"337412";"UO_0000065";"14.14";"0.27";"6.88";"4.81";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3938325";"";"None";"484.52";"1";"2.39";"BDBM187673";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cnc(N2CCOCC2)nc1";"IC50";"'='";"6.7";"nM";"8.17";"";"337358";"UO_0000065";"16.87";"0.31";"5.78";"5.57";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108248";"";"None";"548.56";"2";"2.15";"BDBM187992";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1CCN(c2ncc(F)cn2)C1";"IC50";"'='";"5.5";"nM";"8.26";"";"337664";"UO_0000065";"15.06";"0.28";"6.11";"5.24";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3927286";"";"None";"508.63";"1";"4.74";"BDBM188987";"Cc1ccc(-n2nc(C3CCN(C4CCC(C#N)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338842";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3943097";"";"None";"394.46";"0";"2.87";"BDBM206098";"COc1cc2ncccc2cc1NC(=O)c1csc2cnc(NCCN)nc12";"IC50";"'='";"10.0";"nM";"8.00";"";"364769";"UO_0000065";"20.28";"0.39";"5.13";"6.95";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4111218";"";"None";"533.54";"1";"2.36";"BDBM187929";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CN(c2ncc(F)cn2)C1";"IC50";"'='";"2.0";"nM";"8.70";"";"337604";"UO_0000065";"16.30";"0.30";"6.34";"6.00";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3921310";"";"None";"458.57";"0";"3.71";"BDBM189012";"Cc1ccc(-n2nc(C3CCN(CC(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338867";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3915439";"";"None";"481.56";"0";"3.58";"BDBM188964";"Cc1ccc(-n2nc(C3CCN(Cc4ccn[nH]4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338819";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108818";"";"None";"562.59";"2";"2.54";"BDBM188001";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCN(c2ncc(F)cn2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"337672";"UO_0000065";"15.15";"0.28";"5.98";"5.40";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114980";"";"None";"450.52";"0";"3.49";"BDBM187409";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCC1";"IC50";"'='";"1.8";"nM";"8.74";"";"337145";"UO_0000065";"19.41";"0.36";"5.25";"7.55";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115333";"";"None";"458.47";"0";"1.87";"BDBM187555";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC(CO)CF";"IC50";"'='";"6.8";"nM";"8.17";"";"337266";"UO_0000065";"17.81";"0.34";"6.30";"6.00";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113144";"";"None";"475.95";"0";"3.50";"BDBM187431";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(Cl)cnc32)cc1NC1CCOCC1";"IC50";"'='";"1.9";"nM";"8.72";"";"337167";"UO_0000065";"18.32";"0.36";"5.22";"8.61";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110413";"";"None";"451.60";"0";"3.47";"BDBM203560";"O=c1[nH]c(N2CCCCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2c(C3CC3)nccc2s1";"IC50";"'='";"8.6";"nM";"8.07";"";"361040";"UO_0000065";"17.86";"0.34";"4.60";"8.16";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108900";"";"None";"541.55";"2";"2.46";"BDBM187987";"Cn1nnnc1-c1ccc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"337659";"UO_0000065";"15.74";"0.29";"6.06";"4.95";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3403430";"";"None";"413.50";"0";"1.73";"9";"Nc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(C2CC2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3622522";"";"None";"426.55";"0";"2.57";"BDBM203533";"NC1CCCC(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)C1";"IC50";"'='";"258.0";"nM";"6.59";"";"361013";"UO_0000065";"15.45";"0.30";"4.02";"6.04";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4083655";"";"None";"314.34";"0";"1.60";"26";"COc1cc2c(OC[C@@H]3CCC(=O)N3)cccc2cc1C(N)=O";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"28.27";"0.53";"7.29";"9.80";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4086222";"";"None";"330.39";"0";"4.26";"12";"CC(C)Oc1cc2c(-c3ccc(C#N)cc3)cccc2cc1C(N)=O";"IC50";"'='";"71.9";"nM";"7.14";"";"";"UO_0000065";"21.62";"0.39";"2.88";"9.39";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4096351";"";"None";"290.44";"0";"3.28";"3";"Cc1cc2c(N[C@H]3CC[C@H](N(C)C)CC3)ncnc2s1";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"18.74";"0.37";"2.16";"13.26";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4105582";"";"None";"287.41";"0";"2.86";"7";"Cc1[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1C";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"17.56";"0.33";"2.19";"8.88";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL2022379";"";"None";"542.67";"2";"4.37";"53";"Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1";"IC50";"'='";"1142.0";"nM";"5.94";"";"";"UO_0000065";"10.95";"0.21";"1.57";"5.03";"0";"CHEMBL2024840";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021851";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL3622187";"";"None";"444.51";"0";"1.49";"9";"O=c1[nH]c(OC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"1688.0";"nM";"5.77";"";"";"UO_0000065";"12.99";"0.25";"4.28";"4.11";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3622526";"";"None";"426.50";"0";"1.57";"27";"O=C1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"14.88";"0.29";"4.78";"5.65";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4109312";"";"None";"501.52";"1";"2.97";"BDBM187459";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc(C(N)=O)cc1";"IC50";"'='";"1.8";"nM";"8.74";"";"337195";"UO_0000065";"17.44";"0.32";"5.77";"5.50";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3920819";"";"None";"458.57";"0";"3.75";"BDBM187478";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)ccc43)cc2NC(C)C)CC1";"IC50";"'='";"11.6";"nM";"7.94";"";"337214";"UO_0000065";"17.30";"0.32";"4.19";"7.10";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3954007";"";"None";"501.59";"1";"2.92";"BDBM187486";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CCOCC2)CC1";"IC50";"'='";"7.1";"nM";"8.15";"";"337221";"UO_0000065";"16.25";"0.30";"5.23";"6.08";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3403440";"";"None";"374.43";"0";"0.24";"21";"Nc1ncc(-c2nc3ccncc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"20.82";"0.41";"7.56";"5.19";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4109646";"";"None";"410.45";"0";"2.56";"BDBM187447";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)O";"IC50";"'='";"1.4";"nM";"8.85";"";"337183";"UO_0000065";"21.57";"0.40";"6.29";"7.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3895223";"";"None";"487.61";"0";"3.93";"BDBM187490";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(=O)NC(C)C)CC1";"IC50";"'='";"1.9";"nM";"8.72";"";"337225";"UO_0000065";"17.89";"0.33";"4.79";"6.99";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3958699";"";"None";"418.50";"0";"3.15";"BDBM187498";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](O)CC1";"IC50";"'='";"3.3";"nM";"8.48";"";"337233";"UO_0000065";"20.27";"0.37";"5.33";"7.32";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110840";"";"None";"469.50";"0";"2.83";"BDBM188094";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(F)C1";"IC50";"'='";"2.2";"nM";"8.66";"";"337757";"UO_0000065";"18.44";"0.35";"5.83";"6.72";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3930830";"";"None";"377.45";"0";"3.04";"BDBM187649";"CCCCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"6.3";"nM";"8.20";"";"337334";"UO_0000065";"21.73";"0.40";"5.16";"7.56";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3403435";"";"None";"316.36";"0";"0.24";"16";"Nc1ncc(-c2ccccc2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL255235";"";"None";"331.78";"0";"3.35";"Page3212, C1R23";"O=C(Nc1ccccc1Cl)c1csc(-c2ccc[n+]([O-])c2)n1";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"15.56";"0.32";"1.81";"7.49";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4109783";"";"None";"418.45";"0";"2.42";"BDBM187524";"CC(CF)Nc1cc(-n2ccc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.9";"nM";"8.72";"";"337248";"UO_0000065";"20.84";"0.40";"6.30";"8.31";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113245";"";"None";"437.48";"0";"2.35";"BDBM188071";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCC1CC1";"IC50";"'='";"7.5";"nM";"8.12";"";"337737";"UO_0000065";"18.57";"0.35";"5.77";"6.31";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3926706";"";"None";"485.59";"0";"3.68";"BDBM187491";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(=O)NC2CC2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"337226";"UO_0000065";"17.91";"0.33";"5.02";"6.97";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115485";"";"None";"515.48";"1";"3.71";"BDBM187852";"CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"2.2";"nM";"8.66";"";"337529";"UO_0000065";"16.80";"0.32";"4.95";"6.85";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110597";"";"None";"424.48";"0";"2.95";"BDBM187536";"C[C@H](CF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(C)O";"IC50";"'='";"5.1";"nM";"8.29";"";"337255";"UO_0000065";"19.54";"0.37";"5.34";"7.16";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113330";"";"None";"439.45";"0";"1.34";"BDBM187782";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1NC1COC1";"IC50";"'='";"12.6";"nM";"7.90";"";"337467";"UO_0000065";"17.98";"0.34";"6.56";"5.73";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111230";"";"None";"490.54";"0";"3.48";"BDBM187840";"CCCn1cc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"1.4";"nM";"8.85";"";"337517";"UO_0000065";"18.05";"0.34";"5.37";"6.62";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3982186";"";"None";"453.48";"0";"1.32";"BDBM188111";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1C[C@H]1CO";"IC50";"'='";"5.4";"nM";"8.27";"";"337775";"UO_0000065";"18.23";"0.34";"6.95";"5.55";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3932579";"";"None";"462.56";"0";"2.08";"BDBM187699";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCN(C)CC1";"IC50";"'='";"8.3";"nM";"8.08";"";"337384";"UO_0000065";"17.47";"0.32";"6.00";"6.12";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3912832";"";"None";"503.61";"2";"5.11";"BDBM187624";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](F)(c2nccs2)CC1";"IC50";"'='";"5.3";"nM";"8.28";"";"337315";"UO_0000065";"16.43";"0.31";"3.17";"7.63";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3922192";"";"None";"407.48";"0";"2.26";"BDBM187769";"CC(C)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H](C)CO";"IC50";"'='";"5.6";"nM";"8.25";"";"337454";"UO_0000065";"20.25";"0.38";"5.99";"6.41";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3925644";"";"None";"460.54";"0";"2.68";"BDBM187600";"CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"3.5";"nM";"8.46";"";"337299";"UO_0000065";"18.36";"0.34";"5.78";"6.14";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115604";"";"None";"557.61";"1";"0.68";"BDBM187706";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(=O)N1CCN(S(C)(=O)=O)CC1";"IC50";"'='";"8.9";"nM";"8.05";"";"337391";"UO_0000065";"14.44";"0.28";"7.37";"4.84";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107752";"";"None";"456.50";"0";"3.29";"BDBM187885";"CC(CCF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.6";"nM";"8.80";"";"337560";"UO_0000065";"19.27";"0.36";"5.51";"7.59";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110545";"";"None";"486.94";"0";"3.27";"BDBM187814";"CCn1cc(Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"1.7";"nM";"8.77";"";"337491";"UO_0000065";"18.01";"0.35";"5.50";"7.14";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110464";"";"None";"522.92";"1";"3.51";"BDBM187816";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"1.3";"nM";"8.89";"";"337493";"UO_0000065";"16.99";"0.34";"5.38";"7.24";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109266";"";"None";"551.60";"1";"3.25";"BDBM187456";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(NS(C)(=O)=O)c1";"IC50";"'='";"1.5";"nM";"8.82";"";"337192";"UO_0000065";"16.00";"0.31";"5.57";"5.45";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107426";"";"None";"494.45";"0";"2.47";"BDBM187750";"CC(Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)C(F)(F)F";"IC50";"'='";"2.4";"nM";"8.62";"";"337435";"UO_0000065";"17.43";"0.34";"6.15";"5.57";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111435";"";"None";"418.45";"0";"2.61";"BDBM187593";"CC(C)Nc1cc(-n2ncc3cc(F)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"5.3";"nM";"8.28";"";"337292";"UO_0000065";"19.78";"0.38";"5.67";"7.88";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107049";"";"None";"455.49";"0";"1.71";"BDBM188038";"CC(O)CCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"9.1";"nM";"8.04";"";"337704";"UO_0000065";"17.65";"0.33";"6.33";"5.40";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3940416";"";"None";"434.50";"0";"1.35";"BDBM187704";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCNC1";"IC50";"'='";"7.5";"nM";"8.12";"";"337389";"UO_0000065";"18.70";"0.35";"6.77";"5.77";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109707";"";"None";"466.52";"0";"1.82";"BDBM188107";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(N)C1";"IC50";"'='";"3.2";"nM";"8.49";"";"337772";"UO_0000065";"18.21";"0.34";"6.67";"5.49";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3900741";"";"None";"456.51";"0";"3.38";"BDBM187685";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(C(C)(C)O)cn1";"IC50";"'='";"11.6";"nM";"7.94";"";"337370";"UO_0000065";"17.38";"0.32";"4.56";"5.60";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4795391";"";"None";"390.40";"0";"1.82";"6";"Cn1cc(NC(=O)c2cnc3ccc(N[C@H]4CCCNC4)nn23)c(C(F)F)n1";"IC50";"'='";"36.2";"nM";"7.44";"";"";"UO_0000065";"19.06";"0.36";"5.62";"7.36";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3923198";"";"None";"477.57";"0";"2.95";"BDBM187740";"COC1CCC(O)(CCNC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"3.5";"nM";"8.46";"";"337425";"UO_0000065";"17.71";"0.33";"5.51";"6.13";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3969520";"";"None";"495.59";"0";"4.07";"BDBM187621";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](O)(c2cccnc2)CC1";"IC50";"'='";"3.6";"nM";"8.44";"";"337312";"UO_0000065";"17.04";"0.31";"4.37";"6.56";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3590435";"";"None";"285.27";"0";"-0.19";"1";"Cn1cc(NC(=O)c2cnn3cccnc23)c(C(N)=O)n1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"24.39";"0.45";"7.15";"5.79";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3590516";"";"None";"426.38";"0";"1.61";"35";"Cn1cc(NC(=O)c2cnn3ccc(N4C[C@H](N)C[C@@H](F)C4)nc23)c(C(F)(F)F)n1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.81";"0.42";"7.69";"8.74";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL2441273";"";"None";"459.62";"1";"5.70";"13";"CCc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1";"IC50";"'='";"3.981";"nM";"8.40";"";"";"UO_0000065";"18.28";"0.35";"2.70";"10.13";"0";"CHEMBL2446684";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440060";"1";"Scientific Literature";"ACS Med Chem Lett";"2013";"None";""
"CHEMBL4111872";"";"None";"449.49";"0";"2.49";"BDBM188104";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC12CC(C1)C2";"IC50";"'='";"1.8";"nM";"8.74";"";"337767";"UO_0000065";"19.45";"0.36";"6.25";"6.79";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3906627";"";"None";"501.52";"1";"2.58";"BDBM188762";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(F)cc3F)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338617";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3981292";"";"None";"549.54";"1";"3.20";"BDBM188764";"COc1ccc(-n2nc(C3CCN(S(=O)(=O)C(F)(F)F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338619";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4560045";"";"None";"934.03";"3";"5.15";"Example 4";"O=C(Nc1nc2cc(CN3CCN(CCOCCOCCOCCOc4ccc5c(c4)C(=O)N(C4CCCNC4=O)C5=O)CC3)ccc2n1[C@H]1CC[C@@H](CO)CC1)c1cccc(C(F)(F)F)c1";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4307631";"Inhibition of N-terminal GST-tagged human IRAK4 (2 to end residues) expressed in baculovirus infected Sf9 cells using Ser/Thr 7 peptide as substrate in presence of ATP after 1 hr by Z'-LYTE assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304808";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";""
"CHEMBL3746678";"";"None";"465.60";"1";"5.29";"32";"CCc1cc2c(cc1-c1cnn(CCCN(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O";"IC50";"'='";"234.0";"nM";"6.63";"";"";"UO_0000065";"14.24";"0.26";"1.34";"8.53";"0";"CHEMBL3748848";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745656";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3361253";"";"None";"358.51";"0";"3.24";"11";"c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c3c(sc2n1)CCC3";"IC50";"'<='";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380178";"Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4107447";"";"None";"439.50";"0";"2.74";"BDBM187735";"CC(C)(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.7";"nM";"8.77";"";"337420";"UO_0000065";"19.95";"0.37";"6.03";"6.81";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107049";"";"None";"455.49";"0";"1.71";"BDBM188038";"CC(O)CCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"8.8";"nM";"8.06";"";"337705";"UO_0000065";"17.69";"0.33";"6.35";"5.41";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115287";"";"None";"469.50";"0";"2.83";"BDBM188047";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCC1(F)CCC1";"IC50";"'='";"8.4";"nM";"8.08";"";"337713";"UO_0000065";"17.20";"0.32";"5.25";"6.27";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3403448";"";"None";"445.55";"0";"1.72";"29";"COCCCNc1ncc(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"228000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3403432";"";"None";"399.52";"0";"3.18";"(+/-)-12";"CCCNc1nc(C)c(-c2nc3ccccc3s2)c(N[C@@H]2CC[C@@H](O)[C@H]2O)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4089619";"";"None";"329.40";"0";"2.25";"16";"CC(C)Oc1cc2c(O[C@@H]3CCCNC3)nccc2cc1C(N)=O";"IC50";"'='";"1552.0";"nM";"5.81";"";"";"UO_0000065";"17.64";"0.33";"3.56";"6.72";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4111603";"";"None";"513.62";"1";"3.29";"BDBM187970";"CCCNC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"5.9";"nM";"8.23";"";"337645";"UO_0000065";"16.02";"0.30";"4.94";"6.18";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3590491";"";"None";"458.40";"0";"2.66";"31";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCC(F)(F)C[C@@H]4N)nc23)c(C(F)(F)F)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.59";"0.36";"5.86";"7.40";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4114139";"";"None";"454.51";"0";"2.32";"BDBM187540";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C(N)=O)cnc32)cc1NC1CCC1";"IC50";"'='";"4.8";"nM";"8.32";"";"337259";"UO_0000065";"18.30";"0.34";"6.00";"6.15";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109623";"";"None";"434.90";"0";"3.13";"BDBM187573";"CC(C)Nc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.7";"nM";"8.57";"";"337272";"UO_0000065";"19.70";"0.39";"5.44";"8.16";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106606";"";"None";"479.35";"0";"3.24";"BDBM187594";"CC(C)Nc1cc(-n2ncc3cc(Br)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.2";"nM";"8.38";"";"337293";"UO_0000065";"17.48";"0.38";"5.14";"7.98";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586498";"";"None";"479.57";"0";"2.61";"20";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"11.72";"0.23";"3.01";"4.91";"0";"CHEMBL3588654";"Inhibition of IRAK4 in human THP1-XBlue cells assessed as suppression of TLR4 agonist LPS-induced activation of NF-kappaB preincubated for 1 hr followed by LPS challenge measured after 5 hrs by secreted embryonic alkaline phosphatase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL4088745";"";"None";"414.54";"0";"1.80";"19";"CS(=O)(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"19.53";"0.38";"6.30";"7.92";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4098698";"";"None";"373.42";"0";"3.03";"4";"NC(=O)c1cnc(Nc2ccc3c(c2)CC(=O)N3)cc1NCc1ccccc1";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"17.26";"0.31";"3.41";"5.90";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4071076";"";"None";"397.50";"0";"3.51";"19";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H]1CCCC[C@H]1O";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"18.43";"0.36";"3.82";"7.39";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3938382";"";"None";"380.45";"0";"2.38";"BDBM206201";"O=C(Nc1cccc(NCCO)c1N1CCCCC1)c1cnn2cccnc12";"IC50";"'='";"1029.0";"nM";"5.99";"";"364872";"UO_0000065";"15.74";"0.29";"3.61";"6.32";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3926214";"";"None";"561.62";"1";"4.66";"BDBM189101";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(F)cc4F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338959";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586485";"";"None";"454.49";"0";"4.16";"BDBM188867";"COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1OC";"IC50";"'<'";"100.0";"nM";"";"";"338722";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3966073";"";"None";"562.70";"1";"3.08";"BDBM188980";"Cc1ccc(-n2nc(C3CCN(C4CN(S(=O)(=O)C(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338835";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3978719";"";"None";"335.32";"0";"2.24";"BDBM206096";"COc1cc2ncccc2cc1NC(=O)c1cnn2cc(O)cnc12";"IC50";"'='";"9.0";"nM";"8.05";"";"364767";"UO_0000065";"23.99";"0.44";"5.81";"7.92";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL378693";"";"None";"381.44";"0";"3.54";"45";"CCN(CC)CCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"14.48";"0.27";"1.98";"5.92";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL4103497";"";"None";"357.41";"0";"2.03";"32";"CCC[C@@H]1CC(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"24.86";"0.47";"6.86";"8.58";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4473472";"";"None";"419.37";"0";"2.20";"26";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC(F)(F)F)c3)n2)c(C(N)=O)n1";"IC50";"'='";"294.0";"nM";"6.53";"";"";"UO_0000065";"15.57";"0.30";"4.33";"5.11";"0";"CHEMBL4427853";"Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL258004";"";"None";"293.37";"0";"2.56";"6";"c1cc(NC2CCNCC2)nc(-c2cnc3ccccn23)c1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"25.41";"0.46";"4.90";"13.74";"1";"CHEMBL956501";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4518902";"";"None";"310.32";"0";"0.96";"35";"Cn1cc(NC(=O)c2cccc(-n3cccc3)n2)c(C(N)=O)n1";"IC50";"'='";"653.0";"nM";"6.18";"";"";"UO_0000065";"19.93";"0.37";"5.23";"5.74";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL402174";"";"None";"323.40";"0";"2.59";"4";"COc1ccc2ncn(-c3cccc(NC4CCNCC4)n3)c2c1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"24.19";"0.45";"5.23";"12.22";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL256719";"";"None";"298.73";"0";"3.38";"3f";"O=C(Nc1ccccc1Cl)c1cccc(-c2cn[nH]c2)n1";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"20.69";"0.40";"2.80";"8.75";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL408077";"";"None";"311.37";"0";"3.47";"2h";"COc1cccc(NC(=O)c2csc(-c3cccnc3)n2)c1";"IC50";"'='";"8900.0";"nM";"5.05";"";"";"UO_0000065";"16.22";"0.31";"1.58";"7.88";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL259213";"";"None";"295.37";"0";"3.77";"2c";"Cc1ccccc1NC(=O)c1csc(-c2cccnc2)n1";"IC50";"'='";"7300.0";"nM";"5.14";"";"";"UO_0000065";"17.39";"0.33";"1.37";"9.36";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL265923";"";"None";"311.37";"0";"3.47";"2i";"COc1ccc(NC(=O)c2csc(-c3cccnc3)n2)cc1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"17.44";"0.34";"1.96";"8.47";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"40; PF-06650833";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"24.07";"0.46";"7.12";"8.40";"0";"CHEMBL4015988";"Inhibition of IRAK4 in human whole blood assessed as reduction R848-induced IL-6 secretion by measuring plasma protein binding corrected IC50 preincubated for 30 mins prior to R848 addition after 4 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL258024";"";"None";"304.36";"0";"2.74";"30";"Cn1cnc(CNc2cccc(-c3cnc4ccccn34)n2)c1";"IC50";"'='";"497.0";"nM";"6.30";"";"";"UO_0000065";"20.71";"0.37";"3.56";"10.50";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL485324";"";"None";"308.39";"0";"1.98";"4";"CN(c1nccc(-c2cnc3ccccn23)n1)C1CCNCC1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"21.72";"0.40";"4.72";"11.48";"0";"CHEMBL956501";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL210682";"";"None";"316.70";"0";"3.38";"17";"O=C(Nc1nc2cc(Cl)ccc2[nH]1)c1cccc([N+](=O)[O-])c1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"16.49";"0.32";"1.84";"5.17";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL210821";"";"None";"310.31";"0";"3.34";"28";"Cc1cc2nc(NC(=O)c3cccc([N+](=O)[O-])c3)[nH]c2cc1C";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"16.43";"0.30";"1.76";"5.05";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL402295";"";"None";"319.41";"0";"3.09";"34";"c1cc(NC2C[C@H]3CC[C@@H](C2)N3)nc(-c2cnc3ccccn23)c1";"IC50";"'='";"225.0";"nM";"6.65";"";"";"UO_0000065";"20.81";"0.38";"3.56";"12.25";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL404471";"";"None";"311.35";"0";"4.01";"27";"N#Cc1ccccc1Nc1cccc(-c2cnc3ccccn23)n1";"IC50";"'='";"433.0";"nM";"6.36";"";"";"UO_0000065";"20.44";"0.36";"2.35";"9.64";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL404472";"";"None";"307.40";"0";"2.89";"11";"Cc1ccc2c(c1)ncn2-c1cccc(NC2CCNCC2)n1";"IC50";"'='";"1085.0";"nM";"5.96";"";"";"UO_0000065";"19.40";"0.35";"3.07";"10.89";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL3355482";"";"None";"380.47";"0";"3.76";"2";"CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372435";"Inhibition of IRAK4 (unknown origin) in presence of 1 mM ATP";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351882";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL142425";"";"None";"362.41";"0";"4.22";"42b";"C[C@H](O)CNc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cc2)ccn1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL698856";"Inhibition of Interleukin-1 receptor-associated kinase-4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145138";"1";"Scientific Literature";"J Med Chem";"2003";"None";""
"CHEMBL4436128";"";"None";"504.60";"1";"2.40";"18";"CCn1c(N2CCOCC2)nc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc21";"IC50";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"11.97";"0.22";"3.64";"5.34";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4108348";"";"None";"406.49";"0";"1.99";"BDBM203536";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"26.0";"nM";"7.58";"";"361016";"UO_0000065";"18.66";"0.35";"5.60";"7.97";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113028";"";"None";"467.58";"0";"3.89";"BDBM203624";"O=c1[nH]c(N2CCCC2c2ccncc2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"3180.0";"nM";"5.50";"";"361105";"UO_0000065";"11.76";"0.21";"1.61";"5.56";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL256942";"";"None";"362.26";"0";"3.89";"9";"Clc1cc2ncn(-c3cccc(NC4CCNCC4)n3)c2cc1Cl";"IC50";"'='";"166.0";"nM";"6.78";"";"";"UO_0000065";"18.72";"0.39";"2.89";"12.38";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL402612";"";"None";"353.43";"0";"2.60";"6";"COc1cc2ncn(-c3cccc(NC4CCNCC4)n3)c2cc1OC";"IC50";"'='";"181.0";"nM";"6.74";"";"";"UO_0000065";"19.08";"0.35";"4.14";"9.21";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL403210";"";"None";"318.38";"0";"2.43";"48";"N#Cc1ccc2ncc(-c3cccc(N[C@@H]4CCCNC4)n3)n2c1";"IC50";"'='";"95.0";"nM";"7.02";"";"";"UO_0000065";"22.06";"0.40";"4.59";"9.00";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL256735";"";"None";"406.49";"0";"2.03";"23";"O=C(c1ccc2ncc(-c3cccc(NC4CCNCC4)n3)n2c1)N1CCOCC1";"IC50";"'='";"263.0";"nM";"6.58";"";"";"UO_0000065";"16.19";"0.30";"4.55";"7.85";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL256717";"";"None";"406.49";"0";"2.49";"4a";"COc1cc(N2CCN(C)CC2)ccc1NC(=O)c1cccc(-c2cnn(C)c2)n1";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"15.69";"0.29";"3.89";"8.44";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4104915";"";"None";"384.52";"0";"3.51";"35";"c1cc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"19.91";"0.37";"4.15";"12.27";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL403358";"";"None";"336.40";"0";"1.66";"22";"NC(=O)c1ccc2ncc(-c3cccc(NC4CCNCC4)n3)n2c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"24.68";"0.45";"6.64";"8.53";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL402344";"";"None";"279.35";"0";"2.17";"rac-38";"c1cc(NC2CCNC2)nc(-c2cnc3ccccn23)c1";"IC50";"'='";"545.0";"nM";"6.26";"";"";"UO_0000065";"22.42";"0.41";"4.09";"11.55";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL403395";"";"None";"293.37";"0";"2.56";"rac-36";"c1cc(NCC2CCCN2)nc(-c2cnc3ccccn23)c1";"IC50";"'='";"313.0";"nM";"6.50";"";"";"UO_0000065";"22.17";"0.40";"3.94";"11.99";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4113443";"";"None";"462.48";"0";"3.10";"BDBM188087";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(F)C1";"IC50";"'='";"4.0";"nM";"8.40";"";"337751";"UO_0000065";"18.16";"0.35";"5.30";"8.00";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3969623";"";"None";"382.47";"0";"2.53";"BDBM187443";"CC(C)Nc1cc(-n2ccc3cncnc32)ncc1C(=O)NCCC(C)(C)O";"IC50";"'='";"4.2";"nM";"8.38";"";"337179";"UO_0000065";"21.90";"0.41";"5.85";"7.98";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109716";"";"None";"376.49";"0";"1.20";"BDBM203545";"Cc1cnc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)s1";"IC50";"'='";"1271.0";"nM";"5.90";"";"361025";"UO_0000065";"15.66";"0.31";"4.70";"6.20";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3891604";"";"None";"490.55";"0";"2.38";"BDBM189064";"Cc1ccc(-n2nc(-c3cnn(CCS(C)(=O)=O)c3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338922";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3971390";"";"None";"552.68";"1";"4.25";"BDBM188989";"Cc1ccc(-n2nc(C3CCN(C4CCC5(CCC(=O)N5)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338844";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3968683";"";"None";"480.58";"0";"3.96";"BDBM188992";"Cc1ccc(-n2nc(C3CCN(C4CC(C#N)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338847";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3968371";"";"None";"523.62";"1";"3.09";"BDBM188757";"COc1ccc(-n2nc(C3CCN(S(=O)(=O)C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338612";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108397";"";"None";"537.65";"2";"1.67";"BDBM203823";"O=c1[nH]c(N2CCC(Cn3cccn3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"119.0";"nM";"6.92";"";"361003";"UO_0000065";"12.88";"0.25";"5.25";"4.54";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112264";"";"None";"438.60";"0";"3.69";"BDBM203745";"CC1CC(C)CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)C1";"IC50";"'='";"570.0";"nM";"6.24";"";"361219";"UO_0000065";"14.24";"0.28";"2.55";"7.27";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108230";"";"None";"436.52";"0";"1.34";"BDBM203615";"COC1CN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C[C@@H]1O";"IC50";"'='";"40.0";"nM";"7.40";"";"361096";"UO_0000065";"16.95";"0.32";"6.06";"6.41";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3895042";"";"None";"427.53";"0";"2.60";"BDBM203717";"O=c1[nH]c(N2CCOCC2)nc(NC2CCC(O)CC2)c1-c1nc2ccccc2s1";"IC50";"'='";"620.0";"nM";"6.21";"";"361191";"UO_0000065";"14.52";"0.28";"3.61";"6.01";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4566431";"";"None";"537.60";"1";"1.57";"24";"CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(C4COC4)CC3)cc2C1=O";"IC50";"'='";"0.078";"nM";"10.11";"";"";"UO_0000065";"18.80";"0.35";"8.54";"8.75";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4113216";"";"None";"537.09";"1";"4.62";"BDBM203768";"CC1(c2ccc(Cl)cc2)CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1";"IC50";"'='";"2500.0";"nM";"5.60";"";"361242";"UO_0000065";"10.43";"0.21";"0.98";"5.89";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107142";"";"None";"444.52";"1";"0.92";"BDBM203518";"O=c1[nH]c(NC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2cnccc2s1";"IC50";"'='";"2.5";"nM";"8.60";"";"360978";"UO_0000065";"19.35";"0.38";"7.68";"5.50";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3945726";"";"None";"440.57";"0";"2.78";"BDBM203706";"O=c1[nH]c(N2CCOCC2)nc(NCCN2CCCCC2)c1-c1nc2ccccc2s1";"IC50";"'='";"2.0";"nM";"8.70";"";"361180";"UO_0000065";"19.74";"0.38";"5.92";"10.07";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3921524";"";"None";"495.57";"0";"1.15";"BDBM187469";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCC(=O)NC1CCS(=O)(=O)C1";"IC50";"'='";"2.8";"nM";"8.55";"";"337205";"UO_0000065";"17.26";"0.33";"7.40";"5.38";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3938709";"";"None";"449.49";"0";"3.27";"BDBM187743";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(F)=C1CCOCC1";"IC50";"'='";"13.4";"nM";"7.87";"";"337428";"UO_0000065";"17.52";"0.33";"4.60";"6.69";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3973484";"";"None";"443.47";"0";"2.53";"BDBM187717";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cnn(C2COC2)c1";"IC50";"'='";"10.6";"nM";"7.97";"";"337402";"UO_0000065";"17.98";"0.33";"5.44";"5.88";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109209";"";"None";"476.49";"0";"4.56";"BDBM187974";"CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(O)c1";"IC50";"'='";"1.2";"nM";"8.92";"";"337649";"UO_0000065";"18.72";"0.35";"4.36";"7.70";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107813";"";"None";"466.52";"0";"2.46";"BDBM187423";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(O)C1";"IC50";"'='";"1.4";"nM";"8.85";"";"337159";"UO_0000065";"18.98";"0.36";"6.39";"6.51";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3904382";"";"None";"442.47";"0";"2.90";"BDBM187533";"C[C@@H](CF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.4";"nM";"8.62";"";"337252";"UO_0000065";"19.48";"0.37";"5.72";"7.44";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107813";"";"None";"466.52";"0";"2.46";"BDBM187423";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(O)C1";"IC50";"'='";"2.5";"nM";"8.60";"";"337161";"UO_0000065";"18.44";"0.35";"6.14";"6.32";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107813";"";"None";"466.52";"0";"2.46";"BDBM187423";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(O)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"337162";"UO_0000065";"18.85";"0.35";"6.34";"6.46";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111656";"";"None";"418.45";"0";"2.43";"BDBM187798";"CC(C)Nc1cc(-n2cnc3cnc(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)F";"IC50";"'='";"3.6";"nM";"8.44";"";"337480";"UO_0000065";"20.18";"0.38";"6.01";"6.83";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111310";"";"None";"488.52";"0";"3.88";"BDBM187450";"COc1cccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)c1";"IC50";"'='";"4.4";"nM";"8.36";"";"337186";"UO_0000065";"17.11";"0.32";"4.48";"6.68";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3890756";"";"None";"504.58";"1";"2.13";"BDBM187700";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1";"IC50";"'='";"3.1";"nM";"8.51";"";"337385";"UO_0000065";"16.86";"0.32";"6.38";"5.04";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3931358";"";"None";"384.47";"0";"1.27";"BDBM203702";"O=c1[nH]c(N2CCOCC2)nc(NC2CNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"300.0";"nM";"6.52";"";"361176";"UO_0000065";"16.97";"0.33";"5.25";"6.85";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3921034";"";"None";"446.56";"0";"3.78";"BDBM187500";"CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)CC1";"IC50";"'='";"2.5";"nM";"8.60";"";"337235";"UO_0000065";"19.26";"0.36";"4.82";"7.42";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3892469";"";"None";"390.45";"0";"2.37";"BDBM187771";"CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC1(C)CC1";"IC50";"'='";"6.7";"nM";"8.17";"";"337456";"UO_0000065";"20.93";"0.38";"5.80";"6.08";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3914088";"";"None";"429.44";"0";"2.56";"BDBM188030";"COc1cnc(NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)cn1";"IC50";"'='";"20.1";"nM";"7.70";"";"337696";"UO_0000065";"17.92";"0.33";"5.14";"5.36";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4285338";"";"None";"384.53";"0";"2.77";"24";"CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"331.13";"nM";"6.48";"";"";"UO_0000065";"16.85";"0.32";"3.71";"7.32";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4112197";"";"None";"528.63";"1";"3.96";"BDBM187955";"CC(C)COC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"5.7";"nM";"8.24";"";"337630";"UO_0000065";"15.60";"0.30";"4.28";"6.32";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3980538";"";"None";"509.59";"1";"2.88";"BDBM188086";"CC(C)(O)[C@H]1CC[C@H](Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1";"IC50";"'='";"2.8";"nM";"8.55";"";"337749";"UO_0000065";"16.78";"0.32";"5.67";"5.74";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4783351";"EMAVUSERTIB";"1.0";"491.51";"1";"2.24";"24; CA-4948";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1";"IC50";"'='";"1375.0";"nM";"5.86";"";"";"UO_0000065";"11.93";"0.22";"3.62";"4.10";"0";"CHEMBL4673036";"Inhibition of IRAK4 in human whole blood assessed as inhibition of IL-1R-mediated IL-1beta-induced IL-6 release preincubated for 1 hr followed by IL-1beta stimulation and measured after 16 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3634384";"";"None";"440.40";"0";"2.58";"30";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CC(F)(F)CC[C@@H]4N)nc23)c(C(F)F)n1";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"14.88";"0.29";"3.97";"5.69";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634502";"";"None";"408.39";"0";"1.90";"32";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCNC4)nc23)c(C(F)(F)F)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"19.40";"0.37";"6.02";"7.83";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3977735";"";"None";"450.52";"0";"3.34";"BDBM187908";"C[C@H](Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)C1CC1";"IC50";"'='";"4.4";"nM";"8.36";"";"337583";"UO_0000065";"18.55";"0.35";"5.02";"7.21";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3922475";"";"None";"470.56";"0";"1.57";"BDBM187713";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)NS(C)(=O)=O";"IC50";"'='";"6.5";"nM";"8.19";"";"337398";"UO_0000065";"17.40";"0.34";"6.62";"5.29";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109992";"";"None";"520.59";"1";"2.39";"BDBM187786";"CC(C)Nc1cc(-n2ncc3cnc(NC[C@@H](F)C(C)(C)O)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"18.5";"nM";"7.73";"";"337468";"UO_0000065";"14.85";"0.29";"5.34";"5.15";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4064608";"";"None";"385.51";"0";"2.91";"28";"c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"21.53";"0.40";"5.39";"11.02";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3915404";"";"None";"469.56";"0";"3.41";"BDBM187891";"C[C@@H](CO)Nc1cc(-n2ccc3cc(F)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)CC1";"IC50";"'='";"2.1";"nM";"8.68";"";"337566";"UO_0000065";"18.48";"0.35";"5.27";"7.73";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3947585";"";"None";"482.57";"0";"0.97";"BDBM187660";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCN1CCS(=O)(=O)CC1";"IC50";"'='";"8.1";"nM";"8.09";"";"337345";"UO_0000065";"16.77";"0.33";"7.12";"5.55";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4093475";"";"None";"259.36";"0";"2.24";"5";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]ccc23)CC1";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"23.88";"0.45";"3.95";"10.90";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL2022369";"";"None";"561.74";"2";"4.71";"42";"Cc1cn2c(-c3cnn(CC(=O)NCc4cccs4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1";"IC50";"'='";"873.0";"nM";"6.06";"";"";"UO_0000065";"10.79";"0.21";"1.35";"5.76";"0";"CHEMBL2024840";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021851";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL4280028";"";"None";"471.61";"0";"2.42";"38";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(=O)N(C)C)c34)CC2)CC1";"IC50";"'='";"8910.0";"nM";"5.05";"";"";"UO_0000065";"10.71";"0.20";"2.63";"5.30";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4280028";"";"None";"471.61";"0";"2.42";"38";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(=O)N(C)C)c34)CC2)CC1";"IC50";"'='";"8912.51";"nM";"5.05";"";"";"UO_0000065";"10.71";"0.20";"2.63";"5.30";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4097089";"";"None";"344.46";"0";"3.10";"23";"CN(C)[C@H]1CC[C@H](Oc2ncnc3[nH]cc(C4CCOCC4)c23)CC1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"21.36";"0.40";"4.26";"11.63";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4063689";"";"None";"273.38";"0";"2.55";"9";"Cc1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"30.36";"0.57";"5.75";"14.60";"1";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3938948";"";"None";"505.60";"1";"3.15";"BDBM188778";"Cc1ccc(-n2nc(C3CCCN(S(=O)(=O)C4CC4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338633";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3941465";"";"None";"435.46";"0";"2.78";"BDBM188795";"COc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1";"IC50";"'<'";"100.0";"nM";"";"";"338650";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4561018";"";"None";"407.43";"0";"1.06";"33";"Cn1cc(NC(=O)c2cccc(-c3ccc(N4CCOCC4)nc3)n2)c(C(N)=O)n1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"14.62";"0.27";"4.90";"4.65";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3586508";"";"None";"487.58";"0";"4.77";"30";"CC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"16.17";"0.30";"3.12";"9.81";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4436908";"";"None";"362.39";"0";"2.11";"30";"Cn1cc(NC(=O)c2cccc(-c3ccc(C4CC4)nc3)n2)c(C(N)=O)n1";"IC50";"'='";"121.0";"nM";"6.92";"";"";"UO_0000065";"19.09";"0.35";"4.81";"5.97";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3586484";"";"None";"424.46";"0";"4.15";"6";"COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"15.95";"0.29";"2.62";"7.84";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3586492";"";"None";"402.46";"0";"3.37";"14";"Cc1ccc(-n2nc(C3CCOCC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"15.87";"0.29";"3.02";"7.40";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4467632";"";"None";"356.77";"0";"1.88";"32";"Cn1cc(NC(=O)c2cccc(-c3cnccc3Cl)n2)c(C(N)=O)n1";"IC50";"'='";"683.0";"nM";"6.17";"";"";"UO_0000065";"17.28";"0.34";"4.29";"5.32";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3960922";"";"None";"496.59";"0";"3.34";"BDBM187953";"CC(C)CC(O)[C@H](C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"10.9";"nM";"7.96";"";"337628";"UO_0000065";"16.03";"0.30";"4.62";"5.85";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3601077";"";"None";"414.49";"0";"1.24";"8";"OC[C@H]1C[C@@H](Nc2nc(NC3CC3)ncc2-c2nc3cnccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"647.0";"nM";"6.19";"";"";"UO_0000065";"14.93";"0.29";"4.95";"4.54";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3586507";"";"None";"481.54";"0";"1.40";"29";"Cc1cnc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"14.01";"0.27";"5.34";"4.81";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4091863";"";"None";"477.59";"0";"3.83";"11";"COCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"15.06";"0.29";"3.36";"6.64";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4096937";"";"None";"473.60";"0";"4.59";"13";"O=C(NCC1CC1)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"15.11";"0.29";"2.56";"7.21";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4091402";"";"None";"459.58";"0";"4.34";"14";"O=C(NC1CC1)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"15.89";"0.30";"2.96";"7.36";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4069401";"";"None";"435.51";"0";"3.04";"30";"NC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"17.68";"0.34";"4.66";"5.77";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4473420";"";"None";"485.55";"0";"2.58";"23";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)NCCn2cccn2)n1";"IC50";"'='";"2677.0";"nM";"5.57";"";"";"UO_0000065";"11.48";"0.21";"2.99";"4.23";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4278882";"";"None";"384.53";"0";"2.74";"30";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1";"IC50";"'='";"21.88";"nM";"7.66";"";"";"UO_0000065";"19.92";"0.37";"4.92";"11.65";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4559589";"";"None";"356.77";"0";"1.88";"31";"Cn1cc(NC(=O)c2cccc(-c3cncc(Cl)c3)n2)c(C(N)=O)n1";"IC50";"'='";"202.0";"nM";"6.70";"";"";"UO_0000065";"18.76";"0.37";"4.81";"5.78";"0";"CHEMBL4427853";"Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL4294023";"";"None";"343.48";"0";"2.91";"28";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c12";"IC50";"'='";"15.49";"nM";"7.81";"";"";"UO_0000065";"22.74";"0.43";"4.90";"14.28";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4108900";"";"None";"541.55";"2";"2.46";"BDBM187987";"Cn1nnnc1-c1ccc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cc1";"IC50";"'='";"4.8";"nM";"8.32";"";"337661";"UO_0000065";"15.36";"0.28";"5.86";"4.83";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109920";"";"None";"506.46";"1";"3.00";"BDBM187841";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"2.3";"nM";"8.64";"";"337518";"UO_0000065";"17.06";"0.33";"5.64";"7.04";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108474";"";"None";"464.51";"0";"2.07";"BDBM188106";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC12CC(C1)C2";"IC50";"'='";"1.5";"nM";"8.82";"";"337769";"UO_0000065";"19.00";"0.35";"6.75";"5.70";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108248";"";"None";"548.56";"2";"2.15";"BDBM187992";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1CCN(c2ncc(F)cn2)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"337666";"UO_0000065";"16.09";"0.30";"6.67";"5.59";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107168";"";"None";"516.97";"1";"2.89";"BDBM187823";"COCCn1cc(Nc2cc(-n3cnc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"7.9";"nM";"8.10";"";"337500";"UO_0000065";"15.67";"0.31";"5.21";"6.14";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115151";"";"None";"417.46";"0";"3.22";"BDBM187437";"CC(C)Nc1cc(-n2ccc3cc(F)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.6";"nM";"8.80";"";"337173";"UO_0000065";"21.07";"0.40";"5.58";"9.55";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106842";"";"None";"524.56";"1";"4.06";"BDBM187466";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc(-n2cccn2)cc1";"IC50";"'='";"1.7";"nM";"8.77";"";"337202";"UO_0000065";"16.72";"0.31";"4.71";"6.56";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4463551";"";"None";"447.54";"0";"3.34";"9";"CC(C)CNC(=O)c1nn(C)cc1NC(=O)c1cccc(-c2ccnc(NCC3CC3)c2)n1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4114114";"";"None";"494.57";"0";"3.24";"BDBM187460";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@H]1CC[C@@](C)(O)CC1";"IC50";"'='";"1.3";"nM";"8.89";"";"337196";"UO_0000065";"17.97";"0.34";"5.65";"6.53";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3962798";"";"None";"501.59";"1";"3.06";"BDBM187488";"CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CCOCC2)CC1";"IC50";"'='";"7.1";"nM";"8.15";"";"337223";"UO_0000065";"16.25";"0.30";"5.09";"6.08";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL255446";"";"None";"373.46";"0";"2.96";"19";"Cn1cc(-c2ccc3ncc(-c4cccc(NC5CCNCC5)n4)n3c2)cn1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"21.84";"0.40";"5.19";"11.32";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL403442";"";"None";"327.82";"0";"3.24";"8";"Clc1ccc2c(c1)ncn2-c1cccc(NC2CCNCC2)n1";"IC50";"'='";"112.0";"nM";"6.95";"";"";"UO_0000065";"21.20";"0.41";"3.71";"12.69";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4280028";"";"None";"471.61";"0";"2.42";"38";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(=O)N(C)C)c34)CC2)CC1";"IC50";"'='";"1190.0";"nM";"5.92";"";"";"UO_0000065";"12.56";"0.24";"3.50";"6.22";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4109973";"";"None";"466.52";"0";"2.72";"BDBM187406";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCOC1";"IC50";"'='";"1.6";"nM";"8.80";"";"337142";"UO_0000065";"18.85";"0.35";"6.08";"7.03";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3954542";"";"None";"448.49";"0";"1.10";"BDBM187656";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(=O)N1CCOCC1";"IC50";"'='";"14.4";"nM";"7.84";"";"337341";"UO_0000065";"17.48";"0.32";"6.74";"5.68";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113174";"";"None";"474.54";"0";"2.84";"BDBM203645";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2cc(F)cc(F)c2)cs1";"IC50";"'='";"99.0";"nM";"7.00";"";"361126";"UO_0000065";"14.76";"0.29";"4.16";"7.36";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110300";"";"None";"499.51";"0";"3.15";"BDBM187895";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc2nn[nH]c2c1";"IC50";"'='";"1.8";"nM";"8.74";"";"337570";"UO_0000065";"17.51";"0.32";"5.59";"5.55";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4279192";"";"None";"384.53";"0";"3.00";"2";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"758.0";"nM";"6.12";"";"";"UO_0000065";"15.92";"0.30";"3.12";"6.12";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4292700";"";"None";"384.53";"0";"3.00";"23";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"13600.0";"nM";"4.87";"";"";"UO_0000065";"12.66";"0.24";"1.87";"4.87";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4101382";"";"None";"432.48";"1";"2.57";"33";"CNC(=O)c1cnc(Nc2ccc3[nH]ncc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"13.40";"0.25";"3.23";"4.29";"0";"CHEMBL4047625";"Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4075955";"";"None";"449.54";"0";"3.30";"29";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"14.51";"0.28";"3.22";"5.46";"1";"CHEMBL4047625";"Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4104915";"";"None";"384.52";"0";"3.51";"35";"c1cc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"16.82";"0.32";"2.96";"10.36";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4069200";"";"None";"371.44";"0";"3.96";"22";"N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCC(F)(F)CC4)CC3)c2c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"22.95";"0.43";"4.56";"13.14";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4063689";"";"None";"273.38";"0";"2.55";"9";"Cc1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"25.07";"0.47";"4.30";"12.06";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3960537";"";"None";"384.87";"0";"2.81";"BDBM206112";"NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"37.0";"nM";"7.43";"";"364789";"UO_0000065";"19.31";"0.38";"4.62";"8.39";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3931955";"";"None";"371.83";"0";"2.77";"BDBM206179";"O=C(Nc1cc(Cl)ccc1OC1CCNCC1)c1cnn2cccnc12";"IC50";"'='";"476.0";"nM";"6.32";"";"364850";"UO_0000065";"17.00";"0.33";"3.55";"7.85";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3933253";"";"None";"500.58";"1";"4.32";"BDBM189072";"Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)C(C)C)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338930";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3912286";"";"None";"487.55";"0";"3.05";"BDBM189078";"CNS(=O)(=O)c1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338936";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4067302";"";"None";"386.50";"0";"2.87";"33";"c1nc(O[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"19.36";"0.36";"4.61";"10.32";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4079743";"";"None";"433.54";"0";"3.81";"10";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"18.45";"0.35";"4.19";"8.07";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4099198";"";"None";"362.43";"0";"2.94";"2";"NC(=O)c1cnc(Nc2ccccc2)cc1N[C@H](CO)Cc1ccccc1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"16.93";"0.31";"3.20";"6.12";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4073250";"";"None";"329.36";"0";"1.39";"22";"CCOc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O";"IC50";"'='";"23.9";"nM";"7.62";"";"";"UO_0000065";"23.14";"0.43";"6.23";"7.36";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4076912";"";"None";"343.38";"0";"1.49";"36";"COc1cc2c(OC[C@H]3NC(=O)[C@@H](C)[C@H]3C)nccc2cc1C(N)=O";"IC50";"'='";"29.2";"nM";"7.54";"";"";"UO_0000065";"21.94";"0.41";"6.04";"7.28";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4071526";"";"None";"347.35";"0";"1.19";"39";"COc1cc2c(OC[C@H]3NC(=O)[C@H](F)[C@H]3C)nccc2cc1C(N)=O";"IC50";"'='";"29.5";"nM";"7.53";"";"";"UO_0000065";"21.68";"0.41";"6.34";"7.27";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4084228";"";"None";"341.37";"0";"1.10";"45";"COc1cc2c(OC[C@H]3NC(=O)[C@@H]4[C@@H](C)[C@@H]43)nccc2cc1C(N)=O";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"25.25";"0.47";"7.52";"8.33";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4072093";"";"None";"298.43";"0";"3.48";"9";"CCc1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"26.03";"0.48";"4.29";"18.93";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4097259";"";"None";"284.41";"0";"3.22";"4";"Cc1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"27.15";"0.50";"4.50";"18.81";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3601079";"";"None";"481.54";"1";"1.81";"10";"COc1cc(Nc2ncc(-c3nc4ccncc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.06";"0.35";"6.89";"5.49";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601074";"";"None";"451.51";"1";"1.80";"5";"OC[C@H]1C[C@@H](Nc2nc(Nc3cccnc3)ncc2-c2nc3cnccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"17.63";"0.34";"6.16";"5.33";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4115340";"";"None";"425.56";"0";"2.14";"BDBM203771";"NC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"240.0";"nM";"6.62";"";"361245";"UO_0000065";"15.56";"0.30";"4.48";"5.91";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3601197";"";"None";"479.56";"0";"3.02";"31";"COc1cc(Nc2cc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)cn2)ccn1";"IC50";"'='";"373.0";"nM";"6.43";"";"";"UO_0000065";"13.40";"0.26";"3.41";"4.85";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601195";"";"None";"466.54";"0";"3.76";"29";"OC[C@H]1C[C@@H](Nc2cc(Nc3ccc(F)cc3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"1140.0";"nM";"5.94";"";"";"UO_0000065";"12.74";"0.25";"2.18";"5.38";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3622524";"";"None";"440.53";"0";"1.96";"25";"O=C1NCCCC[C@H]1Nc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"2429.0";"nM";"5.62";"";"";"UO_0000065";"12.75";"0.25";"3.65";"5.00";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3621219";"";"None";"459.53";"0";"0.40";"18";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"375.0";"nM";"6.43";"";"";"UO_0000065";"13.98";"0.27";"6.03";"4.47";"0";"CHEMBL3625601";"Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL3622520";"";"None";"398.49";"0";"1.66";"21";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"18.68";"0.36";"5.78";"7.82";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL2178352";"";"None";"468.61";"1";"5.18";"9e";"CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2188526";"Inhibition of human recombinant IRAK4 by radiometric kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177100";"1";"Scientific Literature";"J Med Chem";"2012";"None";""
"CHEMBL3622517";"";"None";"472.57";"0";"0.31";"17";"CN1CCN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"15.59";"0.30";"7.06";"5.34";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3967712";"";"None";"439.50";"0";"2.74";"BDBM187738";"CC[C@H](C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.7";"nM";"8.33";"";"337423";"UO_0000065";"18.95";"0.36";"5.59";"6.47";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114212";"";"None";"547.56";"1";"3.62";"BDBM187945";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(NCC(F)(F)F)C1";"IC50";"'='";"6.8";"nM";"8.17";"";"337620";"UO_0000065";"14.92";"0.29";"4.55";"6.39";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107792";"";"None";"527.52";"2";"2.25";"BDBM187867";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(-c2ncccn2)c1";"IC50";"'='";"1.5";"nM";"8.82";"";"337544";"UO_0000065";"16.73";"0.31";"6.57";"5.12";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3976685";"";"None";"424.48";"0";"2.96";"BDBM187756";"CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NCCC(C)(C)F";"IC50";"'='";"2.0";"nM";"8.70";"";"337441";"UO_0000065";"20.49";"0.38";"5.74";"6.47";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3917045";"";"None";"525.64";"1";"1.94";"BDBM187758";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(S(=O)(=O)NC(C)C)CC1";"IC50";"'='";"18.4";"nM";"7.74";"";"337443";"UO_0000065";"14.72";"0.29";"5.80";"4.90";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111288";"";"None";"529.60";"1";"1.58";"BDBM187922";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCN(S(C)(=O)=O)C1";"IC50";"'='";"1.3";"nM";"8.89";"";"337597";"UO_0000065";"16.78";"0.33";"7.31";"5.80";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112117";"";"None";"479.52";"0";"1.77";"BDBM187925";"CC(=O)N1CC(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1";"IC50";"'='";"5.8";"nM";"8.24";"";"337600";"UO_0000065";"17.18";"0.32";"6.47";"6.05";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3951794";"";"None";"462.91";"0";"2.10";"BDBM188114";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1N[C@@H]1C[C@H]1CO";"IC50";"'='";"10.5";"nM";"7.98";"";"337778";"UO_0000065";"17.24";"0.34";"5.88";"6.37";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106835";"";"None";"552.70";"1";"4.67";"BDBM187968";"CC(C)Nc1cc(-n2ccc3cc(CNC(=O)CC4CCCCC4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"5.4";"nM";"8.27";"";"337643";"UO_0000065";"14.96";"0.28";"3.60";"6.82";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3966110";"";"None";"510.62";"1";"2.44";"BDBM187721";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(S(=O)(=O)C(C)C)CC1";"IC50";"'='";"5.1";"nM";"8.29";"";"337406";"UO_0000065";"16.24";"0.31";"5.85";"5.68";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112848";"";"None";"437.48";"0";"2.49";"BDBM187790";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1NC1CCC1";"IC50";"'='";"4.5";"nM";"8.35";"";"337472";"UO_0000065";"19.08";"0.36";"5.86";"6.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3634506";"";"None";"390.40";"0";"1.82";"36";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCNC4)nc23)c(C(F)F)n1";"IC50";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601076";"";"None";"493.59";"1";"2.47";"7";"CN(C)c1cccc(Nc2ncc(-c3nc4cnccc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"16.05";"0.31";"5.45";"5.68";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601190";"";"None";"500.56";"1";"2.89";"23";"OC[C@H]1C[C@@H](Nc2nc(Nc3ccnc(OC4CC4)c3)ncc2-c2ccc3ccccc3n2)[C@H](O)[C@@H]1O";"IC50";"'='";"341.0";"nM";"6.47";"";"";"UO_0000065";"12.92";"0.24";"3.58";"4.44";"0";"CHEMBL3603426";"Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL3601073";"";"None";"452.50";"1";"1.20";"4";"OC[C@H]1C[C@@H](Nc2nc(Nc3cncnc3)ncc2-c2nc3cnccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.50";"0.34";"6.72";"4.89";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634505";"";"None";"425.44";"0";"2.86";"35";"Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCNC4)nc23)c(C(F)(F)F)n1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"19.17";"0.38";"5.29";"8.43";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634509";"";"None";"407.45";"0";"2.78";"39";"Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCNC4)nc23)c(C(F)F)n1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"23.07";"0.46";"6.62";"9.71";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3586488";"";"None";"395.43";"0";"3.54";"10";"Cc1ccc(-n2nc(-c3cccnc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"99.0";"nM";"7.00";"";"";"UO_0000065";"17.71";"0.32";"3.46";"7.78";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3933496";"";"None";"504.58";"1";"3.17";"BDBM188855";"[C-]#[N+]c1cnc2c(C(=O)Nc3cc(C4CCN(S(C)(=O)=O)CC4)nn3-c3ccc(C)cc3)cnn2c1";"IC50";"'<'";"1000.0";"nM";"";"";"338710";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3353219";"";"None";"400.87";"0";"2.52";"54";"NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cc(O)cnc23)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.45";"0.44";"6.48";"8.27";"1";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3353215";"";"None";"449.47";"0";"3.63";"49";"O=C1Nc2nc3ccccc3n2Cc2cc(ccc2O)-c2ccc(=O)n(n2)Cc2cccc1c2";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372369";"Inhibition of IRAK4 (unknown origin) by radiochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3353201";"";"None";"506.63";"1";"3.80";"35";"Cc1cc(Nc2ncc(-c3nc4ccccc4s3)c(NC3C[C@H](C(C)(C)O)[C@@H](O)[C@H]3O)n2)cc(C)n1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"17.09";"0.33";"4.86";"6.35";"0";"CHEMBL3380186";"Inhibition of IRAK4 (unknown origin) by fluorescence polarization based kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3353197";"";"None";"438.58";"1";"5.05";"31";"CNC(=O)c1nc(-c2cnc(Nc3ccc4ncsc4c3)cc2NC(C)C)sc1C";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"19.94";"0.40";"3.69";"9.52";"1";"CHEMBL3380182";"Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3403429";"";"None";"401.49";"0";"1.41";"8";"CCc1nc(N)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"6850.0";"nM";"5.16";"";"";"UO_0000065";"12.86";"0.25";"3.75";"3.76";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3601199";"";"None";"426.54";"0";"2.84";"33";"OC[C@H]1C[C@@H](Nc2nc(NC3CCC3)ccc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"11900.0";"nM";"4.92";"";"";"UO_0000065";"11.55";"0.22";"2.08";"4.46";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL2018064";"";"None";"373.44";"0";"0.85";"6";"Nc1ncc(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"17.73";"0.35";"5.77";"4.82";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4104802";"";"None";"455.61";"0";"2.87";"25";"CN(C)C(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.71";"0.35";"5.65";"9.51";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4089379";"";"None";"343.48";"0";"3.14";"21";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOCC4)c23)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"23.94";"0.45";"5.08";"12.44";"1";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4075333";"";"None";"329.45";"0";"3.09";"18b";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCO4)c23)CC1";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"19.89";"0.37";"3.46";"9.92";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4097418";"";"None";"327.48";"0";"3.90";"17";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCC4)c23)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"25.11";"0.47";"4.32";"14.46";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL256713";"";"None";"379.42";"0";"2.57";"JH-I-25";"COc1cc(N2CCOCC2)ccc1NC(=O)c1cccc(-c2ccn[nH]2)n1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"20.48";"0.38";"5.20";"8.41";"0";"CHEMBL4731592";"Inhibition of wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system by Kinomescan method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725474";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3403428";"";"None";"403.46";"0";"0.86";"5";"COc1nc(N)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3403427";"";"None";"388.45";"1";"0.43";"4";"Nc1nc(N)c(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"5190.0";"nM";"5.29";"";"";"UO_0000065";"13.60";"0.27";"4.85";"3.23";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3403433";"";"None";"397.55";"0";"4.46";"(+/-)13";"CCCNc1nc(C)c(-c2nc3ccccc3s2)c(N[C@H]2CC[C@@H](CO)C2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3403434";"";"None";"369.49";"0";"3.72";"14";"CCCNc1nc(C)c(-c2nc3ccccc3s2)c(N2CCOCC2)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL2018071";"";"None";"441.56";"0";"2.40";"15";"Cc1nc(NCC2CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3586503";"";"None";"497.56";"0";"2.75";"BDBM188791";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1";"IC50";"'<'";"100.0";"nM";"";"";"338646";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3980372";"";"None";"517.97";"1";"3.10";"BDBM188763";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(Cl)cc3F)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338618";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109926";"";"None";"424.57";"0";"3.45";"BDBM203746";"CC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"69.0";"nM";"7.16";"";"361220";"UO_0000065";"16.87";"0.33";"3.71";"8.33";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3971606";"";"None";"414.49";"0";"1.43";"BDBM203710";"CC(=O)NCCNc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"8200.0";"nM";"5.09";"";"361184";"UO_0000065";"12.27";"0.24";"3.66";"4.53";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108111";"";"None";"456.57";"0";"2.06";"BDBM203735";"COCC1CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1";"IC50";"'='";"81.0";"nM";"7.09";"";"361209";"UO_0000065";"15.53";"0.30";"5.03";"6.79";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3910472";"";"None";"493.97";"0";"4.69";"BDBM188785";"O=C(Nc1cc(C2CCN(C3CCC3)CC2)nn1-c1ccc(Cl)cc1F)c1cnn2cccnc12";"IC50";"'<'";"100.0";"nM";"";"";"338640";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL1938680";"";"None";"381.86";"0";"4.26";"1";"O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1";"IC50";"'='";"7500.0";"nM";"5.12";"";"";"UO_0000065";"13.42";"0.26";"0.86";"8.91";"0";"CHEMBL2019907";"Inhibition of human IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2016522";"1";"Scientific Literature";"ACS Med Chem Lett";"2011";"None";""
"CHEMBL3353209";"";"None";"457.54";"0";"2.55";"43";"Cc1ccc(-n2nc(N3CCN(C4CCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3343040";"";"None";"401.43";"0";"3.92";"10";"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(N)nc2cc1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL4109973";"";"None";"466.52";"0";"2.72";"BDBM187406";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCOC1";"IC50";"'='";"1.7";"nM";"8.77";"";"337143";"UO_0000065";"18.80";"0.35";"6.05";"7.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3353192";"";"None";"414.49";"0";"3.06";"25";"Cc1cc(C#N)cnc1Nc1cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"20.37";"0.38";"5.38";"6.87";"0";"CHEMBL3380182";"Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3361256";"";"None";"326.47";"0";"4.13";"14";"CN(C)[C@H]1CC[C@H](Nc2ncnc3sc4ccccc4c23)CC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380178";"Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3343046";"";"None";"362.39";"0";"3.91";"16a";"COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)ccc1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL4647594";"";"None";"427.57";"0";"4.39";"13";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NC[C@@H](C)C(C)(C)O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4064168";"";"None";"315.47";"0";"3.54";"13";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C(C)(C)C)c23)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"21.73";"0.41";"3.31";"12.06";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4093475";"";"None";"259.36";"0";"2.24";"10";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]ccc23)CC1";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"23.88";"0.45";"3.95";"10.90";"1";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4086053";"";"None";"273.38";"0";"2.55";"8";"Cc1cc2c(N[C@H]3CC[C@H](N(C)C)CC3)ncnc2[nH]1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4079194";"";"None";"409.53";"0";"3.38";"36";"N#Cc1cnc2[nH]cc(C3CCOCC3)c2c1N[C@H]1CC[C@H](N2CCOCC2)CC1";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"17.71";"0.33";"3.87";"8.41";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3949312";"";"None";"492.59";"0";"4.25";"BDBM189033";"Cc1ccc(-n2nc(C3CCCN(Cc4ccncc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338888";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3974264";"";"None";"492.59";"0";"4.25";"BDBM189035";"Cc1ccc(-n2nc(C3CCCN(Cc4ccccn4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338890";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3972812";"";"None";"470.56";"0";"3.53";"BDBM189041";"Cc1ccc(-n2nc(C3CN(Cc4nccs4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338896";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586502";"";"None";"505.60";"1";"3.18";"24";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3)n2)CC1";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"14.30";"0.27";"4.05";"6.31";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4648202";"";"None";"449.53";"0";"4.39";"14";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCC(F)(F)C(C)(C)O";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"18.61";"0.37";"3.98";"8.44";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4107902";"";"None";"443.46";"0";"2.30";"BDBM187527";"C[C@H](CF)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.6";"nM";"8.34";"";"337249";"UO_0000065";"18.80";"0.36";"6.04";"6.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4556866";"";"None";"490.57";"1";"2.48";"11";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)nc34)CC2)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"16.92";"0.31";"5.82";"6.05";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4438228";"";"None";"532.65";"2";"3.41";"15";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C(C)(C)C#N)nc34)CC2)CC1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"10.88";"0.20";"2.39";"4.23";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3894314";"";"None";"453.53";"0";"1.67";"BDBM187659";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC1CCS(=O)(=O)C1";"IC50";"'='";"15.3";"nM";"7.82";"";"337344";"UO_0000065";"17.23";"0.33";"6.15";"5.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106742";"";"None";"468.51";"0";"3.44";"BDBM187464";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCC1(F)CCC1";"IC50";"'='";"1.5";"nM";"8.82";"";"337200";"UO_0000065";"18.83";"0.35";"5.38";"7.62";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111593";"";"None";"409.47";"0";"3.23";"BDBM187761";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)C";"IC50";"'='";"9.2";"nM";"8.04";"";"337446";"UO_0000065";"19.63";"0.37";"4.81";"7.41";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3951721";"";"None";"406.45";"0";"1.61";"BDBM188022";"CCCCNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC1COC1";"IC50";"'='";"5.3";"nM";"8.28";"";"337691";"UO_0000065";"20.36";"0.38";"6.67";"5.76";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586495";"";"None";"443.56";"0";"4.06";"17";"Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"16.52";"0.30";"3.27";"9.12";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4295137";"";"None";"260.34";"0";"2.51";"9";"CN(C)[C@H]1CC[C@H](Nc2ncnc3ccoc23)CC1";"IC50";"'='";"4080.0";"nM";"5.39";"";"";"UO_0000065";"20.70";"0.39";"2.88";"9.95";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4294023";"";"None";"343.48";"0";"2.91";"28";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c12";"IC50";"'='";"267.0";"nM";"6.57";"";"";"UO_0000065";"19.14";"0.36";"3.66";"12.02";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3946225";"";"None";"593.64";"2";"5.40";"BDBM189112";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(C(F)(F)F)cc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338970";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3892227";"";"None";"475.51";"0";"3.12";"BDBM188766";"COC(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(OC)cc3)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338621";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3967276";"";"None";"405.48";"0";"3.62";"BDBM206143";"O=C(Nc1cc2cccnc2cc1OC1CCNCC1)c1csc2cncnc12";"IC50";"'='";"125.0";"nM";"6.90";"";"364814";"UO_0000065";"17.02";"0.33";"3.28";"7.75";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3922852";"";"None";"443.51";"0";"4.14";"BDBM188737";"CON=C1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338592";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3913498";"";"None";"433.49";"0";"3.42";"BDBM188794";"Cc1ccc(-n2nc(C3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1";"IC50";"'<'";"1000.0";"nM";"";"";"338649";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586493";"";"None";"401.47";"0";"2.94";"BDBM188741";"Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338596";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3899478";"";"None";"558.64";"1";"3.12";"BDBM188976";"COCCOC(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1";"IC50";"'<'";"1000.0";"nM";"";"";"338831";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3952093";"";"None";"575.57";"1";"3.74";"BDBM188753";"O=C(Nc1cc(C2CCN(S(=O)(=O)C3CC3)CC2)nn1-c1ccc(OC(F)(F)F)cc1)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338608";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3343042";"";"None";"506.57";"2";"5.39";"12a";"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(NCCc3ccccn3)nc2cc1O";"IC50";"'='";"579.0";"nM";"6.24";"";"";"UO_0000065";"12.31";"0.22";"0.85";"5.14";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL3590438";"";"None";"343.35";"0";"-0.82";"10";"Cn1cc(NC(=O)c2cnn3ccc(NCCN)nc23)c(C(N)=O)n1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"25.34";"0.48";"9.52";"5.50";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3590483";"";"None";"432.49";"0";"1.85";"23";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(-c2cncnc2)n1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"15.71";"0.29";"4.95";"4.82";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3590515";"";"None";"426.38";"0";"1.83";"34";"Cn1cc(NC(=O)c2cnn3ccc(N4C[C@H](N)CC(F)(F)C4)nc23)c(C(F)F)n1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"21.81";"0.42";"7.47";"8.74";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4079243";"";"None";"359.38";"0";"0.87";"33";"COC[C@@H]1CC(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"IC50";"'='";"373.0";"nM";"6.43";"";"";"UO_0000065";"17.89";"0.34";"5.56";"5.70";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3907139";"";"None";"512.60";"1";"1.01";"BDBM187909";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCNS(=O)(=O)N1CCOCC1";"IC50";"'='";"5.2";"nM";"8.28";"";"337584";"UO_0000065";"16.16";"0.31";"7.27";"5.37";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3921676";"";"None";"439.50";"0";"1.15";"BDBM187910";"CS(=O)(=O)NCCNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CC1";"IC50";"'='";"4.4";"nM";"8.36";"";"337585";"UO_0000065";"19.01";"0.37";"7.21";"5.89";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108546";"";"None";"550.64";"1";"3.02";"BDBM188110";"CC(C)NC(=O)[C@H]1CC[C@H](Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)CC1";"IC50";"'='";"6.4";"nM";"8.19";"";"337773";"UO_0000065";"14.88";"0.28";"5.17";"5.19";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107445";"";"None";"540.91";"1";"3.81";"BDBM187817";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1Nc1cnn(CC(F)(F)F)c1";"IC50";"'='";"1.5";"nM";"8.82";"";"337494";"UO_0000065";"16.31";"0.33";"5.01";"7.19";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107137";"";"None";"474.50";"0";"3.58";"BDBM187445";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(O)c1";"IC50";"'='";"2.2";"nM";"8.66";"";"337181";"UO_0000065";"18.25";"0.34";"5.08";"6.36";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586501";"";"None";"495.57";"0";"2.31";"BDBM188750";"COc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338605";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110321";"";"None";"386.48";"0";"2.22";"BDBM203506";"CC(C)[C@H]1C[C@@H](Nc2nc[nH]c(=O)c2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"850.0";"nM";"6.07";"";"360966";"UO_0000065";"15.71";"0.31";"3.85";"5.46";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"40; PF-06650833";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"24.07";"0.46";"7.12";"8.40";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4109546";"";"None";"493.54";"0";"2.16";"BDBM187926";"CC(=O)N1CC[C@@H](Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1";"IC50";"'='";"2.9";"nM";"8.54";"";"337601";"UO_0000065";"17.30";"0.32";"6.38";"6.27";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4473656";"";"None";"390.45";"0";"2.66";"6";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)c2)c(C(N)=O)n1";"IC50";"'='";"428.0";"nM";"6.37";"";"";"UO_0000065";"16.31";"0.30";"3.71";"5.54";"0";"CHEMBL4427853";"Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL3601196";"";"None";"477.59";"0";"3.63";"30";"Cc1cc(Nc2cc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)cn2)cc(C)n1";"IC50";"'='";"3452.0";"nM";"5.46";"";"";"UO_0000065";"11.44";"0.22";"1.83";"4.43";"0";"CHEMBL3603426";"Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL4076912";"";"None";"343.38";"0";"1.49";"36";"COc1cc2c(OC[C@H]3NC(=O)[C@@H](C)[C@H]3C)nccc2cc1C(N)=O";"IC50";"'='";"2836.0";"nM";"5.55";"";"";"UO_0000065";"16.15";"0.30";"4.06";"5.36";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3403439";"";"None";"374.43";"0";"0.24";"20";"Nc1ncc(-c2nc3cccnc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"16.76";"0.33";"6.04";"4.18";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3403456";"";"None";"451.51";"1";"1.80";"37";"OC[C@H]1C[C@@H](Nc2nc(Nc3cncnc3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"11.57";"0.22";"3.42";"3.50";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3403457";"";"None";"479.57";"1";"2.42";"38";"Cc1cc(Nc2ncc(-c3nc4ccncc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"13.60";"0.26";"4.10";"4.37";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3403431";"";"None";"441.44";"0";"1.87";"10";"Nc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(C(F)(F)F)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4101382";"";"None";"432.48";"1";"2.57";"33";"CNC(=O)c1cnc(Nc2ccc3[nH]ncc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"19.42";"0.36";"5.83";"6.21";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4107577";"";"None";"515.55";"1";"3.23";"BDBM187454";"CNC(=O)c1cccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)c1";"IC50";"'='";"3.6";"nM";"8.44";"";"337190";"UO_0000065";"16.38";"0.30";"5.21";"5.82";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3973778";"";"None";"435.53";"0";"2.67";"BDBM187481";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cncnc43)cc2NC(C)C)CC1";"IC50";"'='";"14.2";"nM";"7.85";"";"337216";"UO_0000065";"18.02";"0.33";"5.18";"6.89";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3403426";"";"None";"398.45";"0";"0.72";"3";"N#Cc1nc(N)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4643871";"";"None";"431.54";"0";"4.09";"11";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"13.21";"0.26";"1.61";"5.75";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4075955";"";"None";"449.54";"0";"3.30";"1";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"14.51";"0.28";"3.22";"5.46";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4633251";"";"None";"341.44";"0";"3.61";"3";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C";"IC50";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"15.66";"0.30";"1.74";"6.77";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4647567";"";"None";"411.53";"0";"3.90";"10";"CC(C)(O)CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"19.44";"0.38";"4.10";"8.07";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4639599";"";"None";"355.47";"0";"4.00";"5";"CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4641090";"";"None";"415.47";"0";"2.53";"20";"CC(C)Nc1cc(Nc2ccn3nccc3n2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"15.57";"0.29";"3.94";"5.55";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4471452";"";"None";"383.50";"0";"3.05";"9";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C)cc34)CC2)CC1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"19.35";"0.36";"4.37";"10.51";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3601194";"";"None";"426.54";"0";"2.84";"28";"OC[C@H]1C[C@@H](Nc2cc(NC3CCC3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"204.0";"nM";"6.69";"";"";"UO_0000065";"15.69";"0.30";"3.85";"6.05";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601189";"";"None";"474.52";"0";"2.35";"22";"COc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"17.06";"0.32";"5.75";"5.56";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601086";"";"None";"413.44";"1";"0.32";"17";"COc1cc(Nc2ncc(-n3cccn3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"6008.0";"nM";"5.22";"";"";"UO_0000065";"12.63";"0.24";"4.90";"3.47";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601081";"";"None";"451.51";"1";"1.80";"12";"OC[C@H]1C[C@@H](Nc2nc(Nc3cccnc3)ncc2-c2nc3ccncc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"17.15";"0.33";"5.94";"5.19";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4645407";"";"None";"432.53";"0";"3.49";"17";"CC(C)Nc1cc(Nc2ccc3nsnc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"15.02";"0.30";"3.00";"5.80";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4632511";"";"None";"383.52";"0";"4.79";"7";"CCCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL288441";"BOSUTINIB";"4.0";"530.46";"2";"5.19";"SKI-606";"COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl";"IC50";"'='";"574.0";"nM";"6.24";"";"";"UO_0000065";"11.77";"0.24";"1.05";"7.53";"0";"CHEMBL1244586";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240341";"1";"Scientific Literature";"Leukemia";"2009";"None";""
"CHEMBL4452662";"";"None";"459.55";"0";"3.62";"10";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)NC2CCCC2)n1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4530226";"";"None";"395.42";"0";"1.29";"27";"COCCNc1cc(-c2cccc(C(=O)Nc3cn(C)nc3C(N)=O)n2)ccn1";"IC50";"'='";"187.0";"nM";"6.73";"";"";"UO_0000065";"17.02";"0.32";"5.44";"4.91";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4452521";"";"None";"432.53";"0";"3.03";"5";"Cn1cc(Nc2nc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c3cc(C#N)ccc3n2)cn1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"20.11";"0.37";"5.67";"8.37";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3590479";"";"None";"404.43";"0";"2.33";"26";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)F)n1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"20.76";"0.40";"6.07";"7.29";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4113269";"";"None";"460.49";"0";"2.12";"BDBM188078";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(O)C1";"IC50";"'='";"22.7";"nM";"7.64";"";"337741";"UO_0000065";"16.60";"0.32";"5.52";"6.11";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111696";"";"None";"515.55";"1";"3.83";"BDBM187453";"CC(=O)Nc1cccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)c1";"IC50";"'='";"1.8";"nM";"8.74";"";"337189";"UO_0000065";"16.96";"0.31";"4.91";"6.03";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107885";"";"None";"426.50";"0";"2.70";"BDBM188033";"CC(C)Nc1cc(N2CCc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"9.9";"nM";"8.00";"";"337699";"UO_0000065";"18.77";"0.35";"5.30";"7.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115045";"";"None";"495.56";"0";"2.63";"BDBM188076";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@@](C)(O)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"337739";"UO_0000065";"16.95";"0.32";"5.77";"5.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4473269";"";"None";"393.45";"0";"2.53";"5; DHBF-23";"CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"21.46";"0.40";"5.91";"10.43";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4294023";"";"None";"343.48";"0";"2.91";"28";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c12";"IC50";"'='";"269.15";"nM";"6.57";"";"";"UO_0000065";"19.13";"0.36";"3.66";"12.01";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL255272";"";"None";"293.37";"0";"2.58";"3";"c1cc(NC2CCNCC2)nc(-n2cnc3ccccc32)c1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"24.39";"0.44";"4.57";"13.06";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4097847";"";"None";"276.41";"0";"2.98";"6";"CN(C)[C@H]1CC[C@H](Nc2ncnc3sccc23)CC1";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"19.42";"0.39";"2.39";"13.07";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4295137";"";"None";"260.34";"0";"2.51";"9";"CN(C)[C@H]1CC[C@H](Nc2ncnc3ccoc23)CC1";"IC50";"'='";"4073.8";"nM";"5.39";"";"";"UO_0000065";"20.70";"0.39";"2.88";"9.95";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4282412";"";"None";"343.48";"0";"2.91";"21";"CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc(C4CCOCC4)c23)CC1";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"20.41";"0.38";"4.10";"12.82";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3343047";"";"None";"377.40";"0";"3.49";"16b";"COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)c(N)cc1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL4073250";"";"None";"329.36";"0";"1.39";"22";"CCOc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O";"IC50";"'='";"672.0";"nM";"6.17";"";"";"UO_0000065";"18.74";"0.35";"4.78";"5.96";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4790193";"";"None";"509.57";"1";"4.03";"6";"CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2ccc(NC(=O)c3cccc(-c4ccn[nH]4)n3)cc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731588";"Inhibition of IRAK4 (unknown origin) using methylcoumarin-labeled peptide as substrate in presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725474";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4276955";"";"None";"301.44";"0";"3.30";"17";"CC(C)n1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c21";"IC50";"'='";"69.18";"nM";"7.16";"";"";"UO_0000065";"23.75";"0.44";"3.86";"15.57";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3586491";"";"None";"400.49";"0";"4.52";"13";"Cc1ccc(-n2nc(C3CCCCC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"14.03";"0.26";"1.10";"7.29";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3621219";"";"None";"459.53";"0";"0.40";"18";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"17.32";"0.34";"7.56";"5.53";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3343058";"";"None";"423.43";"0";"2.13";"37";"CCNC(=O)Nc1ccc(NC(=O)c2cc(OC)cc(-c3c[nH]c(=O)[nH]c3=O)c2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL3586505";"";"None";"480.55";"0";"2.01";"BDBM188887";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338744";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3969090";"";"None";"487.55";"0";"3.51";"BDBM188837";"Cc1ccc(-n2nc(-c3ccc(NS(C)(=O)=O)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338692";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3943605";"";"None";"538.41";"1";"2.94";"BDBM188846";"Cc1ccc(-n2nc(C3CCN(C(=O)CO)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338701";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4085735";"";"None";"301.44";"0";"3.37";"14";"CC(C)c1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"27.54";"0.52";"4.93";"14.60";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4285338";"";"None";"384.53";"0";"2.77";"24";"CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"44.67";"nM";"7.35";"";"";"UO_0000065";"19.11";"0.36";"4.58";"8.30";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4283453";"";"None";"385.51";"0";"2.74";"27";"CN(C)[C@H]1CC[C@H](Oc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"2344.23";"nM";"5.63";"";"";"UO_0000065";"14.60";"0.27";"2.89";"6.57";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4073229";"";"None";"431.52";"0";"3.86";"27";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1c2ccccc2C[C@@H]1O";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"13.21";"0.25";"1.84";"5.75";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4114107";"";"None";"398.44";"0";"2.23";"BDBM187440";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cncnc32)cc1NC1CC1";"IC50";"'='";"1.9";"nM";"8.72";"";"337176";"UO_0000065";"21.89";"0.41";"6.49";"8.31";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3940719";"";"None";"498.59";"0";"3.41";"BDBM187615";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](O)(c2ccnn2C)CC1";"IC50";"'='";"2.3";"nM";"8.64";"";"337308";"UO_0000065";"17.33";"0.32";"5.23";"6.46";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3898331";"";"None";"498.59";"0";"3.41";"BDBM187620";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](O)(c2nccn2C)CC1";"IC50";"'='";"6.4";"nM";"8.19";"";"337311";"UO_0000065";"16.43";"0.30";"4.78";"6.13";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3899111";"";"None";"495.59";"0";"4.07";"BDBM187622";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](O)(c2ccccn2)CC1";"IC50";"'='";"3.7";"nM";"8.43";"";"337313";"UO_0000065";"17.01";"0.31";"4.36";"6.55";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110352";"";"None";"540.56";"2";"3.07";"BDBM187468";"Cn1nnnc1-c1ccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cc1";"IC50";"'='";"1.3";"nM";"8.89";"";"337204";"UO_0000065";"16.44";"0.30";"5.82";"5.57";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112926";"";"None";"454.51";"0";"2.31";"BDBM187476";"CC(C)(O)CNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.6";"nM";"8.59";"";"337212";"UO_0000065";"18.89";"0.36";"6.28";"6.31";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586507";"";"None";"481.54";"0";"1.40";"BDBM188904";"Cc1cnc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338759";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3343039";"";"None";"443.46";"0";"3.50";"7c";"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(N)=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL403490";"";"None";"293.37";"0";"2.20";"43";"c1cc(-c2cnc3ccccn23)nc(N2CCCNCC2)c1";"IC50";"'='";"487.0";"nM";"6.31";"";"";"UO_0000065";"21.52";"0.39";"4.11";"13.89";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL402079";"";"None";"293.37";"0";"2.32";"41";"NC1CCN(c2cccc(-c3cnc4ccccn34)n2)CC1";"IC50";"'='";"1880.0";"nM";"5.73";"";"";"UO_0000065";"19.52";"0.36";"3.41";"9.63";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL255439";"";"None";"307.40";"0";"2.81";"35";"c1cc(NCC2CCNCC2)nc(-c2cnc3ccccn23)c1";"IC50";"'='";"3030.0";"nM";"5.52";"";"";"UO_0000065";"17.95";"0.33";"2.71";"10.17";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL1270795";"";"None";"343.44";"0";"3.35";"10i";"CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1";"IC50";"'='";"167.0";"nM";"6.78";"";"";"UO_0000065";"19.73";"0.40";"3.43";"8.09";"0";"CHEMBL1805337";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1799927";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL3906505";"";"None";"482.60";"1";"3.38";"BDBM203283";"CC(C)Nc1cc(Nc2ccc3nsnc3c2)ncc1-c1nnc(C(=O)N2CC[C@@H](O)C2)s1";"IC50";"'='";"2.5";"nM";"8.60";"";"360844";"UO_0000065";"17.82";"0.36";"5.22";"6.67";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4584820";"";"None";"436.52";"0";"1.81";"38";"CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(CCO)CC3)cc2O1";"IC50";"'='";"97.0";"nM";"7.01";"";"";"UO_0000065";"16.07";"0.30";"5.20";"7.36";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL428598";"";"None";"315.79";"0";"4.11";"3b";"O=C(Nc1ccccc1Cl)c1cccc(-c2cncs2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL485323";"";"None";"365.44";"0";"1.41";"2";"CNC(=O)CN1CCC(Nc2nccc(-c3cnc4ccccn34)n2)CC1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"15.11";"0.28";"4.11";"6.32";"0";"CHEMBL956501";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL256963";"";"None";"299.77";"0";"2.43";"44";"Clc1ccc2ncc(-c3cccc(NC4CNC4)n3)n2c1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"27.43";"0.53";"5.79";"15.16";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL255098";"";"None";"294.36";"0";"1.96";"1";"c1ccn2c(-c3ccnc(NC4CCNCC4)n3)cnc2c1";"IC50";"'='";"216.0";"nM";"6.67";"";"";"UO_0000065";"22.64";"0.41";"4.71";"9.93";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL3341771";"";"None";"457.45";"0";"2.64";"24a";"COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL3960442";"";"None";"442.53";"0";"3.25";"BDBM188881";"CN1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cn3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338736";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3353203";"";"None";"430.51";"0";"2.00";"37";"O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CNCC[C@@H]2F)c1-c1nc2ccccc2s1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"18.24";"0.36";"5.85";"8.25";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3897625";"";"None";"505.60";"1";"3.15";"BDBM188760";"Cc1ccc(-n2nc(C3CCN(S(=O)(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338615";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3975374";"";"None";"460.50";"0";"2.21";"BDBM188839";"COc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cc(NC=O)cnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338694";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3946413";"";"None";"346.77";"0";"2.66";"BDBM206211";"COCCOc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"1710.0";"nM";"5.77";"";"364882";"UO_0000065";"16.63";"0.33";"3.11";"7.42";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4077863";"";"None";"446.51";"0";"2.58";"34";"CNC(=O)c1cnc(Nc2ccc3c(cnn3C)c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"11.87";"0.22";"2.72";"4.26";"0";"CHEMBL4047625";"Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3586483";"";"None";"394.44";"0";"4.14";"2";"Cc1ccc(-n2nc(-c3ccccc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"690.0";"nM";"6.16";"";"";"UO_0000065";"15.62";"0.28";"2.02";"7.99";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3586497";"";"None";"444.50";"0";"2.73";"19";"Cc1ccc(-n2nc(C3CCN(C(N)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"14.98";"0.28";"3.93";"5.39";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4535152";"";"None";"392.42";"0";"1.45";"7";"Cn1cc(NC(=O)c2ccnc(-c3ccnc(NCC4CC4)c3)n2)c(C(N)=O)n1";"IC50";"'='";"285.0";"nM";"6.54";"";"";"UO_0000065";"16.68";"0.31";"5.10";"4.65";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3952633";"";"None";"477.52";"0";"4.18";"BDBM188783";"O=C(Nc1cc(C2CCN(C3CCC3)CC2)nn1-c1ccc(F)cc1F)c1cnn2cccnc12";"IC50";"'<'";"100.0";"nM";"";"";"338638";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL255873";"";"None";"318.38";"0";"2.43";"16";"N#Cc1ccc2ncc(-c3cccc(NC4CCNCC4)n3)n2c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"26.38";"0.48";"5.97";"10.76";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL207226";"";"None";"352.39";"0";"4.39";"32";"CCCCCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"13.33";"0.25";"0.31";"5.22";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL4472816";"";"None";"488.60";"0";"2.63";"13";"CN1CCC(CNC(=O)c2nn(C)cc2NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)C1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"12.56";"0.23";"3.51";"5.24";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4287208";"";"None";"276.41";"0";"2.98";"8";"CN(C)[C@H]1CC[C@H](Nc2ncnc3ccsc23)CC1";"IC50";"'='";"602.56";"nM";"6.22";"";"";"UO_0000065";"22.50";"0.45";"3.24";"15.15";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4436754";"";"None";"327.37";"0";"1.89";"36";"Cn1cc(NC(=O)c2cccc(-c3ccsc3)n2)c(C(N)=O)n1";"IC50";"'='";"401.0";"nM";"6.40";"";"";"UO_0000065";"19.54";"0.38";"4.51";"6.22";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL414028";"";"None";"366.45";"0";"3.29";"2m";"O=C(Nc1ccc(N2CCOCC2)cc1)c1csc(-c2cccnc2)n1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"15.15";"0.29";"2.26";"8.24";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL260339";"";"None";"281.34";"0";"3.46";"2b";"O=C(Nc1ccccc1)c1csc(-c2cccnc2)n1";"IC50";"'='";"7200.0";"nM";"5.14";"";"";"UO_0000065";"18.28";"0.35";"1.68";"9.37";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4063689";"";"None";"273.38";"0";"2.55";"13";"Cc1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"30.36";"0.57";"5.75";"14.60";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL254545";"";"None";"309.39";"0";"4.07";"2o";"Cc1cccc(C)c1NC(=O)c1csc(-c2cccnc2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4059689";"";"None";"381.51";"0";"4.54";"18";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CCCCC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"20.18";"0.39";"3.16";"9.75";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4075948";"";"None";"343.41";"0";"2.20";"22";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NCCO";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"19.71";"0.39";"4.57";"6.83";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4293607";"";"None";"427.55";"0";"1.60";"33";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1";"IC50";"'='";"21.38";"nM";"7.67";"";"";"UO_0000065";"17.94";"0.34";"6.07";"7.05";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4112525";"";"None";"524.91";"1";"4.49";"BDBM187859";"CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"2.5";"nM";"8.60";"";"337536";"UO_0000065";"16.39";"0.33";"4.11";"8.39";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112384";"";"None";"489.52";"0";"2.87";"BDBM187861";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cc(C2CC2)n[nH]1";"IC50";"'='";"1.1";"nM";"8.96";"";"337538";"UO_0000065";"18.30";"0.34";"6.09";"5.69";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3343055";"";"None";"459.46";"0";"3.04";"33";"COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(N2CCC(=O)NC2=O)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL4078264";"";"None";"397.50";"0";"3.51";"24";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1CCC[C@H](O)C1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"19.12";"0.37";"4.09";"7.67";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4059465";"";"None";"417.47";"0";"2.56";"35";"CNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"19.88";"0.37";"5.74";"6.37";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4521212";"";"None";"479.59";"0";"2.92";"12";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C)nc34)CC2)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"14.29";"0.27";"3.93";"6.05";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4452765";"";"None";"476.54";"0";"2.20";"16";"O=C(Nc1cc2c(cc1N1CCOCC1)C(=O)N(CC1CCOCC1)C2)c1cnn2cccnc12";"IC50";"'='";"0.47";"nM";"9.33";"";"";"UO_0000065";"19.57";"0.36";"7.13";"9.21";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4282348";"";"None";"467.62";"0";"2.38";"32";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H]5CC[C@H](C(N)=O)CC5)c34)CC2)CC1";"IC50";"'='";"77.62";"nM";"7.11";"";"";"UO_0000065";"15.20";"0.29";"4.73";"6.53";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3343044";"";"None";"363.37";"0";"3.30";"14a";"COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)ccc1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL3343038";"";"None";"444.45";"0";"4.10";"7b";"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(=O)O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL4649875";"";"None";"413.55";"0";"4.15";"9";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCC(C)(C)O";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"20.28";"0.39";"4.24";"8.46";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3915142";"";"None";"386.84";"0";"3.32";"BDBM206190";"O=C(Nc1cc(Cl)ccc1OC1CCCC(O)C1)c1cnn2cccnc12";"IC50";"'='";"605.0";"nM";"6.22";"";"364861";"UO_0000065";"16.07";"0.31";"2.90";"7.01";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3915495";"";"None";"411.43";"0";"3.24";"BDBM188861";"COc1ccc(-n2nc(-c3ccncc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338716";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4455718";"";"None";"394.48";"0";"2.61";"4";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"17.23";"0.32";"4.19";"7.20";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3634509";"";"None";"407.45";"0";"2.78";"39";"Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCNC4)nc23)c(C(F)F)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"20.92";"0.42";"5.74";"8.81";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3353198";"";"None";"432.51";"0";"3.42";"32";"Nc1ccc(-c2cccc(C(=O)Nc3ccc4nc(N5CCOCC5)sc4c3)n2)cn1";"IC50";"'<'";"50.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380184";"Inhibition of IRAK4 (unknown origin) by TR-FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3634501";"";"None";"440.40";"0";"2.58";"31";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CC(F)(F)CC[C@@H]4N)nn23)c(C(F)F)n1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"15.56";"0.30";"4.27";"5.95";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3353220";"";"None";"408.49";"0";"2.90";"BDBM50040727";"COc1cc2ncccc2cc1NC(=O)c1csc2cnc(N(C)CCN)nc12";"IC50";"'='";"8.0";"nM";"8.10";"";"364765";"UO_0000065";"19.82";"0.38";"5.20";"7.62";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3634503";"";"None";"408.39";"0";"1.90";"33";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCNC4)nn23)c(C(F)(F)F)n1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"18.29";"0.35";"5.57";"7.38";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3986856";"";"None";"478.00";"0";"4.72";"BDBM188800";"Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)c(Cl)c1";"IC50";"'<'";"1000.0";"nM";"";"";"338655";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3950375";"";"None";"499.59";"0";"4.92";"BDBM188809";"O=C(Nc1cc(C2CCN(C3CCC3)CC2)nn1-c1ccc(C2CC2)cc1F)c1cnn2cccnc12";"IC50";"'<'";"100.0";"nM";"";"";"338664";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3735401";"";"None";"465.56";"0";"4.42";"6; JH-VIII-157-02";"CCc1cc2c(cc1-c1cnn(CC(=O)N(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O";"IC50";"'='";"465.0";"nM";"6.33";"";"";"UO_0000065";"13.60";"0.25";"1.91";"6.68";"0";"CHEMBL3748848";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745656";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4787051";"";"None";"1044.33";"None";"None";"13";"Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)CCC(=O)N2CCN([C@H]3CC[C@@H](Nc4ncnn5ccc(C(C)C)c45)CC3)CC2)C(C)(C)C)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL3353193";"";"None";"427.88";"0";"3.67";"26";"CC(C)Nc1cc(Nc2ncc(Cl)cc2F)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"19.76";"0.40";"4.79";"8.53";"0";"CHEMBL3380182";"Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3634512";"";"None";"388.86";"0";"2.05";"42";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(Cl)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"20.37";"0.40";"5.87";"6.88";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634514";"";"None";"387.88";"0";"2.66";"44";"Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(Cl)n1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"20.33";"0.40";"5.23";"7.71";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3745885";"";"None";"467.46";"0";"3.66";"7ao; ON1231320";"Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3748221";"Inhibition of human IRAK4 using MBP as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745707";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";""
"CHEMBL3634502";"";"None";"408.39";"0";"1.90";"32";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCNC4)nc23)c(C(F)(F)F)n1";"IC50";"'<'";"0.5";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4559589";"";"None";"356.77";"0";"1.88";"31";"Cn1cc(NC(=O)c2cccc(-c3cncc(Cl)c3)n2)c(C(N)=O)n1";"IC50";"'='";"106.0";"nM";"6.97";"";"";"UO_0000065";"19.55";"0.38";"5.09";"6.02";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3353190";"";"None";"434.90";"0";"3.40";"23";"CC(C)Nc1cc(Nc2ncc(C#N)cc2Cl)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"20.05";"0.40";"5.32";"7.09";"0";"CHEMBL3380182";"Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4109069";"";"None";"545.51";"2";"2.38";"BDBM187868";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(-c2ncc(F)cn2)c1";"IC50";"'='";"1.6";"nM";"8.80";"";"337545";"UO_0000065";"16.12";"0.30";"6.42";"5.10";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3895603";"";"None";"463.95";"0";"3.10";"BDBM187733";"CC[C@H](C)Nc1cc(-n2ncc3cc(Cl)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.9";"nM";"8.72";"";"337418";"UO_0000065";"18.80";"0.37";"5.62";"6.66";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4094792";"";"None";"397.50";"0";"3.51";"25";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1CCC[C@@H](O)C1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"20.02";"0.39";"4.45";"8.03";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4098137";"";"None";"397.50";"0";"3.51";"20";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1CCCC[C@H]1O";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"17.32";"0.34";"3.38";"6.94";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4526990";"";"None";"391.44";"0";"2.05";"4";"Cn1cc(NC(=O)c2ccnc(-c3ccnc(NCC4CC4)c3)c2)c(C(N)=O)n1";"IC50";"'='";"1449.0";"nM";"5.84";"";"";"UO_0000065";"14.92";"0.27";"3.79";"4.57";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4473269";"";"None";"393.45";"0";"2.53";"23";"CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"17.21";"0.32";"4.24";"8.36";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4456286";"";"None";"418.46";"0";"2.40";"30";"CC1(C)Cc2cc(NC(=O)c3cnn4cc(C#N)cnc34)c(N3CCOCC3)cc2O1";"IC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"16.91";"0.31";"4.68";"6.75";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3353187";"";"None";"432.87";"0";"1.94";"20";"Cc1cc(-c2nc(C(=O)Nc3cn(C4CCOCC4)nc3C(N)=O)co2)ccn1.Cl";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"19.37";"0.36";"5.74";"5.56";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"40; PF-06650833";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"26.84";"0.51";"8.12";"9.37";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3601082";"";"None";"400.46";"0";"1.25";"13";"OC[C@H]1C[C@@H](Nc2nc(Nc3ccncc3)ncc2-c2nccs2)[C@H](O)[C@@H]1O";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3353206";"";"None";"325.33";"0";"0.57";"37";"Cn1cc(-c2cccc(C(=O)Nc3cn(C)nc3C(N)=O)n2)cn1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"22.88";"0.42";"6.87";"6.17";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3919594";"";"None";"380.43";"0";"3.25";"BDBM206145";"O=C(Nc1cc2cccnc2cc1OCCCO)c1csc2cncnc12";"IC50";"'='";"131.0";"nM";"6.88";"";"364816";"UO_0000065";"18.09";"0.35";"3.63";"7.08";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4068348";"";"None";"313.39";"0";"2.84";"16";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"19.58";"0.38";"3.30";"7.77";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4065667";"";"None";"447.50";"1";"2.19";"31";"CNC(=O)c1cnc(Nc2ccc3c(c2)CC(=O)N3)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"12.84";"0.24";"3.55";"4.24";"0";"CHEMBL4047625";"Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3601075";"";"None";"481.54";"1";"1.81";"6";"COc1cc(Nc2ncc(-c3nc4cnccc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"16.94";"0.33";"6.34";"5.15";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3622512";"";"None";"443.53";"0";"1.16";"12";"O=c1[nH]c(N2CCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"17.46";"0.34";"6.58";"5.75";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL2063926";"";"None";"505.70";"1";"3.58";"17";"CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12";"IC50";"'<'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2065149";"Inhibition of IRAK4 by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062359";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL4582624";"";"None";"504.60";"2";"2.68";"13";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"16.64";"0.31";"5.72";"6.12";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3343037";"";"None";"430.46";"0";"4.01";"7a";"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCO";"IC50";"'='";"24400.0";"nM";"4.61";"";"";"UO_0000065";"10.72";"0.20";"0.60";"4.37";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL4645407";"";"None";"432.53";"0";"3.49";"17";"CC(C)Nc1cc(Nc2ccc3nsnc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"19.55";"0.38";"4.97";"7.55";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4528699";"";"None";"378.48";"0";"2.39";"3";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"16.85";"0.31";"3.99";"7.49";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4283847";"";"None";"259.36";"0";"2.24";"10";"CN(C)[C@H]1CC[C@H](Nc2ncnc3cc[nH]c23)CC1";"IC50";"'='";"1770.0";"nM";"5.75";"";"";"UO_0000065";"22.18";"0.41";"3.51";"10.12";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3918584";"";"None";"532.63";"1";"3.11";"BDBM188884";"O=C(Nc1cc(C2CCN(S(=O)(=O)C3CC3)CC2)nn1-c1ccc(C2CC2)cn1)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338739";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622525";"";"None";"428.52";"0";"1.02";"BDBM203548";"O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CNC[C@H](O)C2)c1-c1nc2ccccc2s1";"IC50";"'='";"85.0";"nM";"7.07";"";"361028";"UO_0000065";"16.50";"0.32";"6.05";"6.13";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113628";"";"None";"527.51";"1";"3.12";"BDBM187822";"CC(F)(F)Cn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"1.7";"nM";"8.77";"";"337499";"UO_0000065";"16.62";"0.32";"5.65";"5.98";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112750";"";"None";"466.52";"0";"2.46";"BDBM187427";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCC1(O)CCC1";"IC50";"'='";"2.8";"nM";"8.55";"";"337163";"UO_0000065";"18.33";"0.34";"6.09";"6.28";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109995";"";"None";"411.44";"0";"1.96";"BDBM187574";"CCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"6.4";"nM";"8.19";"";"337273";"UO_0000065";"19.91";"0.37";"6.23";"6.36";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3944928";"";"None";"455.52";"0";"3.49";"BDBM187710";"COc1ccc(CCNC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)cc1";"IC50";"'='";"3.4";"nM";"8.47";"";"337395";"UO_0000065";"18.59";"0.34";"4.98";"7.19";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3965584";"";"None";"406.49";"0";"3.00";"BDBM187410";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(C)O";"IC50";"'='";"1.7";"nM";"8.77";"";"337146";"UO_0000065";"21.57";"0.40";"5.77";"7.57";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114108";"";"None";"454.51";"0";"2.58";"BDBM187770";"COC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC(C)C";"IC50";"'='";"3.1";"nM";"8.51";"";"337455";"UO_0000065";"18.72";"0.35";"5.93";"5.92";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3925564";"";"None";"448.53";"0";"2.77";"BDBM187411";"CC(C)(O)CCNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCOCC1";"IC50";"'='";"1.7";"nM";"8.77";"";"337147";"UO_0000065";"19.55";"0.36";"6.00";"7.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110171";"";"None";"533.57";"2";"2.82";"BDBM187806";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(C2CCOCC2)c1";"IC50";"'='";"3.3";"nM";"8.48";"";"337483";"UO_0000065";"15.90";"0.30";"5.66";"5.44";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107284";"";"None";"484.51";"0";"2.67";"BDBM187510";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCOCC1F";"IC50";"'='";"1.8";"nM";"8.74";"";"337242";"UO_0000065";"18.05";"0.34";"6.07";"6.99";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109217";"";"None";"464.42";"0";"3.11";"BDBM187404";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCC(F)(F)F";"IC50";"'='";"2.3";"nM";"8.64";"";"337140";"UO_0000065";"18.60";"0.36";"5.53";"7.46";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3977557";"";"None";"451.55";"0";"4.19";"BDBM187887";"CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(F)cnc43)cc2NC2CC2)CC1";"IC50";"'='";"4.6";"nM";"8.34";"";"337562";"UO_0000065";"18.46";"0.35";"4.15";"9.06";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3898670";"";"None";"494.56";"0";"3.48";"BDBM189049";"COc1cccc(CN2CC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)C2)n1";"IC50";"'<'";"100.0";"nM";"";"";"338904";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3972360";"";"None";"416.49";"0";"2.68";"BDBM189130";"Cc1ccc(-n2nc(C3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338988";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111572";"";"None";"494.65";"0";"2.99";"BDBM203591";"O=c1[nH]c(N2CCN(c3nccs3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"12.0";"nM";"7.92";"";"361072";"UO_0000065";"16.01";"0.32";"4.93";"7.76";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3936996";"";"None";"485.59";"0";"3.83";"BDBM188940";"Cc1ccc(-n2nc(C3CCN(C4CCOCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338795";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115108";"";"None";"454.51";"0";"2.31";"BDBM187881";"CC(O)CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.9";"nM";"8.54";"";"337594";"UO_0000065";"18.78";"0.35";"6.23";"6.27";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3956292";"";"None";"541.69";"1";"4.38";"BDBM189020";"Cc1ccc(-n2nc(C3CCCN(Cc4cnc(N(C)C)s4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338875";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3925792";"";"None";"282.30";"0";"2.30";"BDBM206240";"COc1ccc(C)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"3769.0";"nM";"5.42";"";"364911";"UO_0000065";"19.21";"0.35";"3.12";"7.92";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3940329";"";"None";"298.30";"0";"2.00";"BDBM206245";"COc1ccc(NC(=O)c2cnn3cccnc23)c(OC)c1";"IC50";"'='";"4169.0";"nM";"5.38";"";"364916";"UO_0000065";"18.04";"0.33";"3.38";"6.92";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4799481";"";"None";"452.47";"0";"4.10";"2";"C=CC(=O)Nc1ccc(C(=O)Nc2ccc(NC(=O)c3cccc(-c4ccn[nH]4)n3)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731588";"Inhibition of IRAK4 (unknown origin) using methylcoumarin-labeled peptide as substrate in presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725474";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3941904";"";"None";"453.51";"0";"2.80";"BDBM189040";"Cc1ccc(-n2nc(C3CN(Cc4ccn[nH]4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338895";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3353210";"";"None";"374.40";"0";"2.28";"44";"O=C(c1ccc(-n2cc(-c3n[nH]c4ccccc34)nn2)cc1)N1CCOCC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"18.70";"0.34";"4.72";"7.87";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3353204";"";"None";"470.60";"0";"1.42";"38";"NCCNc1cccc2nc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)sc12";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"16.57";"0.32";"6.38";"5.85";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3978540";"";"None";"404.43";"0";"1.53";"BDBM188900";"Cc1ccc(-n2nc(C3COCCN3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"1000.0";"nM";"";"";"338755";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3949446";"";"None";"402.46";"0";"2.34";"BDBM188901";"Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)cn1";"IC50";"'<'";"1000.0";"nM";"";"";"338757";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3353200";"";"None";"584.15";"2";"2.76";"34";"CN1CCN(c2cccc(Nc3ncc(-c4nc5ccccc5s4)c(NC4C[C@H](CO)[C@@H](O)[C@H]4O)n3)c2)CC1.Cl";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"15.67";"0.30";"5.83";"6.61";"0";"CHEMBL3380186";"Inhibition of IRAK4 (unknown origin) by fluorescence polarization based kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL208116";"";"None";"300.25";"0";"2.86";"18";"O=C(Nc1nc2cc(F)ccc2[nH]1)c1cccc([N+](=O)[O-])c1";"IC50";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"17.81";"0.33";"2.49";"5.30";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL208667";"";"None";"318.24";"0";"3.00";"25";"O=C(Nc1nc2cc(F)c(F)cc2[nH]1)c1cccc([N+](=O)[O-])c1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"14.21";"0.27";"1.52";"4.48";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL209202";"";"None";"324.34";"0";"3.78";"30";"CC(C)n1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"18.50";"0.34";"2.22";"6.66";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3586498";"";"None";"479.57";"0";"2.61";"20";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"14.96";"0.29";"4.56";"6.27";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3924141";"";"None";"324.34";"0";"2.00";"BDBM206239";"COc1ccc(/C=C/CO)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"3698.0";"nM";"5.43";"";"364910";"UO_0000065";"16.75";"0.31";"3.43";"6.12";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3980233";"";"None";"359.82";"0";"2.45";"BDBM206236";"CN(CCCO)c1ccc(Cl)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"3395.0";"nM";"5.47";"";"364907";"UO_0000065";"15.20";"0.30";"3.02";"6.61";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3928306";"";"None";"443.51";"0";"3.25";"BDBM188829";"Cc1ccc(-n2nc(C3CCC(NC=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338684";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3982232";"";"None";"388.43";"0";"3.43";"BDBM206152";"O=C(Nc1cc2ccccc2cc1OC1CCC(O)C1)c1cnn2cccnc12";"IC50";"'='";"177.0";"nM";"6.75";"";"364823";"UO_0000065";"17.38";"0.32";"3.32";"7.61";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3972219";"";"None";"493.58";"0";"3.29";"BDBM189058";"Cc1ccc(-n2nc(-c3cncc(N4CCN(C)CC4)c3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338916";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3972248";"";"None";"524.60";"1";"4.95";"BDBM188949";"Cc1ccc(-n2nc(C3CCN(C(C)c4cccc(F)n4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338804";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4278882";"";"None";"384.53";"0";"2.74";"30";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"19.91";"0.37";"4.92";"11.64";"0";"CHEMBL4266497";"Inhibition of recombinant human N-terminal His6-tagged full length IRAK4 expressed in baculovirus infected Sf21 insect cells in presence of 5000 uM ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4108684";"";"None";"502.49";"1";"3.28";"BDBM187988";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cccc(C#N)c1F";"IC50";"'='";"3.3";"nM";"8.48";"";"337660";"UO_0000065";"16.88";"0.31";"5.20";"5.56";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL404473";"";"None";"307.40";"0";"2.89";"10";"Cc1ccc2ncn(-c3cccc(NC4CCNCC4)n3)c2c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"26.02";"0.48";"5.11";"14.61";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4592457";"";"None";"749.75";"2";"4.20";"Example 60";"COc1cc2nn(C3CCN(CCOCCOc4ccc5c(c4)CN(C4CCC(=O)NC4=O)C5=O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4307631";"Inhibition of N-terminal GST-tagged human IRAK4 (2 to end residues) expressed in baculovirus infected Sf9 cells using Ser/Thr 7 peptide as substrate in presence of ATP after 1 hr by Z'-LYTE assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304808";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";""
"CHEMBL4570072";"";"None";"883.97";"3";"6.19";"Example 67";"O=C1CCC(N2C(=O)c3ccc(OC4CCC(CN5CCN(Cc6ccc7c(c6)nc(NC(=O)c6cccc(C(F)(F)F)c6)n7[C@H]6CC[C@@H](CO)CC6)CC5)CC4)cc3C2=O)C(=O)N1";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4307631";"Inhibition of N-terminal GST-tagged human IRAK4 (2 to end residues) expressed in baculovirus infected Sf9 cells using Ser/Thr 7 peptide as substrate in presence of ATP after 1 hr by Z'-LYTE assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304808";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";""
"CHEMBL4108381";"";"None";"457.56";"1";"1.92";"BDBM203467";"O=c1[nH]c(NC2CCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"92.0";"nM";"7.04";"";"360927";"UO_0000065";"15.38";"0.30";"5.12";"4.91";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3965265";"";"None";"376.42";"0";"2.47";"BDBM206135";"O=C1Cc2cc(N3CCCCC3)c(NC(=O)c3cnn4cccnc34)cc2N1";"IC50";"'='";"98.0";"nM";"7.01";"";"364806";"UO_0000065";"18.62";"0.34";"4.54";"7.65";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3931877";"";"None";"394.48";"0";"2.77";"BDBM206231";"O=C(Nc1cccc(NCCCO)c1N1CCCCC1)c1cnn2cccnc12";"IC50";"'='";"2849.0";"nM";"5.54";"";"364902";"UO_0000065";"14.06";"0.26";"2.78";"5.85";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3891363";"";"None";"540.65";"1";"3.91";"BDBM189128";"Cc1ccc(-n2nc(C3CCN([S+]([O-])Cc4ccccn4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338986";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586510";"";"None";"417.48";"0";"1.62";"32";"Cc1ccc(-n2nc(N3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"16.96";"0.31";"5.46";"7.34";"0";"CHEMBL3588654";"Inhibition of IRAK4 in human THP1-XBlue cells assessed as suppression of TLR4 agonist LPS-induced activation of NF-kappaB preincubated for 1 hr followed by LPS challenge measured after 5 hrs by secreted embryonic alkaline phosphatase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL3936790";"";"None";"443.53";"0";"1.43";"BDBM203510";"C[C@H]1C[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"23.0";"nM";"7.64";"";"360970";"UO_0000065";"17.22";"0.34";"6.21";"6.18";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108757";"";"None";"524.61";"2";"0.99";"BDBM203810";"O=c1[nH]c(N2CCC(n3ccnn3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"11.8";"nM";"7.93";"";"360990";"UO_0000065";"15.11";"0.29";"6.94";"4.80";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586504";"";"None";"523.59";"1";"3.32";"26";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)CC1";"IC50";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"13.50";"0.26";"3.75";"6.18";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3586509";"";"None";"444.54";"0";"3.46";"31";"Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"18.34";"0.34";"4.69";"8.75";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4109251";"";"None";"522.55";"1";"3.46";"BDBM203546";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(OC(F)(F)F)cc2)cs1";"IC50";"'='";"2246.0";"nM";"5.65";"";"361026";"UO_0000065";"10.81";"0.21";"2.19";"5.41";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108814";"";"None";"510.88";"1";"4.62";"BDBM187851";"CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1Nc1cnn(C(F)F)c1";"IC50";"'='";"2.8";"nM";"8.55";"";"337528";"UO_0000065";"16.74";"0.33";"3.93";"8.34";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115314";"";"None";"519.64";"2";"2.80";"BDBM203604";"O=c1[nH]c(N2CCN(c3nnc(C4CC4)o3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"27.0";"nM";"7.57";"";"361085";"UO_0000065";"14.57";"0.28";"4.77";"5.91";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115029";"";"None";"437.57";"0";"3.08";"BDBM203561";"O=c1[nH]c(N2CCCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2c(C3CC3)nccc2s1";"IC50";"'='";"14.0";"nM";"7.85";"";"361041";"UO_0000065";"17.95";"0.35";"4.77";"7.95";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3901226";"";"None";"416.87";"0";"3.33";"BDBM206163";"COc1cnc2c(C(=O)Nc3cc(Cl)ccc3OC3CCC(O)CC3)cnn2c1";"IC50";"'='";"301.0";"nM";"6.52";"";"364834";"UO_0000065";"15.64";"0.31";"3.19";"6.66";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3907736";"";"None";"522.66";"1";"4.12";"BDBM203286";"CC(=O)NC1CCN(C(=O)c2nnc(-c3cnc(Nc4ccc5ncsc5c4)cc3NC(C)C)s2)C1";"IC50";"'='";"3.3";"nM";"8.48";"";"360847";"UO_0000065";"16.23";"0.32";"4.36";"6.78";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3622516";"";"None";"505.60";"1";"2.12";"BDBM203492";"O=c1[nH]c(N2CCc3ccccc3C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"7.2";"nM";"8.14";"";"360988";"UO_0000065";"16.10";"0.31";"6.02";"6.05";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3933655";"";"None";"407.50";"0";"4.57";"BDBM206160";"COc1cc2ncccc2cc1NC(=O)c1csc2cnc(NCC(C)C)nc12";"IC50";"'='";"271.0";"nM";"6.57";"";"364831";"UO_0000065";"16.12";"0.31";"2.00";"7.38";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4108513";"";"None";"389.44";"1";"0.14";"BDBM203465";"Nc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"694.0";"nM";"6.16";"";"360925";"UO_0000065";"15.81";"0.31";"6.02";"3.91";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622518";"";"None";"412.52";"0";"2.05";"19";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"187.0";"nM";"6.73";"";"";"UO_0000065";"16.31";"0.32";"4.68";"7.07";"0";"CHEMBL3625601";"Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL3622523";"";"None";"426.55";"0";"2.44";"24";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"16.65";"0.32";"4.66";"7.46";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4061227";"";"None";"343.48";"0";"3.14";"20";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCOC4)c23)CC1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"20.91";"0.39";"4.04";"10.87";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4550566";"";"None";"433.51";"0";"3.41";"29";"CC1(C)Cc2cc(NC(=O)c3cnn4cc(C5CC5)cnc34)c(N3CCOCC3)cc2O1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4080656";"";"None";"348.41";"0";"3.07";"3";"NC(=O)c1cnc(Nc2ccccc2)cc1N[C@H](CO)c1ccccc1";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"17.44";"0.32";"3.01";"6.06";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4064608";"";"None";"385.51";"0";"2.91";"28";"c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"21.53";"0.40";"5.39";"11.02";"0";"CHEMBL4027007";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected Sf21 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3361252";"";"None";"316.47";"0";"3.46";"1";"CN(C)[C@H]1CC[C@H](Nc2ncnc3sc4c(c23)CCC4)CC1";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"19.94";"0.39";"2.85";"15.37";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4075333";"";"None";"329.45";"0";"3.09";"18b";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCO4)c23)CC1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"17.23";"0.32";"2.59";"8.59";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4111756";"";"None";"438.60";"0";"3.41";"BDBM203676";"CCN1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"1400.0";"nM";"5.85";"";"361150";"UO_0000065";"13.35";"0.26";"2.44";"6.81";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4089379";"";"None";"343.48";"0";"3.14";"21";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOCC4)c23)CC1";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"21.05";"0.39";"4.09";"10.94";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4110722";"";"None";"516.58";"1";"4.10";"BDBM187458";"CC(C)(O)c1cccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)c1";"IC50";"'='";"1.6";"nM";"8.80";"";"337194";"UO_0000065";"17.03";"0.32";"4.70";"6.46";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4097847";"";"None";"276.41";"0";"2.98";"5";"CN(C)[C@H]1CC[C@H](Nc2ncnc3sccc23)CC1";"IC50";"'='";"8400.0";"nM";"5.08";"";"";"UO_0000065";"18.36";"0.36";"2.10";"12.36";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4111965";"";"None";"406.49";"0";"1.99";"BDBM203669";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1cc2ccccc2cn1";"IC50";"'='";"466.0";"nM";"6.33";"";"361148";"UO_0000065";"15.58";"0.29";"4.34";"6.65";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3403450";"";"None";"427.53";"0";"2.23";"31";"OC[C@H]1C[C@@H](Nc2nc(NC3CCC3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"403000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3892790";"";"None";"469.59";"0";"4.60";"BDBM188773";"Cc1ccc(-n2nc(C3CCN(C4CCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338628";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110283";"";"None";"460.49";"0";"2.38";"BDBM188010";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCCOC1";"IC50";"'='";"16.6";"nM";"7.78";"";"337679";"UO_0000065";"16.89";"0.32";"5.40";"6.81";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3634614";"";"None";"379.43";"0";"1.27";"47";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C#N)n1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"20.04";"0.37";"6.33";"5.47";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3951282";"";"None";"473.58";"0";"3.69";"BDBM188945";"COCC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338800";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3890904";"";"None";"398.43";"0";"2.88";"BDBM189057";"Cc1ccc(-n2nc(-c3cnn(C)c3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338915";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3976036";"";"None";"543.61";"1";"3.16";"BDBM188875";"Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338730";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3936469";"";"None";"455.57";"0";"4.21";"BDBM188772";"Cc1ccc(-n2nc(C3CCN(C4CCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338627";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3957868";"";"None";"459.55";"0";"3.76";"BDBM188781";"COc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338636";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112444";"";"None";"533.61";"1";"3.00";"BDBM188098";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)c(N)nc43)cc2N[C@@H]2CCCC[C@H]2F)CC1";"IC50";"'='";"3.3";"nM";"8.48";"";"337761";"UO_0000065";"15.89";"0.30";"5.48";"5.18";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115117";"";"None";"511.95";"1";"3.16";"BDBM187831";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1Nc1cnn(CCC#N)c1";"IC50";"'='";"3.3";"nM";"8.48";"";"337508";"UO_0000065";"16.57";"0.32";"5.32";"5.79";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107486";"";"None";"412.52";"0";"1.78";"BDBM203755";"O=c1[nH]c(N2CC[C@H](O)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"23.0";"nM";"7.64";"";"361229";"UO_0000065";"18.52";"0.36";"5.86";"7.19";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113747";"";"None";"527.54";"2";"1.27";"BDBM187842";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(S(C)(=O)=O)c1";"IC50";"'='";"0.9";"nM";"9.05";"";"337519";"UO_0000065";"17.15";"0.33";"7.78";"5.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3931506";"";"None";"488.55";"0";"3.50";"BDBM188917";"COC(=O)NCC1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cn3)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338772";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112769";"";"None";"534.64";"1";"2.34";"BDBM203813";"O=c1[nH]c(N2CCC(c3cccnc3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"13.3";"nM";"7.88";"";"360993";"UO_0000065";"14.73";"0.28";"5.54";"5.34";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109857";"";"None";"534.64";"1";"2.34";"BDBM203815";"O=c1[nH]c(N2CCC(c3ccncc3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"19.0";"nM";"7.72";"";"360995";"UO_0000065";"14.44";"0.28";"5.38";"5.24";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107379";"";"None";"556.62";"1";"3.95";"BDBM203578";"O=c1[nH]c(N2CCN(c3ccc(C(F)(F)F)cn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"11.0";"nM";"7.96";"";"361058";"UO_0000065";"14.30";"0.28";"4.01";"7.80";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3961117";"";"None";"347.83";"0";"4.38";"BDBM206161";"CC(C)Oc1ccc(Cl)cc1NC(=O)c1csc2cncnc12";"IC50";"'='";"290.0";"nM";"6.54";"";"364832";"UO_0000065";"18.80";"0.39";"2.16";"10.20";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4114571";"";"None";"420.52";"0";"2.37";"BDBM203618";"COC1(C)CN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1";"IC50";"'='";"22.0";"nM";"7.66";"";"361099";"UO_0000065";"18.21";"0.34";"5.29";"8.05";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3945695";"";"None";"518.55";"2";"5.86";"BDBM189070";"Cc1ccc(-n2nc(-c3c(F)cccc3OCc3ccccc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338928";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114255";"";"None";"557.72";"1";"4.33";"BDBM203779";"COc1ccc(N2CCC3(CCN(c4nc(N[C@@H]5CCCNC5)c(-c5nc6ccccc6s5)c(=O)[nH]4)C3)C2)cc1";"IC50";"'='";"21.0";"nM";"7.68";"";"361253";"UO_0000065";"13.77";"0.26";"3.35";"7.80";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4070214";"";"None";"337.43";"0";"2.56";"2";"N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c2c1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"19.57";"0.36";"4.04";"8.91";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3953074";"";"None";"441.54";"0";"3.82";"BDBM188774";"Cc1ccc(-n2nc(C3CCN(C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338629";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112564";"";"None";"487.63";"0";"3.99";"BDBM203694";"O=c1[nH]c(C2CCN(c3cccnc3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"89.0";"nM";"7.05";"";"361168";"UO_0000065";"14.46";"0.28";"3.06";"7.13";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3908895";"";"None";"426.55";"0";"2.39";"BDBM203701";"CN1CCCC(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)C1";"IC50";"'='";"1200.0";"nM";"5.92";"";"361175";"UO_0000065";"13.88";"0.27";"3.53";"6.85";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107481";"";"None";"493.60";"1";"2.23";"BDBM203581";"Cc1nonc1N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"15.0";"nM";"7.82";"";"361062";"UO_0000065";"15.85";"0.31";"5.59";"6.11";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111939";"";"None";"479.44";"0";"2.89";"BDBM188026";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCCC(F)(F)F";"IC50";"'='";"5.0";"nM";"8.30";"";"337695";"UO_0000065";"17.31";"0.33";"5.41";"6.45";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111358";"";"None";"555.63";"1";"4.56";"BDBM203590";"O=c1[nH]c(N2CCN(c3ccccc3C(F)(F)F)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"45.0";"nM";"7.35";"";"361071";"UO_0000065";"13.22";"0.26";"2.79";"8.24";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114259";"";"None";"440.57";"0";"2.83";"BDBM203574";"CC1(C)CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1";"IC50";"'='";"145.0";"nM";"6.84";"";"361054";"UO_0000065";"15.52";"0.30";"4.01";"7.19";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110735";"";"None";"465.53";"0";"2.42";"BDBM187947";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(N)C1";"IC50";"'='";"7.0";"nM";"8.15";"";"337624";"UO_0000065";"17.52";"0.33";"5.73";"5.75";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586503";"";"None";"497.56";"0";"2.75";"25";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"14.87";"0.29";"4.65";"6.46";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4110996";"";"None";"465.63";"0";"2.74";"BDBM203774";"CN1CCC2(CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)C2)C1";"IC50";"'='";"24.0";"nM";"7.62";"";"361248";"UO_0000065";"16.36";"0.32";"4.88";"8.54";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3893206";"";"None";"378.44";"0";"1.21";"BDBM203724";"O=c1[nH]c(N2CCOCC2)nc(NC2CNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"150.0";"nM";"6.82";"";"361198";"UO_0000065";"18.03";"0.33";"5.61";"7.17";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3899755";"";"None";"419.46";"0";"3.08";"BDBM188790";"Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1";"IC50";"'<'";"100.0";"nM";"";"";"338645";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108414";"";"None";"375.41";"0";"0.37";"BDBM203664";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1ncc(F)cn1";"IC50";"'='";"220.0";"nM";"6.66";"";"361143";"UO_0000065";"17.73";"0.34";"6.29";"6.16";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3970117";"";"None";"387.45";"0";"2.55";"BDBM188814";"Cc1ccc(-n2nc(C3CCNC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338669";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3958640";"";"None";"548.67";"1";"2.69";"BDBM188977";"CCS(=O)(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1";"IC50";"'<'";"1000.0";"nM";"";"";"338832";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3949661";"";"None";"551.62";"2";"5.78";"BDBM188984";"Cc1ccc(-n2nc(C3CCN(C4CCC(C(F)(F)F)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338839";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3914393";"";"None";"454.49";"0";"3.06";"BDBM189052";"Cc1ccc(-n2nc(C3CN(Cc4cocn4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338907";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3916738";"";"None";"457.54";"0";"3.52";"BDBM188840";"COc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cc(C4CC4)cnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338695";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3953368";"";"None";"564.49";"1";"4.60";"BDBM188843";"Cc1ccc(-n2nc(C3CCN(C4CCCOC4)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338698";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108358";"";"None";"426.55";"0";"2.36";"BDBM203757";"Cc1ccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc2c1";"IC50";"'='";"50.0";"nM";"7.30";"";"361264";"UO_0000065";"17.12";"0.33";"4.94";"7.67";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110735";"";"None";"465.53";"0";"2.42";"BDBM187947";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(N)C1";"IC50";"'='";"4.3";"nM";"8.37";"";"337622";"UO_0000065";"17.97";"0.34";"5.95";"5.90";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3921439";"";"None";"506.70";"2";"6.69";"BDBM203292";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(=O)NCC2CCCCC2)cs1";"IC50";"'='";"795.0";"nM";"6.10";"";"360854";"UO_0000065";"12.04";"0.24";"-0.59";"6.64";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3929293";"";"None";"389.48";"0";"4.48";"BDBM206100";"O=C(Nc1cc2cccnc2cc1N1CCCCC1)c1csc2cncnc12";"IC50";"'='";"12.0";"nM";"7.92";"";"364771";"UO_0000065";"20.34";"0.39";"3.44";"11.15";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3915121";"";"None";"365.41";"0";"3.60";"BDBM206117";"COc1cc2ncccc2cc1NC(=O)c1csc2cc(CO)cnc12";"IC50";"'='";"35.0";"nM";"7.46";"";"364788";"UO_0000065";"20.40";"0.39";"3.86";"8.84";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3951560";"";"None";"484.61";"0";"4.24";"BDBM189006";"Cc1ccc(-n2nc(C3CCN(C4CCC(C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338861";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112653";"";"None";"480.62";"0";"4.53";"BDBM203629";"O=c1[nH]c(N2CCC(c3ccccc3)CC2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"16.0";"nM";"7.80";"";"361110";"UO_0000065";"16.22";"0.30";"3.27";"9.07";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3353208";"";"None";"487.57";"0";"2.17";"42";"Cc1ccc(-n2nc(N3CCN(C4CCOCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3353189";"";"None";"445.79";"0";"1.80";"22";"Cl.Cn1cc(NC(=O)c2coc(-c3ccnc(NCC(F)(F)F)c3)n2)c(C(N)=O)n1";"IC50";"'='";"0.24";"nM";"9.62";"";"";"UO_0000065";"23.50";"0.45";"7.82";"6.82";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4112539";"";"None";"467.51";"0";"2.12";"BDBM187797";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1NC1CCOCC1";"IC50";"'='";"7.4";"nM";"8.13";"";"337479";"UO_0000065";"17.39";"0.33";"6.01";"5.89";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4063472";"";"None";"310.45";"0";"3.79";"11";"CN(C)[C@H]1CC[C@H](Nc2ncnc3ccc(C4CC4)cc23)CC1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"25.51";"0.47";"4.13";"19.30";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4110155";"";"None";"424.44";"0";"1.32";"BDBM187678";"CNC(=O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"9.6";"nM";"8.02";"";"337363";"UO_0000065";"18.89";"0.35";"6.70";"5.83";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3892729";"";"None";"408.48";"0";"2.70";"BDBM203619";"O=c1[nH]c(N2CC[C@H](F)C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"13.0";"nM";"7.89";"";"361100";"UO_0000065";"19.31";"0.36";"5.19";"9.18";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3963673";"";"None";"397.44";"0";"0.59";"BDBM203730";"O=c1[nH]c(N2CCOCC2)nc(NCC(O)CO)c1-c1ccc2ccccc2n1";"IC50";"'='";"1700.0";"nM";"5.77";"";"361204";"UO_0000065";"14.52";"0.27";"5.18";"4.67";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3977868";"";"None";"403.46";"0";"0.65";"BDBM203695";"O=c1[nH]c(N2CCOCC2)nc(NCC(O)CO)c1-c1nc2ccccc2s1";"IC50";"'='";"8100.0";"nM";"5.09";"";"361169";"UO_0000065";"12.62";"0.25";"4.44";"4.12";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3924798";"";"None";"443.56";"0";"4.07";"BDBM188954";"CCCN1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338809";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110685";"";"None";"528.63";"1";"2.86";"BDBM187956";"CC(C)Nc1cc(-n2ccc3cc(CNC(=O)CC(C)(C)O)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"6.1";"nM";"8.21";"";"337631";"UO_0000065";"15.54";"0.30";"5.35";"5.81";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109113";"";"None";"500.97";"1";"3.66";"BDBM187838";"CCCn1cc(Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"2.5";"nM";"8.60";"";"337515";"UO_0000065";"17.17";"0.34";"4.94";"7.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3894449";"";"None";"453.51";"0";"2.80";"BDBM189039";"Cc1ccc(-n2nc(C3CN(Cc4cn[nH]c4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338894";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3892422";"";"None";"400.51";"1";"5.80";"BDBM203307";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1ccc2cn[nH]c2c1";"IC50";"'='";"812.8";"nM";"6.09";"";"360869";"UO_0000065";"15.21";"0.29";"0.29";"7.76";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3586506";"";"None";"506.59";"1";"2.58";"BDBM188883";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cn3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338738";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109106";"";"None";"457.56";"1";"1.92";"BDBM203480";"CC1(Nc2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCC1";"IC50";"'='";"1693.0";"nM";"5.77";"";"360940";"UO_0000065";"12.61";"0.25";"3.85";"4.02";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114568";"";"None";"458.54";"1";"0.33";"BDBM203500";"O=c1[nH]c(NC2CCNC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"2000.0";"nM";"5.70";"";"360960";"UO_0000065";"12.43";"0.24";"5.37";"3.67";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3967770";"";"None";"390.49";"0";"2.75";"BDBM203557";"O=c1[nH]c(N2CCCC2)nc(NC2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"24.0";"nM";"7.62";"";"361037";"UO_0000065";"19.51";"0.36";"4.87";"8.87";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622529";"";"None";"426.55";"0";"2.44";"BDBM203566";"C[C@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1";"IC50";"'='";"847.0";"nM";"6.07";"";"361046";"UO_0000065";"14.24";"0.28";"3.63";"6.38";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3968849";"";"None";"491.60";"0";"4.86";"BDBM188952";"Cc1ccc(-n2nc(C3CCN(Cc4ccccc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"100.0";"nM";"";"";"338807";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3955381";"";"None";"344.80";"0";"3.67";"BDBM206222";"CC(C)COc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"2280.0";"nM";"5.64";"";"364893";"UO_0000065";"16.36";"0.32";"1.97";"8.23";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3263640";"";"None";"589.70";"2";"6.09";"20";"Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3270974";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259754";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";""
"CHEMBL4779374";"";"None";"511.53";"1";"3.14";"8";"CCS(=O)(=O)N1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)C1";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"14.16";"0.28";"4.10";"6.17";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL3943129";"";"None";"523.60";"1";"3.65";"BDBM189025";"COc1ncc(CN2CCCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)C2)cn1";"IC50";"'<'";"1000.0";"nM";"";"";"338880";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4473656";"";"None";"390.45";"0";"2.66";"6";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)c2)c(C(N)=O)n1";"IC50";"'='";"187.0";"nM";"6.73";"";"";"UO_0000065";"17.23";"0.32";"4.07";"5.85";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4473472";"";"None";"419.37";"0";"2.20";"26";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC(F)(F)F)c3)n2)c(C(N)=O)n1";"IC50";"'='";"128.0";"nM";"6.89";"";"";"UO_0000065";"16.44";"0.31";"4.69";"5.39";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3909411";"";"None";"344.80";"0";"2.95";"BDBM206232";"O=C(Nc1cc(Cl)ccc1CCCCO)c1cnn2cccnc12";"IC50";"'='";"2949.0";"nM";"5.53";"";"364903";"UO_0000065";"16.04";"0.31";"2.58";"6.95";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3900596";"";"None";"486.56";"0";"3.44";"BDBM189066";"Cc1ccc(-n2nc(-c3csc(N4CCOCC4)n3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338924";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3928663";"";"None";"347.17";"0";"2.75";"BDBM206214";"COc1ccc(Br)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"2144.0";"nM";"5.67";"";"364885";"UO_0000065";"16.33";"0.37";"2.92";"8.27";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3972442";"";"None";"539.67";"1";"4.52";"BDBM189118";"Cc1ccc(-n2nc(C3CCN([S+]([O-])Cc4ccccc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338976";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3958889";"";"None";"377.85";"0";"3.61";"BDBM206249";"COc1ccc(Cl)cc1NC(=O)c1csc2ccc(NCCO)nc12";"IC50";"'='";"4655.0";"nM";"5.33";"";"364920";"UO_0000065";"14.11";"0.29";"1.72";"6.39";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL2022373";"";"None";"563.64";"2";"5.00";"46";"Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)c4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1";"IC50";"'='";"1423.0";"nM";"5.85";"";"";"UO_0000065";"10.37";"0.20";"0.85";"5.55";"0";"CHEMBL2024840";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021851";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL4746200";"";"None";"499.52";"0";"2.87";"6";"CCS(=O)(=O)NCCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(C(C)(C)O)cc2n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL3904732";"";"None";"395.44";"0";"2.90";"BDBM206097";"COc1cc2nc(NCCO)ccc2cc1NC(=O)c1csc2cncnc12";"IC50";"'='";"10.0";"nM";"8.00";"";"364768";"UO_0000065";"20.23";"0.39";"5.10";"7.32";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3944798";"";"None";"401.85";"0";"2.55";"BDBM206103";"O=C(Nc1cc(Cl)ccc1N1CCC(CO)CC1)c1cnn2cc(O)cnc12";"IC50";"'='";"18.0";"nM";"7.75";"";"364774";"UO_0000065";"19.27";"0.38";"5.19";"7.52";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3891037";"";"None";"548.56";"2";"2.15";"BDBM187994";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CCN(c2ncc(F)cn2)C1";"IC50";"'='";"10.3";"nM";"7.99";"";"337665";"UO_0000065";"14.56";"0.27";"5.84";"5.06";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4787247";"";"None";"404.43";"0";"2.21";"9";"Cn1cc(NC(=O)c2cnc3ccc(N[C@@H]4CCCCNC4)nn23)c(C(F)F)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"19.89";"0.38";"5.84";"7.95";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4111216";"";"None";"469.52";"0";"1.95";"BDBM188063";"CC(C)C(O)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"15.6";"nM";"7.81";"";"337729";"UO_0000065";"16.63";"0.31";"5.86";"5.24";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112570";"";"None";"449.92";"0";"2.71";"BDBM187731";"CC(C)Nc1cc(-n2ncc3cc(Cl)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.1";"nM";"8.39";"";"337416";"UO_0000065";"18.64";"0.37";"5.68";"6.40";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107060";"";"None";"580.54";"1";"3.00";"BDBM188053";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCCNC(=O)OC(C)(C)C(F)(F)F";"IC50";"'='";"13.8";"nM";"7.86";"";"337719";"UO_0000065";"13.54";"0.26";"4.86";"4.70";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3634506";"";"None";"390.40";"0";"1.82";"4";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCNC4)nc23)c(C(F)F)n1";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"22.03";"0.42";"6.78";"8.50";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3948096";"";"None";"498.64";"0";"3.75";"BDBM188939";"Cc1ccc(-n2nc(C3CCN(C4CCN(C)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338794";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3909791";"";"None";"356.82";"0";"2.17";"BDBM206196";"NC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)C1";"IC50";"'='";"766.0";"nM";"6.12";"";"364867";"UO_0000065";"17.14";"0.33";"3.95";"6.91";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3972016";"";"None";"443.52";"0";"2.19";"BDBM188935";"CN1CCN(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cn3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338790";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3914986";"";"None";"398.43";"0";"2.88";"BDBM189062";"Cc1ccc(-n2nc(-c3ccnn3C)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338920";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3741589";"";"None";"366.24";"0";"4.09";"29; A-971432";"O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3742719";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739276";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4791581";"";"None";"390.40";"0";"1.82";"5";"Cn1cc(NC(=O)c2cnc3ccc(N[C@@H]4CCCNC4)nn23)c(C(F)F)n1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"22.76";"0.43";"7.07";"8.78";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4112802";"";"None";"442.47";"0";"2.90";"BDBM187963";"C[C@@H](F)CNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.5";"nM";"8.82";"";"337638";"UO_0000065";"19.94";"0.38";"5.92";"7.62";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111100";"";"None";"426.47";"0";"2.65";"BDBM203617";"O=c1[nH]c(N2CC(F)[C@@H](F)C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"17.0";"nM";"7.77";"";"361098";"UO_0000065";"18.22";"0.34";"5.12";"9.04";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115189";"";"None";"439.50";"0";"2.59";"BDBM187681";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(O)C(C)C";"IC50";"'='";"3.6";"nM";"8.44";"";"337367";"UO_0000065";"19.21";"0.36";"5.85";"6.56";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3916413";"";"None";"393.45";"0";"2.01";"BDBM187687";"CC(O)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"5.3";"nM";"8.28";"";"337373";"UO_0000065";"21.03";"0.39";"6.27";"6.43";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4290222";"";"None";"426.57";"0";"2.51";"31";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"16.47";"0.31";"4.52";"9.37";"0";"CHEMBL4266497";"Inhibition of recombinant human N-terminal His6-tagged full length IRAK4 expressed in baculovirus infected Sf21 insect cells in presence of 5000 uM ATP";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3634381";"";"None";"404.43";"0";"2.33";"27";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)F)n1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"23.00";"0.44";"6.97";"8.08";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3945782";"";"None";"431.46";"0";"1.13";"BDBM188894";"NC(=O)c1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"1000.0";"nM";"";"";"338749";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3911370";"";"None";"321.34";"0";"2.78";"BDBM206159";"COc1cc2cc(C)[nH]c2cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"255.0";"nM";"6.59";"";"364830";"UO_0000065";"20.52";"0.38";"3.81";"7.82";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3959696";"";"None";"319.77";"0";"3.61";"BDBM206215";"COc1ccc(Cl)cc1NC(=O)c1csc2cncnc12";"IC50";"'='";"2200.0";"nM";"5.66";"";"364886";"UO_0000065";"17.69";"0.37";"2.05";"8.82";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3960163";"";"None";"543.63";"1";"4.52";"BDBM189097";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(F)cc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338955";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622528";"";"None";"427.53";"0";"2.60";"BDBM203551";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCC[C@@H](O)C2)c1-c1nc2ccccc2s1";"IC50";"'='";"454.0";"nM";"6.34";"";"361031";"UO_0000065";"14.84";"0.29";"3.74";"6.14";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3970164";"";"None";"420.52";"0";"2.33";"BDBM203728";"O=c1[nH]c(N2CCOCC2)nc(NCCN2CCCC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"4900.0";"nM";"5.31";"";"361202";"UO_0000065";"12.63";"0.23";"2.98";"6.15";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107689";"";"None";"447.54";"0";"1.86";"BDBM203607";"CC(=O)NC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1";"IC50";"'='";"54.0";"nM";"7.27";"";"361088";"UO_0000065";"16.24";"0.30";"5.41";"6.32";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111214";"";"None";"464.64";"0";"3.80";"BDBM203678";"O=c1[nH]c(C2CCN(CC3CC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"340.0";"nM";"6.47";"";"361152";"UO_0000065";"13.92";"0.27";"2.67";"7.53";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3892709";"";"None";"454.60";"0";"2.95";"BDBM203750";"CN(c1nc(NC2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1)[C@H]1CC[C@H](O)CC1";"IC50";"'='";"390.0";"nM";"6.41";"";"361224";"UO_0000065";"14.10";"0.27";"3.46";"6.04";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3899809";"";"None";"518.63";"1";"4.22";"BDBM189016";"Cc1ccc(-n2nc(C3CCN(C4Cc5ccccc5C4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338871";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3916631";"";"None";"496.60";"0";"2.10";"BDBM187602";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](NS(C)(=O)=O)CC1";"IC50";"'='";"4.6";"nM";"8.34";"";"337301";"UO_0000065";"16.79";"0.33";"6.24";"5.39";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586495";"";"None";"443.56";"0";"4.06";"BDBM188771";"Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338626";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4284323";"";"None";"273.38";"0";"2.32";"19";"Cc1ccn2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"234.42";"nM";"6.63";"";"";"UO_0000065";"24.25";"0.45";"4.31";"14.58";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4292700";"";"None";"384.53";"0";"3.00";"23";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"354.81";"nM";"6.45";"";"";"UO_0000065";"16.77";"0.31";"3.45";"6.45";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4111055";"";"None";"452.49";"0";"2.19";"BDBM187428";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCC1COC1";"IC50";"'='";"3.7";"nM";"8.43";"";"337164";"UO_0000065";"18.63";"0.35";"6.24";"6.74";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4290222";"";"None";"426.57";"0";"2.51";"31";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"16.47";"0.31";"4.52";"9.37";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4108607";"";"None";"533.64";"1";"2.98";"BDBM203799";"O=c1[nH]c(N2CCN(c3ncccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(F)cc2)cs1";"IC50";"'='";"21.0";"nM";"7.68";"";"361273";"UO_0000065";"14.39";"0.28";"4.70";"6.68";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107909";"";"None";"412.52";"0";"1.78";"BDBM203764";"O=c1[nH]c(N2CC[C@@H](O)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"17.0";"nM";"7.77";"";"361238";"UO_0000065";"18.83";"0.37";"5.99";"7.32";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3967745";"";"None";"561.62";"1";"4.66";"BDBM189091";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cc(F)cc(F)c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338949";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3884319";"";"None";"386.45";"0";"4.24";"33";"CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"12.94";"0.24";"0.76";"6.38";"0";"CHEMBL3876073";"Inhibition of human recombinant full length His-tagged IRAK4 expressed in baculovirus expression system";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875183";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4112526";"";"None";"442.55";"0";"1.41";"BDBM203568";"O=c1[nH]c(N2CCOCC2CO)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"864.0";"nM";"6.06";"";"361048";"UO_0000065";"13.70";"0.27";"4.65";"5.25";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106665";"";"None";"507.57";"1";"2.59";"BDBM187943";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](C(N)=O)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"337618";"UO_0000065";"17.58";"0.33";"6.33";"5.61";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108028";"";"None";"443.46";"0";"2.30";"BDBM188048";"C[C@@H](F)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.8";"nM";"8.42";"";"337714";"UO_0000065";"18.99";"0.36";"6.12";"6.54";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106523";"";"None";"534.53";"2";"1.76";"BDBM188000";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CN(c2ncc(F)cn2)C1";"IC50";"'='";"6.3";"nM";"8.20";"";"337671";"UO_0000065";"15.34";"0.29";"6.44";"5.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4286802";"";"None";"385.51";"0";"2.68";"29";"c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)ccn2n1";"IC50";"'='";"363.08";"nM";"6.44";"";"";"UO_0000065";"16.71";"0.31";"3.76";"10.08";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3899909";"";"None";"495.57";"0";"1.16";"BDBM188891";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(CN)cn3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338746";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3908966";"";"None";"509.60";"1";"1.72";"BDBM188898";"C[C@H](N)c1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338753";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3987115";"";"None";"339.36";"0";"1.69";"BDBM206259";"COc1cc(C(=O)N(C)C)ccc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"7651.0";"nM";"5.12";"";"364930";"UO_0000065";"15.08";"0.28";"3.43";"5.76";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3894394";"";"None";"444.54";"0";"3.46";"BDBM189014";"CCCN1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cn3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338869";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109207";"";"None";"508.60";"1";"3.75";"BDBM60810";"COC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCC(CO)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"312098";"UO_0000065";"17.29";"0.32";"5.05";"7.03";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4280559";"";"None";"443.55";"0";"1.82";"36";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"17.36";"0.33";"5.88";"6.52";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4110619";"";"None";"426.46";"0";"1.54";"BDBM188043";"CCNc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.2";"nM";"8.49";"";"337709";"UO_0000065";"19.92";"0.37";"6.95";"5.49";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3921810";"";"None";"442.47";"0";"2.90";"BDBM187964";"C[C@H](F)CNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.4";"nM";"8.85";"";"337639";"UO_0000065";"20.01";"0.38";"5.95";"7.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112394";"";"None";"498.60";"0";"3.50";"BDBM187967";"CCCC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"3.2";"nM";"8.49";"";"337642";"UO_0000065";"17.04";"0.32";"4.99";"7.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111012";"";"None";"416.46";"0";"2.18";"BDBM187589";"CC(C)Nc1cc(-n2ncc3cc(O)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.1";"nM";"8.51";"";"337329";"UO_0000065";"20.43";"0.39";"6.33";"6.80";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107389";"";"None";"558.57";"1";"2.63";"BDBM188102";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](NC(=O)C(F)F)CC1";"IC50";"'='";"3.3";"nM";"8.48";"";"337765";"UO_0000065";"15.18";"0.29";"5.85";"5.37";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112867";"";"None";"535.60";"1";"4.00";"BDBM188105";"CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC12CC3CC(CC(O)(C3)C1)C2";"IC50";"'='";"3.0";"nM";"8.52";"";"337768";"UO_0000065";"15.91";"0.30";"4.52";"6.62";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3914366";"";"None";"469.98";"0";"3.32";"BDBM187588";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(Cl)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"5.6";"nM";"8.25";"";"337287";"UO_0000065";"17.56";"0.34";"4.93";"7.25";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3987067";"";"None";"422.52";"0";"3.69";"BDBM203299";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(NC2CNC2)o1";"IC50";"'='";"26.4";"nM";"7.58";"";"360861";"UO_0000065";"17.94";"0.35";"3.89";"6.72";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3912316";"";"None";"461.55";"0";"4.20";"BDBM188792";"Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1";"IC50";"'<'";"100.0";"nM";"";"";"338647";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108815";"";"None";"429.55";"0";"2.70";"BDBM203715";"CC(C)C[C@H](CO)Nc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"2500.0";"nM";"5.60";"";"361189";"UO_0000065";"13.04";"0.26";"2.90";"5.42";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114583";"";"None";"480.52";"0";"3.07";"BDBM203787";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cccc(C(F)(F)F)c2s1";"IC50";"'='";"520.0";"nM";"6.28";"";"361261";"UO_0000065";"13.08";"0.26";"3.21";"6.60";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111811";"";"None";"370.46";"0";"1.14";"BDBM203552";"Cc1cccc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)n1";"IC50";"'='";"1474.0";"nM";"5.83";"";"361032";"UO_0000065";"15.74";"0.29";"4.69";"6.13";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3934248";"";"None";"481.61";"0";"3.98";"BDBM203284";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(C(=O)N2CCC(O)C2)s1";"IC50";"'='";"2.8";"nM";"8.55";"";"360845";"UO_0000065";"17.76";"0.35";"4.57";"7.36";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3901125";"";"None";"453.59";"1";"5.86";"BDBM203288";"CCOC(=O)c1nc(-c2cnc(Nc3ccc4ncsc4c3)cc2NC(C)C)sc1C";"IC50";"'='";"960.7";"nM";"6.02";"";"360849";"UO_0000065";"13.27";"0.27";"0.16";"6.76";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3924209";"";"None";"458.47";"0";"1.88";"BDBM188056";"C[C@H](F)CNc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.9";"nM";"8.72";"";"337722";"UO_0000065";"19.02";"0.36";"6.84";"5.63";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107905";"";"None";"430.48";"0";"2.48";"BDBM187645";"COc1cnc2c(cnn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"19.4";"nM";"7.71";"";"337330";"UO_0000065";"17.92";"0.34";"5.23";"6.75";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109180";"";"None";"523.07";"1";"3.59";"BDBM203580";"O=c1[nH]c(N2CCN(c3cccc(Cl)n3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"25.0";"nM";"7.60";"";"361060";"UO_0000065";"14.53";"0.29";"4.01";"7.45";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3920200";"";"None";"485.59";"0";"3.69";"BDBM188962";"Cc1ccc(-n2nc(C3CCN(CC4CCOC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338817";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3889847";"";"None";"364.79";"0";"4.43";"BDBM206248";"O=C(Nc1cc(Cl)ccc1Oc1ccccc1)c1cnn2cccnc12";"IC50";"'='";"4647.0";"nM";"5.33";"";"364919";"UO_0000065";"14.62";"0.28";"0.90";"7.78";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3908856";"";"None";"557.66";"1";"3.67";"BDBM189010";"CCOC(=O)N1CCC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cn4)n3)CC2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338865";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622525";"";"None";"428.52";"0";"1.02";"26";"O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CNC[C@H](O)C2)c1-c1nc2ccccc2s1";"IC50";"'='";"333.0";"nM";"6.48";"";"";"UO_0000065";"15.12";"0.29";"5.46";"5.61";"0";"CHEMBL3625601";"Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL3978235";"";"None";"285.28";"0";"2.73";"BDBM206246";"COc1ccc(F)cc1NC(=O)c1cnn2ccccc12";"IC50";"'='";"4302.0";"nM";"5.37";"";"364917";"UO_0000065";"18.81";"0.35";"2.64";"9.65";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3904807";"";"None";"513.56";"1";"2.45";"BDBM188798";"COc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1";"IC50";"'<'";"100.0";"nM";"";"";"338653";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3943924";"";"None";"419.89";"0";"3.15";"BDBM206262";"COc1ccc(Cl)cc1NC(=O)c1csc2cnc(NCCNC(C)=O)nc12";"IC50";"'='";"8087.0";"nM";"5.09";"";"364933";"UO_0000065";"12.13";"0.25";"1.94";"4.84";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3962309";"";"None";"345.38";"0";"2.00";"BDBM206242";"COc1cc(S(C)(=O)=O)ccc1NC(=O)c1ccn2cccnc12";"IC50";"'='";"4011.0";"nM";"5.40";"";"364913";"UO_0000065";"15.63";"0.31";"3.40";"6.01";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3918974";"";"None";"477.54";"0";"3.90";"BDBM188796";"COc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)c(F)c1";"IC50";"'<'";"100.0";"nM";"";"";"338651";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3962911";"";"None";"371.83";"0";"2.60";"BDBM206178";"O=C(Nc1cc(Cl)ccc1N1CCCC(O)C1)c1cnn2cccnc12";"IC50";"'='";"474.0";"nM";"6.32";"";"364849";"UO_0000065";"17.01";"0.33";"3.72";"7.64";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3979848";"";"None";"318.34";"0";"3.14";"BDBM206191";"COc1cc2ccccc2cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"613.0";"nM";"6.21";"";"364862";"UO_0000065";"19.52";"0.35";"3.07";"9.07";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4097847";"";"None";"276.41";"0";"2.98";"6";"CN(C)[C@H]1CC[C@H](Nc2ncnc3sccc23)CC1";"IC50";"'='";"4265.8";"nM";"5.37";"";"";"UO_0000065";"19.43";"0.39";"2.39";"13.08";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4115629";"";"None";"452.53";"0";"4.00";"BDBM187905";"CCOC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"2.4";"nM";"8.62";"";"337580";"UO_0000065";"19.05";"0.36";"4.62";"8.22";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108784";"";"None";"467.51";"0";"2.12";"BDBM187578";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCCOC1";"IC50";"'='";"6.5";"nM";"8.19";"";"337278";"UO_0000065";"17.51";"0.33";"6.07";"5.93";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107578";"";"None";"476.94";"0";"2.90";"BDBM187571";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1NC1CCOCC1";"IC50";"'='";"4.5";"nM";"8.35";"";"337270";"UO_0000065";"17.50";"0.35";"5.45";"7.31";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115586";"";"None";"472.47";"0";"3.34";"BDBM187452";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CC(F)(F)C1";"IC50";"'='";"1.9";"nM";"8.72";"";"337188";"UO_0000065";"18.46";"0.35";"5.38";"7.53";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108427";"";"None";"470.48";"0";"2.28";"BDBM187915";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1COC[C@H]1F";"IC50";"'='";"7.1";"nM";"8.15";"";"337590";"UO_0000065";"17.32";"0.33";"5.87";"6.51";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113934";"";"None";"473.46";"0";"2.74";"BDBM188113";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CC(F)(F)C1";"IC50";"'='";"4.3";"nM";"8.37";"";"337776";"UO_0000065";"17.67";"0.34";"5.63";"6.50";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112370";"";"None";"456.52";"0";"3.04";"BDBM187444";"CC(=O)Nc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"23.2";"nM";"7.63";"";"337180";"UO_0000065";"16.72";"0.32";"4.59";"6.30";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3900127";"";"None";"403.89";"0";"4.28";"BDBM206168";"O=C(Nc1cc(Cl)ccc1O[C@H]1CC[C@H](O)CC1)c1csc2cncnc12";"IC50";"'='";"338.0";"nM";"6.47";"";"364839";"UO_0000065";"16.02";"0.33";"2.19";"7.67";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3948538";"";"None";"425.47";"0";"2.35";"BDBM188121";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.6";"nM";"8.59";"";"337268";"UO_0000065";"20.18";"0.38";"6.24";"6.67";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114846";"";"None";"495.52";"0";"1.99";"BDBM187938";"COC(=O)N1CC(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1";"IC50";"'='";"1.9";"nM";"8.72";"";"337613";"UO_0000065";"17.60";"0.33";"6.73";"6.00";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107195";"";"None";"442.55";"0";"1.41";"BDBM203734";"O=c1[nH]c(N2CCOC(CO)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"43.0";"nM";"7.37";"";"361208";"UO_0000065";"16.65";"0.32";"5.96";"6.38";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115542";"";"None";"548.62";"1";"2.60";"BDBM188101";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC12CC3CC(CC(O)(C3)C1)C2";"IC50";"'='";"2.6";"nM";"8.59";"";"337764";"UO_0000065";"15.65";"0.29";"5.99";"4.91";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3908695";"";"None";"420.52";"0";"3.66";"BDBM187446";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCCOC(C)C";"IC50";"'='";"5.6";"nM";"8.25";"";"337182";"UO_0000065";"19.62";"0.36";"4.59";"7.87";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108005";"";"None";"424.57";"0";"3.45";"BDBM203739";"CC1CCCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)C1";"IC50";"'='";"140.0";"nM";"6.85";"";"361213";"UO_0000065";"16.14";"0.31";"3.40";"7.98";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3922407";"";"None";"456.55";"0";"3.46";"BDBM189015";"Cc1ccc(-n2nc(C3CCN(CC4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338870";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3936414";"";"None";"530.68";"2";"5.84";"BDBM203294";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(=O)NC[C@H](O)c2ccccc2)cs1";"IC50";"'='";"26.0";"nM";"7.58";"";"360856";"UO_0000065";"14.29";"0.28";"1.75";"6.77";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4089379";"";"None";"343.48";"0";"3.14";"15";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOCC4)c23)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"23.94";"0.45";"5.08";"12.44";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4114030";"";"None";"548.62";"1";"2.78";"BDBM188092";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](NC(=O)C2CC2)CC1";"IC50";"'='";"5.2";"nM";"8.28";"";"337755";"UO_0000065";"15.10";"0.28";"5.50";"5.25";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3986395";"";"None";"443.46";"0";"2.64";"BDBM187603";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(F)(F)C(C)(C)O";"IC50";"'='";"10.5";"nM";"7.98";"";"337302";"UO_0000065";"17.99";"0.34";"5.34";"6.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112662";"";"None";"468.54";"0";"1.92";"BDBM188051";"CC(C)(CN)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"8.5";"nM";"8.07";"";"337717";"UO_0000065";"17.22";"0.32";"6.15";"5.21";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3901331";"";"None";"485.55";"0";"3.10";"BDBM187674";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(OCCN(C)C)cn1";"IC50";"'='";"9.2";"nM";"8.04";"";"337359";"UO_0000065";"16.55";"0.30";"4.94";"6.00";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4439253";"";"None";"409.45";"0";"1.50";"42";"C[C@@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"15.77";"0.29";"4.96";"6.38";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4107511";"";"None";"537.58";"1";"2.52";"BDBM187449";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(S(N)(=O)=O)c1";"IC50";"'='";"1.9";"nM";"8.72";"";"337185";"UO_0000065";"16.22";"0.31";"6.20";"4.95";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3902828";"";"None";"459.55";"0";"3.15";"BDBM187480";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"1.1";"nM";"8.96";"";"337215";"UO_0000065";"19.49";"0.36";"5.81";"7.18";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109646";"";"None";"410.45";"0";"2.56";"BDBM187447";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)O";"IC50";"'='";"3.2";"nM";"8.49";"";"337184";"UO_0000065";"20.70";"0.39";"5.93";"7.33";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110348";"";"None";"442.47";"0";"2.90";"BDBM187477";"CC(CF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.9";"nM";"8.54";"";"337213";"UO_0000065";"19.30";"0.36";"5.64";"7.37";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4789541";"";"None";"410.50";"0";"3.11";"80";"CC(C)Nc1c(-c2cn(CCCO)nn2)cnc2sc(-c3ccc(=O)[nH]c3)cc12";"IC50";"'='";"5.2";"nM";"8.28";"";"";"UO_0000065";"20.18";"0.39";"5.17";"7.62";"0";"CHEMBL4739586";"Inhibition of IRAK4 (unknown origin) using IPTSPITTTYFFFKKK peptide as substrate in presence of ATP measured after 60 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732264";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.0 hr"
"CHEMBL4762550";"";"None";"432.52";"0";"3.31";"59";"CC(C)Nc1c(C(=O)NC[C@@H](F)C(C)(C)O)cnc2sc(-c3ccc(=O)[nH]c3)cc12";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"19.47";"0.38";"5.11";"7.86";"0";"CHEMBL4739586";"Inhibition of IRAK4 (unknown origin) using IPTSPITTTYFFFKKK peptide as substrate in presence of ATP measured after 60 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732264";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.0 hr"
"CHEMBL4749904";"";"None";"405.50";"0";"3.35";"21";"CC(C)Nc1c(C(=O)NC[C@@H](F)C(C)(C)O)cnc2sc(-c3cn[nH]c3)cc12";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"21.26";"0.42";"5.27";"8.37";"0";"CHEMBL4739586";"Inhibition of IRAK4 (unknown origin) using IPTSPITTTYFFFKKK peptide as substrate in presence of ATP measured after 60 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732264";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.0 hr"
"CHEMBL3954582";"";"None";"404.43";"0";"1.71";"BDBM188936";"Cc1ccc(-n2nc(N3CCOCC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338791";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3960537";"";"None";"384.87";"0";"2.81";"BDBM206112";"NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"31.0";"nM";"7.51";"";"364783";"UO_0000065";"19.51";"0.38";"4.70";"8.48";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4279192";"";"None";"384.53";"0";"3.00";"2";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.84";"0.41";"5.40";"8.40";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3634384";"";"None";"440.40";"0";"2.58";"30";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CC(F)(F)CC[C@@H]4N)nc23)c(C(F)F)n1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"16.85";"0.33";"4.84";"6.44";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3979633";"";"None";"378.39";"0";"1.94";"BDBM206091";"COc1cc2nc(NCCO)ccc2cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"3.0";"nM";"8.52";"";"364761";"UO_0000065";"22.52";"0.42";"6.58";"7.50";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3902455";"";"None";"420.49";"0";"4.17";"BDBM206106";"O=C(Nc1cc2cccnc2cc1OC1CCC(O)CC1)c1csc2cncnc12";"IC50";"'='";"24.0";"nM";"7.62";"";"364777";"UO_0000065";"18.12";"0.35";"3.45";"7.84";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3930442";"";"None";"372.82";"0";"2.73";"BDBM206107";"O=C(Nc1cc(Cl)ccc1N1CCCCC1)c1cnn2nc(O)cnc12";"IC50";"'='";"24.0";"nM";"7.62";"";"364778";"UO_0000065";"20.44";"0.40";"4.89";"7.97";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3951842";"";"None";"403.44";"0";"3.21";"BDBM206110";"O=C(Nc1cc2cccnc2cc1OC1CCC(O)CC1)c1cnn2cccnc12";"IC50";"'='";"29.0";"nM";"7.54";"";"364781";"UO_0000065";"18.68";"0.34";"4.33";"7.42";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4111974";"";"None";"502.51";"2";"2.38";"BDBM187833";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CCC#N)c1";"IC50";"'='";"2.1";"nM";"8.68";"";"337510";"UO_0000065";"17.27";"0.32";"6.30";"5.09";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108324";"";"None";"443.46";"0";"2.30";"BDBM188061";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCCCF";"IC50";"'='";"5.3";"nM";"8.28";"";"337727";"UO_0000065";"18.66";"0.35";"5.98";"6.43";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111555";"";"None";"501.62";"1";"3.58";"BDBM203753";"O=C1C[C@H](Nc2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)Cc2ccccc2N1";"IC50";"'='";"8900.0";"nM";"5.05";"";"361227";"UO_0000065";"10.07";"0.19";"1.47";"4.08";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3353213";"";"None";"452.47";"0";"2.97";"47";"O=C(Nc1nc2ccc(CO)cc2[nH]1)c1cccc(Cn2nc(-c3cccnc3)ccc2=O)c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372369";"Inhibition of IRAK4 (unknown origin) by radiochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4283847";"";"None";"259.36";"0";"2.24";"10";"CN(C)[C@H]1CC[C@H](Nc2ncnc3cc[nH]c23)CC1";"IC50";"'='";"1778.28";"nM";"5.75";"";"";"UO_0000065";"22.17";"0.41";"3.51";"10.12";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4288305";"";"None";"400.53";"0";"2.96";"35";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1";"IC50";"'='";"33.11";"nM";"7.48";"";"";"UO_0000065";"18.68";"0.35";"4.52";"9.97";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3622185";"";"None";"402.48";"0";"1.12";"7";"CCc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"972.0";"nM";"6.01";"";"";"UO_0000065";"14.94";"0.29";"4.89";"4.58";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4107171";"";"None";"591.06";"1";"4.60";"BDBM203576";"O=c1[nH]c(N2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"17.0";"nM";"7.77";"";"361056";"UO_0000065";"13.15";"0.27";"3.17";"7.61";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3970853";"";"None";"412.52";"0";"2.05";"BDBM203651";"C[C@H]1C[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1";"IC50";"'='";"359.0";"nM";"6.45";"";"361132";"UO_0000065";"15.62";"0.30";"4.39";"6.77";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108950";"";"None";"518.65";"1";"2.94";"BDBM203584";"COc1ccnc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)c1";"IC50";"'='";"6.0";"nM";"8.22";"";"361065";"UO_0000065";"15.85";"0.30";"5.28";"7.39";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112861";"";"None";"518.65";"1";"2.94";"BDBM203585";"COc1cccc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"361066";"UO_0000065";"15.42";"0.30";"5.06";"7.19";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113113";"";"None";"448.50";"0";"2.29";"BDBM203654";"O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CNCC(F)(F)C2)c1-c1nc2ccccc2s1";"IC50";"'='";"792.0";"nM";"6.10";"";"361135";"UO_0000065";"13.60";"0.27";"3.81";"6.41";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3903386";"";"None";"426.55";"0";"2.44";"BDBM203703";"O=c1[nH]c(N2CCOCC2)nc(NCC2CCCCN2)c1-c1nc2ccccc2s1";"IC50";"'='";"1600.0";"nM";"5.80";"";"361177";"UO_0000065";"13.59";"0.26";"3.36";"6.09";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106730";"";"None";"535.63";"2";"1.74";"BDBM203812";"O=c1[nH]c(N2CCC(c3cnccn3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"12.5";"nM";"7.90";"";"360992";"UO_0000065";"14.75";"0.28";"6.16";"4.93";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110192";"";"None";"540.65";"1";"1.01";"BDBM203809";"CN1CCC2(CCN(c3nc(N[C@@H]4C[C@H](CO)[C@@H](O)[C@H]4O)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)C1=O";"IC50";"'='";"8.8";"nM";"8.06";"";"360989";"UO_0000065";"14.90";"0.29";"7.05";"5.20";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107847";"";"None";"488.62";"0";"3.38";"BDBM203693";"O=c1[nH]c(C2CCN(c3ncccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"260.0";"nM";"6.58";"";"361167";"UO_0000065";"13.48";"0.26";"3.21";"5.89";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109845";"";"None";"413.51";"0";"1.44";"BDBM203556";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cnccc2s1";"IC50";"'='";"12.0";"nM";"7.92";"";"361036";"UO_0000065";"19.16";"0.37";"6.48";"7.33";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3957973";"";"None";"455.57";"0";"4.07";"BDBM189031";"Cc1ccc(-n2nc(C3CCCN(CC4CC4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338886";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3892790";"";"None";"469.59";"0";"4.60";"BDBM188773";"Cc1ccc(-n2nc(C3CCN(C4CCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338914";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3590482";"";"None";"431.50";"0";"2.46";"22";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(-c2ccncc2)n1";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"16.70";"0.31";"4.75";"5.63";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4114042";"";"None";"469.57";"0";"1.16";"BDBM203736";"CNC(=O)C1CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1";"IC50";"'='";"110.0";"nM";"6.96";"";"361210";"UO_0000065";"14.82";"0.29";"5.80";"5.60";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115548";"";"None";"440.57";"0";"2.82";"BDBM203743";"CC1CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC(C)O1";"IC50";"'='";"300.0";"nM";"6.52";"";"361217";"UO_0000065";"14.81";"0.29";"3.70";"6.85";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108981";"";"None";"438.56";"0";"2.56";"BDBM203659";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1csc(-c2ccccc2)n1";"IC50";"'='";"7.0";"nM";"8.15";"";"361141";"UO_0000065";"18.59";"0.36";"5.59";"8.57";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114262";"";"None";"466.52";"1";"1.70";"BDBM203517";"O=c1[nH]c(Nc2ccncc2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"654.0";"nM";"6.18";"";"360977";"UO_0000065";"13.26";"0.26";"4.48";"3.96";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3934248";"";"None";"481.61";"0";"3.98";"BDBM203284";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(C(=O)N2CCC(O)C2)s1";"IC50";"'='";"3.2";"nM";"8.49";"";"360846";"UO_0000065";"17.64";"0.35";"4.51";"7.31";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3977526";"";"None";"394.48";"0";"1.80";"BDBM203721";"CN(C)CCNc1nc(N2CCOCC2)[nH]c(=O)c1-c1ccc2ccccc2n1";"IC50";"'='";"1600.0";"nM";"5.80";"";"361195";"UO_0000065";"14.69";"0.27";"4.00";"6.71";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3935887";"";"None";"522.61";"1";"4.26";"BDBM189036";"COc1ccc(CN2CCCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)C2)cn1";"IC50";"'<'";"1000.0";"nM";"";"";"338891";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2381116";"";"None";"450.52";"0";"2.37";"39";"COc1ccc2c(c1)C(=O)N(c1nc(C(=O)Nc3cnccc3N3CCNCC3)cs1)C2";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"13.23";"0.25";"3.59";"5.98";"0";"CHEMBL2384686";"Inhibition of human IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2380296";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";""
"CHEMBL4112330";"";"None";"422.51";"0";"3.09";"BDBM203625";"O=c1[nH]c(N2CCC[C@H]2CF)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"85.0";"nM";"7.07";"";"361106";"UO_0000065";"16.73";"0.31";"3.98";"8.23";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113721";"";"None";"452.58";"0";"2.94";"BDBM203690";"CC(=O)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"450.0";"nM";"6.35";"";"361164";"UO_0000065";"14.02";"0.27";"3.41";"6.16";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114417";"";"None";"420.52";"0";"2.37";"BDBM203620";"CO[C@H]1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1";"IC50";"'='";"35.0";"nM";"7.46";"";"361101";"UO_0000065";"17.73";"0.33";"5.09";"7.83";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109853";"";"None";"370.46";"0";"1.14";"BDBM203553";"Cc1ccc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)nc1";"IC50";"'='";"872.0";"nM";"6.06";"";"361033";"UO_0000065";"16.36";"0.31";"4.92";"6.37";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112758";"";"None";"396.52";"0";"2.81";"BDBM203744";"O=c1[nH]c(N2CCCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"11.0";"nM";"7.96";"";"361218";"UO_0000065";"20.07";"0.39";"5.15";"9.26";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112018";"";"None";"531.64";"1";"3.27";"BDBM203597";"O=c1[nH]c(N2CCN(c3ccc4c(c3)OCO4)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"11.0";"nM";"7.96";"";"361078";"UO_0000065";"14.97";"0.29";"4.69";"7.39";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3901315";"";"None";"437.50";"0";"1.36";"BDBM203509";"C[C@H]1C[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2ccc3ccccc3n2)[C@H](O)[C@@H]1O";"IC50";"'='";"5.0";"nM";"8.30";"";"360969";"UO_0000065";"18.97";"0.35";"6.94";"6.72";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108856";"";"None";"483.53";"1";"2.44";"BDBM203515";"O=c1[nH]c(Nc2ccc(F)cc2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"284.0";"nM";"6.55";"";"360975";"UO_0000065";"13.54";"0.26";"4.11";"4.57";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3919163";"";"None";"398.49";"0";"1.66";"BDBM203528";"O=c1[nH]c(N2CCOCC2)nc(NC2CCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"177.0";"nM";"6.75";"";"361008";"UO_0000065";"16.94";"0.33";"5.09";"7.09";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3909577";"";"None";"465.74";"0";"4.08";"BDBM206148";"O=C(Nc1cc(Cl)ccc1OC1CCC(O)CC1)c1cnn2cc(Br)cnc12";"IC50";"'='";"137.0";"nM";"6.86";"";"364819";"UO_0000065";"14.74";"0.33";"2.78";"7.73";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3933937";"";"None";"403.45";"0";"1.73";"BDBM188903";"Cc1cnc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'>'";"1000.0";"nM";"";"";"338758";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3940677";"";"None";"466.53";"0";"1.70";"BDBM188907";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccccn3)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338762";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3948235";"";"None";"492.59";"0";"4.25";"BDBM189034";"Cc1ccc(-n2nc(C3CCCN(Cc4cccnc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338889";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112572";"";"None";"523.07";"1";"3.59";"BDBM203587";"O=c1[nH]c(N2CCN(c3cc(Cl)ccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"9.0";"nM";"8.05";"";"361068";"UO_0000065";"15.38";"0.31";"4.46";"7.88";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114351";"";"None";"547.69";"1";"3.55";"BDBM203603";"COc1ccc(OC)c(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)c1";"IC50";"'='";"14.0";"nM";"7.85";"";"361084";"UO_0000065";"14.34";"0.28";"4.30";"7.30";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3892745";"";"None";"481.56";"0";"3.58";"BDBM189028";"Cc1ccc(-n2nc(C3CCCN(Cc4cn[nH]c4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338883";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115260";"";"None";"452.63";"0";"3.80";"BDBM203677";"CC(C)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"660.0";"nM";"6.18";"";"361151";"UO_0000065";"13.65";"0.26";"2.38";"7.19";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4280028";"";"None";"471.61";"0";"2.42";"38";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(=O)N(C)C)c34)CC2)CC1";"IC50";"'='";"1202.26";"nM";"5.92";"";"";"UO_0000065";"12.55";"0.24";"3.50";"6.21";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4293607";"";"None";"427.55";"0";"1.60";"33";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"17.96";"0.34";"6.08";"7.05";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4286802";"";"None";"385.51";"0";"2.68";"29";"c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)ccn2n1";"IC50";"'='";"87.1";"nM";"7.06";"";"";"UO_0000065";"18.31";"0.34";"4.38";"11.05";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4290222";"";"None";"426.57";"0";"2.51";"31";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"14.95";"0.28";"3.87";"8.50";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4106558";"";"None";"520.62";"1";"1.95";"BDBM203819";"O=c1[nH]c(N2CCC(c3ccncc3)C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"30.9";"nM";"7.51";"";"360999";"UO_0000065";"14.43";"0.28";"5.56";"5.09";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622187";"";"None";"444.51";"0";"1.49";"BDBM203478";"O=c1[nH]c(OC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"1686.0";"nM";"5.77";"";"360938";"UO_0000065";"12.99";"0.25";"4.28";"4.11";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109108";"";"None";"477.50";"0";"2.31";"BDBM187870";"Cc1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)n(C)n1";"IC50";"'='";"7.0";"nM";"8.15";"";"337547";"UO_0000065";"17.08";"0.32";"5.84";"5.56";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109437";"";"None";"423.49";"0";"3.56";"BDBM187398";"CC(C)Nc1cc(-n2ccc3cc(C#N)ccc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.3";"nM";"8.48";"";"337136";"UO_0000065";"20.03";"0.37";"4.92";"8.24";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4069060";"";"None";"304.46";"0";"3.59";"2";"Cc1sc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1C";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"19.13";"0.38";"2.23";"14.19";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4108787";"";"None";"494.57";"0";"3.09";"BDBM187902";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCC(CO)C1";"IC50";"'='";"5.3";"nM";"8.28";"";"337577";"UO_0000065";"16.73";"0.31";"5.19";"6.08";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4086115";"";"None";"454.62";"0";"3.38";"29";"CN(C)C(=O)C1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"14.45";"0.27";"3.19";"7.60";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4761018";"";"None";"400.53";"0";"3.88";"79";"CC(C)Nc1c(-c2cn(CCCO)nn2)cnc2sc(-c3cncs3)cc12";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"21.57";"0.44";"4.76";"9.73";"0";"CHEMBL4739586";"Inhibition of IRAK4 (unknown origin) using IPTSPITTTYFFFKKK peptide as substrate in presence of ATP measured after 60 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732264";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.0 hr"
"CHEMBL1945559";"";"None";"363.25";"0";"2.96";"20";"Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1948125";"Inhibition of IRAK4 using ATP as substrate";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1944596";"1";"Scientific Literature";"J Med Chem";"2012";"None";""
"CHEMBL4109597";"";"None";"440.48";"0";"1.93";"BDBM187793";"CC(C)Nc1cc(-n2cnc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.9";"nM";"8.72";"";"337475";"UO_0000065";"19.80";"0.37";"6.79";"5.63";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110867";"";"None";"501.52";"1";"2.97";"BDBM187455";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(C(N)=O)c1";"IC50";"'='";"2.5";"nM";"8.60";"";"337191";"UO_0000065";"17.15";"0.32";"5.63";"5.41";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113645";"";"None";"458.47";"0";"1.88";"BDBM188057";"C[C@@H](F)CNc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.7";"nM";"8.57";"";"337723";"UO_0000065";"18.69";"0.35";"6.69";"5.54";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113443";"";"None";"462.48";"0";"3.10";"BDBM188087";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(F)C1";"IC50";"'='";"5.8";"nM";"8.24";"";"337750";"UO_0000065";"17.81";"0.34";"5.14";"7.85";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3908153";"";"None";"458.57";"0";"3.93";"BDBM187888";"CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CC2)CC1";"IC50";"'='";"1.5";"nM";"8.82";"";"337563";"UO_0000065";"19.24";"0.35";"4.89";"7.62";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5091399";"";"None";"519.61";"1";"4.08";"19";"N#Cc1cccc(-c2cnc(Nc3cccc(C(=O)N4CCCC4)c3)nc2N[C@H]2[C@@H](C(N)=O)[C@@H]3C=C[C@H]2C3)c1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"15.18";"0.28";"3.81";"5.75";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL3974894";"";"None";"528.62";"1";"3.50";"BDBM188973";"CCOC(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1";"IC50";"'<'";"1000.0";"nM";"";"";"338828";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3895084";"";"None";"413.42";"0";"3.68";"BDBM188862";"Cc1ccc(-n2nc(-c3ccncc3)cc2NC(=O)c2cnn3cccnc23)cc1F";"IC50";"'<'";"1000.0";"nM";"";"";"338717";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4780247";"";"None";"404.43";"0";"1.84";"13";"CN(c1ccc2ncc(C(=O)Nc3cn(C)nc3C(F)F)n2n1)[C@@H]1CCCNC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4799791";"";"None";"436.44";"0";"2.94";"19";"CC(C)n1cc(NC(=O)c2cnc3ccc(N[C@@H]4CCCNC4)nn23)c(C(F)(F)F)n1";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"16.30";"0.31";"4.17";"7.03";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4097778";"TP-030n";"None";"458.54";"0";"1.13";"TP-030n";"CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21";"IC50";"";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4885316";"IRAK4(IRK4LGF1) Takeda global kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507327";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM"
"CHEMBL4633251";"";"None";"341.44";"0";"3.61";"3";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"22.49";"0.44";"4.07";"9.73";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4641090";"";"None";"415.47";"0";"2.53";"20";"CC(C)Nc1cc(Nc2ccn3nccc3n2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"16.85";"0.32";"4.47";"6.01";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4293993";"";"None";"427.55";"0";"1.60";"34";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@@H](C)CC(N)=O)c34)CC2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4648225";"";"None";"385.49";"0";"3.37";"8";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCCO";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"19.77";"0.39";"4.25";"7.68";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3586511";"";"None";"481.54";"0";"0.95";"BDBM188933";"Cc1ccc(-n2nc(N3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338788";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL210194";"";"None";"368.35";"0";"2.76";"36";"CCOC(=O)Cn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"17.37";"0.32";"3.64";"5.50";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL4746543";"";"None";"917.08";"2";"2.20";"19";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)NCCOCCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)c12";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL4757221";"";"None";"417.43";"0";"2.35";"7";"Nc1ccc(-c2cccc(C(=O)Nc3ccc4nc(N5CCOCC5)oc4n3)n2)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4672982";"Inhibition of IRAK4 in human THP-1 cells assessed as inhibition of LTA-induced TNF-alpha production preincubated for 60 mins followed by LTA stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3909778";"";"None";"394.46";"0";"3.64";"BDBM206115";"CC(O)CCOc1cc2ncccc2cc1NC(=O)c1csc2cncnc12";"IC50";"'='";"33.0";"nM";"7.48";"";"364786";"UO_0000065";"18.97";"0.36";"3.84";"7.69";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3917117";"";"None";"423.43";"0";"2.91";"BDBM188801";"O=C(Nc1cc(C2CCNCC2)nn1-c1cc(F)cc(F)c1)c1cnn2cccnc12";"IC50";"'>'";"1000.0";"nM";"";"";"338656";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107103";"";"None";"526.54";"2";"2.85";"BDBM187986";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1ccc(-n2cncn2)cc1";"IC50";"'='";"3.7";"nM";"8.43";"";"337658";"UO_0000065";"16.01";"0.30";"5.58";"5.29";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115046";"";"None";"448.89";"0";"2.12";"BDBM188014";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1NC1COC1";"IC50";"'='";"12.6";"nM";"7.90";"";"337683";"UO_0000065";"17.60";"0.35";"5.78";"6.92";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3343045";"";"None";"378.34";"0";"3.20";"14b";"O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1ccc(O)c([N+](=O)[O-])c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL3938296";"";"None";"370.84";"0";"2.42";"BDBM206188";"NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)C1";"IC50";"'='";"564.0";"nM";"6.25";"";"364859";"UO_0000065";"16.85";"0.33";"3.83";"7.06";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3960718";"";"None";"556.65";"1";"3.08";"BDBM189073";"Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338931";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3955427";"";"None";"513.58";"1";"3.54";"BDBM189075";"Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N4CCC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338933";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622530";"";"None";"426.55";"0";"2.44";"31";"C[C@@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1";"IC50";"'='";"93.0";"nM";"7.03";"";"";"UO_0000065";"16.48";"0.32";"4.59";"7.39";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3622527";"";"None";"412.52";"0";"2.05";"28";"O=c1[nH]c(N2CCOCC2)nc(NC2CCNCC2)c1-c1nc2ccccc2s1";"IC50";"'='";"121.0";"nM";"6.92";"";"";"UO_0000065";"16.77";"0.33";"4.87";"7.27";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4114460";"";"None";"436.49";"0";"3.10";"BDBM187416";"CC1(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"337152";"UO_0000065";"20.44";"0.38";"5.82";"7.70";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3918603";"";"None";"425.45";"0";"3.03";"BDBM189061";"Cc1ccc(-n2nc(-c3ccc(CO)nc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338919";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3923780";"";"None";"582.72";"1";"4.99";"BDBM189115";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc5ncsc5c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338973";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3951256";"";"None";"471.57";"0";"2.94";"BDBM189054";"Cc1ccc(-n2nc(N3CCN(C4CCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338912";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3986973";"";"None";"593.64";"2";"5.40";"BDBM189102";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccc(C(F)(F)F)c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338960";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3927769";"";"None";"353.41";"0";"2.68";"BDBM206223";"O=C(Nc1nc2ccccc2n1CCCO)c1csc2cncnc12";"IC50";"'='";"2310.0";"nM";"5.64";"";"364894";"UO_0000065";"15.95";"0.31";"2.96";"6.07";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3958152";"";"None";"408.48";"0";"4.03";"BDBM206122";"CC(C)(CCO)Oc1cc2ncccc2cc1NC(=O)c1csc2cncnc12";"IC50";"'='";"49.0";"nM";"7.31";"";"364793";"UO_0000065";"17.90";"0.34";"3.28";"7.52";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3957910";"";"None";"332.75";"0";"2.01";"BDBM206266";"O=C(Nc1cc(Cl)ccc1OCCO)c1cnn2cccnc12";"IC50";"'='";"5000.0";"nM";"5.30";"";"364937";"UO_0000065";"15.93";"0.31";"3.29";"5.97";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3973751";"";"None";"451.49";"0";"3.50";"BDBM189081";"CNC(=O)c1cccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)c1";"IC50";"'<'";"1000.0";"nM";"";"";"338939";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4789126";"";"None";"401.43";"0";"3.37";"1";"O=C(Nc1ccc2nc(N3CCOCC3)oc2c1)c1cccc(-c2ccncc2)n1";"IC50";"'='";"1488.0";"nM";"5.83";"";"";"UO_0000065";"14.52";"0.27";"2.46";"6.24";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4743091";"";"None";"500.56";"1";"3.34";"9";"Nc1ccc(-c2cccc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCCCC3)n2)cn1";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"17.09";"0.32";"5.21";"6.31";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4559539";"";"None";"481.56";"0";"3.88";"18";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)NCc2ccccc2)n1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4435482";"";"None";"504.64";"1";"3.41";"12";"CN(C)CCCCCNC(=O)c1nn(C)cc1NC(=O)c1cccc(-c2ccnc(NCC3CC3)c2)n1";"IC50";"'='";"2197.0";"nM";"5.66";"";"";"UO_0000065";"11.21";"0.21";"2.25";"4.83";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4546753";"";"None";"482.55";"0";"3.28";"19";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)NCc2ccncc2)n1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4800602";"";"None";"432.45";"0";"4.74";"14";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)cc(C3CC3)c2n1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"15.65";"0.30";"2.03";"8.46";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4782761";"";"None";"433.43";"0";"3.42";"5";"CN1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)C1";"IC50";"'='";"176.0";"nM";"6.75";"";"";"UO_0000065";"15.58";"0.30";"3.33";"8.11";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL3951115";"";"None";"412.43";"0";"4.28";"BDBM188869";"Cc1ccc(-n2nc(-c3ccc(F)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338724";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622521";"";"None";"426.55";"0";"2.39";"22";"CN1CCC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)C1";"IC50";"'='";"354.0";"nM";"6.45";"";"";"UO_0000065";"15.12";"0.29";"4.06";"7.47";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL210658";"";"None";"282.26";"0";"2.72";"1";"O=C(Nc1nc2ccccc2[nH]1)c1cccc([N+](=O)[O-])c1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"19.12";"0.35";"2.68";"5.35";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3910160";"";"None";"451.51";"0";"1.83";"BDBM188817";"Cc1ccc(-n2nc(C3CN(S(C)(=O)=O)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338672";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3984259";"";"None";"405.44";"0";"2.77";"BDBM188744";"O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(F)cc1)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338599";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3982170";"";"None";"401.47";"0";"2.94";"BDBM188749";"Cc1cccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)c1";"IC50";"'<'";"1000.0";"nM";"";"";"338604";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586499";"";"None";"479.57";"0";"2.61";"BDBM188751";"Cc1cccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)c1";"IC50";"'<'";"1000.0";"nM";"";"";"338606";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3917931";"";"None";"473.52";"0";"3.08";"BDBM188833";"Cc1ccc(-n2nc(-c3ccc(N[SH](=O)=O)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338688";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111310";"";"None";"488.52";"0";"3.88";"BDBM187450";"COc1cccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)c1";"IC50";"'='";"4.4";"nM";"8.36";"";"337552";"UO_0000065";"17.11";"0.32";"4.48";"6.68";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3899414";"";"None";"506.59";"1";"2.54";"BDBM188888";"Cc1ccc(-n2nc(C3CCN(S(=O)(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338743";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115090";"";"None";"451.51";"0";"1.90";"BDBM187923";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCNC1";"IC50";"'='";"13.9";"nM";"7.86";"";"337598";"UO_0000065";"17.40";"0.33";"5.96";"6.14";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108617";"";"None";"410.45";"0";"2.83";"BDBM187545";"COC[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"2.8";"nM";"8.55";"";"337262";"UO_0000065";"20.84";"0.39";"5.72";"8.16";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4280559";"";"None";"443.55";"0";"1.82";"36";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1";"IC50";"'='";"19.5";"nM";"7.71";"";"";"UO_0000065";"17.38";"0.33";"5.89";"6.53";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4636136";"";"None";"510.65";"1";"3.88";"4";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"11.59";"0.23";"2.04";"4.26";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4763127";"";"None";"417.39";"0";"3.74";"19";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)cc(C#N)c2n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4520118";"";"None";"436.47";"0";"1.63";"31";"CC1(C)Cc2cc(NC(=O)c3cnn4cc(C(N)=O)cnc34)c(N3CCOCC3)cc2O1";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"16.61";"0.31";"5.62";"5.84";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4434908";"";"None";"460.54";"0";"1.98";"15";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)N2CC(CN)C2)n1";"IC50";"'='";"191.0";"nM";"6.72";"";"";"UO_0000065";"14.59";"0.27";"4.74";"5.13";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3914726";"";"None";"444.92";"0";"3.24";"BDBM206265";"O=C(Nc1cc(Cl)ccc1OC1CCC(O)CC1)c1cnn2cc(CCCO)cnc12";"IC50";"'='";"9417.0";"nM";"5.03";"";"364936";"UO_0000065";"11.30";"0.22";"1.79";"4.61";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4106779";"";"None";"454.56";"0";"1.38";"BDBM203611";"CS(=O)(=O)C1CN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1";"IC50";"'='";"32.0";"nM";"7.50";"";"361092";"UO_0000065";"16.49";"0.32";"6.11";"6.24";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3898909";"";"None";"493.53";"0";"3.41";"BDBM187716";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCc1nc(Cc2ccccc2)no1";"IC50";"'='";"4.5";"nM";"8.35";"";"337401";"UO_0000065";"16.91";"0.31";"4.94";"5.66";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4756721";"";"None";"416.52";"0";"4.02";"23";"CC(C)Nc1c(C(=O)NC[C@@H](F)C(C)(C)O)cnc2sc(-c3ccncc3)cc12";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"19.97";"0.39";"4.30";"9.55";"0";"CHEMBL4739586";"Inhibition of IRAK4 (unknown origin) using IPTSPITTTYFFFKKK peptide as substrate in presence of ATP measured after 60 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732264";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.0 hr"
"CHEMBL3913888";"";"None";"394.46";"0";"4.01";"BDBM203297";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(N)=O)co1";"IC50";"'='";"2.7";"nM";"8.57";"";"360859";"UO_0000065";"21.72";"0.42";"4.56";"7.20";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3590481";"";"None";"422.45";"1";"1.45";"21";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(-c2nnco2)n1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"19.46";"0.36";"6.77";"5.34";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3938085";"";"None";"373.42";"0";"2.16";"BDBM188816";"Cc1ccc(-n2nc(C3CNC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338671";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3903890";"";"None";"294.31";"0";"2.63";"BDBM206230";"C=Cc1ccc(OC)c(NC(=O)c2cnn3cccnc23)c1";"IC50";"'='";"2748.0";"nM";"5.56";"";"364901";"UO_0000065";"18.89";"0.35";"2.93";"8.12";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3889839";"";"None";"385.86";"0";"2.84";"BDBM206131";"CC(O)C1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)C1";"IC50";"'='";"76.0";"nM";"7.12";"";"364802";"UO_0000065";"18.45";"0.36";"4.28";"8.60";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL482709";"";"None";"295.35";"0";"1.92";"5";"c1ccn2c(-c3ccnc(OC4CCNCC4)n3)cnc2c1";"IC50";"'='";"1189.0";"nM";"5.92";"";"";"UO_0000065";"20.06";"0.37";"4.00";"9.21";"0";"CHEMBL956501";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL3942826";"";"None";"561.07";"1";"4.43";"BDBM189119";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccnc4Cl)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338977";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115149";"";"None";"468.49";"0";"1.30";"BDBM187912";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1COC[C@H]1O";"IC50";"'='";"4.8";"nM";"8.32";"";"337588";"UO_0000065";"17.76";"0.33";"7.02";"5.72";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3986533";"";"None";"443.49";"0";"3.62";"BDBM187709";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCc1ccc(F)cc1";"IC50";"'='";"3.3";"nM";"8.48";"";"337394";"UO_0000065";"19.12";"0.35";"4.86";"7.82";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3942146";"";"None";"438.56";"0";"2.39";"BDBM203650";"O=c1[nH]c(N2CCOCC2)nc(NC2CN3CCC2CC3)c1-c1nc2ccccc2s1";"IC50";"'='";"50.0";"nM";"7.30";"";"361131";"UO_0000065";"16.65";"0.32";"4.91";"8.45";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107570";"";"None";"557.62";"2";"4.10";"BDBM187990";"Cc1nnc(-c2ccc(Nc3cc(-n4ncc5cc(C#N)cnc54)ncc3C(=O)NC[C@@H](F)C(C)(C)O)cc2)s1";"IC50";"'='";"11.4";"nM";"7.94";"";"337662";"UO_0000065";"14.24";"0.27";"3.84";"5.14";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL377801";"";"None";"367.41";"0";"3.15";"44";"CN(C)CCCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"14.69";"0.27";"2.25";"5.79";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3910394";"";"None";"437.47";"0";"3.64";"BDBM187672";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cc2cc[nH]c2cn1";"IC50";"'='";"4.0";"nM";"8.40";"";"337357";"UO_0000065";"19.20";"0.35";"4.76";"6.12";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112508";"";"None";"422.49";"0";"1.02";"BDBM203640";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1cncc(-n2cccc2)n1";"IC50";"'='";"3457.0";"nM";"5.46";"";"361121";"UO_0000065";"12.93";"0.24";"4.44";"4.83";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3955423";"";"None";"415.46";"0";"2.20";"BDBM187760";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCc1c[nH]cn1";"IC50";"'='";"4.7";"nM";"8.33";"";"337445";"UO_0000065";"20.05";"0.37";"6.13";"6.07";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3942315";"";"None";"498.62";"0";"4.31";"BDBM189018";"Cc1ccc(-n2nc(C3CCCN(Cc4cncs4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338873";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3927390";"";"None";"459.53";"0";"3.99";"BDBM188822";"CC(C)N1CC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)C1";"IC50";"'<'";"100.0";"nM";"";"";"338677";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112779";"";"None";"528.59";"3";"0.00";"BDBM203824";"O=C1CNC2(CCN(c3nc(N[C@@H]4C[C@H](CO)[C@@H](O)[C@H]4O)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)O1";"IC50";"'='";"196.0";"nM";"6.71";"";"361004";"UO_0000065";"12.69";"0.25";"None";"3.88";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3936809";"";"None";"498.64";"0";"4.63";"BDBM189011";"Cc1ccc(-n2nc(C3CCN(C4CCCC(C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338866";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3986051";"";"None";"344.37";"0";"3.66";"BDBM206252";"COc1cc(-c2ccccc2)ccc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"5205.0";"nM";"5.28";"";"364923";"UO_0000065";"15.34";"0.28";"1.62";"7.71";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3971526";"";"None";"493.59";"0";"2.79";"BDBM188826";"Cc1ccc(-n2nc(C3(C)CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338681";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4090409";"";"None";"306.36";"0";"3.19";"13";"CN(C)[C@H]1CC[C@H](Nc2ncnc3cc(F)c(F)cc23)CC1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"21.29";"0.40";"3.33";"15.89";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3923977";"";"None";"482.55";"0";"3.60";"BDBM187671";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(N2CCOCC2)cc1";"IC50";"'='";"5.1";"nM";"8.29";"";"337356";"UO_0000065";"17.18";"0.31";"4.69";"6.85";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108089";"";"None";"516.62";"1";"4.51";"BDBM187412";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC12CC3CC(CC(C3)C1)C2";"IC50";"'='";"12.0";"nM";"7.92";"";"337148";"UO_0000065";"15.33";"0.28";"3.41";"6.84";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109866";"";"None";"513.48";"1";"2.73";"BDBM187832";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"1.8";"nM";"8.74";"";"337509";"UO_0000065";"17.03";"0.32";"6.01";"5.97";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3889742";"";"None";"473.58";"0";"3.54";"BDBM187492";"CCNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"1.7";"nM";"8.77";"";"337227";"UO_0000065";"18.52";"0.34";"5.23";"7.03";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3917746";"";"None";"488.59";"0";"3.03";"BDBM187493";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2CCC(C)(C)O)CC1";"IC50";"'='";"8.4";"nM";"8.08";"";"337228";"UO_0000065";"16.53";"0.31";"5.05";"6.08";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112812";"";"None";"542.62";"1";"3.61";"BDBM187996";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCN(c2ccccc2)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"337667";"UO_0000065";"15.48";"0.29";"4.79";"6.36";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3905289";"";"None";"483.54";"0";"2.99";"BDBM187665";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(N2CCOCC2)nc1";"IC50";"'='";"4.5";"nM";"8.35";"";"337350";"UO_0000065";"17.26";"0.32";"5.36";"6.23";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108104";"";"None";"516.52";"1";"3.09";"BDBM187520";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCC(F)(F)C1O";"IC50";"'='";"4.4";"nM";"8.36";"";"337247";"UO_0000065";"16.18";"0.31";"5.27";"6.14";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113524";"";"None";"427.46";"0";"3.32";"BDBM187794";"CC(C)Nc1cc(-n2cnc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)F";"IC50";"'='";"8.7";"nM";"8.06";"";"337476";"UO_0000065";"18.86";"0.36";"4.74";"7.43";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109034";"";"None";"518.96";"1";"3.61";"BDBM187827";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1Nc1cnn(CCCF)c1";"IC50";"'='";"2.6";"nM";"8.59";"";"337504";"UO_0000065";"16.54";"0.33";"4.98";"6.99";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3955922";"";"None";"531.64";"1";"3.72";"BDBM188788";"O=C(Nc1cc(C2CCN(S(=O)(=O)C3CC3)CC2)nn1-c1ccc(C2CC2)cc1)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338643";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3949459";"";"None";"491.55";"0";"2.30";"BDBM187541";"CC(=O)OC(C)(C)C(=O)NCCNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"6.7";"nM";"8.17";"";"337260";"UO_0000065";"16.63";"0.31";"5.87";"5.41";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4471452";"";"None";"383.50";"0";"3.05";"9";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C)cc34)CC2)CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"17.47";"0.33";"3.65";"9.49";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3927317";"";"None";"477.57";"0";"2.68";"BDBM187726";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCC(C)(O)CC1";"IC50";"'='";"5.9";"nM";"8.23";"";"337411";"UO_0000065";"17.23";"0.32";"5.55";"5.52";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114115";"";"None";"520.53";"2";"2.04";"BDBM187843";"CCNC(=O)n1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"1.5";"nM";"8.82";"";"337520";"UO_0000065";"16.95";"0.32";"6.78";"5.02";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3634382";"";"None";"403.44";"0";"2.94";"28";"Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)F)n1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"18.84";"0.36";"4.66";"7.43";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634508";"";"None";"389.41";"0";"2.42";"38";"Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCNC4)nn23)c(C(F)F)n1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"21.32";"0.40";"5.88";"9.40";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3938766";"";"None";"465.47";"0";"3.28";"BDBM187848";"CC(C)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"6.2";"nM";"8.21";"";"337525";"UO_0000065";"17.63";"0.33";"4.93";"6.50";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL426133";"";"None";"262.27";"0";"2.69";"6";"N#Cc1cccc(C(=O)Nc2nc3ccccc3[nH]2)c1";"IC50";"'='";"13600.0";"nM";"4.87";"";"";"UO_0000065";"18.56";"0.33";"2.18";"5.97";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL209118";"";"None";"300.25";"0";"2.86";"8";"O=C(Nc1nc2ccccc2[nH]1)c1ccc(F)c([N+](=O)[O-])c1";"IC50";"'='";"6500.0";"nM";"5.19";"";"";"UO_0000065";"17.28";"0.32";"2.33";"5.14";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL209715";"";"None";"296.29";"0";"3.03";"9";"Cc1ccc(C(=O)Nc2nc3ccccc3[nH]2)cc1[N+](=O)[O-]";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"16.61";"0.31";"1.89";"4.88";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL209716";"";"None";"338.37";"0";"4.00";"2";"CCCCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"16.84";"0.31";"1.70";"6.33";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL209075";"";"None";"362.26";"1";"5.40";"11";"CCCCn1c(NC(=O)c2ccc(Cl)c(Cl)c2)nc2ccccc21";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"15.25";"0.31";"0.12";"11.77";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL209820";"";"None";"388.41";"0";"2.91";"22";"CCCS(=O)(=O)c1ccc2[nH]c(NC(=O)c3cccc([N+](=O)[O-])c3)nc2c1";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"13.90";"0.27";"2.49";"4.00";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL210983";"";"None";"366.38";"0";"3.38";"39";"O=C(Nc1nc2ccccc2n1CC1CCCO1)c1cccc([N+](=O)[O-])c1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"17.20";"0.32";"2.92";"6.35";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL4282412";"";"None";"343.48";"0";"2.91";"21";"CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc(C4CCOCC4)c23)CC1";"IC50";"'='";"97.72";"nM";"7.01";"";"";"UO_0000065";"20.41";"0.38";"4.10";"12.82";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4292700";"";"None";"384.53";"0";"3.00";"23";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"13489.63";"nM";"4.87";"";"";"UO_0000065";"12.66";"0.24";"1.87";"4.87";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4758887";"";"None";"567.65";"2";"4.56";"23";"CC1(C)OC(=O)c2ccc(Nc3ncc(-c4nnc(C56CCN(CC5)CC6)o4)c(N[C@H](CO)c4ccccc4)n3)cc21";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"11.35";"0.21";"1.88";"4.65";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4798349";"";"None";"458.44";"0";"3.71";"10";"Cn1nccc1Cn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(C(C)(C)O)cc2n1";"IC50";"'='";"113.0";"nM";"6.95";"";"";"UO_0000065";"15.15";"0.29";"3.24";"7.10";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4799896";"";"None";"486.45";"0";"3.23";"7";"CC(C)(O)c1cc2nn(C3CN(C(=O)CC#N)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1";"IC50";"'='";"36.7";"nM";"7.43";"";"";"UO_0000065";"15.28";"0.29";"4.21";"5.99";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4776227";"";"None";"433.47";"0";"2.87";"8";"CC1(C)OC(=O)c2ccc(Nc3ncc(C(N)=O)c(N[C@H](CO)c4ccccc4)n3)cc21";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"15.68";"0.29";"3.93";"4.87";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL3986164";"";"None";"430.51";"0";"3.29";"BDBM187413";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC12CCC(O)(CC1)C2";"IC50";"'='";"14.8";"nM";"7.83";"";"337549";"UO_0000065";"18.19";"0.33";"4.54";"6.76";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107087";"";"None";"505.51";"2";"2.04";"BDBM187805";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(C2COC2)c1";"IC50";"'='";"1.8";"nM";"8.74";"";"337482";"UO_0000065";"17.30";"0.32";"6.70";"5.61";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106715";"";"None";"477.50";"0";"2.49";"BDBM187812";"CCn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"2.4";"nM";"8.62";"";"337489";"UO_0000065";"18.05";"0.34";"6.13";"5.88";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114212";"";"None";"547.56";"1";"3.62";"BDBM187945";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(NCC(F)(F)F)C1";"IC50";"'='";"4.3";"nM";"8.37";"";"337621";"UO_0000065";"15.28";"0.29";"4.75";"6.54";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3920482";"";"None";"437.41";"0";"2.64";"BDBM187850";"CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"3.5";"nM";"8.46";"";"337527";"UO_0000065";"19.33";"0.36";"5.82";"6.69";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106687";"";"None";"524.56";"1";"4.06";"BDBM187928";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc(-n2ccnc2)cc1";"IC50";"'='";"10.1";"nM";"8.00";"";"337603";"UO_0000065";"15.24";"0.28";"3.94";"5.98";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111235";"";"None";"524.58";"2";"2.95";"BDBM187978";"CC(C)(O)c1cnc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)s1";"IC50";"'='";"3.5";"nM";"8.46";"";"337653";"UO_0000065";"16.12";"0.31";"5.51";"5.22";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3937404";"";"None";"533.64";"1";"4.00";"BDBM189002";"Cc1ccc(-n2nc(C3CCN(C4CCc5ccncc5C4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338857";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3953525";"";"None";"418.53";"0";"3.67";"BDBM206101";"NCC1CCN(c2cc3ncccc3cc2NC(=O)c2csc3cncnc23)CC1";"IC50";"'='";"12.0";"nM";"7.92";"";"364772";"UO_0000065";"18.93";"0.36";"4.25";"8.16";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3963677";"";"None";"456.55";"0";"2.63";"BDBM188968";"Cc1ccc(-n2nc(C3CCN(C4CNC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338823";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3952937";"";"None";"319.32";"0";"2.54";"7";"COc1cc2ncccc2cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"20.14";"0.37";"3.89";"7.90";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4460458";"";"None";"457.54";"0";"3.36";"11";"O=C(Nc1cc2ccc(N3CCOCC3)nc2cc1N1CCCCC1)c1cnn2cccnc12";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"12.86";"0.24";"2.53";"6.70";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3906500";"";"None";"482.59";"0";"4.17";"BDBM188882";"O=C(Nc1cc(C2CCN(C3CCC3)CC2)nn1-c1ccc(C2CC2)cn1)c1cnn2cccnc12";"IC50";"'<'";"100.0";"nM";"";"";"338737";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3975370";"";"None";"383.80";"0";"3.51";"BDBM206208";"Cc1ncoc1COc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"1553.0";"nM";"5.81";"";"364879";"UO_0000065";"15.14";"0.29";"2.30";"6.14";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4531013";"";"None";"421.50";"0";"3.05";"37";"CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCCC(O)CC3)cc2O1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"16.34";"0.30";"3.84";"7.49";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3900568";"";"None";"399.46";"0";"2.85";"BDBM188872";"Cc1ccc(-n2nc(C3=CCNCC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338727";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3894494";"";"None";"523.62";"1";"1.90";"BDBM188893";"CC(C)(N)c1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338748";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3978471";"";"None";"450.52";"0";"2.77";"BDBM188832";"Cc1ccc(-n2nc(C3CCS(=O)(=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338687";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4549667";"TP-030-2";"None";"481.35";"0";"3.12";"EUB0000720";"CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21";"IC50";"";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4885025";"IRAK4(IRK4LGF1) Takeda global kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507326";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM"
"CHEMBL4111657";"";"None";"456.57";"0";"1.80";"BDBM203572";"O=c1[nH]c(N2CCOC(CCO)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"57.0";"nM";"7.24";"";"361052";"UO_0000065";"15.87";"0.31";"5.44";"6.28";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3900682";"";"None";"460.54";"0";"2.54";"BDBM187596";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"3.8";"nM";"8.42";"";"337297";"UO_0000065";"18.28";"0.34";"5.88";"6.12";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3923273";"";"None";"407.48";"0";"2.40";"BDBM187582";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(C)O";"IC50";"'='";"6.5";"nM";"8.19";"";"337281";"UO_0000065";"20.09";"0.37";"5.79";"6.36";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3954623";"";"None";"607.51";"1";"3.27";"BDBM188851";"Cc1ccc(-n2nc(C3CCN(C(=O)C4CN(C)CCO4)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338706";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3967229";"";"None";"459.51";"0";"2.73";"BDBM187753";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cnn(CC(C)(C)O)c1";"IC50";"'='";"10.7";"nM";"7.97";"";"337438";"UO_0000065";"17.35";"0.32";"5.24";"5.44";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3892637";"";"None";"397.44";"0";"3.93";"BDBM206123";"Cc1cc2cc(-c3ccc(CO)cc3)c(NC(=O)c3cnn4cccnc34)cc2[nH]1";"IC50";"'='";"52.0";"nM";"7.28";"";"364794";"UO_0000065";"18.33";"0.33";"3.35";"7.64";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3980609";"";"None";"371.83";"0";"2.60";"BDBM206147";"O=C(Nc1cc(Cl)ccc1N1CCC(O)CC1)c1cnn2cccnc12";"IC50";"'='";"136.0";"nM";"6.87";"";"364818";"UO_0000065";"18.47";"0.36";"4.27";"8.30";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3965787";"";"None";"509.62";"1";"4.07";"BDBM189037";"CCn1nccc1CN1CCCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)C1";"IC50";"'<'";"1000.0";"nM";"";"";"338892";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3900682";"";"None";"460.54";"0";"2.54";"BDBM187596";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"5.8";"nM";"8.24";"";"337295";"UO_0000065";"17.88";"0.33";"5.70";"5.99";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3931420";"";"None";"496.55";"0";"1.71";"BDBM188890";"COc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"1000.0";"nM";"";"";"338745";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3922501";"";"None";"537.65";"1";"1.94";"BDBM188892";"CC(C)(CN)c1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338747";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5093825";"";"None";"501.57";"1";"3.35";"26";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3ccnc(N4CCOCC4)c3)ncc2-c2cccc(F)c2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"16.14";"0.30";"4.75";"6.84";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL3926826";"";"None";"308.30";"0";"1.87";"BDBM206156";"COc1cc2[nH]ncc2cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"231.0";"nM";"6.64";"";"364827";"UO_0000065";"21.53";"0.39";"4.77";"6.83";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3967335";"";"None";"427.47";"0";"2.72";"BDBM189085";"Cc1ccc(-n2nc(C3=CC(=O)N(C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338943";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3976249";"";"None";"550.65";"1";"4.25";"BDBM189093";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccccc4C#N)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338951";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3343033";"";"None";"386.41";"0";"4.34";"1";"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL3890521";"";"None";"425.45";"0";"3.03";"BDBM189063";"Cc1ccc(-n2nc(-c3cncc(CO)c3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338921";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3923236";"";"None";"345.79";"0";"2.06";"BDBM206216";"CN(CCO)c1ccc(Cl)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"2203.0";"nM";"5.66";"";"364887";"UO_0000065";"16.36";"0.32";"3.60";"6.84";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4106712";"";"None";"489.46";"0";"1.97";"BDBM188017";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1COCC1(F)F";"IC50";"'='";"5.5";"nM";"8.26";"";"337686";"UO_0000065";"16.87";"0.32";"6.29";"5.99";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3929117";"";"None";"492.59";"0";"4.25";"BDBM188960";"Cc1ccc(-n2nc(C3CCN(Cc4ccccn4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338815";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3980882";"";"None";"477.57";"0";"4.74";"BDBM188877";"Cc1ccc(-n2nc(-c3ccc(CN4CCCC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338732";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3959174";"";"None";"543.63";"1";"4.52";"BDBM189109";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccccc4F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338967";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112700";"";"None";"409.47";"0";"3.29";"BDBM206126";"COc1cc2ncccc2cc1NC(=O)c1csc2cnc(N[C@H](C)CO)nc12";"IC50";"'='";"63.0";"nM";"7.20";"";"364797";"UO_0000065";"17.59";"0.34";"3.91";"6.59";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3894089";"";"None";"542.64";"1";"3.88";"BDBM188974";"Cc1ccc(-n2nc(C3CCN(C4CN(C(=O)OC(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338829";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3971750";"";"None";"534.65";"1";"2.30";"BDBM188978";"Cc1ccc(-n2nc(C3CCN(C4CN(S(C)(=O)=O)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338833";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3916129";"";"None";"531.69";"1";"4.65";"BDBM189104";"Cc1ccc(-n2nc(C3CCN([S+]([O-])C4CCCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338962";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3903627";"";"None";"529.63";"1";"3.11";"BDBM189106";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cnn(C)c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338964";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586509";"";"None";"444.54";"0";"3.46";"BDBM189004";"Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338859";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3900405";"";"None";"414.51";"0";"4.77";"BDBM188827";"Cc1ccc(-n2nc(C3CCC(C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338682";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3907425";"";"None";"386.84";"0";"3.32";"BDBM206177";"O=C(Nc1cc(Cl)ccc1OC1CCC(O)CC1)c1cnn2cccnc12";"IC50";"'='";"459.0";"nM";"6.34";"";"364848";"UO_0000065";"16.38";"0.32";"3.02";"7.14";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4790895";"";"None";"440.46";"0";"1.75";"17";"O=C(Nc1cc2oc(N3CCOCC3)nc2nc1C1CC1)c1coc(N2CC[C@H](O)C2)n1";"IC50";"'='";"505.0";"nM";"6.30";"";"";"UO_0000065";"14.30";"0.27";"4.55";"4.84";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4789918";"";"None";"507.53";"1";"3.61";"18";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCCC(F)C3)co2)ccn1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"17.14";"0.32";"5.09";"7.09";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4783351";"EMAVUSERTIB";"1.0";"491.51";"1";"2.24";"24; CA-4948";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1";"IC50";"'='";"31.7";"nM";"7.50";"";"";"UO_0000065";"15.26";"0.28";"5.26";"5.25";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4069378";"";"None";"298.43";"0";"3.53";"14";"Cc1cc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2cc1C";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"19.84";"0.37";"2.39";"14.42";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3945929";"";"None";"376.80";"0";"1.76";"BDBM206183";"O=C(Nc1cc(Cl)ccc1OCCC(O)CO)c1cnn2cccnc12";"IC50";"'='";"506.0";"nM";"6.30";"";"364854";"UO_0000065";"16.71";"0.33";"4.54";"5.78";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4755398";"";"None";"490.52";"1";"2.21";"20";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](N)C3)co2)ccn1";"IC50";"'='";"62.5";"nM";"7.20";"";"";"UO_0000065";"14.69";"0.27";"4.99";"4.85";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4114949";"";"None";"466.52";"0";"2.46";"BDBM187429";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCC[C@H]1O";"IC50";"'='";"2.2";"nM";"8.66";"";"337165";"UO_0000065";"18.56";"0.35";"6.20";"6.36";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3960537";"";"None";"384.87";"0";"2.81";"BDBM206112";"NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"31.0";"nM";"7.51";"";"364785";"UO_0000065";"19.51";"0.38";"4.70";"8.48";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3939338";"";"None";"414.90";"0";"2.82";"BDBM206158";"COc1cnc2c(C(=O)Nc3cc(Cl)ccc3N3CCC(CN)CC3)cnn2c1";"IC50";"'='";"254.0";"nM";"6.59";"";"364829";"UO_0000065";"15.90";"0.31";"3.78";"6.74";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3920995";"";"None";"407.50";"0";"4.35";"BDBM206172";"COc1cc2ncccc2cc1NC(=O)c1csc2cnc(N(C)C(C)C)nc12";"IC50";"'='";"432.0";"nM";"6.37";"";"364843";"UO_0000065";"15.62";"0.30";"2.01";"7.93";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4112058";"";"None";"498.52";"0";"3.75";"BDBM187898";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc2nc[nH]c2c1";"IC50";"'='";"2.6";"nM";"8.59";"";"337573";"UO_0000065";"17.22";"0.32";"4.84";"5.94";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3891376";"";"None";"418.46";"0";"1.61";"BDBM188021";"N#Cc1cc2cnn(-c3cc(NC4COC4)c(C(=O)NCCC4CC4)cn3)c2nc1N";"IC50";"'='";"6.1";"nM";"8.21";"";"337690";"UO_0000065";"19.63";"0.36";"6.60";"5.71";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3940896";"";"None";"355.35";"0";"0.71";"BDBM206233";"COc1cc(C(=O)NCCO)ccc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"2961.0";"nM";"5.53";"";"364904";"UO_0000065";"15.56";"0.29";"4.82";"4.69";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3941016";"";"None";"566.11";"2";"5.09";"BDBM189124";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(Cl)s4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338982";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3946350";"";"None";"553.69";"1";"4.56";"BDBM189126";"Cc1ccc(-n2nc(C3CCN([S+]([O-])CCc4ccccc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338984";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586494";"";"None";"415.50";"0";"3.28";"BDBM188770";"Cc1ccc(-n2nc(C3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338625";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4089619";"";"None";"329.40";"0";"2.25";"16";"CC(C)Oc1cc2c(O[C@@H]3CCCNC3)nccc2cc1C(N)=O";"IC50";"'='";"121.0";"nM";"6.92";"";"";"UO_0000065";"21.00";"0.39";"4.67";"8.00";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3634615";"";"None";"378.44";"0";"1.87";"48";"Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C#N)n1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"24.19";"0.45";"7.28";"7.26";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634380";"";"None";"439.47";"0";"3.38";"25";"Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)(F)F)n1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"17.52";"0.35";"4.32";"6.95";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4752693";"";"None";"434.45";"0";"3.47";"9";"CC1(C)OC(=O)c2ccc(Nc3ncc(C(=O)O)c(N[C@H](CO)c4ccccc4)n3)cc21";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"11.17";"0.21";"1.38";"3.63";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4797475";"";"None";"422.41";"0";"3.87";"16";"COc1cc(NC(=O)c2cccc(C(F)(F)F)n2)cc2cn(CCC(C)(C)O)nc12";"IC50";"'='";"8.3";"nM";"8.08";"";"";"UO_0000065";"19.13";"0.37";"4.21";"9.05";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4786242";"";"None";"452.47";"0";"4.10";"3";"C=CC(=O)Nc1ccc(C(=O)Nc2cccc(NC(=O)c3cccc(-c4ccn[nH]4)n3)c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731588";"Inhibition of IRAK4 (unknown origin) using methylcoumarin-labeled peptide as substrate in presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725474";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4113715";"";"None";"457.56";"1";"1.92";"BDBM203504";"C[C@@]1(O)[C@H](O)[C@@H](CO)C[C@H]1Nc1nc(NC2CCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"459.0";"nM";"6.34";"";"360964";"UO_0000065";"13.85";"0.27";"4.42";"4.42";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114443";"";"None";"471.58";"0";"2.06";"BDBM203505";"CC(C)[C@H]1C[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"72.0";"nM";"7.14";"";"360965";"UO_0000065";"15.15";"0.30";"5.08";"5.78";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3978447";"";"None";"418.51";"0";"3.15";"BDBM187773";"CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC1CCCCC1";"IC50";"'='";"6.6";"nM";"8.18";"";"337458";"UO_0000065";"19.55";"0.36";"5.03";"6.08";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3947754";"";"None";"480.59";"0";"3.20";"BDBM187506";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](S(C)(=O)=O)CC1";"IC50";"'='";"3.6";"nM";"8.44";"";"337237";"UO_0000065";"17.57";"0.34";"5.24";"6.51";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115438";"";"None";"387.44";"1";"0.31";"BDBM203484";"O=c1[nH]c(NC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1ccccn1";"IC50";"'='";"590.0";"nM";"6.23";"";"360944";"UO_0000065";"16.08";"0.30";"5.92";"4.34";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3353197";"";"None";"438.58";"1";"5.05";"BDBM50040790";"CNC(=O)c1nc(-c2cnc(Nc3ccc4ncsc4c3)cc2NC(C)C)sc1C";"IC50";"'='";"1.8";"nM";"8.74";"";"360851";"UO_0000065";"19.94";"0.40";"3.69";"9.52";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3894727";"";"None";"624.80";"2";"5.95";"BDBM203291";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(=O)N2CCC3(CC2)C(=O)NCN3c2ccccc2)cs1";"IC50";"'='";"575.9";"nM";"6.24";"";"360853";"UO_0000065";"9.99";"0.19";"0.29";"5.41";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3969713";"";"None";"579.50";"1";"3.90";"BDBM188847";"Cc1ccc(-n2nc(C3CCN(C(=O)CCN(C)C)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338702";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3909526";"";"None";"471.61";"0";"4.70";"BDBM188942";"Cc1ccc(-n2nc(C3CCN(C(C)C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338797";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115236";"";"None";"486.55";"0";"1.18";"BDBM188031";"CC(CNc1cc(-n2ncc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)N1CCOCC1";"IC50";"'='";"15.7";"nM";"7.80";"";"337697";"UO_0000065";"16.04";"0.30";"6.62";"5.99";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622511";"";"None";"417.49";"0";"0.63";"BDBM203493";"CN(C)c1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"542.0";"nM";"6.27";"";"360953";"UO_0000065";"15.01";"0.30";"5.64";"4.66";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3973605";"";"None";"481.54";"0";"1.40";"BDBM188906";"Cc1cnc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"338761";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3945877";"";"None";"409.45";"0";"3.85";"BDBM188913";"Cc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cn3)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338768";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3891636";"";"None";"484.59";"0";"1.96";"BDBM187755";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(C)NS(C)(=O)=O";"IC50";"'='";"4.8";"nM";"8.32";"";"337440";"UO_0000065";"17.17";"0.33";"6.36";"5.38";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114135";"";"None";"509.59";"1";"2.26";"BDBM187940";"CC1COCCN1CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"10.8";"nM";"7.97";"";"337615";"UO_0000065";"15.63";"0.29";"5.71";"6.21";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3962443";"";"None";"482.57";"0";"1.66";"BDBM187695";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CCCN(S(C)(=O)=O)C1";"IC50";"'='";"19.8";"nM";"7.70";"";"337380";"UO_0000065";"15.96";"0.31";"6.04";"5.28";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108543";"";"None";"543.63";"1";"1.97";"BDBM187920";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCN(S(C)(=O)=O)CC1";"IC50";"'='";"1.7";"nM";"8.77";"";"337595";"UO_0000065";"16.13";"0.32";"6.80";"5.72";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112912";"";"None";"486.52";"0";"2.65";"BDBM187451";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.4";"nM";"8.62";"";"337187";"UO_0000065";"17.72";"0.34";"5.97";"6.33";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109233";"";"None";"440.48";"0";"1.93";"BDBM187711";"CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.3";"nM";"8.89";"";"337396";"UO_0000065";"20.17";"0.38";"6.96";"5.74";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110422";"";"None";"513.48";"1";"2.73";"BDBM187864";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1ccn(CC(F)F)n1";"IC50";"'='";"3.1";"nM";"8.51";"";"337541";"UO_0000065";"16.57";"0.31";"5.78";"5.81";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3954359";"";"None";"483.55";"0";"1.16";"BDBM187936";"CS(=O)(=O)NCCNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCOCC1";"IC50";"'='";"5.7";"nM";"8.24";"";"337611";"UO_0000065";"17.05";"0.33";"7.08";"5.46";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3973407";"";"None";"480.60";"1";"3.42";"BDBM203300";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(N2CCN(CCO)CC2)o1";"IC50";"'='";"25.4";"nM";"7.59";"";"360862";"UO_0000065";"15.80";"0.31";"4.18";"6.58";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL1439445";"";"None";"318.34";"0";"2.48";"1";"Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2ccccc2)n1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"17.77";"0.32";"3.18";"7.34";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3586486";"";"None";"395.43";"0";"3.54";"8";"Cc1ccc(-n2nc(-c3ccncc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"18.25";"0.33";"3.67";"8.02";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3586489";"";"None";"425.45";"0";"3.55";"11";"COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cn1";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"15.30";"0.28";"2.96";"6.56";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4290202";"";"None";"457.58";"0";"2.08";"37";"CNC(=O)C[C@@H](C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCN(C(=O)OC)CC4)CC3)c12";"IC50";"'='";"1995.26";"nM";"5.70";"";"";"UO_0000065";"12.46";"0.24";"3.62";"5.48";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3622516";"";"None";"505.60";"1";"2.12";"16";"O=c1[nH]c(N2CCc3ccccc3C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"141.0";"nM";"6.85";"";"";"UO_0000065";"13.55";"0.26";"4.73";"5.09";"0";"CHEMBL3625601";"Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL3622530";"";"None";"426.55";"0";"2.44";"31";"C[C@@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1";"IC50";"'='";"580.0";"nM";"6.24";"";"";"UO_0000065";"14.62";"0.28";"3.80";"6.55";"0";"CHEMBL3625601";"Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL4113532";"";"None";"537.60";"1";"3.16";"BDBM187914";"CC(C)(C)OC(=O)N1CC(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1";"IC50";"'='";"10.3";"nM";"7.99";"";"337589";"UO_0000065";"14.86";"0.28";"4.83";"5.49";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108657";"";"None";"527.65";"1";"3.68";"BDBM187973";"CCCCNC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"8.6";"nM";"8.07";"";"337648";"UO_0000065";"15.29";"0.29";"4.39";"6.06";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4741488";"";"None";"491.51";"1";"2.24";"25";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@H](O)C3)co2)ccn1";"IC50";"'='";"233.0";"nM";"6.63";"";"";"UO_0000065";"13.49";"0.25";"4.39";"4.64";"0";"CHEMBL4672982";"Inhibition of IRAK4 in human THP-1 cells assessed as inhibition of LTA-induced TNF-alpha production preincubated for 60 mins followed by LTA stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4761304";"";"None";"475.55";"0";"3.91";"5";"CC(C)NC(=O)c1cnc(Nc2ccc3c(c2)C(C)(C)OC3=O)nc1N[C@H](CO)c1ccccc1";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"13.33";"0.25";"2.43";"5.05";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4792398";"";"None";"489.58";"0";"4.25";"7";"CCCN(C)C(=O)c1cnc(Nc2ccc3c(c2)C(C)(C)OC3=O)nc1N[C@H](CO)c1ccccc1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4799896";"";"None";"486.45";"0";"3.23";"7";"CC(C)(O)c1cc2nn(C3CN(C(=O)CC#N)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4782761";"";"None";"433.43";"0";"3.42";"5";"CN1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4743091";"";"None";"500.56";"1";"3.34";"9";"Nc1ccc(-c2cccc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCCCC3)n2)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4672982";"Inhibition of IRAK4 in human THP-1 cells assessed as inhibition of LTA-induced TNF-alpha production preincubated for 60 mins followed by LTA stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4761337";"";"None";"461.44";"0";"3.21";"9";"CC(C)(O)c1cc2nn(C[C@@H]3CCC(=O)N3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"15.88";"0.30";"4.12";"6.71";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4745104";"";"None";"448.53";"0";"3.44";"12";"Cc1cc(-c2nc(C(=O)Nc3cc4cn(CCN(C)C)nc4cc3C(C)(C)O)co2)ccn1";"IC50";"'='";"58.7";"nM";"7.23";"";"";"UO_0000065";"16.12";"0.30";"3.79";"6.62";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4793479";"";"None";"419.51";"0";"3.94";"1";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)c1ccccc1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"18.41";"0.35";"3.78";"7.79";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4790192";"";"None";"472.51";"0";"4.13";"11";"Cc1noc(-c2cnc(Nc3ccc4c(c3)C(C)(C)OC4=O)nc2N[C@H](CO)c2ccccc2)n1";"IC50";"'='";"740.0";"nM";"6.13";"";"";"UO_0000065";"12.97";"0.24";"2.00";"4.53";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4780798";"";"None";"567.65";"2";"4.56";"19";"CC1(C)OC(=O)c2ccc(Nc3ncc(-c4nc(C56CCN(CC5)CC6)no4)c(N[C@H](CO)c4ccccc4)n3)cc21";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"12.13";"0.22";"2.33";"4.97";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4112120";"";"None";"504.55";"1";"0.49";"BDBM188052";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCCNS(C)(=O)=O";"IC50";"'='";"9.7";"nM";"8.01";"";"337718";"UO_0000065";"15.88";"0.31";"7.52";"4.58";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107330";"";"None";"469.52";"0";"2.36";"BDBM188059";"COC(C)(C)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"19.6";"nM";"7.71";"";"337725";"UO_0000065";"16.42";"0.31";"5.35";"5.59";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL590109";"";"None";"425.52";"0";"4.40";"31a";"NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1073303";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153138";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL4793633";"";"None";"416.49";"0";"3.16";"2";"CCc1cc(Nc2ncc(C(=O)NC)c(N[C@H](CO)c3ccccc3)n2)ccc1C#N";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"17.82";"0.33";"4.26";"6.03";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4790504";"";"None";"416.44";"0";"2.96";"3";"Nc1ccc(-c2cccc(C(=O)Nc3ccc4nc(N5CCOCC5)oc4c3)n2)cn1";"IC50";"'='";"397.0";"nM";"6.40";"";"";"UO_0000065";"15.37";"0.28";"3.44";"5.36";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4757687";"";"None";"499.58";"0";"3.95";"4";"Nc1ccc(-c2cccc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCCCC3)n2)cn1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"16.21";"0.30";"4.15";"6.60";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4742305";"";"None";"474.53";"0";"3.09";"8";"O=C(Nc1cc2oc(N3CCOCC3)nc2nc1N1CCCCC1)c1cccc(-c2cn[nH]c2)n1";"IC50";"'='";"10.3";"nM";"7.99";"";"";"UO_0000065";"16.83";"0.31";"4.90";"6.37";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4104802";"";"None";"455.61";"0";"2.87";"25";"CN(C)C(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"16.39";"0.31";"4.60";"8.33";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4069890";"";"None";"357.50";"0";"3.16";"22";"CN(C)[C@H]1CC[C@H](N(C)c2ncnc3[nH]cc(C4CCOCC4)c23)CC1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"17.90";"0.34";"3.24";"11.17";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"6.19";"nM";"8.21";"";"";"UO_0000065";"17.59";"0.32";"3.86";"11.82";"0";"CHEMBL4145877";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145442";"1";"Scientific Literature";"Eur J Med Chem";"2017";"None";""
"CHEMBL103667";"DORAMAPIMOD";"2.0";"527.67";"2";"5.99";"BIRB 0796";"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1932877";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1926590";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";""
"CHEMBL4644871";"";"None";"369.49";"0";"4.40";"6";"CCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"21.44";"0.42";"3.52";"10.03";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3922334";"";"None";"433.52";"0";"2.93";"BDBM187701";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCCC1";"IC50";"'='";"3.6";"nM";"8.44";"";"337386";"UO_0000065";"19.48";"0.36";"5.51";"6.56";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3900602";"";"None";"481.58";"0";"1.88";"BDBM187904";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(C[SH](=O)=O)CC1";"IC50";"'='";"5.3";"nM";"8.28";"";"337579";"UO_0000065";"17.18";"0.33";"6.40";"6.22";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3955658";"";"None";"493.59";"0";"2.92";"BDBM188856";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cc(C)cnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338711";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108510";"";"None";"462.49";"0";"2.61";"BDBM187856";"Cn1cc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"1.3";"nM";"8.89";"";"337533";"UO_0000065";"19.21";"0.36";"6.28";"6.65";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4759406";"";"None";"514.59";"2";"5.12";"14";"CC(C)(C)c1noc(-c2cnc(Nc3ccc4c(c3)C(C)(C)OC4=O)nc2N[C@H](CO)c2ccccc2)n1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4067341";"";"None";"438.56";"0";"3.65";"26";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1CC[C@H](NC(C)=O)CC1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"17.51";"0.34";"4.03";"7.11";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4065667";"";"None";"447.50";"1";"2.19";"31";"CNC(=O)c1cnc(Nc2ccc3c(c2)CC(=O)N3)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"18.55";"0.34";"6.11";"6.12";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4068127";"";"None";"422.49";"0";"2.70";"37";"CNC(=O)c1cnc(Nc2ccc(OC)cc2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"18.94";"0.35";"5.30";"6.91";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4095514";"";"None";"440.48";"0";"2.84";"38";"CNC(=O)c1cnc(Nc2ccc(OC)c(F)c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"17.90";"0.34";"5.05";"6.81";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4447180";"";"None";"337.34";"0";"0.81";"25";"Cn1cc(NC(=O)c2cccc(-c3ccnc(N)c3)n2)c(C(N)=O)n1";"IC50";"'='";"101.0";"nM";"7.00";"";"";"UO_0000065";"20.74";"0.38";"6.19";"4.93";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4436908";"";"None";"362.39";"0";"2.11";"30";"Cn1cc(NC(=O)c2cccc(-c3ccc(C4CC4)nc3)n2)c(C(N)=O)n1";"IC50";"'='";"307.0";"nM";"6.51";"";"";"UO_0000065";"17.97";"0.33";"4.40";"5.62";"0";"CHEMBL4427853";"Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL255503";"";"None";"350.23";"0";"4.76";"2n";"O=C(Nc1c(Cl)cccc1Cl)c1csc(-c2cccnc2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4649636";"";"None";"416.46";"0";"3.02";"18";"CC(C)Nc1cc(Nc2ccc3nonc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"19.35";"0.37";"5.04";"6.44";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3590487";"";"None";"394.36";"0";"1.14";"27";"Cn1cc(NC(=O)c2cnn3ccc(N4CCNCC4)nc23)c(C(F)(F)F)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"20.29";"0.39";"6.86";"8.66";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4064106";"";"None";"490.63";"0";"3.74";"12";"CN(C)CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"14.88";"0.28";"3.56";"7.13";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4645368";"";"None";"429.52";"0";"3.85";"15";"CC(C)(O)[C@@H](F)CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"14.29";"0.28";"2.29";"6.19";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL3403441";"";"None";"374.43";"0";"0.24";"22";"Nc1ncc(-c2nc3cnccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"20.35";"0.40";"7.38";"5.07";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4114283";"";"None";"505.62";"1";"3.68";"BDBM203588";"O=c1[nH]c(N2CCN(c3ccccc3F)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"16.0";"nM";"7.80";"";"361069";"UO_0000065";"15.42";"0.30";"4.12";"8.74";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3926860";"";"None";"555.66";"1";"4.39";"BDBM189116";"COc1cccc([S+]([O-])N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)c1";"IC50";"'>'";"1000.0";"nM";"";"";"338974";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3896123";"";"None";"415.95";"0";"4.03";"BDBM206238";"CNCC1CCN(c2ccc(Cl)cc2NC(=O)c2csc3cncnc23)CC1";"IC50";"'='";"3545.0";"nM";"5.45";"";"364909";"UO_0000065";"13.10";"0.27";"1.42";"7.77";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3937335";"";"None";"543.63";"1";"4.52";"BDBM189110";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccc(F)c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338968";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107607";"";"None";"473.48";"0";"1.66";"BDBM188041";"CC(F)(CO)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"11.8";"nM";"7.93";"";"337707";"UO_0000065";"16.74";"0.32";"6.27";"5.32";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL256570";"";"None";"327.82";"0";"3.21";"12";"Clc1ccc2ncc(-c3cccc(NC4CCNCC4)n3)n2c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"27.45";"0.53";"5.79";"16.59";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4466517";"";"None";"409.45";"0";"1.50";"41";"C[C@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"16.53";"0.31";"5.27";"6.69";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL437208";"";"None";"265.32";"0";"1.78";"37";"c1cc(NC2CNC2)nc(-c2cnc3ccccn23)c1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"27.92";"0.51";"5.63";"13.66";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL256345";"";"None";"324.77";"0";"3.63";"3d";"Nc1ccc(-c2cccc(C(=O)Nc3ccccc3Cl)n2)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL258025";"";"None";"295.39";"0";"2.76";"31";"CN(C)CCCNc1cccc(-c2cnc3ccccn23)n1";"IC50";"'='";"8100.0";"nM";"5.09";"";"";"UO_0000065";"17.24";"0.32";"2.33";"11.20";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL256734";"";"None";"286.34";"0";"4.14";"26";"c1ccc(Nc2cccc(-c3cnc4ccccn34)n2)cc1";"IC50";"'='";"1156.0";"nM";"5.94";"";"";"UO_0000065";"20.73";"0.37";"1.80";"14.06";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL403662";"";"None";"396.47";"0";"3.30";"2q";"COc1cc(N2CCOCC2)ccc1NC(=O)c1csc(-c2cccnc2)n1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"17.14";"0.33";"3.50";"8.87";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4111238";"";"None";"482.57";"0";"1.66";"BDBM187694";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@@H]1CCCN(S(C)(=O)=O)C1";"IC50";"'='";"15.7";"nM";"7.80";"";"337379";"UO_0000065";"16.17";"0.31";"6.14";"5.35";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3981196";"";"None";"577.72";"1";"2.91";"BDBM188997";"Cc1ccc(-n2nc(C3CCN(C4CCC(NS(C)(=O)=O)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338852";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3946035";"";"None";"372.41";"0";"1.67";"BDBM206209";"COc1cc(C(=O)NCCO)ccc1NC(=O)c1csc2cncnc12";"IC50";"'='";"1619.0";"nM";"5.79";"";"364880";"UO_0000065";"15.55";"0.30";"4.12";"5.10";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3922067";"";"None";"302.72";"0";"2.64";"BDBM206210";"COc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"1633.0";"nM";"5.79";"";"364881";"UO_0000065";"19.12";"0.38";"3.15";"8.45";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3981649";"";"None";"410.44";"0";"3.12";"BDBM189086";"Cc1ccc(-n2nc(-c3ccnc(N)c3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338944";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3932526";"";"None";"561.62";"1";"4.66";"BDBM189096";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(F)c(F)c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338954";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109374";"";"None";"420.52";"0";"2.37";"BDBM203564";"C[C@@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2ccc3ccccc3n2)CN1";"IC50";"'='";"38.0";"nM";"7.42";"";"361044";"UO_0000065";"17.65";"0.33";"5.05";"7.80";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3940306";"";"None";"311.30";"0";"1.09";"BDBM206221";"COc1cc(C(N)=O)ccc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"2256.0";"nM";"5.65";"";"364892";"UO_0000065";"18.14";"0.34";"4.56";"5.06";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3969172";"";"None";"360.80";"0";"3.05";"BDBM206225";"COCCCOc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"2419.0";"nM";"5.62";"";"364896";"UO_0000065";"15.57";"0.31";"2.57";"7.22";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3948919";"";"None";"471.01";"0";"4.35";"BDBM187586";"CC(C)Nc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"337285";"UO_0000065";"17.08";"0.33";"3.70";"7.67";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4287208";"";"None";"276.41";"0";"2.98";"8";"CN(C)[C@H]1CC[C@H](Nc2ncnc3ccsc23)CC1";"IC50";"'='";"609.0";"nM";"6.21";"";"";"UO_0000065";"22.49";"0.45";"3.24";"15.14";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4107994";"";"None";"531.47";"1";"3.03";"BDBM187865";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1ccn(CC(F)(F)F)n1";"IC50";"'='";"1.8";"nM";"8.74";"";"337542";"UO_0000065";"16.45";"0.31";"5.71";"5.97";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112434";"";"None";"468.51";"0";"3.43";"BDBM187515";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(F)C1";"IC50";"'='";"1.0";"nM";"9.00";"";"337244";"UO_0000065";"19.21";"0.36";"5.57";"7.77";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4537124";"";"None";"329.36";"0";"-0.42";"24";"Cn1cc(NC(=O)c2cccc(N3CCNCC3)n2)c(C(N)=O)n1";"IC50";"'='";"3452.0";"nM";"5.46";"";"";"UO_0000065";"16.58";"0.31";"5.88";"4.62";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3951794";"";"None";"462.91";"0";"2.10";"BDBM188114";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1N[C@@H]1C[C@H]1CO";"IC50";"'='";"6.9";"nM";"8.16";"";"337777";"UO_0000065";"17.63";"0.35";"6.06";"6.52";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4091434";"";"None";"343.38";"0";"1.64";"31";"CC[C@@H]1CC(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"23.43";"0.44";"6.41";"7.77";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3962848";"";"None";"416.49";"0";"3.44";"BDBM188779";"Cc1ccc(-n2nc(CC3CCOCC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338634";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3960537";"";"None";"384.87";"0";"2.81";"BDBM206112";"NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"31.0";"nM";"7.51";"";"364784";"UO_0000065";"19.51";"0.38";"4.70";"8.48";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL482522";"";"None";"304.40";"0";"3.46";"12";"c1cc(NC2CCNCC2)nc(-c2cncc3ccccc23)c1";"IC50";"'='";"1934.0";"nM";"5.71";"";"";"UO_0000065";"18.77";"0.34";"2.25";"11.46";"0";"CHEMBL956501";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL3918899";"";"None";"515.60";"1";"3.70";"BDBM189076";"Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N(C)C)cc3C)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338934";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3923791";"";"None";"596.70";"2";"1.81";"BDBM187718";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCc1ccc(N(C[SH](=O)=O)S(C)(=O)=O)cc1";"IC50";"'='";"3.6";"nM";"8.44";"";"337403";"UO_0000065";"14.15";"0.28";"6.63";"4.69";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109694";"";"None";"477.45";"0";"2.18";"BDBM188064";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCCOC(F)F";"IC50";"'='";"16.6";"nM";"7.78";"";"337730";"UO_0000065";"16.29";"0.31";"5.60";"5.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3353218";"";"None";"497.58";"0";"1.29";"52";"O=C1Nc2cn(CCN3CCOCC3)nc2C(=O)NCCOCCc2cc(ccn2)-c2nc1cs2";"IC50";"'<='";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL2018068";"";"None";"429.55";"0";"2.40";"11";"CCCNc1nc(C)c(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"15.41";"0.30";"4.22";"5.36";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4067302";"";"None";"386.50";"0";"2.87";"33";"c1nc(O[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"17.58";"0.33";"3.93";"9.37";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL1650551";"";"None";"454.93";"0";"3.47";"25";"Cl.[2H]C([2H])(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCC(F)(F)C1";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"14.87";"0.29";"2.72";"7.12";"0";"CHEMBL1656203";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649074";"1";"Scientific Literature";"J Med Chem";"2011";"None";""
"CHEMBL256961";"";"None";"327.82";"0";"3.21";"rac-46";"Clc1ccc2ncc(-c3cccc(NC4CCCNC4)n3)n2c1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"24.54";"0.48";"4.84";"14.83";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL3934160";"";"None";"482.55";"0";"3.84";"BDBM189023";"Cc1ccc(-n2nc(C3CCCN(Cc4ncco4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338878";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3925304";"";"None";"408.49";"0";"3.26";"BDBM206137";"COc1cc2ncccc2cc1NC(=O)c1csc2cnc(NCCCN)nc12";"IC50";"'='";"101.0";"nM";"7.00";"";"364808";"UO_0000065";"17.13";"0.33";"3.74";"6.08";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3939266";"";"None";"298.30";"0";"1.48";"BDBM206264";"COc1cc(CO)ccc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"8673.0";"nM";"5.06";"";"364935";"UO_0000065";"16.97";"0.31";"3.58";"5.70";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3934835";"";"None";"453.91";"0";"3.77";"BDBM188784";"CN1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(Cl)cc3F)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338639";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3966402";"";"None";"527.63";"1";"3.07";"BDBM188971";"CCNC(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1";"IC50";"'<'";"1000.0";"nM";"";"";"338826";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3890299";"";"None";"399.88";"0";"3.23";"BDBM206093";"CC(O)C1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"364763";"UO_0000065";"20.76";"0.40";"5.07";"10.03";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4441283";"";"None";"763.73";"2";"3.84";"Example 58";"COc1cc2nn(C3CCN(CCOCCOc4ccc5c(c4)C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4307631";"Inhibition of N-terminal GST-tagged human IRAK4 (2 to end residues) expressed in baculovirus infected Sf9 cells using Ser/Thr 7 peptide as substrate in presence of ATP after 1 hr by Z'-LYTE assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304808";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";""
"CHEMBL4115525";"";"None";"480.54";"0";"2.97";"BDBM187939";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCC1CCOCC1";"IC50";"'='";"17.4";"nM";"7.76";"";"337614";"UO_0000065";"16.15";"0.30";"4.79";"6.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107260";"";"None";"473.00";"0";"3.21";"BDBM203644";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(Cl)cc2)cs1";"IC50";"'='";"153.0";"nM";"6.82";"";"361125";"UO_0000065";"14.41";"0.29";"3.61";"7.16";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3903061";"";"None";"373.42";"0";"2.92";"BDBM188915";"Cc1ccc(-n2nc(C3(C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'>'";"1000.0";"nM";"";"";"338770";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3909414";"";"None";"415.50";"0";"3.12";"BDBM188825";"Cc1ccc(-n2nc(C3(C)CCNCC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338680";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3976959";"";"None";"450.54";"0";"1.69";"BDBM203731";"O=c1[nH]c(N2CCOCC2)nc(NCCN2CCC(O)CC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"2200.0";"nM";"5.66";"";"361205";"UO_0000065";"12.56";"0.23";"3.97";"5.31";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3920387";"";"None";"349.35";"0";"1.88";"BDBM188916";"COc1cc(NC(=O)c2cnn3cccnc23)n(-c2ccc(C)cn2)n1";"IC50";"'<'";"1000.0";"nM";"";"";"338771";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3903671";"";"None";"414.47";"0";"3.70";"BDBM188735";"Cc1ccc(-n2nc(C3CCC(=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338590";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3893657";"";"None";"429.48";"0";"2.86";"BDBM188738";"Cc1ccc(-n2nc(C3CCNC(=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338593";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3908722";"";"None";"401.47";"0";"2.94";"BDBM188748";"Cc1ccccc1-n1nc(C2CCNCC2)cc1NC(=O)c1cnn2cccnc12";"IC50";"'>'";"1000.0";"nM";"";"";"338603";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3956904";"";"None";"534.61";"2";"1.90";"BDBM188909";"Cc1nn(C)c2nc(-n3nc(C4CCN(S(C)(=O)=O)CC4)cc3NC(=O)c3cnn4cccnc34)ccc12";"IC50";"'<'";"1000.0";"nM";"";"";"338764";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3900908";"";"None";"416.49";"0";"3.49";"BDBM188740";"Cc1ccc(-n2nc(C3CCC(O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338595";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3954648";"";"None";"452.49";"1";"5.16";"BDBM188835";"Cc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338690";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3944644";"";"None";"480.37";"0";"3.71";"BDBM188841";"Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338696";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622183";"";"None";"429.50";"1";"1.14";"4";"O=c1[nH]c(NC2CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"17.70";"0.35";"6.46";"5.30";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3622514";"";"None";"457.56";"0";"1.55";"14";"O=c1[nH]c(N2CCCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"16.10";"0.31";"5.82";"5.47";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4109005";"";"None";"450.52";"0";"3.34";"BDBM187907";"C[C@@H](Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)C1CC1";"IC50";"'='";"2.8";"nM";"8.55";"";"337582";"UO_0000065";"18.98";"0.35";"5.21";"7.38";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113763";"";"None";"515.57";"1";"1.19";"BDBM187933";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CN(S(C)(=O)=O)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"337608";"UO_0000065";"16.53";"0.32";"7.33";"5.56";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622516";"";"None";"505.60";"1";"2.12";"16";"O=c1[nH]c(N2CCc3ccccc3C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"14.97";"0.29";"5.45";"5.62";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4108247";"";"None";"488.64";"0";"2.35";"BDBM203684";"CS(=O)(=O)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"380.0";"nM";"6.42";"";"361158";"UO_0000065";"13.14";"0.27";"4.07";"5.35";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3955522";"";"None";"424.53";"0";"2.05";"BDBM203766";"O=c1[nH]c(N2CC3(COC3)C2)nc(NC2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"25.0";"nM";"7.60";"";"361240";"UO_0000065";"17.91";"0.35";"5.55";"7.99";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107588";"";"None";"454.56";"0";"1.41";"BDBM203767";"NC(=O)N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"74.0";"nM";"7.13";"";"361241";"UO_0000065";"15.69";"0.30";"5.72";"5.39";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3590436";"";"None";"342.36";"0";"-0.29";"8";"Cn1cc(NC(=O)c2cnn3ccc(CCCN)nc23)c(C(N)=O)n1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"19.93";"0.37";"7.11";"4.67";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3403449";"";"None";"427.53";"0";"2.09";"30";"OC[C@H]1C[C@@H](Nc2nc(NCC3CC3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"333000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4085199";"";"None";"359.36";"0";"1.19";"50";"COc1cc2c(OC[C@H]3NC(=O)[C@@]4(F)[C@@H]3[C@@H]4C)nccc2cc1C(N)=O";"IC50";"'='";"16.8";"nM";"7.78";"";"";"UO_0000065";"21.63";"0.41";"6.58";"7.51";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3909061";"";"None";"359.39";"0";"2.75";"BDBM188914";"Cc1ccc(-n2nc(C3CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'>'";"1000.0";"nM";"";"";"338769";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3932829";"";"None";"495.57";"0";"1.85";"BDBM188820";"COCCS(=O)(=O)N1CC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)C1";"IC50";"'<'";"1000.0";"nM";"";"";"338675";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3917961";"";"None";"402.84";"0";"1.94";"BDBM206109";"O=C(Nc1cc(Cl)ccc1N1CCC(CO)CC1)c1cnn2nc(O)cnc12";"IC50";"'='";"28.0";"nM";"7.55";"";"364780";"UO_0000065";"18.75";"0.37";"5.61";"6.52";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3920485";"";"None";"525.66";"1";"3.68";"BDBM189001";"Cc1ccc(-n2nc(C3CCN(C4CCN(C5CC5)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338856";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113337";"";"None";"498.52";"0";"3.75";"BDBM187897";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc2[nH]ncc2c1";"IC50";"'='";"2.5";"nM";"8.60";"";"337572";"UO_0000065";"17.26";"0.32";"4.85";"5.95";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3944351";"";"None";"435.49";"0";"1.78";"BDBM187686";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCOC1";"IC50";"'='";"6.7";"nM";"8.17";"";"337371";"UO_0000065";"18.77";"0.35";"6.39";"5.92";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107849";"";"None";"529.67";"1";"3.11";"BDBM203773";"O=c1[nH]c(N2CCC3(CCN(c4ncccn4)C3)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"12.0";"nM";"7.92";"";"361247";"UO_0000065";"14.95";"0.28";"4.81";"6.89";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110658";"";"None";"428.47";"0";"1.79";"BDBM187539";"CCNc1cc(-n2ccc3cc(C(N)=O)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.5";"nM";"8.35";"";"337258";"UO_0000065";"19.48";"0.37";"6.56";"6.18";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3955009";"";"None";"471.54";"0";"4.14";"BDBM188823";"O=C(Nc1cc(C2CN(C3CCC3)C2)nn1-c1ccc(C2CC2)cc1F)c1cnn2cccnc12";"IC50";"'<'";"100.0";"nM";"";"";"338678";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4790504";"";"None";"416.44";"0";"2.96";"3";"Nc1ccc(-c2cccc(C(=O)Nc3ccc4nc(N5CCOCC5)oc4c3)n2)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4672982";"Inhibition of IRAK4 in human THP-1 cells assessed as inhibition of LTA-induced TNF-alpha production preincubated for 60 mins followed by LTA stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3590484";"";"None";"407.40";"0";"3.48";"24";"Cn1cc(NC(=O)c2cnn3ccc(NC4CCCCC4)nc23)c(C(F)(F)F)n1";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"15.51";"0.30";"2.84";"7.09";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4109995";"";"None";"411.44";"0";"1.96";"BDBM187574";"CCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"8.9";"nM";"8.05";"";"337700";"UO_0000065";"19.57";"0.37";"6.09";"6.25";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114343";"";"None";"495.56";"0";"2.63";"BDBM188077";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@](C)(O)CC1";"IC50";"'='";"12.6";"nM";"7.90";"";"337740";"UO_0000065";"15.94";"0.30";"5.27";"5.30";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113386";"";"None";"440.57";"0";"2.83";"BDBM203742";"COC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"63.0";"nM";"7.20";"";"361216";"UO_0000065";"16.34";"0.32";"4.37";"7.57";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3964473";"";"None";"360.76";"0";"2.19";"BDBM206247";"COC(=O)COc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"4305.0";"nM";"5.37";"";"364918";"UO_0000065";"14.87";"0.29";"3.18";"5.66";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL2381601";"";"None";"384.87";"0";"2.83";"8e";"NC(=O)c1cnc(N[C@H]2CC[C@H](N)CC2)c2nc(-c3ccc(Cl)cc3)cn12";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"15.48";"0.30";"3.13";"5.35";"0";"CHEMBL2383894";"Inhibition of human CAMK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2380230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";""
"CHEMBL258853";"";"None";"315.79";"0";"4.11";"2a";"O=C(Nc1ccccc1Cl)c1csc(-c2cccnc2)n1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"17.58";"0.36";"1.44";"10.12";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL257125";"";"None";"309.76";"0";"4.05";"3a";"O=C(Nc1ccccc1Cl)c1cccc(-c2cccnc2)n1";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"17.65";"0.34";"1.42";"9.96";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4113637";"";"None";"416.43";"0";"2.37";"BDBM187592";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CC1";"IC50";"'='";"9.5";"nM";"8.02";"";"337291";"UO_0000065";"19.26";"0.37";"5.65";"7.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586487";"";"None";"425.45";"0";"3.55";"9";"COc1cc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)ccn1";"IC50";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"15.06";"0.27";"2.86";"6.46";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL256917";"";"None";"312.76";"0";"3.39";"3g";"Cn1cc(-c2cccc(C(=O)Nc3ccccc3Cl)n2)cn1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"19.66";"0.38";"2.76";"10.28";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL257366";"";"None";"298.73";"0";"3.38";"3e";"O=C(Nc1ccccc1Cl)c1cccc(-c2ccn[nH]2)n1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"19.40";"0.38";"2.42";"8.20";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4642013";"";"None";"429.52";"0";"3.85";"12";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"20.07";"0.39";"4.77";"8.69";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4112958";"";"None";"514.94";"1";"3.74";"BDBM188069";"CC(C)(CNc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)OC(F)F";"IC50";"'='";"6.7";"nM";"8.17";"";"337735";"UO_0000065";"15.87";"0.32";"4.43";"7.16";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115026";"";"None";"499.59";"0";"4.07";"BDBM203635";"O=c1[nH]c(N2CCC(c3cccc(F)n3)CC2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"45.0";"nM";"7.35";"";"361116";"UO_0000065";"14.71";"0.27";"3.28";"7.43";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3909500";"";"None";"423.50";"0";"2.26";"BDBM203713";"O=c1[nH]c(N2CCOCC2)nc(NCCc2ncc[nH]2)c1-c1nc2ccccc2s1";"IC50";"'='";"180.0";"nM";"6.75";"";"361187";"UO_0000065";"15.93";"0.31";"4.48";"6.03";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114137";"";"None";"437.50";"1";"1.46";"BDBM203483";"O=c1[nH]c(NC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1ccc2ccccc2n1";"IC50";"'='";"19.0";"nM";"7.72";"";"360943";"UO_0000065";"17.65";"0.33";"6.26";"5.38";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622185";"";"None";"402.48";"0";"1.12";"BDBM203524";"CCc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"1162.0";"nM";"5.93";"";"360984";"UO_0000065";"14.75";"0.29";"4.81";"4.52";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4066705";"";"None";"361.37";"0";"1.58";"41";"CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@@H]1F";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"22.66";"0.43";"6.61";"7.91";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4647594";"";"None";"427.57";"0";"4.39";"13";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NC[C@@H](C)C(C)(C)O";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"18.06";"0.35";"3.33";"7.79";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4784665";"";"None";"507.53";"1";"3.61";"22";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(F)CC3)co2)ccn1";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"16.64";"0.31";"4.83";"6.88";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL3897686";"";"None";"457.58";"0";"4.31";"BDBM188953";"Cc1ccc(-n2nc(C3CCN(CC(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338808";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3353219";"";"None";"400.87";"0";"2.52";"BDBM50040728";"NCC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cc(O)cnc23)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"364759";"UO_0000065";"22.45";"0.44";"6.48";"8.27";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3959961";"";"None";"465.52";"0";"2.87";"BDBM189038";"Cc1ccc(-n2nc(C3CN(Cc4cnccn4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338893";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3946548";"";"None";"415.88";"0";"2.85";"BDBM206116";"COc1cnc2c(C(=O)Nc3cc(Cl)ccc3N3CCC(CO)CC3)cnn2c1";"IC50";"'='";"33.0";"nM";"7.48";"";"364787";"UO_0000065";"17.99";"0.35";"4.63";"8.13";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3969501";"";"None";"594.53";"2";"5.68";"BDBM189122";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(Cl)cc4Cl)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338980";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3923938";"";"None";"402.91";"0";"4.25";"BDBM206205";"NC1CCC(Oc2ccc(Cl)cc2NC(=O)c2csc3cncnc23)CC1";"IC50";"'='";"1471.0";"nM";"5.83";"";"364876";"UO_0000065";"14.48";"0.30";"1.58";"6.47";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3900252";"";"None";"481.60";"0";"4.45";"BDBM188988";"Cc1ccc(-n2nc(C3CCN(C4CCC5CC54)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338843";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3969222";"";"None";"428.92";"0";"3.12";"BDBM206124";"CN(C)CC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cc(O)cnc23)CC1";"IC50";"'='";"53.0";"nM";"7.28";"";"364795";"UO_0000065";"16.96";"0.33";"4.16";"8.46";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4114655";"";"None";"572.67";"1";"4.65";"BDBM189027";"Cc1ccc(-n2nc(C3CCCN(Cc4ccc(C5(C#N)COC5)cc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338882";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3940314";"";"None";"497.63";"0";"4.92";"BDBM188957";"Cc1ccc(-n2nc(C3CCN(Cc4ccsc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338812";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3898083";"";"None";"402.91";"0";"3.81";"BDBM206136";"O=C(Nc1cc(Cl)ccc1N1CCC(CO)CC1)c1csc2cncnc12";"IC50";"'='";"100.0";"nM";"7.00";"";"364807";"UO_0000065";"17.37";"0.35";"3.19";"8.93";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3951493";"";"None";"611.73";"2";"3.61";"BDBM189114";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4ccc(N5CCOCC5)nc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338972";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622183";"";"None";"429.50";"1";"1.14";"BDBM203466";"O=c1[nH]c(NC2CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"25.0";"nM";"7.60";"";"360926";"UO_0000065";"17.70";"0.35";"6.46";"5.30";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4781524";"";"None";"407.40";"0";"3.27";"22";"COc1cc(NC(=O)c2cccc(C(F)(F)F)n2)cc2cn(CCN(C)C)nc12";"IC50";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"17.23";"0.33";"3.75";"9.71";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL3958308";"";"None";"576.73";"1";"3.52";"BDBM188986";"Cc1ccc(-n2nc(C3CCN(C4CCC(NS(C)(=O)=O)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338841";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3958620";"";"None";"494.40";"0";"4.05";"BDBM188845";"Cc1ccc(-n2nc(C3CCN(C)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338700";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3898402";"";"None";"346.77";"0";"2.40";"BDBM206171";"O=C(Nc1cc(Cl)ccc1OCCCO)c1cnn2cccnc12";"IC50";"'='";"430.0";"nM";"6.37";"";"364842";"UO_0000065";"18.36";"0.36";"3.97";"7.17";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4093475";"";"None";"259.36";"0";"2.24";"5";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]ccc23)CC1";"IC50";"'='";"630.96";"nM";"6.20";"";"";"UO_0000065";"23.90";"0.45";"3.96";"10.91";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3904136";"";"None";"460.58";"0";"4.17";"BDBM187496";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"337231";"UO_0000065";"19.22";"0.36";"4.68";"7.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3958009";"";"None";"435.53";"0";"2.81";"BDBM187484";"CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cncnc43)cc2NC(C)C)CC1";"IC50";"'='";"9.3";"nM";"8.03";"";"337219";"UO_0000065";"18.44";"0.34";"5.22";"7.06";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4636136";"";"None";"510.65";"1";"3.88";"4";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"16.14";"0.32";"4.36";"5.93";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4639599";"";"None";"355.47";"0";"4.00";"5";"CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"22.01";"0.43";"3.82";"9.91";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4064608";"";"None";"385.51";"0";"2.91";"28";"c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"18.89";"0.36";"4.37";"9.67";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4115086";"";"None";"524.60";"1";"2.05";"BDBM188036";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCC(C)(C)N1CCOCC1";"IC50";"'='";"10.7";"nM";"7.97";"";"337702";"UO_0000065";"15.19";"0.29";"5.92";"5.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3932554";"";"None";"520.58";"2";"1.77";"BDBM187730";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cnn(C2CN(S(C)(=O)=O)C2)c1";"IC50";"'='";"7.8";"nM";"8.11";"";"337415";"UO_0000065";"15.57";"0.30";"6.34";"4.95";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112547";"";"None";"477.54";"0";"3.13";"BDBM187764";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(O)(C1CC1)C1CC1";"IC50";"'='";"10.7";"nM";"7.97";"";"337449";"UO_0000065";"16.69";"0.31";"4.84";"6.19";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115627";"";"None";"433.92";"0";"3.73";"BDBM187475";"CC(C)Nc1cc(-n2ccc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.5";"nM";"8.82";"";"337211";"UO_0000065";"20.34";"0.40";"5.09";"9.58";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3902828";"";"None";"459.55";"0";"3.15";"BDBM187480";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"1.7";"nM";"8.77";"";"337229";"UO_0000065";"19.08";"0.35";"5.62";"7.03";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3918335";"";"None";"430.89";"0";"2.85";"BDBM206234";"O=C(Nc1cc(Cl)ccc1OC1CCC(O)CC1)c1cnn2cc(CCO)cnc12";"IC50";"'='";"3045.0";"nM";"5.52";"";"364905";"UO_0000065";"12.80";"0.25";"2.67";"5.06";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3343057";"";"None";"463.49";"0";"2.07";"27";"COc1cc(C(=O)Nc2ccc(NC(=O)C3CCCCN3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL4115518";"";"None";"421.44";"0";"1.68";"BDBM187559";"CNC(=O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CC1";"IC50";"'='";"4.7";"nM";"8.33";"";"337267";"UO_0000065";"19.76";"0.37";"6.65";"6.68";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4293607";"";"None";"427.55";"0";"1.60";"33";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1";"IC50";"'='";"141.0";"nM";"6.85";"";"";"UO_0000065";"16.02";"0.30";"5.25";"6.29";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3343051";"";"None";"427.42";"0";"2.63";"24b";"O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1cccc(-c2c[nH]c(=O)[nH]c2=O)c1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL4285338";"";"None";"384.53";"0";"2.77";"24";"CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"19.11";"0.36";"4.58";"8.30";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4293161";"";"None";"384.53";"0";"2.77";"25";"CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc([C@H]4CC[C@@H](C(N)=O)CC4)c23)CC1";"IC50";"'>'";"8500.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4791626";"";"None";"435.45";"0";"3.49";"2";"CN(C)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(C(C)(C)O)cc2n1";"IC50";"'='";"0.55";"nM";"9.26";"";"";"UO_0000065";"21.26";"0.41";"5.77";"11.12";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4764582";"";"None";"433.43";"0";"3.98";"23";"COc1cc(NC(=O)c2cccc(C(F)(F)F)n2)cc2cn(C3CCN(C)CC3)nc12";"IC50";"'='";"125.0";"nM";"6.90";"";"";"UO_0000065";"15.93";"0.30";"2.92";"9.55";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4782801";"";"None";"450.46";"0";"4.09";"1";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(C(C)(C)O)cc2n1";"IC50";"'='";"8.6";"nM";"8.07";"";"";"UO_0000065";"17.91";"0.34";"3.98";"8.04";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL1834657";"INFIGRATINIB PHOSPHATE";"4.0";"658.48";"2";"5.35";"1h, NVP-BGJ398";"CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1839907";"Inhibition of recombinant IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833940";"1";"Scientific Literature";"J Med Chem";"2011";"None";""
"CHEMBL4453861";"";"None";"402.46";"0";"2.74";"6";"O=C(Nc1cc2cccnc2cc1N1CCC(CO)CC1)c1cnn2cccnc12";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"18.53";"0.34";"4.72";"7.80";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3979848";"";"None";"318.34";"0";"3.14";"8";"COc1cc2ccccc2cc1NC(=O)c1cnn2cccnc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4569648";"";"None";"372.43";"0";"3.52";"10";"O=C(Nc1cc2cccnc2cc1N1CCCCC1)c1cnn2cccnc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4460055";"";"None";"476.54";"0";"1.90";"16";"O=C(Nc1cc2[nH]c(N3CCOCC3)nc2cc1N1CCC(CO)CC1)c1cnn2cccnc12";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"13.85";"0.26";"4.70";"5.33";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4783351";"EMAVUSERTIB";"1.0";"491.51";"1";"2.24";"24; CA-4948";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1";"IC50";"'='";"989.0";"nM";"6.00";"";"";"UO_0000065";"12.22";"0.23";"3.76";"4.20";"0";"CHEMBL4673035";"Inhibition of IRAK4 in human whole blood assessed as inhibition of TLR2-mediated LTA-induced IL-6 release preincubated for 1 hr followed by LTA stimulation and measured after 16 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4110426";"";"None";"370.48";"0";"2.28";"BDBM203738";"CN(C)c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"74.0";"nM";"7.13";"";"361212";"UO_0000065";"19.25";"0.37";"4.85";"8.30";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107813";"";"None";"466.52";"0";"2.46";"BDBM187423";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(O)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"337160";"UO_0000065";"18.91";"0.35";"6.36";"6.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4567291";"";"None";"319.32";"0";"2.54";"9";"COc1cc2cccnc2cc1NC(=O)c1cnn2cccnc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4290202";"";"None";"457.58";"0";"2.08";"37";"CNC(=O)C[C@@H](C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCN(C(=O)OC)CC4)CC3)c12";"IC50";"'='";"1990.0";"nM";"5.70";"";"";"UO_0000065";"12.46";"0.24";"3.62";"5.48";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4294631";"";"None";"301.44";"0";"3.14";"20";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"24.47";"0.46";"4.24";"16.23";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4107284";"";"None";"484.51";"0";"2.67";"BDBM187510";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCOCC1F";"IC50";"'='";"3.5";"nM";"8.46";"";"337243";"UO_0000065";"17.45";"0.33";"5.79";"6.76";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112434";"";"None";"468.51";"0";"3.43";"BDBM187515";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(F)C1";"IC50";"'='";"1.3";"nM";"8.89";"";"337245";"UO_0000065";"18.97";"0.36";"5.46";"7.67";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113503";"";"None";"547.69";"1";"3.40";"BDBM203507";"CC(C)[C@H]1C[C@@H](Nc2nc(N3CCC(c4cncnc4)CC3)[nH]c(=O)c2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"23.0";"nM";"7.64";"";"360967";"UO_0000065";"13.95";"0.27";"4.24";"5.45";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622520";"";"None";"398.49";"0";"1.66";"BDBM203530";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"36.0";"nM";"7.44";"";"361010";"UO_0000065";"18.68";"0.36";"5.78";"7.82";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3898966";"";"None";"351.44";"0";"4.04";"BDBM203282";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc[nH]1";"IC50";"'='";"25.3";"nM";"7.60";"";"360843";"UO_0000065";"21.62";"0.42";"3.56";"8.31";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4463353";"";"None";"409.45";"0";"2.24";"25";"CC1(C)Cc2cc(NC(=O)c3cnn4c(O)ccnc34)c(N3CCOCC3)cc2O1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3914855";"";"None";"486.62";"0";"4.56";"BDBM187901";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC1CCC(C(C)(O)C2CC2)CC1";"IC50";"'='";"3.9";"nM";"8.41";"";"337578";"UO_0000065";"17.28";"0.32";"3.85";"7.26";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107090";"";"None";"550.99";"2";"2.27";"BDBM188002";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CN(c2ncc(Cl)cn2)C1";"IC50";"'='";"14.4";"nM";"7.84";"";"337673";"UO_0000065";"14.23";"0.27";"5.57";"4.97";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4466092";"";"None";"409.45";"0";"2.24";"26";"CC1(C)Cc2cc(NC(=O)c3cnn4cc(O)cnc34)c(N3CCOCC3)cc2O1";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"15.83";"0.30";"4.24";"6.40";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4583622";"";"None";"384.48";"0";"2.44";"10";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C)nc34)CC2)CC1";"IC50";"'='";"279.0";"nM";"6.55";"";"";"UO_0000065";"17.05";"0.32";"4.11";"7.85";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4548760";"";"None";"518.63";"2";"3.24";"14";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C(C)C#N)nc34)CC2)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"15.85";"0.30";"4.98";"6.00";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3951199";"";"None";"439.45";"0";"1.34";"BDBM187692";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(F)C1(O)COC1";"IC50";"'='";"5.3";"nM";"8.28";"";"337377";"UO_0000065";"18.83";"0.35";"6.94";"6.00";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111498";"";"None";"518.96";"1";"3.61";"BDBM187824";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1Nc1cnn(CCCF)c1";"IC50";"'='";"1.3";"nM";"8.89";"";"337501";"UO_0000065";"17.12";"0.34";"5.28";"7.24";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3970825";"";"None";"447.50";"0";"3.43";"BDBM187495";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H]([N+](=O)[O-])CC1";"IC50";"'='";"5.1";"nM";"8.29";"";"337230";"UO_0000065";"18.53";"0.34";"4.86";"5.98";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112124";"";"None";"439.55";"0";"1.96";"BDBM203649";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccccn2)cs1";"IC50";"'='";"21.0";"nM";"7.68";"";"361130";"UO_0000065";"17.47";"0.34";"5.72";"7.11";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4284323";"";"None";"273.38";"0";"2.32";"19";"Cc1ccn2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"236.0";"nM";"6.63";"";"";"UO_0000065";"24.24";"0.45";"4.31";"14.58";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4113542";"";"None";"525.55";"1";"3.46";"BDBM187467";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc(-n2cncn2)cc1";"IC50";"'='";"2.1";"nM";"8.68";"";"337203";"UO_0000065";"16.51";"0.30";"5.22";"5.92";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3941496";"";"None";"426.55";"0";"2.36";"BDBM203789";"Cc1cccc2nc(-c3c(NC4CCCNC4)nc(N4CCOCC4)[nH]c3=O)sc12";"IC50";"'='";"580.0";"nM";"6.24";"";"361263";"UO_0000065";"14.62";"0.28";"3.88";"6.55";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106632";"";"None";"400.51";"0";"1.64";"BDBM203741";"CN(CCO)c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"190.0";"nM";"6.72";"";"361215";"UO_0000065";"16.78";"0.33";"5.08";"6.33";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4545955";"";"None";"469.51";"0";"2.99";"21";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)Nc2cncnc2)n1";"IC50";"'='";"1582.0";"nM";"5.80";"";"";"UO_0000065";"12.35";"0.23";"2.81";"4.15";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3906640";"";"None";"472.58";"0";"3.44";"BDBM187472";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC1CCc2nc(N)sc2C1";"IC50";"'='";"13.1";"nM";"7.88";"";"337208";"UO_0000065";"16.68";"0.32";"4.44";"5.86";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4077863";"";"None";"446.51";"0";"2.58";"34";"CNC(=O)c1cnc(Nc2ccc3c(cnn3C)c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"17.66";"0.33";"5.31";"6.34";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3921909";"";"None";"499.58";"0";"2.79";"BDBM187724";"[C-]#[N+]CC(=O)N1CCC(CCNC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"337409";"UO_0000065";"16.21";"0.30";"5.31";"6.08";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106949";"";"None";"442.47";"0";"2.90";"BDBM187534";"C[C@H](CF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.8";"nM";"8.74";"";"337253";"UO_0000065";"19.76";"0.37";"5.84";"7.55";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4472363";"";"None";"868.96";"3";"5.47";"Example 9";"O=C1CCC(N2C(=O)c3ccc(N4CCC(CN5CCN(Cc6ccc7c(c6)nc(NC(=O)c6cccc(C(F)(F)F)c6)n7[C@H]6CC[C@@H](CO)CC6)CC5)CC4)cc3C2=O)C(=O)N1";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4307631";"Inhibition of N-terminal GST-tagged human IRAK4 (2 to end residues) expressed in baculovirus infected Sf9 cells using Ser/Thr 7 peptide as substrate in presence of ATP after 1 hr by Z'-LYTE assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4304808";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"CHEMBL3308860";""
"CHEMBL3923644";"";"None";"395.47";"0";"2.00";"BDBM188812";"O=C(Nc1cc(C2CCNCC2)nn1C1CCOCC1)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338667";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3951199";"";"None";"439.45";"0";"1.34";"BDBM187692";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(F)C1(O)COC1";"IC50";"'='";"3.6";"nM";"8.44";"";"337382";"UO_0000065";"19.21";"0.36";"7.10";"6.12";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110386";"";"None";"474.59";"0";"3.28";"BDBM203740";"O=c1[nH]c(N[C@H]2c3ccccc3C[C@@H]2O)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"3000.0";"nM";"5.52";"";"361214";"UO_0000065";"11.64";"0.22";"2.24";"4.80";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108358";"";"None";"426.55";"0";"2.36";"BDBM203757";"Cc1ccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc2c1";"IC50";"'='";"120.0";"nM";"6.92";"";"361231";"UO_0000065";"16.23";"0.32";"4.56";"7.27";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112969";"";"None";"446.53";"0";"3.45";"BDBM203761";"O=c1[nH]c(N2CCC(F)(F)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"78.0";"nM";"7.11";"";"361235";"UO_0000065";"15.92";"0.31";"3.66";"8.27";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4087063";"";"None";"402.56";"0";"3.59";"34";"c1nc(S[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"20.86";"0.41";"4.81";"13.27";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4061890";"";"None";"315.33";"0";"1.00";"23";"COc1cc2c(OC[C@@H]3CCC(=O)N3)ccnc2cc1C(N)=O";"IC50";"'='";"2118.0";"nM";"5.67";"";"";"UO_0000065";"17.99";"0.34";"4.67";"5.48";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4114010";"";"None";"439.50";"0";"2.74";"BDBM187732";"CC[C@@H](C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.8";"nM";"8.55";"";"337417";"UO_0000065";"19.46";"0.37";"5.81";"6.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109957";"";"None";"480.59";"0";"1.77";"BDBM203616";"O=c1[nH]c(N2CC3CC2CS(=O)(=O)C3)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"139.0";"nM";"6.86";"";"361097";"UO_0000065";"14.27";"0.28";"5.09";"5.71";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4645368";"";"None";"429.52";"0";"3.85";"15";"CC(C)(O)[C@@H](F)CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4643871";"";"None";"431.54";"0";"4.09";"11";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"14.64";"0.29";"2.23";"6.37";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4639599";"";"None";"355.47";"0";"4.00";"5";"CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4642013";"";"None";"429.52";"0";"3.85";"12";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1";"IC50";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"14.18";"0.28";"2.24";"6.14";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3902184";"";"None";"434.54";"0";"2.72";"BDBM203726";"CCN1CCCC1CNc1nc(N2CCOCC2)[nH]c(=O)c1-c1ccc2ccccc2n1";"IC50";"'='";"1600.0";"nM";"5.80";"";"361200";"UO_0000065";"13.34";"0.25";"3.08";"6.71";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3985891";"";"None";"384.46";"0";"1.39";"BDBM203696";"N[C@H]1C[C@H]1Nc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"3000.0";"nM";"5.52";"";"361170";"UO_0000065";"14.37";"0.28";"4.13";"5.06";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3920512";"";"None";"504.58";"1";"1.99";"BDBM188927";"C#Cc1cnc2c(C(=O)Nc3cc(C4CCN(S(C)(=O)=O)CC4)nn3-c3ccc(C)cn3)cnn2c1";"IC50";"'<'";"100.0";"nM";"";"";"338782";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3897735";"";"None";"427.51";"0";"3.51";"BDBM188786";"O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(C2CC2)cc1)c1cnn2cccnc12";"IC50";"'<'";"100.0";"nM";"";"";"338641";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4645368";"";"None";"429.52";"0";"3.85";"15";"CC(C)(O)[C@@H](F)CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1";"IC50";"'='";"9.3";"nM";"8.03";"";"";"UO_0000065";"18.70";"0.37";"4.18";"8.10";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4644871";"";"None";"369.49";"0";"4.40";"6";"CCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL3622512";"";"None";"443.53";"0";"1.16";"BDBM203488";"O=c1[nH]c(N2CCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"18.0";"nM";"7.75";"";"360948";"UO_0000065";"17.46";"0.34";"6.58";"5.75";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3963416";"";"None";"354.84";"0";"4.68";"BDBM206199";"O=C(Nc1cc(Cl)ccc1C1CCCCC1)c1cnn2cccnc12";"IC50";"'='";"799.0";"nM";"6.10";"";"364870";"UO_0000065";"17.18";"0.33";"1.42";"10.28";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3903828";"";"None";"490.57";"0";"2.05";"BDBM187723";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](NC(=O)[C@H](C)O)CC1";"IC50";"'='";"6.2";"nM";"8.21";"";"337408";"UO_0000065";"16.73";"0.31";"6.16";"5.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622188";"";"None";"420.52";"0";"1.28";"BDBM203523";"CSc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"352.0";"nM";"6.45";"";"360983";"UO_0000065";"15.35";"0.31";"5.17";"4.91";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109064";"";"None";"517.66";"1";"3.55";"BDBM203596";"COc1ccc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"361077";"UO_0000065";"15.45";"0.30";"4.45";"8.13";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114134";"";"None";"396.50";"0";"1.71";"BDBM203668";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1ccc(C2CC2)cn1";"IC50";"'='";"512.0";"nM";"6.29";"";"361147";"UO_0000065";"15.87";"0.30";"4.58";"6.61";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115559";"";"None";"530.49";"1";"3.63";"BDBM187828";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)(F)F)c1";"IC50";"'='";"2.1";"nM";"8.68";"";"337505";"UO_0000065";"16.36";"0.31";"5.05";"6.49";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3954291";"";"None";"496.58";"0";"3.59";"BDBM187675";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(CN2CCOCC2)cc1";"IC50";"'='";"6.8";"nM";"8.17";"";"337360";"UO_0000065";"16.45";"0.30";"4.58";"6.75";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4748475";"";"None";"488.55";"0";"3.10";"10";"Cn1cc(-c2cccc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCCCC3)n2)cn1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"16.29";"0.30";"4.86";"6.95";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4788562";"";"None";"401.43";"0";"3.37";"2";"O=C(Nc1ccc2nc(N3CCOCC3)oc2c1)c1cccc(-c2cccnc2)n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4672982";"Inhibition of IRAK4 in human THP-1 cells assessed as inhibition of LTA-induced TNF-alpha production preincubated for 60 mins followed by LTA stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4757687";"";"None";"499.58";"0";"3.95";"4";"Nc1ccc(-c2cccc(C(=O)Nc3cc4oc(N5CCOCC5)nc4cc3N3CCCCC3)n2)cn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4672982";"Inhibition of IRAK4 in human THP-1 cells assessed as inhibition of LTA-induced TNF-alpha production preincubated for 60 mins followed by LTA stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4783351";"EMAVUSERTIB";"1.0";"491.51";"1";"2.24";"24; CA-4948";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1";"IC50";"'='";"696.0";"nM";"6.16";"";"";"UO_0000065";"12.53";"0.23";"3.92";"4.31";"0";"CHEMBL4673037";"Inhibition of IRAK4 in human whole blood assessed as inhibition of TLR5-mediated FLA-ST-induced IL-6 release preincubated for 1 hr followed by FLA-ST stimulation and measured after 16 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4763990";"";"None";"505.54";"2";"3.36";"14";"COc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCCCC3)co2)ccn1";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"16.51";"0.31";"4.99";"6.33";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4643871";"";"None";"431.54";"0";"4.09";"11";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"19.97";"0.39";"4.53";"8.69";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL260007";"";"None";"323.42";"0";"4.58";"2d";"CC(C)c1ccccc1NC(=O)c1csc(-c2cccnc2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4569508";"";"None";"529.59";"2";"5.28";"1";"O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"12.61";"0.25";"1.40";"9.31";"0";"CHEMBL4479732";"Inhibition of full-length recombinant human His-tagged IRAK4 expressed in baculovirus expression system by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL4462969";"";"None";"443.45";"0";"3.47";"28";"CC1(C)Cc2cc(NC(=O)c3cnn4cc(C(F)F)cnc34)c(N3CCOCC3)cc2O1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"13.35";"0.25";"2.45";"7.31";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4079743";"";"None";"433.54";"0";"3.81";"2";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"18.36";"0.35";"4.15";"8.03";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4107485";"";"None";"402.52";"0";"1.77";"BDBM203543";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(C2CC2)cs1";"IC50";"'='";"433.0";"nM";"6.36";"";"361023";"UO_0000065";"15.81";"0.31";"4.59";"6.69";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107194";"";"None";"430.51";"0";"2.19";"BDBM203555";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccc(F)cc2s1";"IC50";"'='";"46.0";"nM";"7.34";"";"361035";"UO_0000065";"17.04";"0.33";"5.15";"7.71";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3963873";"";"None";"591.71";"2";"6.62";"BDBM203290";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(=O)N2CCN(c3ccc(F)cc3F)CC2)cs1";"IC50";"'='";"763.8";"nM";"6.12";"";"360852";"UO_0000065";"10.34";"0.20";"-0.50";"7.09";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3949446";"";"None";"402.46";"0";"2.34";"BDBM188901";"Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"338756";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622518";"";"None";"412.52";"0";"2.05";"BDBM203526";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"19.0";"nM";"7.72";"";"361006";"UO_0000065";"18.72";"0.36";"5.67";"8.11";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4093120";"";"None";"347.35";"0";"1.19";"38";"COc1cc2c(OC[C@H]3NC(=O)[C@@H](F)[C@H]3C)nccc2cc1C(N)=O";"IC50";"'='";"12.7";"nM";"7.90";"";"";"UO_0000065";"22.73";"0.43";"6.71";"7.63";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4641090";"";"None";"415.47";"0";"2.53";"20";"CC(C)Nc1cc(Nc2ccn3nccc3n2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.2";"nM";"8.49";"";"";"UO_0000065";"20.45";"0.39";"5.96";"7.29";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4634922";"";"None";"433.46";"0";"2.67";"21";"CC(C)Nc1cc(Nc2nc3ccnn3cc2F)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"19.54";"0.37";"5.80";"7.27";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4641886";"";"None";"414.49";"0";"3.13";"19";"CC(C)Nc1cc(Nc2ccn3nccc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"14.93";"0.28";"3.06";"5.97";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4109047";"";"None";"424.48";"0";"2.95";"BDBM187474";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"7.6";"nM";"8.12";"";"337210";"UO_0000065";"19.13";"0.36";"5.17";"7.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3978710";"";"None";"477.57";"0";"2.58";"BDBM187483";"CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cncnc43)cc2NC2CCOCC2)CC1";"IC50";"'='";"4.9";"nM";"8.31";"";"337218";"UO_0000065";"17.40";"0.32";"5.73";"6.75";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110865";"";"None";"453.57";"0";"1.88";"BDBM203765";"CC(=O)N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"450.0";"nM";"6.35";"";"361239";"UO_0000065";"13.99";"0.27";"4.47";"5.97";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3982860";"";"None";"426.55";"0";"2.57";"BDBM203712";"NC1CCCCC1Nc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"230.0";"nM";"6.64";"";"361186";"UO_0000065";"15.56";"0.30";"4.07";"6.08";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4523017";"";"None";"391.44";"0";"2.05";"5";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(N)=O)n1";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"18.22";"0.34";"5.08";"5.58";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4112425";"";"None";"424.53";"0";"2.05";"BDBM203653";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2C[C@@H]3CN[C@H]2C3)c1-c1nc2ccccc2s1";"IC50";"'='";"191.0";"nM";"6.72";"";"361134";"UO_0000065";"15.83";"0.31";"4.67";"7.06";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3928207";"";"None";"438.56";"0";"2.58";"BDBM203749";"O=c1[nH]c(N2CC3CCC(C2)O3)nc(NC2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"43.0";"nM";"7.37";"";"361223";"UO_0000065";"16.80";"0.32";"4.79";"7.74";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109278";"";"None";"456.55";"0";"2.70";"BDBM203541";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(F)cc2)cs1";"IC50";"'='";"24.0";"nM";"7.62";"";"361021";"UO_0000065";"16.69";"0.33";"4.92";"8.01";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3949920";"";"None";"412.52";"0";"2.05";"BDBM203549";"O=c1[nH]c(N2CCOCC2)nc(NC2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"244.0";"nM";"6.61";"";"361029";"UO_0000065";"16.03";"0.31";"4.56";"6.95";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4079743";"";"None";"433.54";"0";"3.81";"2";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)Cc1ccccc1";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"12.77";"0.24";"1.73";"5.58";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4518357";"";"None";"504.60";"1";"1.70";"16";"CN(C)[C@H]1CN(C(=O)c2nn(C)cc2NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)C[C@@H]1O";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"13.32";"0.25";"5.02";"5.23";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4107224";"";"None";"479.44";"0";"2.89";"BDBM187746";"CC(Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)C(F)(F)F";"IC50";"'='";"4.1";"nM";"8.39";"";"337431";"UO_0000065";"17.49";"0.34";"5.50";"6.51";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3948840";"";"None";"448.60";"0";"4.52";"BDBM187501";"CS[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"7.8";"nM";"8.11";"";"337236";"UO_0000065";"18.07";"0.35";"3.59";"8.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112923";"";"None";"491.42";"0";"2.81";"BDBM203794";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cc(Br)ccc2s1";"IC50";"'='";"19.0";"nM";"7.72";"";"361268";"UO_0000065";"15.71";"0.35";"4.91";"8.11";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112188";"";"None";"399.48";"0";"1.11";"BDBM203751";"NC(=O)CNc1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"2300.0";"nM";"5.64";"";"361225";"UO_0000065";"14.11";"0.28";"4.53";"4.09";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3909465";"";"None";"499.62";"0";"3.14";"BDBM189003";"Cc1ccc(-n2nc(C3CCN(C4CC(N(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338858";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3957189";"";"None";"388.43";"0";"2.66";"BDBM206119";"O=C(Nc1cc2cccnc2cc1OC1CCNCC1)c1cnn2cccnc12";"IC50";"'='";"40.0";"nM";"7.40";"";"364790";"UO_0000065";"19.05";"0.35";"4.74";"7.92";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4111747";"";"None";"484.61";"0";"3.56";"BDBM203634";"Cc1cc(C2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4ccc5ccccc5n4)c(=O)[nH]3)CC2)[nH]n1";"IC50";"'='";"66.0";"nM";"7.18";"";"361115";"UO_0000065";"14.82";"0.27";"3.62";"6.26";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107335";"";"None";"396.45";"0";"1.58";"BDBM203638";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2o1";"IC50";"'='";"1802.0";"nM";"5.74";"";"361119";"UO_0000065";"14.49";"0.27";"4.16";"5.30";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622527";"";"None";"412.52";"0";"2.05";"BDBM203531";"O=c1[nH]c(N2CCOCC2)nc(NC2CCNCC2)c1-c1nc2ccccc2s1";"IC50";"'='";"121.0";"nM";"6.92";"";"361011";"UO_0000065";"16.77";"0.33";"4.87";"7.27";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3931304";"";"None";"387.47";"0";"1.78";"BDBM203512";"O=c1[nH]c(NC2CCC2)nc(NC[C@H](O)CO)c1-c1nc2ccccc2s1";"IC50";"'='";"5327.0";"nM";"5.27";"";"360972";"UO_0000065";"13.61";"0.27";"3.49";"4.28";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110364";"";"None";"488.62";"0";"2.93";"BDBM203575";"O=c1[nH]c(N2CCN(c3ccccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"8.0";"nM";"8.10";"";"361055";"UO_0000065";"16.57";"0.32";"5.17";"7.93";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4102532";"";"None";"397.50";"0";"3.51";"23";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1CC[C@H](O)CC1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"18.61";"0.36";"3.89";"7.46";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4069224";"";"None";"397.50";"0";"3.51";"21";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H]1CCCC[C@@H]1O";"IC50";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"17.83";"0.35";"3.58";"7.15";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3353202";"";"None";"488.62";"0";"2.93";"BDBM50040871";"O=c1[nH]c(N2CCN(c3cccnc3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"6.0";"nM";"8.22";"";"361061";"UO_0000065";"16.83";"0.32";"5.29";"8.06";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586505";"";"None";"480.55";"0";"2.01";"27";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"15.75";"0.30";"5.56";"5.94";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3890485";"";"None";"421.46";"0";"1.39";"BDBM188016";"CC(C)(O)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1COC1";"IC50";"'='";"11.2";"nM";"7.95";"";"337685";"UO_0000065";"18.86";"0.35";"6.56";"5.76";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3961524";"";"None";"350.39";"0";"1.45";"BDBM187754";"CNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC(C)C";"IC50";"'='";"9.2";"nM";"8.04";"";"337439";"UO_0000065";"22.94";"0.42";"6.59";"5.97";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113034";"";"None";"561.54";"1";"3.10";"BDBM187930";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCN(C(=O)CC(F)(F)F)C1";"IC50";"'='";"4.1";"nM";"8.39";"";"337605";"UO_0000065";"14.94";"0.29";"5.29";"6.16";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109550";"";"None";"515.57";"1";"4.48";"BDBM187463";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1ccc2ncsc2c1";"IC50";"'='";"1.7";"nM";"8.77";"";"337199";"UO_0000065";"17.01";"0.32";"4.29";"6.81";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3931326";"";"None";"485.59";"0";"3.69";"BDBM189017";"Cc1ccc(-n2nc(C3CCCN(CC4CCOC4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338872";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3892921";"";"None";"487.55";"0";"3.60";"BDBM203304";"NC(=O)c1nnc(-c2cnc(Nc3ccc4ncsc4c3)cc2N[C@H](CO)Cc2ccccc2)o1";"IC50";"'='";"24.5";"nM";"7.61";"";"360866";"UO_0000065";"15.61";"0.30";"4.01";"5.00";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4114067";"";"None";"555.69";"2";"1.34";"BDBM203818";"O=c1[nH]c(N2CCN(Cc3nccs3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"226.0";"nM";"6.65";"";"360998";"UO_0000065";"11.96";"0.24";"5.31";"4.41";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113284";"";"None";"437.48";"0";"2.49";"BDBM187795";"CC1(Nc2cc(-n3cnc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)CC1";"IC50";"'='";"3.5";"nM";"8.46";"";"337477";"UO_0000065";"19.33";"0.36";"5.97";"6.57";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108062";"";"None";"469.52";"0";"0.99";"BDBM187932";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C(N)=O)cnc32)cc1NCC1CNC1";"IC50";"'='";"6.7";"nM";"8.17";"";"337607";"UO_0000065";"17.41";"0.33";"7.18";"5.55";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109689";"";"None";"466.52";"0";"2.58";"BDBM187419";"CC1(CNc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)COC1";"IC50";"'='";"5.7";"nM";"8.24";"";"337155";"UO_0000065";"17.67";"0.33";"5.66";"6.59";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3982186";"";"None";"453.48";"0";"1.32";"BDBM188111";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1C[C@H]1CO";"IC50";"'='";"4.8";"nM";"8.32";"";"337774";"UO_0000065";"18.34";"0.34";"7.00";"5.58";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3907661";"";"None";"443.94";"0";"2.35";"BDBM187590";"CC(C)Nc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NCCN1CCOCC1";"IC50";"'='";"12.0";"nM";"7.92";"";"337289";"UO_0000065";"17.84";"0.35";"5.57";"8.15";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3932942";"";"None";"451.44";"0";"3.03";"BDBM187845";"CC(C)NC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"11.2";"nM";"7.95";"";"337522";"UO_0000065";"17.61";"0.33";"4.92";"6.29";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622516";"";"None";"505.60";"1";"2.12";"BDBM203492";"O=c1[nH]c(N2CCc3ccccc3C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"27.5";"nM";"7.56";"";"360952";"UO_0000065";"14.95";"0.29";"5.44";"5.62";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3976316";"";"None";"488.35";"0";"4.61";"BDBM188928";"Cc1ccc(-c2cc(NC(=O)c3cnn4cc(Br)cnc34)n(-c3ccc(C)cn3)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338783";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586487";"";"None";"425.45";"0";"3.55";"BDBM188863";"COc1cc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)ccn1";"IC50";"'<'";"1000.0";"nM";"";"";"338718";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3902377";"";"None";"370.84";"0";"2.56";"BDBM206157";"NC1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"251.0";"nM";"6.60";"";"364828";"UO_0000065";"17.80";"0.35";"4.04";"7.45";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3986164";"";"None";"430.51";"0";"3.29";"BDBM187413";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC12CCC(O)(CC1)C2";"IC50";"'='";"14.8";"nM";"7.83";"";"337149";"UO_0000065";"18.19";"0.33";"4.54";"6.76";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107911";"";"None";"492.56";"0";"2.99";"BDBM187415";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC12CCC(O)(CC1)C2";"IC50";"'='";"1.2";"nM";"8.92";"";"337151";"UO_0000065";"18.11";"0.34";"5.93";"6.56";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110098";"";"None";"454.51";"0";"2.31";"BDBM187420";"CC(CCO)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.3";"nM";"8.64";"";"337156";"UO_0000065";"19.01";"0.36";"6.33";"6.35";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3984663";"";"None";"452.49";"0";"2.33";"BDBM187900";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@H]1CCOC1";"IC50";"'='";"3.0";"nM";"8.52";"";"337575";"UO_0000065";"18.84";"0.35";"6.19";"6.81";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107673";"";"None";"399.43";"0";"1.62";"BDBM187570";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cncnc32)cc1NC1CC1";"IC50";"'='";"6.9";"nM";"8.16";"";"337269";"UO_0000065";"20.43";"0.38";"6.54";"6.93";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107887";"";"None";"434.54";"0";"2.36";"BDBM203614";"CC(C)(O)C1CN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1";"IC50";"'='";"42.0";"nM";"7.38";"";"361095";"UO_0000065";"16.98";"0.31";"5.02";"6.95";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3927487";"";"None";"506.61";"1";"3.89";"BDBM188878";"Cc1ccc(-n2nc(-c3ccc(CN4CCN(C)CC4)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338733";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113003";"";"None";"507.59";"2";"-0.21";"BDBM203814";"CS(=O)(=O)C1CN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)C1";"IC50";"'='";"17.9";"nM";"7.75";"";"360994";"UO_0000065";"15.26";"0.31";"7.96";"4.59";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622184";"";"None";"388.45";"0";"0.87";"BDBM203525";"Cc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"635.0";"nM";"6.20";"";"360985";"UO_0000065";"15.95";"0.31";"5.33";"4.72";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106614";"";"None";"495.56";"0";"1.88";"BDBM187937";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCCN1CCOCC1";"IC50";"'='";"4.0";"nM";"8.40";"";"337612";"UO_0000065";"16.95";"0.32";"6.52";"6.54";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113443";"";"None";"462.48";"0";"3.10";"BDBM188087";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(F)C1";"IC50";"'='";"4.0";"nM";"8.40";"";"337753";"UO_0000065";"18.16";"0.35";"5.30";"8.00";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113585";"";"None";"536.61";"1";"2.24";"BDBM188091";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](NC2COC2)CC1";"IC50";"'='";"5.2";"nM";"8.28";"";"337754";"UO_0000065";"15.44";"0.29";"6.04";"5.52";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3930748";"";"None";"519.02";"1";"3.66";"BDBM188097";"CC(C)(O)[C@H]1CC[C@H](Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1";"IC50";"'='";"3.3";"nM";"8.48";"";"337760";"UO_0000065";"16.34";"0.32";"4.82";"6.77";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115161";"";"None";"410.45";"0";"2.56";"BDBM187403";"CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.4";"nM";"8.85";"";"337139";"UO_0000065";"21.57";"0.40";"6.29";"7.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3950483";"";"None";"499.62";"0";"3.14";"BDBM189009";"Cc1ccc(-n2nc(C3CCN(C4CCN(C)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338864";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3890249";"";"None";"457.96";"0";"3.56";"BDBM187435";"CC(C)(O)CCNC(=O)c1cnc(-n2ccc3cc(Cl)cnc32)cc1NC1CCOCC1";"IC50";"'='";"3.1";"nM";"8.51";"";"337171";"UO_0000065";"18.58";"0.36";"4.95";"8.40";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3965902";"";"None";"540.67";"1";"4.06";"BDBM188947";"Cc1ccc(-n2nc(C3CCN(C(C)C(=O)N4CCCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338802";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3968119";"";"None";"581.70";"2";"6.19";"BDBM203302";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(-c2ccc(F)c(S(=O)(=O)NC(C)(C)C)c2)o1";"IC50";"'='";"675.9";"nM";"6.17";"";"360864";"UO_0000065";"10.61";"0.21";"-0.02";"4.57";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4108417";"";"None";"465.54";"1";"2.30";"BDBM203516";"O=c1[nH]c(Nc2ccccc2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"327.0";"nM";"6.49";"";"360976";"UO_0000065";"13.93";"0.27";"4.19";"4.52";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108784";"";"None";"467.51";"0";"2.12";"BDBM187578";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCCOC1";"IC50";"'='";"11.4";"nM";"7.94";"";"337277";"UO_0000065";"16.99";"0.32";"5.82";"5.76";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110095";"";"None";"538.67";"1";"4.28";"BDBM187961";"CC(C)Nc1cc(-n2ccc3cc(CNC(=O)CC4CCCC4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.3";"nM";"8.37";"";"337636";"UO_0000065";"15.53";"0.29";"4.09";"6.90";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3944795";"";"None";"401.92";"0";"3.77";"BDBM206151";"NCC1CCN(c2ccc(Cl)cc2NC(=O)c2csc3cncnc23)CC1";"IC50";"'='";"167.0";"nM";"6.78";"";"364822";"UO_0000065";"16.86";"0.34";"3.01";"8.05";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3922205";"";"None";"522.45";"1";"4.83";"BDBM188842";"Cc1ccc(-n2nc(C3CCN(C(C)C)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338697";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3952231";"";"None";"455.44";"0";"3.65";"BDBM188745";"O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(C(F)(F)F)cc1)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338600";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3984189";"";"None";"507.58";"1";"1.94";"BDBM188905";"Cc1cnc(-n2nc(C3CCN(S(=O)(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"1000.0";"nM";"";"";"338760";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3936851";"";"None";"492.59";"0";"4.25";"BDBM188958";"Cc1ccc(-n2nc(C3CCN(Cc4ccncc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338813";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3962404";"";"None";"557.64";"1";"2.47";"BDBM188912";"Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338767";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3946452";"";"None";"435.49";"0";"4.42";"BDBM188885";"Cc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cn3)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338740";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3924029";"";"None";"402.46";"0";"2.34";"BDBM188886";"Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338741";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3978837";"";"None";"576.69";"1";"4.93";"BDBM189127";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccc5cccnc45)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338985";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3919757";"";"None";"413.42";"0";"3.68";"BDBM188870";"Cc1ccc(-n2nc(-c3cncc(F)c3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338725";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3914235";"";"None";"401.47";"0";"3.07";"BDBM188876";"Cc1ccc(-n2nc(CN3CCCC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338731";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3985571";"";"None";"494.58";"0";"2.32";"BDBM188908";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1C";"IC50";"'<'";"1000.0";"nM";"";"";"338763";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3908242";"";"None";"505.60";"1";"3.15";"BDBM188819";"Cc1ccc(-n2nc(C3CN(S(=O)(=O)C4CCCC4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338674";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4093989";"";"None";"179.22";"0";"1.57";"51";"CC(C)Oc1ccccc1C(N)=O";"IC50";"'='";"55000.0";"nM";"4.26";"";"";"UO_0000065";"23.77";"0.45";"2.69";"8.14";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4092338";"";"None";"343.38";"0";"1.78";"20";"CC(C)Oc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O";"IC50";"'='";"133.0";"nM";"6.88";"";"";"UO_0000065";"20.02";"0.38";"5.10";"6.64";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4100091";"";"None";"315.33";"0";"1.00";"21";"COc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O";"IC50";"'='";"347.0";"nM";"6.46";"";"";"UO_0000065";"20.49";"0.38";"5.46";"6.24";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4113814";"";"None";"501.58";"1";"2.20";"BDBM203522";"O=c1[nH]c(N2CCCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc(-c2ccc(F)cc2)cs1";"IC50";"'='";"22.5";"nM";"7.65";"";"360982";"UO_0000065";"15.25";"0.30";"5.45";"5.68";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4089544";"";"None";"300.41";"0";"2.92";"6";"COc1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"25.95";"0.48";"4.88";"15.50";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3921734";"";"None";"468.52";"0";"3.37";"BDBM189045";"Cc1ccc(-n2nc(C3CN(Cc4cc(C)on4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338900";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115189";"";"None";"439.50";"0";"2.59";"BDBM187681";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(O)C(C)C";"IC50";"'='";"2.3";"nM";"8.64";"";"337366";"UO_0000065";"19.65";"0.37";"6.05";"6.71";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3920407";"";"None";"391.50";"1";"5.33";"BDBM203306";"COc1cccc(-c2cnc(Nc3ccc4ncsc4c3)cc2NC(C)C)n1";"IC50";"'='";"615.8";"nM";"6.21";"";"360868";"UO_0000065";"15.86";"0.30";"0.88";"8.63";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3955819";"";"None";"362.39";"0";"2.90";"BDBM206167";"O=C(Nc1cc2ccccc2cc1OCCCO)c1cnn2cccnc12";"IC50";"'='";"327.0";"nM";"6.49";"";"364838";"UO_0000065";"17.90";"0.33";"3.59";"7.31";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4784784";"";"None";"498.54";"0";"4.70";"21";"CC1(C)OC(=O)c2ccc(Nc3ncc(-c4nnc(C5CC5)o4)c(N[C@H](CO)c4ccccc4)n3)cc21";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"13.75";"0.25";"2.15";"5.07";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4115124";"";"None";"451.60";"0";"2.40";"BDBM203784";"O=c1[nH]c(N2CCC3(CC2)CNC3)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"40.0";"nM";"7.40";"";"361258";"UO_0000065";"16.38";"0.32";"5.00";"7.55";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111880";"";"None";"404.48";"0";"2.62";"BDBM187772";"CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)N[C@H](C)C1CC1";"IC50";"'='";"17.3";"nM";"7.76";"";"337457";"UO_0000065";"19.19";"0.35";"5.14";"5.77";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3910109";"";"None";"423.50";"0";"3.77";"BDBM187737";"CC(C)(F)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)(C)C";"IC50";"'='";"3.4";"nM";"8.47";"";"337422";"UO_0000065";"20.00";"0.37";"4.70";"7.80";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111673";"";"None";"463.48";"0";"2.00";"BDBM187866";"Cn1nccc1Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"17.5";"nM";"7.76";"";"337543";"UO_0000065";"16.74";"0.31";"5.76";"5.29";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113932";"";"None";"362.77";"0";"1.37";"BDBM206250";"O=C(Nc1cc(Cl)ccc1OC[C@H](O)CO)c1cnn2cccnc12";"IC50";"'='";"4664.0";"nM";"5.33";"";"364921";"UO_0000065";"14.70";"0.29";"3.96";"4.89";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4108170";"";"None";"426.46";"0";"1.77";"BDBM188858";"COc1ccc(-c2cc(NC(=O)C3=c4nccc[n+]4=NC3)n(-c3ccc(C)cc3)n2)cn1";"IC50";"'<'";"1000.0";"nM";"";"";"338713";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109668";"";"None";"420.52";"0";"2.11";"BDBM203623";"CC1(O)CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1";"IC50";"'='";"31.0";"nM";"7.51";"";"361104";"UO_0000065";"17.86";"0.33";"5.40";"7.07";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL210354";"";"None";"340.34";"0";"2.84";"34";"COCCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"17.63";"0.33";"3.16";"6.04";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL379787";"";"None";"395.42";"0";"2.53";"46";"O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"16.94";"0.32";"4.17";"6.53";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL4783351";"EMAVUSERTIB";"1.0";"491.51";"1";"2.24";"24; CA-4948";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"13.36";"0.25";"4.33";"4.60";"0";"CHEMBL4673038";"Inhibition of IRAK4 in human MV4-11 cells assessed as modulation of phospho-IRAK1 level by immunoblotting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"MV4-11";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4760206";"";"None";"473.54";"0";"3.69";"5";"O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCCCC1)c1cccc(-c2cn[nH]c2)n1";"IC50";"'='";"58.5";"nM";"7.23";"";"";"UO_0000065";"15.27";"0.28";"3.54";"6.43";"0";"CHEMBL4672982";"Inhibition of IRAK4 in human THP-1 cells assessed as inhibition of LTA-induced TNF-alpha production preincubated for 60 mins followed by LTA stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3753450";"";"None";"380.33";"0";"2.66";"14";"CC(=O)Nc1cn2cc(-c3cnc(N)c(OC(C)C(F)(F)F)n3)ccc2n1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"16.74";"0.32";"3.71";"5.93";"0";"CHEMBL3757421";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3751828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL3939893";"";"None";"478.58";"0";"3.87";"BDBM203305";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(C(=O)N2CCC(N)CC2)o1";"IC50";"'='";"23.0";"nM";"7.64";"";"360867";"UO_0000065";"15.96";"0.31";"3.77";"5.65";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4110783";"";"None";"547.57";"1";"2.75";"BDBM187906";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCN(c2ncc(F)cn2)C1";"IC50";"'='";"1.5";"nM";"8.82";"";"337581";"UO_0000065";"16.11";"0.30";"6.07";"6.09";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115463";"";"None";"488.53";"0";"2.82";"BDBM187917";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CC1c1c[nH]cn1";"IC50";"'='";"3.3";"nM";"8.48";"";"337592";"UO_0000065";"17.36";"0.32";"5.66";"5.87";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108625";"";"None";"396.43";"0";"2.18";"BDBM187777";"CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](C)F";"IC50";"'='";"10.0";"nM";"8.00";"";"337462";"UO_0000065";"20.18";"0.38";"5.82";"5.95";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111088";"";"None";"437.48";"0";"2.49";"BDBM187741";"CC1(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)CC1";"IC50";"'='";"2.7";"nM";"8.57";"";"337426";"UO_0000065";"19.59";"0.37";"6.08";"6.66";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113582";"";"None";"524.56";"1";"4.26";"BDBM187890";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(-c2ncc[nH]2)c1";"IC50";"'='";"2.1";"nM";"8.68";"";"337565";"UO_0000065";"16.54";"0.30";"4.42";"6.00";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106613";"";"None";"438.46";"0";"1.94";"BDBM187896";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1COC1";"IC50";"'='";"1.0";"nM";"9.00";"";"337571";"UO_0000065";"20.53";"0.38";"7.06";"7.19";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4064608";"";"None";"385.51";"0";"2.91";"1";"c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"21.78";"0.41";"5.49";"11.15";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL4064168";"";"None";"315.47";"0";"3.54";"13";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C(C)(C)C)c23)CC1";"IC50";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"19.31";"0.36";"2.55";"10.72";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3622186";"";"None";"390.42";"1";"-0.15";"8";"O=c1[nH]c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"1487.0";"nM";"5.83";"";"";"UO_0000065";"14.93";"0.29";"5.98";"3.85";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3601187";"";"None";"506.59";"2";"2.93";"20";"COc1cc(Nc2ncc(-c3nc(-c4ccccc4)cs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"13.92";"0.27";"4.12";"4.84";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601084";"";"None";"428.52";"0";"1.87";"15";"Cc1cc(Nc2ncc(-c3cncs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1";"IC50";"'='";"2107.0";"nM";"5.68";"";"";"UO_0000065";"13.25";"0.26";"3.81";"4.16";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601193";"";"None";"372.45";"0";"1.45";"27";"Nc1cc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)cn1";"IC50";"'='";"113.0";"nM";"6.95";"";"";"UO_0000065";"18.65";"0.36";"5.50";"5.58";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4743058";"";"None";"801.95";"2";"2.67";"9";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)c12";"IC50";"'='";"7800.0";"nM";"5.11";"";"";"UO_0000065";"6.37";"0.12";"2.44";"2.70";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL4278882";"";"None";"384.53";"0";"2.74";"4";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"19.36";"0.36";"4.70";"11.32";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL4068975";"";"None";"411.44";"0";"4.42";"8";"NC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NCc1cc(F)ccc1F";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"16.39";"0.32";"2.32";"7.26";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4081634";"";"None";"367.48";"0";"4.15";"17";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CCCC1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"21.46";"0.41";"3.74";"9.99";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3343034";"";"None";"400.44";"0";"4.65";"5a";"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(C)nc2cc1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL4075758";"";"None";"461.52";"0";"2.21";"32";"CNC(=O)c1cnc(Nc2ccc3c(c2)CC(=O)N3C)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"690.0";"nM";"6.16";"";"";"UO_0000065";"13.35";"0.25";"3.95";"4.86";"0";"CHEMBL4047625";"Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4108191";"";"None";"463.54";"0";"2.56";"BDBM187745";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@@H]1CC[C@@H](C(C)(C)O)OC1";"IC50";"'='";"7.1";"nM";"8.15";"";"337430";"UO_0000065";"17.58";"0.33";"5.59";"5.91";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586501";"";"None";"495.57";"0";"2.31";"23";"COc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"14.43";"0.28";"4.84";"5.78";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3343048";"";"None";"420.42";"0";"3.66";"17a";"COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)ccc1OCC(=O)O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL4087806";"";"None";"410.45";"0";"2.83";"36";"CNC(=O)c1cnc(Nc2ccc(F)cc2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"19.49";"0.36";"5.17";"7.51";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3938166";"";"None";"585.69";"1";"4.40";"BDBM189090";"COc1ccc([S+]([O-])N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)cc1OC";"IC50";"'<'";"1000.0";"nM";"";"";"338948";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3894684";"";"None";"505.65";"1";"4.12";"BDBM189100";"CCCC[S+]([O-])N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338958";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107413";"";"None";"471.58";"1";"2.31";"BDBM203469";"O=c1[nH]c(NC2CCCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"636.0";"nM";"6.20";"";"360929";"UO_0000065";"13.14";"0.26";"3.89";"4.32";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622186";"";"None";"390.42";"1";"-0.15";"BDBM203470";"O=c1[nH]c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"1487.0";"nM";"5.83";"";"360930";"UO_0000065";"14.93";"0.29";"5.98";"3.85";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3968413";"";"None";"486.56";"0";"3.94";"BDBM189083";"CCS(=O)(=O)c1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338941";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3974126";"";"None";"524.67";"1";"4.28";"BDBM188950";"Cc1ccc(-n2nc(C3CCN(C4CCN(C5CC5)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338805";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3601192";"";"None";"472.55";"0";"2.96";"26";"Cc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1";"IC50";"'='";"0.74";"nM";"9.13";"";"";"UO_0000065";"19.32";"0.36";"6.17";"6.70";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4114295";"";"None";"451.53";"0";"1.49";"BDBM203482";"O=c1[nH]c(N2CCCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1ccc2ccccc2n1";"IC50";"'='";"23.0";"nM";"7.64";"";"360942";"UO_0000065";"16.92";"0.32";"6.15";"5.67";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112827";"";"None";"474.54";"1";"0.10";"BDBM203519";"Cc1nccc2sc(-c3c(N[C@@H]4C[C@H](CO)[C@@H](O)[C@H]4O)nc(N4CCOCC4)[nH]c3=O)nc12";"IC50";"'='";"8.4";"nM";"8.08";"";"360979";"UO_0000065";"17.02";"0.33";"7.98";"5.15";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110611";"";"None";"423.50";"0";"-0.45";"BDBM203495";"Cc1csc(-c2c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)nc(N3CCOCC3)[nH]c2=O)n1";"IC50";"'='";"26.6";"nM";"7.58";"";"360955";"UO_0000065";"17.89";"0.36";"8.03";"5.27";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622532";"";"None";"494.58";"1";"2.32";"BDBM203513";"Cc1cc(Nc2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)cc(C)n1";"IC50";"'='";"73.0";"nM";"7.14";"";"360973";"UO_0000065";"14.43";"0.28";"4.82";"4.57";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"16.01";"0.29";"3.12";"10.75";"0";"CHEMBL973443";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138507";"1";"Scientific Literature";"J Med Chem";"2009";"None";""
"CHEMBL4111056";"";"None";"453.48";"0";"1.73";"BDBM188005";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1CCOC1";"IC50";"'='";"4.1";"nM";"8.39";"";"337676";"UO_0000065";"18.50";"0.35";"6.66";"6.08";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108172";"";"None";"539.58";"1";"3.67";"BDBM187991";"Cn1cc(-c2ccc(Nc3cc(-n4ncc5cc(C#N)cnc54)ncc3C(=O)NC[C@@H](F)C(C)(C)O)cc2)cn1";"IC50";"'='";"2.2";"nM";"8.66";"";"337663";"UO_0000065";"16.05";"0.30";"4.99";"5.91";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112273";"";"None";"442.50";"0";"2.25";"BDBM187439";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cncnc32)cc1NC1CCOCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"337175";"UO_0000065";"19.66";"0.37";"6.45";"7.62";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111430";"";"None";"452.49";"0";"2.10";"BDBM187647";"CC(C)NC(=O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"8.1";"nM";"8.09";"";"337332";"UO_0000065";"17.88";"0.33";"5.99";"5.88";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110605";"";"None";"518.51";"1";"2.64";"BDBM187985";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C(N)=O)cnc32)cc1Nc1ccc2ncoc2c1";"IC50";"'='";"1.6";"nM";"8.80";"";"337657";"UO_0000065";"16.96";"0.32";"6.16";"5.05";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622515";"";"None";"493.54";"0";"1.80";"BDBM203490";"O=c1[nH]c(N2CCC(F)(F)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"134.8";"nM";"6.87";"";"360950";"UO_0000065";"13.92";"0.28";"5.07";"5.10";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109600";"";"None";"535.63";"2";"1.28";"BDBM203806";"O=c1[nH]c(N2CCN(c3cccnc3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"3.7";"nM";"8.43";"";"360986";"UO_0000065";"15.74";"0.30";"7.15";"5.59";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108659";"";"None";"487.49";"0";"3.13";"BDBM188083";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(F)(F)C1";"IC50";"'='";"2.3";"nM";"8.64";"";"337747";"UO_0000065";"17.72";"0.34";"5.51";"6.71";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114483";"";"None";"514.60";"1";"3.71";"BDBM187959";"CC(C)Nc1cc(-n2ccc3cc(CNC(=O)OC(C)C)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.8";"nM";"8.32";"";"337634";"UO_0000065";"16.17";"0.31";"4.61";"6.38";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3893092";"";"None";"426.55";"0";"2.44";"BDBM203571";"C[C@H]1COCCN1c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"431.0";"nM";"6.37";"";"361051";"UO_0000065";"14.92";"0.29";"3.93";"6.69";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109605";"";"None";"489.61";"0";"2.33";"BDBM203579";"O=c1[nH]c(N2CCN(c3ncccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"10.0";"nM";"8.00";"";"361059";"UO_0000065";"16.34";"0.31";"5.67";"6.96";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107471";"";"None";"453.57";"0";"2.32";"BDBM203554";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2c(C3CC3)nccc2s1";"IC50";"'='";"9.0";"nM";"8.05";"";"361034";"UO_0000065";"17.74";"0.34";"5.73";"7.45";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109155";"";"None";"496.50";"0";"1.39";"BDBM188003";"COC(=O)N1CC(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1";"IC50";"'='";"7.3";"nM";"8.14";"";"337674";"UO_0000065";"16.39";"0.31";"6.75";"5.14";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622514";"";"None";"457.56";"0";"1.55";"BDBM203489";"O=c1[nH]c(N2CCCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"43.0";"nM";"7.37";"";"360949";"UO_0000065";"16.10";"0.31";"5.82";"5.47";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3361257";"";"None";"368.51";"0";"3.90";"15";"c1ccc2c(c1)sc1ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c12";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380178";"Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3353207";"";"None";"499.62";"0";"3.72";"41";"Cc1ccc(-n2nc(N3CCN(C4CCCCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL401633";"";"None";"313.79";"0";"2.82";"rac-45";"Clc1ccc2ncc(-c3cccc(NC4CCNC4)n3)n2c1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"28.68";"0.56";"6.18";"16.59";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL255867";"";"None";"359.44";"0";"2.95";"20";"c1cc(NC2CCNCC2)nc(-c2cnc3ccc(-c4cc[nH]n4)cn23)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"24.20";"0.44";"5.75";"10.49";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4112885";"";"None";"515.69";"1";"3.97";"BDBM203781";"O=c1[nH]c(N2CCC(NCc3ccccc3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"110.0";"nM";"6.96";"";"361255";"UO_0000065";"13.49";"0.26";"2.99";"7.10";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3921623";"";"None";"501.62";"1";"4.13";"BDBM187619";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](O)(c2nccs2)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"337310";"UO_0000065";"16.55";"0.31";"4.17";"6.45";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3982704";"";"None";"500.58";"1";"4.38";"BDBM187625";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](F)(c2nccn2C)CC1";"IC50";"'='";"4.3";"nM";"8.37";"";"337316";"UO_0000065";"16.71";"0.31";"3.99";"7.37";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3917833";"";"None";"456.57";"0";"1.75";"BDBM203707";"O=c1[nH]c(N2CCOCC2)nc(NCCN2CCC(O)CC2)c1-c1nc2ccccc2s1";"IC50";"'='";"780.0";"nM";"6.11";"";"361181";"UO_0000065";"13.38";"0.26";"4.36";"5.73";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108331";"";"None";"524.70";"1";"2.73";"BDBM203802";"N[C@@H]1CCCC[C@@H]1Nc1cccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc12";"IC50";"'='";"24.0";"nM";"7.62";"";"361276";"UO_0000065";"14.52";"0.28";"4.89";"5.72";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109650";"";"None";"502.65";"1";"3.24";"BDBM203600";"Cc1cnccc1N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"361081";"UO_0000065";"16.11";"0.31";"4.86";"7.93";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL256713";"";"None";"379.42";"0";"2.57";"4b";"COc1cc(N2CCOCC2)ccc1NC(=O)c1cccc(-c2ccn[nH]2)n1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"20.29";"0.38";"5.13";"8.33";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL255253";"";"None";"333.44";"0";"3.43";"33";"CN1[C@@H]2CC[C@H]1CC(Nc1cccc(-c3cnc4ccccn34)n1)C2";"IC50";"'='";"914.0";"nM";"6.04";"";"";"UO_0000065";"18.11";"0.33";"2.61";"13.28";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4110461";"";"None";"453.50";"0";"0.34";"BDBM203481";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1ccc2ccccc2n1";"IC50";"'='";"9.5";"nM";"8.02";"";"360941";"UO_0000065";"17.69";"0.33";"7.68";"5.58";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109175";"";"None";"536.64";"2";"-0.36";"BDBM203475";"CS(=O)(=O)N1CCN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"360935";"UO_0000065";"14.17";"0.29";"7.96";"4.42";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3963318";"";"None";"459.56";"0";"2.65";"BDBM189055";"Cc1ccc(-n2nc(N3CCN(CC(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338913";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3975254";"";"None";"438.46";"0";"1.94";"BDBM187951";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCC(F)C1(O)COC1";"IC50";"'='";"3.0";"nM";"8.52";"";"337626";"UO_0000065";"19.44";"0.36";"6.58";"6.81";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622524";"";"None";"440.53";"0";"1.96";"BDBM203534";"O=C1NCCCC[C@H]1Nc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"2429.0";"nM";"5.62";"";"361014";"UO_0000065";"12.75";"0.25";"3.65";"5.00";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622521";"";"None";"426.55";"0";"2.39";"BDBM203538";"CN1CCC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)C1";"IC50";"'='";"354.0";"nM";"6.45";"";"361018";"UO_0000065";"15.12";"0.29";"4.06";"7.47";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4059675";"";"None";"321.43";"0";"3.32";"17";"N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCCC4)CC3)c2c1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"24.34";"0.45";"4.50";"12.07";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4108325";"";"None";"438.51";"0";"3.61";"BDBM187893";"COC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"1.5";"nM";"8.82";"";"312097";"UO_0000065";"20.12";"0.38";"5.21";"8.41";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3985561";"";"None";"461.57";"0";"3.57";"BDBM187584";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)CC1";"IC50";"'='";"1.4";"nM";"8.85";"";"337283";"UO_0000065";"19.18";"0.36";"5.28";"6.88";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107964";"";"None";"419.89";"0";"3.34";"BDBM187432";"CCNc1cc(-n2ccc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"7.1";"nM";"8.15";"";"337168";"UO_0000065";"19.41";"0.38";"4.81";"8.85";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2018055";"";"None";"407.88";"0";"1.50";"2";"Nc1nc(Cl)c(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"16.60";"0.34";"5.27";"4.93";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4113907";"";"None";"461.54";"1";"1.01";"BDBM203503";"COCCCNc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"60.0";"nM";"7.22";"";"360963";"UO_0000065";"15.65";"0.31";"6.21";"4.73";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113184";"";"None";"557.54";"2";"3.09";"BDBM187836";"CC(Cn1cc(Nc2cc(-n3cnc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1)OC(F)F";"IC50";"'='";"2.5";"nM";"8.60";"";"337513";"UO_0000065";"15.43";"0.29";"5.51";"5.52";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107281";"";"None";"421.51";"0";"2.79";"BDBM187641";"CC[C@@H](C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(C)O";"IC50";"'='";"3.4";"nM";"8.47";"";"337328";"UO_0000065";"20.09";"0.37";"5.68";"6.58";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586490";"";"None";"358.41";"0";"3.35";"12";"Cc1ccc(-n2nc(C3CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"17.95";"0.33";"3.08";"8.34";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3953084";"";"None";"385.86";"0";"2.99";"BDBM206251";"O=C(Nc1cc(Cl)ccc1N1CCCCC1CO)c1cnn2cccnc12";"IC50";"'='";"4848.0";"nM";"5.31";"";"364922";"UO_0000065";"13.77";"0.27";"2.32";"6.42";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4443947";"";"None";"995.19";"3";"2.74";"6";"CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)CCOCCOCCOCC#Cc2cnc(OC[C@@H]3CCC(=O)N3)c3cc(OC)c(C(N)=O)cc23)C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C1CCCCC1";"IC50";"'='";"0.022";"nM";"10.66";"";"";"UO_0000065";"10.71";"0.20";"7.92";"4.25";"0";"CHEMBL4361896";"Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359855";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";""
"CHEMBL3971842";"";"None";"543.65";"1";"4.48";"BDBM189071";"CCN(CC)S(=O)(=O)c1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)c(C)c1";"IC50";"'<'";"1000.0";"nM";"";"";"338929";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3927995";"";"None";"443.90";"0";"4.50";"BDBM188930";"Cc1ccc(-c2cc(NC(=O)c3cnn4cc(Cl)cnc34)n(-c3ccc(C)cn3)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338785";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4081711";"ZIMLOVISERTIB";"2.0";"361.37";"0";"1.58";"40; PF-06650833";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"24.07";"0.46";"7.12";"8.40";"0";"CHEMBL4015987";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production by measuring plasma protein binding corrected IC50 after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4466981";"";"None";"478.55";"0";"2.59";"17";"COC(C)(C)CCN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O";"IC50";"'='";"0.32";"nM";"9.49";"";"";"UO_0000065";"19.84";"0.37";"6.90";"9.37";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4475494";"";"None";"482.52";"0";"1.88";"19";"CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O";"IC50";"'='";"0.19";"nM";"9.72";"";"";"UO_0000065";"20.15";"0.38";"7.84";"8.66";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4111866";"";"None";"457.49";"0";"2.69";"BDBM187655";"CC(CCF)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"7.0";"nM";"8.15";"";"337340";"UO_0000065";"17.83";"0.34";"5.46";"6.33";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3590472";"";"None";"397.44";"0";"0.50";"12";"Cn1cc(NC(=O)c2cnn3ccc(N[C@H]4CCCC[C@@H]4N)nc23)c(C(N)=O)n1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"19.37";"0.36";"7.20";"4.87";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3590473";"";"None";"397.44";"0";"0.50";"13";"Cn1cc(NC(=O)c2cnn3ccc(N[C@H]4CCCC[C@H]4N)nc23)c(C(N)=O)n1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"20.37";"0.38";"7.60";"5.12";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3590490";"";"None";"440.41";"0";"2.58";"30";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC(F)(F)[C@@H]4N)nc23)c(C(F)F)n1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"17.91";"0.35";"5.31";"6.85";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3904526";"";"None";"533.60";"2";"0.31";"BDBM188922";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3nccn3S(C)(=O)=O)n2)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"338777";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111001";"";"None";"508.68";"1";"3.30";"BDBM203599";"Cc1cc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)sn1";"IC50";"'='";"8.0";"nM";"8.10";"";"361080";"UO_0000065";"15.92";"0.32";"4.80";"7.93";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3822972";"";"None";"336.38";"0";"3.50";"BDBM206104";"COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12";"IC50";"'='";"18.0";"nM";"7.75";"";"364775";"UO_0000065";"23.02";"0.44";"4.24";"10.06";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3903725";"";"None";"450.38";"0";"3.29";"BDBM236557";"Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"412025";"UO_0000065";"";"";"";"";"0";"CHEMBL3888668";"Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886794";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4579427";"";"None";"476.46";"0";"2.49";"Compound B";"COc1cc2nn(CC(=O)N3CCN(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"15.70";"0.30";"4.99";"8.08";"0";"CHEMBL4331758";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330088";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL3922728";"";"None";"314.35";"0";"3.65";"BDBM206203";"O=C(Nc1ccccc1-c1ccccc1)c1cnn2cccnc12";"IC50";"'='";"1224.0";"nM";"5.91";"";"364874";"UO_0000065";"18.81";"0.34";"2.26";"9.97";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3933884";"";"None";"416.87";"0";"2.81";"BDBM206220";"O=C(Nc1cc(Cl)ccc1OC1CCC(O)CC1)c1cnn2cc(CO)cnc12";"IC50";"'='";"2253.0";"nM";"5.65";"";"364891";"UO_0000065";"13.55";"0.27";"2.84";"5.18";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3976860";"";"None";"307.31";"0";"2.47";"BDBM206197";"COc1cc2cc[nH]c2cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"787.0";"nM";"6.10";"";"364868";"UO_0000065";"19.86";"0.36";"3.63";"7.24";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3940643";"";"None";"550.65";"1";"4.25";"BDBM189105";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccc(C#N)c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338963";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114391";"";"None";"527.70";"1";"4.32";"BDBM203783";"O=c1[nH]c(N2CCC3(CCN(c4ccccc4)C3)C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"21.0";"nM";"7.68";"";"361257";"UO_0000065";"14.55";"0.28";"3.36";"8.61";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114416";"";"None";"446.96";"0";"2.70";"BDBM203788";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cccc(Cl)c2s1";"IC50";"'='";"180.0";"nM";"6.75";"";"361262";"UO_0000065";"15.09";"0.31";"4.04";"7.09";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586510";"";"None";"417.48";"0";"1.62";"BDBM188932";"Cc1ccc(-n2nc(N3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338787";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3590480";"";"None";"472.42";"0";"3.05";"20";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)(F)C(F)(F)F)n1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.41";"0.36";"5.65";"7.55";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3601189";"";"None";"474.52";"0";"2.35";"22";"COc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"16.02";"0.30";"5.25";"5.22";"0";"CHEMBL3603426";"Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL3601070";"";"None";"502.58";"1";"3.13";"24";"CC(C)Oc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"216.0";"nM";"6.67";"";"";"UO_0000065";"13.26";"0.25";"3.54";"4.58";"0";"CHEMBL3603426";"Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL3590517";"";"None";"426.38";"0";"1.61";"36";"Cn1cc(NC(=O)c2cnn3ccc(N4CC[C@H](F)[C@@H](N)C4)nc23)c(C(F)(F)F)n1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"19.28";"0.37";"6.61";"7.73";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL210774";"";"None";"322.32";"0";"3.38";"31";"C=CCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"18.62";"0.34";"2.62";"6.66";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3601188";"";"None";"477.55";"1";"2.32";"21";"OC[C@H]1C[C@@H](Nc2nc(Nc3cncnc3)ncc2-c2nc(-c3ccccc3)cs2)[C@H](O)[C@@H]1O";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"14.71";"0.28";"4.71";"4.71";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601186";"";"None";"490.59";"0";"3.23";"19";"Cc1cc(Nc2ncc(-c3nc(-c4ccccc4)cs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"16.22";"0.31";"4.73";"5.84";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4112221";"";"None";"492.69";"0";"4.72";"BDBM203681";"O=c1[nH]c(C2CCN(C3CCCCC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"450.0";"nM";"6.35";"";"361155";"UO_0000065";"12.88";"0.25";"1.63";"7.39";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111400";"";"None";"428.52";"0";"1.08";"BDBM203660";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1csc(-n2ccnc2)n1";"IC50";"'='";"4.0";"nM";"8.40";"";"361142";"UO_0000065";"19.60";"0.38";"7.32";"7.43";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3949384";"";"None";"445.50";"0";"3.65";"BDBM188806";"O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(C2CC2)cc1F)c1cnn2cccnc12";"IC50";"'<'";"100.0";"nM";"";"";"338661";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586510";"";"None";"417.48";"0";"1.62";"32";"Cc1ccc(-n2nc(N3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"19.88";"0.37";"6.68";"8.60";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3946723";"";"None";"487.55";"0";"3.51";"BDBM189077";"Cc1ccc(-n2nc(-c3cccc(NS(C)(=O)=O)c3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338935";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113223";"";"None";"431.90";"0";"3.49";"BDBM187433";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(Cl)cnc32)cc1NC1CC1";"IC50";"'='";"5.3";"nM";"8.28";"";"337169";"UO_0000065";"19.16";"0.38";"4.79";"8.99";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110771";"";"None";"412.52";"0";"2.05";"BDBM203652";"C[C@@H]1C[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1";"IC50";"'='";"150.0";"nM";"6.82";"";"361133";"UO_0000065";"16.54";"0.32";"4.77";"7.17";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114603";"";"None";"421.51";"0";"1.62";"BDBM203656";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1cccc(-n2cccc2)n1";"IC50";"'='";"185.0";"nM";"6.73";"";"361138";"UO_0000065";"15.97";"0.30";"5.11";"6.73";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110934";"";"None";"516.69";"1";"3.13";"BDBM203686";"CC(C)S(=O)(=O)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"210.0";"nM";"6.68";"";"361160";"UO_0000065";"12.92";"0.26";"3.55";"5.56";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108284";"";"None";"514.68";"1";"2.88";"BDBM203687";"O=c1[nH]c(C2CCN(S(=O)(=O)C3CC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"170.0";"nM";"6.77";"";"361161";"UO_0000065";"13.15";"0.26";"3.89";"5.64";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3906814";"";"None";"426.55";"0";"2.39";"BDBM203708";"O=c1[nH]c(N2CCOCC2)nc(NCCN2CCCC2)c1-c1nc2ccccc2s1";"IC50";"'='";"2200.0";"nM";"5.66";"";"361182";"UO_0000065";"13.26";"0.26";"3.27";"6.55";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113237";"";"None";"491.53";"0";"2.88";"BDBM187837";"CCCn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"2.9";"nM";"8.54";"";"337514";"UO_0000065";"17.37";"0.32";"5.66";"5.82";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3954452";"";"None";"426.48";"0";"2.87";"BDBM187708";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCc1ccncc1";"IC50";"'='";"2.5";"nM";"8.60";"";"337393";"UO_0000065";"20.17";"0.37";"5.73";"7.09";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3925280";"";"None";"449.52";"0";"2.17";"BDBM187684";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCOCC1";"IC50";"'='";"6.1";"nM";"8.21";"";"337369";"UO_0000065";"18.27";"0.34";"6.04";"5.95";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115108";"";"None";"454.51";"0";"2.31";"BDBM187881";"CC(O)CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.3";"nM";"8.64";"";"337556";"UO_0000065";"19.01";"0.36";"6.33";"6.35";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113648";"";"None";"464.64";"0";"3.94";"BDBM203679";"O=c1[nH]c(C2CCN(C3CCC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"730.0";"nM";"6.14";"";"361153";"UO_0000065";"13.21";"0.25";"2.20";"7.14";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3914563";"";"None";"503.59";"1";"2.73";"BDBM187457";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1";"IC50";"'='";"2.7";"nM";"8.57";"";"337193";"UO_0000065";"17.02";"0.33";"5.84";"5.50";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109340";"";"None";"484.58";"0";"1.98";"BDBM203770";"CCOC(=O)C1CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1";"IC50";"'='";"180.0";"nM";"6.75";"";"361244";"UO_0000065";"13.92";"0.27";"4.76";"5.55";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586496";"";"None";"443.51";"0";"3.20";"18";"CC(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"15.21";"0.28";"3.54";"6.92";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3601085";"";"None";"411.47";"0";"0.93";"16";"Cc1cc(Nc2ncc(-n3cccn3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1";"IC50";"'='";"932.0";"nM";"6.03";"";"";"UO_0000065";"14.66";"0.27";"5.10";"4.27";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4106801";"";"None";"476.52";"0";"3.09";"BDBM187829";"CCn1cc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"1.2";"nM";"8.92";"";"337506";"UO_0000065";"18.72";"0.35";"5.83";"6.67";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111578";"";"None";"484.50";"0";"3.14";"BDBM187983";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1ccc(C#N)cc1";"IC50";"'='";"2.6";"nM";"8.59";"";"337655";"UO_0000065";"17.72";"0.33";"5.45";"5.63";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115670";"";"None";"401.45";"0";"1.87";"BDBM187612";"CC(C)Nc1cc(-n2cnc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"15.1";"nM";"7.82";"";"337305";"UO_0000065";"19.48";"0.37";"5.95";"6.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111152";"";"None";"427.46";"0";"3.32";"BDBM187757";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)F";"IC50";"'='";"3.0";"nM";"8.52";"";"337442";"UO_0000065";"19.94";"0.38";"5.20";"7.85";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107169";"";"None";"432.89";"0";"2.88";"BDBM187572";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1NC1CC1";"IC50";"'='";"3.1";"nM";"8.51";"";"337271";"UO_0000065";"19.66";"0.39";"5.63";"8.11";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106447";"";"None";"487.58";"0";"2.66";"BDBM187633";"CC(C)Nc1cc(-n2ccc3cnc(NCC(C)(C)O)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.9";"nM";"8.72";"";"337322";"UO_0000065";"17.89";"0.34";"6.06";"6.36";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106756";"";"None";"459.53";"0";"1.88";"BDBM187634";"CC(C)Nc1cc(-n2ccc3cnc(NCCO)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.7";"nM";"8.77";"";"337323";"UO_0000065";"19.08";"0.36";"6.89";"6.39";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3948538";"";"None";"425.47";"0";"2.35";"BDBM188121";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.6";"nM";"8.59";"";"337327";"UO_0000065";"20.18";"0.38";"6.24";"6.67";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112012";"";"None";"480.52";"0";"3.07";"BDBM203786";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cc(C(F)(F)F)ccc2s1";"IC50";"'='";"70.0";"nM";"7.16";"";"361260";"UO_0000065";"14.89";"0.30";"4.08";"7.52";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3910846";"";"None";"481.47";"0";"2.66";"BDBM187849";"CCOCCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"7.1";"nM";"8.15";"";"337526";"UO_0000065";"16.92";"0.32";"5.49";"6.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112199";"";"None";"452.58";"0";"2.92";"BDBM203795";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cc(C3CC3)ccc2s1";"IC50";"'='";"330.0";"nM";"6.48";"";"361269";"UO_0000065";"14.32";"0.28";"3.56";"6.81";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110862";"";"None";"509.54";"1";"2.38";"BDBM187931";"COC(=O)N1CC[C@@H](Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1";"IC50";"'='";"1.2";"nM";"8.92";"";"337606";"UO_0000065";"17.51";"0.33";"6.54";"6.14";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107218";"";"None";"509.60";"1";"1.72";"BDBM188897";"C[C@@H](N)c1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338752";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3922946";"";"None";"318.79";"0";"3.36";"BDBM206198";"CSc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"798.0";"nM";"6.10";"";"364869";"UO_0000065";"19.13";"0.40";"2.74";"10.29";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4467170";"";"None";"421.50";"0";"2.90";"24";"CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(CO)CC3)cc2O1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"17.60";"0.33";"4.52";"8.07";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4785023";"";"None";"408.39";"0";"1.90";"14";"Cn1cc(NC(=O)c2cnc3ccc(N[C@@H]4CCCNC4)nn23)c(C(F)(F)F)n1";"IC50";"'='";"23.5";"nM";"7.63";"";"";"UO_0000065";"18.68";"0.36";"5.73";"7.54";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3353212";"";"None";"427.51";"0";"3.59";"46";"CC(=O)N1CCC[C@@H](n2cc(-c3cnc(-c4cccc(-c5cnn(C)c5)c4)nc3)cn2)C1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372371";"Inhibition of IRAK1 (unknown origin) assessed as reduction in biotin tagged phosphorylated peptide substrate1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3969867";"";"None";"392.87";"0";"3.03";"BDBM206244";"COc1ccc(Cl)cc1NC(=O)c1csc2cnc(N(C)CCO)nc12";"IC50";"'='";"4133.0";"nM";"5.38";"";"364915";"UO_0000065";"13.70";"0.28";"2.35";"6.15";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3903995";"";"None";"419.49";"0";"2.48";"BDBM188921";"CC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ncc[nH]3)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338776";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115108";"";"None";"454.51";"0";"2.31";"BDBM187881";"CC(O)CCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.5";"nM";"8.60";"";"337593";"UO_0000065";"18.93";"0.36";"6.29";"6.32";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112231";"";"None";"447.42";"0";"2.20";"BDBM188040";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCC(F)F";"IC50";"'='";"15.3";"nM";"7.82";"";"337706";"UO_0000065";"17.47";"0.33";"5.62";"6.07";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110222";"";"None";"499.46";"0";"2.86";"BDBM187858";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1Nc1cnn(C(F)F)c1";"IC50";"'='";"5.7";"nM";"8.24";"";"337535";"UO_0000065";"16.51";"0.31";"5.38";"5.62";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3902407";"";"None";"387.89";"0";"4.33";"BDBM206180";"O=C(Nc1cc(Cl)ccc1OC1CCNCC1)c1csc2cccnc12";"IC50";"'='";"476.0";"nM";"6.32";"";"364851";"UO_0000065";"16.30";"0.33";"1.99";"10.00";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3909110";"";"None";"370.84";"0";"2.39";"BDBM206184";"CN1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"512.0";"nM";"6.29";"";"364855";"UO_0000065";"16.96";"0.33";"3.90";"9.56";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3353205";"";"None";"524.70";"1";"2.73";"39";"N[C@H]1CCCC[C@H]1Nc1cccc2nc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)sc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.58";"0.32";"5.97";"6.53";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3353186";"";"None";"350.47";"0";"3.99";"19";"CN(C)[C@H]1CC[C@H](Nc2nc(Nc3ccccc3)nc3[nH]ccc23)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"19.97";"0.37";"3.01";"10.16";"0";"CHEMBL3380178";"Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4106743";"";"None";"522.92";"1";"3.51";"BDBM187808";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"2.3";"nM";"8.64";"";"337485";"UO_0000065";"16.52";"0.33";"5.13";"7.04";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108199";"";"None";"356.43";"0";"0.83";"BDBM203641";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1ccccn1";"IC50";"'='";"4759.0";"nM";"5.32";"";"361122";"UO_0000065";"14.93";"0.28";"4.49";"5.59";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3897519";"";"None";"519.60";"2";"5.23";"BDBM188993";"Cc1ccc(-n2nc(C3CCN(C4CCC(F)(F)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338848";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3952402";"";"None";"591.74";"1";"3.25";"BDBM188996";"Cc1ccc(-n2nc(C3CCN(C4CCC(N(C)S(C)(=O)=O)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338851";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3926943";"";"None";"569.69";"1";"4.26";"BDBM189030";"Cc1ccc(-n2nc(C3CCCN(Cc4ccc(S(C)(=O)=O)cc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338885";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3634613";"";"None";"405.92";"0";"3.01";"45";"Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(Cl)n1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"20.09";"0.41";"5.14";"7.36";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634381";"";"None";"404.43";"0";"2.33";"27";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)F)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"19.78";"0.38";"5.67";"6.95";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3622518";"";"None";"412.52";"0";"2.05";"19";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"13.87";"0.27";"3.67";"6.01";"0";"CHEMBL3625606";"Inhibition of IRAK4 in human PBMC assessed as reduction of IL1beta-induced TNFalpha production treated 30 mins before IL1beta stimulation measured after 5 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3907051";"";"None";"398.85";"0";"2.34";"BDBM206127";"NC(=O)C1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"69.0";"nM";"7.16";"";"364798";"UO_0000065";"17.95";"0.35";"4.82";"6.78";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3947085";"";"None";"341.80";"0";"3.24";"BDBM206165";"O=C(Nc1cc(Cl)ccc1N1CCCC1)c1cnn2cccnc12";"IC50";"'='";"312.0";"nM";"6.51";"";"364836";"UO_0000065";"19.03";"0.37";"3.27";"10.40";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3924734";"";"None";"355.83";"0";"3.63";"BDBM206166";"O=C(Nc1cc(Cl)ccc1N1CCCCC1)c1cnn2cccnc12";"IC50";"'='";"314.0";"nM";"6.50";"";"364837";"UO_0000065";"18.28";"0.36";"2.87";"10.40";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3634379";"";"None";"421.43";"0";"3.02";"24";"Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)(F)F)n1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"19.70";"0.38";"5.28";"8.12";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3622529";"";"None";"426.55";"0";"2.44";"30";"C[C@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1";"IC50";"'='";"565.0";"nM";"6.25";"";"";"UO_0000065";"14.65";"0.28";"3.81";"6.57";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3622528";"";"None";"427.53";"0";"2.60";"29";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCC[C@@H](O)C2)c1-c1nc2ccccc2s1";"IC50";"'='";"454.0";"nM";"6.34";"";"";"UO_0000065";"14.84";"0.29";"3.74";"6.14";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3403442";"";"None";"356.39";"0";"-0.11";"23";"Nc1ncc(-c2cnc3ccccn23)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"1140.0";"nM";"5.94";"";"";"UO_0000065";"16.68";"0.31";"6.05";"4.19";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4649636";"";"None";"416.46";"0";"3.02";"18";"CC(C)Nc1cc(Nc2ccc3nonc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"14.87";"0.28";"3.17";"4.95";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4649875";"";"None";"413.55";"0";"4.15";"9";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCC(C)(C)O";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"15.81";"0.31";"2.39";"6.59";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4634922";"";"None";"433.46";"0";"2.67";"21";"CC(C)Nc1cc(Nc2nc3ccnn3cc2F)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"14.84";"0.28";"3.76";"5.52";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4643371";"";"None";"445.56";"0";"4.40";"16";"Cc1nc2ccc(Nc3cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn3)cc2s1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"18.17";"0.36";"3.70";"8.16";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL377125";"";"None";"354.32";"0";"2.67";"43";"O=C(O)CCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"15.23";"0.28";"2.73";"4.24";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3601185";"";"None";"504.62";"1";"3.54";"18";"Cc1cc(Nc2ncc(-c3nc(-c4ccccc4)cs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"16.64";"0.32";"4.86";"6.16";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL1270399";"";"None";"438.56";"0";"3.80";"25";"Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc([C@@H](C)N3C[C@@H](C)O[C@@H](C)C3)ns2)n1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"13.10";"0.25";"1.94";"5.97";"0";"CHEMBL1272500";"Inhibition of IRK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL3353191";"";"None";"432.89";"0";"3.16";"24";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(Nc2ncc(C#N)cc2Cl)cc1NC1CC1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"20.20";"0.40";"5.58";"7.11";"0";"CHEMBL3380182";"Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4288880";"";"None";"343.48";"0";"3.07";"18";"CN(C)[C@H]1CC[C@H](Nc2ncnc3ccn(C4CCOCC4)c23)CC1";"IC50";"'='";"446.0";"nM";"6.35";"";"";"UO_0000065";"18.49";"0.35";"3.28";"11.50";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4278882";"";"None";"384.53";"0";"2.74";"30";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1";"IC50";"'='";"195.0";"nM";"6.71";"";"";"UO_0000065";"17.45";"0.33";"3.97";"10.20";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4068395";"";"None";"349.28";"0";"3.68";"5";"CN(C)[C@H]1CC[C@H](Nc2ncnc3ccc(Br)cc23)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"22.90";"0.52";"4.32";"19.49";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4288288";"";"None";"273.38";"0";"2.25";"16";"Cn1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c21";"IC50";"'='";"738.0";"nM";"6.13";"";"";"UO_0000065";"22.43";"0.42";"3.88";"13.34";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3586493";"";"None";"401.47";"0";"2.94";"15";"Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"17.68";"0.32";"4.16";"7.96";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4285338";"";"None";"384.53";"0";"2.77";"24";"CN(C)[C@H]1CC[C@H](Nc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"331.0";"nM";"6.48";"";"";"UO_0000065";"16.85";"0.32";"3.71";"7.32";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4067181";"";"None";"442.56";"0";"2.96";"27";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"16.01";"0.30";"4.13";"7.41";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL1650533";"";"None";"463.01";"0";"3.22";"1";"CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO.Cl";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"18.98";"0.37";"4.88";"7.55";"0";"CHEMBL1656203";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649074";"1";"Scientific Literature";"J Med Chem";"2011";"None";""
"CHEMBL4288880";"";"None";"343.48";"0";"3.07";"18";"CN(C)[C@H]1CC[C@H](Nc2ncnc3ccn(C4CCOCC4)c23)CC1";"IC50";"'='";"446.68";"nM";"6.35";"";"";"UO_0000065";"18.49";"0.35";"3.28";"11.50";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3601078";"";"None";"452.50";"1";"1.20";"9";"OC[C@H]1C[C@@H](Nc2nc(Nc3cncnc3)ncc2-c2nc3ccncc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"18.17";"0.35";"7.02";"5.07";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4108601";"";"None";"516.55";"1";"3.45";"BDBM203582";"O=c1[nH]c(N2CCn3cc(C(F)(F)F)nc3C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"113.0";"nM";"6.95";"";"361063";"UO_0000065";"13.45";"0.26";"3.50";"6.70";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3969406";"";"None";"296.33";"0";"2.61";"BDBM206255";"COc1c(C)cc(C)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"6516.0";"nM";"5.19";"";"364926";"UO_0000065";"17.50";"0.32";"2.58";"7.57";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL255445";"";"None";"358.45";"0";"3.56";"21";"c1cc(NC2CCNCC2)nc(-c2cnc3ccc(-c4ccc[nH]4)cn23)c1";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"20.09";"0.36";"3.64";"10.28";"0";"CHEMBL921622";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4758572";"";"None";"552.57";"2";"5.63";"16";"CC1(C)OC(=O)c2ccc(Nc3ncc(-c4nc(-c5ccc(F)cc5)no4)c(N[C@H](CO)c4ccccc4)n3)cc21";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL2017214";"";"None";"422.56";"0";"3.12";"8";"CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2019674";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2016462";"1";"Scientific Literature";"ACS Med Chem Lett";"2011";"None";""
"CHEMBL259797";"";"None";"311.37";"0";"3.47";"2e";"COc1ccccc1NC(=O)c1csc(-c2cccnc2)n1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"19.58";"0.38";"2.63";"9.51";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4108507";"";"None";"402.43";"0";"1.06";"BDBM188046";"CCNc1cc(-n2ncc3cnc(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"10.7";"nM";"7.97";"";"337712";"UO_0000065";"19.81";"0.38";"6.91";"5.54";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4556091";"";"None";"535.62";"1";"2.72";"22";"CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(N4CCC4)CC3)cc2C1=O";"IC50";"'='";"0.026";"nM";"10.59";"";"";"UO_0000065";"19.76";"0.37";"7.87";"9.96";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4790546";"";"None";"477.49";"0";"3.70";"15";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)cc(N3CCOCC3)c2n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4787177";"";"None";"450.46";"0";"4.09";"13";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)cc(C(C)(C)O)c2n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4754306";"";"None";"441.48";"0";"3.55";"11";"CN(C)CCn1cc2cc(NC(=O)c3nc(C(F)(F)F)cs3)c(C(C)(C)O)cc2n1";"IC50";"'='";"198.0";"nM";"6.70";"";"";"UO_0000065";"15.18";"0.31";"3.15";"8.05";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4113064";"";"None";"445.93";"0";"3.88";"BDBM187430";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(Cl)cnc32)cc1NC1CCC1";"IC50";"'='";"3.4";"nM";"8.47";"";"337166";"UO_0000065";"18.99";"0.37";"4.59";"9.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110704";"";"None";"399.47";"0";"3.08";"BDBM187473";"CC(C)Nc1cc(-n2ccc3cccnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.3";"nM";"8.37";"";"337209";"UO_0000065";"20.94";"0.39";"5.29";"9.09";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4483551";"";"None";"449.52";"0";"1.30";"39";"CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(CC(N)=O)CC3)cc2O1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"16.91";"0.31";"6.30";"6.44";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4094760";"";"None";"385.51";"0";"2.91";"32";"c1nc(N[C@H]2CC[C@@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"16.20";"0.30";"3.33";"8.29";"1";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4102501";"";"None";"452.60";"0";"3.13";"30";"CN1C(=O)C[C@H]2CN([C@H]3CC[C@H](Nc4ncnc5[nH]cc(C6CCOCC6)c45)CC3)CC[C@H]21";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.22";"0.36";"5.57";"10.07";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4086115";"";"None";"454.62";"0";"3.38";"29";"CN(C)C(=O)C1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"17.70";"0.33";"4.67";"9.31";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4291706";"";"None";"259.36";"0";"2.01";"11";"CN(C)[C@H]1CC[C@H](Nc2ncnn3cccc23)CC1";"IC50";"'='";"1513.56";"nM";"5.82";"";"";"UO_0000065";"22.44";"0.42";"3.81";"12.80";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4536154";"";"None";"518.57";"1";"1.43";"20";"CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2S1(=O)=O";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.20";"0.34";"7.49";"6.90";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3590493";"";"None";"444.37";"0";"1.91";"33";"Cn1cc(NC(=O)c2cnn3ccc(N4C[C@H](N)CC(F)(F)C4)nc23)c(C(F)(F)F)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"20.25";"0.40";"7.09";"8.46";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4459066";"";"None";"369.39";"0";"-0.78";"1";"Cn1cc(NC(=O)c2cnn3ccc(N4CCNCC4)nc23)c(C(N)=O)n1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"18.47";"0.35";"7.60";"5.04";"0";"CHEMBL4427853";"Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL4634634";"";"None";"365.44";"0";"1.44";"29";"C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4603507";"Inhibition of recombinant full length human His-tagged IRAK4 expressed in baculovirus expression system using serine/threonine-7 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4602617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";""
"CHEMBL3590478";"";"None";"422.42";"0";"2.42";"18";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)(F)F)n1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"22.54";"0.43";"7.10";"8.27";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3924317";"";"None";"529.63";"1";"4.17";"BDBM189074";"CCN(CC)S(=O)(=O)c1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338932";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3903182";"";"None";"380.79";"0";"4.13";"BDBM206243";"O=C(Nc1cc(Cl)ccc1Oc1cccc(O)c1)c1cnn2cccnc12";"IC50";"'='";"4047.0";"nM";"5.39";"";"364914";"UO_0000065";"14.16";"0.27";"1.26";"6.08";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4282348";"";"None";"467.62";"0";"2.38";"32";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H]5CC[C@H](C(N)=O)CC5)c34)CC2)CC1";"IC50";"'='";"1650.0";"nM";"5.78";"";"";"UO_0000065";"12.37";"0.23";"3.40";"5.31";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4091013";"";"None";"299.42";"0";"3.12";"15";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CC4)c23)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"26.58";"0.49";"4.84";"14.00";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4079819";"";"None";"290.44";"0";"3.28";"4";"Cc1csc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"19.35";"0.38";"2.34";"13.69";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3909063";"";"None";"556.67";"1";"4.28";"BDBM188941";"CCOC(=O)N1CCC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338796";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106577";"";"None";"502.62";"1";"4.43";"BDBM203800";"O=c1[nH]c(N2CCc3ccccc3C2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(F)cc2)cs1";"IC50";"'='";"57.0";"nM";"7.24";"";"361274";"UO_0000065";"14.41";"0.27";"2.81";"8.43";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3890086";"";"None";"523.58";"1";"1.58";"BDBM188926";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cc(NC=O)cnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338781";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3909327";"";"None";"465.52";"0";"3.84";"BDBM189080";"Cc1ccc(-n2nc(-c3ccc(C(=O)N(C)C)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338938";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3963633";"";"None";"401.47";"0";"2.94";"BDBM188776";"Cc1ccc(-n2nc(C3CCCNC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338631";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3891503";"";"None";"401.92";"0";"4.41";"BDBM206128";"O=C(Nc1cc(Cl)ccc1N1CCC(CO)CC1)c1csc2cccnc12";"IC50";"'='";"70.0";"nM";"7.16";"";"364799";"UO_0000065";"17.80";"0.36";"2.74";"10.93";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4096351";"";"None";"290.44";"0";"3.28";"3";"Cc1cc2c(N[C@H]3CC[C@H](N(C)C)CC3)ncnc2s1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"19.96";"0.40";"2.52";"14.12";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4078222";"";"None";"452.60";"0";"3.13";"31";"CN1C(=O)C[C@@H]2CN([C@H]3CC[C@H](Nc4ncnc5[nH]cc(C6CCOCC6)c45)CC3)CC[C@@H]21";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"16.39";"0.31";"4.29";"8.59";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3956976";"";"None";"405.46";"0";"2.27";"BDBM188020";"CC(C)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1COC1";"IC50";"'='";"5.1";"nM";"8.29";"";"337689";"UO_0000065";"20.45";"0.38";"6.02";"7.04";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"4.21";"nM";"8.38";"";"";"UO_0000065";"17.95";"0.33";"4.03";"12.06";"0";"CHEMBL4328455";"Inhibition of human IRAK4 using MBP as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4325871";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL3593777";"";"None";"379.40";"0";"1.96";"31";"N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3595104";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3593212";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";""
"CHEMBL4078625";"";"None";"313.45";"0";"3.51";"16";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCC4)c23)CC1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"23.53";"0.44";"3.87";"12.98";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4521212";"";"None";"479.59";"0";"2.92";"12";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C)nc34)CC2)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"16.78";"0.31";"5.13";"7.10";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4111375";"";"None";"432.43";"0";"1.60";"BDBM188013";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1COC1";"IC50";"'='";"10.3";"nM";"7.99";"";"337682";"UO_0000065";"18.47";"0.35";"6.39";"6.99";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4105582";"";"None";"287.41";"0";"2.86";"7";"Cc1[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1C";"IC50";"'='";"23000.0";"nM";"4.64";"";"";"UO_0000065";"16.14";"0.30";"1.78";"8.16";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4087705";"";"None";"299.42";"0";"2.73";"6";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]c4c(c23)CCC4)CC1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"19.27";"0.36";"3.04";"10.15";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4091013";"";"None";"299.42";"0";"3.12";"15";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CC4)c23)CC1";"IC50";"'='";"75.0";"nM";"7.12";"";"";"UO_0000065";"23.80";"0.44";"4.00";"12.54";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4760206";"";"None";"473.54";"0";"3.69";"5";"O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCCCC1)c1cccc(-c2cn[nH]c2)n1";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"18.09";"0.33";"4.88";"7.62";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4791469";"";"None";"492.58";"0";"2.23";"11";"N[C@H]1CCN(c2cccc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCCCC3)n2)C1";"IC50";"'='";"104.0";"nM";"6.98";"";"";"UO_0000065";"14.18";"0.26";"4.75";"5.55";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4445579";"";"None";"751.84";"1";"4.34";"5";"COc1cc2c(OC[C@@H]3CCC(=O)N3)ncc(C#CCCCCCCCCCCOc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)c2cc1C(N)=O";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"11.44";"0.21";"4.26";"4.38";"0";"CHEMBL4361896";"Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359855";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";""
"CHEMBL4741772";"";"None";"555.64";"2";"4.63";"22";"CN1CCC(c2nnc(-c3cnc(Nc4ccc5c(c4)C(C)(C)OC5=O)nc3N[C@H](CO)c3ccccc3)o2)CC1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"12.18";"0.23";"2.14";"4.89";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4784181";"";"None";"498.54";"0";"4.70";"15";"CC1(C)OC(=O)c2ccc(Nc3ncc(-c4nc(C5CC5)no4)c(N[C@H](CO)c4ccccc4)n3)cc21";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"12.52";"0.23";"1.54";"4.62";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4466517";"";"None";"409.45";"0";"1.50";"4; DHBF-41";"C[C@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"15.63";"0.29";"4.90";"6.32";"0";"CHEMBL4345169";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IFN alpha production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4445098";"";"None";"571.60";"1";"2.97";"25";"CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(C4CC(F)(F)C4)CC3)cc2C1=O";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"17.49";"0.33";"7.03";"9.41";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3361255";"";"None";"446.57";"0";"1.98";"ND-2158";"NC(=O)[C@@H](O)C[C@H]1CCc2sc3ncnc(O[C@H]4CC[C@H](N5CCOCC5)CC4)c3c21";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"19.90";"0.39";"6.91";"8.02";"0";"CHEMBL4331758";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330088";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL3403444";"";"None";"323.38";"0";"-0.30";"25";"Nc1ncc(-c2nccs2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"16.48";"0.33";"5.63";"3.88";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4064608";"";"None";"385.51";"0";"2.91";"Compound A";"c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"18.92";"0.36";"4.38";"9.68";"0";"CHEMBL4331758";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330088";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4081502";"";"None";"329.45";"0";"2.75";"19b";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOC4)c23)CC1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"22.67";"0.42";"4.72";"11.30";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4078625";"";"None";"313.45";"0";"3.51";"16";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCC4)c23)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"27.19";"0.51";"5.01";"14.99";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4094760";"";"None";"385.51";"0";"2.91";"32";"c1nc(N[C@H]2CC[C@@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"14.29";"0.27";"2.60";"7.32";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3928854";"";"None";"418.45";"0";"2.42";"BDBM187532";"C[C@@H](CF)Nc1cc(-n2ccc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"6.2";"nM";"8.21";"";"337251";"UO_0000065";"19.61";"0.37";"5.79";"7.82";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3914423";"";"None";"424.48";"0";"2.95";"BDBM187535";"C[C@@H](CF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(C)O";"IC50";"'='";"4.4";"nM";"8.36";"";"337254";"UO_0000065";"19.69";"0.37";"5.41";"7.21";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112550";"";"None";"472.57";"1";"0.72";"BDBM203501";"O=c1[nH]c(N[C@@H]2CCCNC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"5123.0";"nM";"5.29";"";"360961";"UO_0000065";"11.20";"0.22";"4.57";"3.40";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4524299";"";"None";"942.11";"2";"3.03";"2";"COc1cc2c(OC[C@@H]3CCC(=O)N3)ncc(C#CCOCCOCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)c2cc1C(N)=O";"IC50";"'='";"0.29";"nM";"9.54";"";"";"UO_0000065";"10.12";"0.19";"6.51";"3.93";"0";"CHEMBL4361896";"Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359855";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";""
"CHEMBL3601196";"";"None";"477.59";"0";"3.63";"30";"Cc1cc(Nc2cc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)cn2)cc(C)n1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"16.44";"0.32";"4.22";"6.36";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4095514";"";"None";"440.48";"0";"2.84";"38";"CNC(=O)c1cnc(Nc2ccc(OC)c(F)c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"12.54";"0.24";"2.68";"4.77";"0";"CHEMBL4047625";"Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3984144";"";"None";"440.48";"0";"1.92";"BDBM187408";"C[C@@H](CO)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.5";"nM";"8.82";"";"337144";"UO_0000065";"20.03";"0.38";"6.90";"6.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3590488";"";"None";"376.37";"0";"1.06";"28";"Cn1cc(NC(=O)c2cnn3ccc(N4CCNCC4)nc23)c(C(F)F)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"23.91";"0.46";"7.94";"9.74";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3590479";"";"None";"404.43";"0";"2.33";"19";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)F)n1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"23.98";"0.46";"7.37";"8.42";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3403447";"";"None";"415.52";"0";"2.09";"28";"CCCNc1ncc(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"1193000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4070515";"";"None";"329.36";"0";"1.25";"30";"COc1cc2c(OC[C@H]3NC(=O)C[C@H]3C)nccc2cc1C(N)=O";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"26.02";"0.49";"7.32";"8.28";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4113534";"";"None";"468.63";"0";"3.34";"BDBM203791";"CC(C)(C)c1ccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc2c1";"IC50";"'='";"1300.0";"nM";"5.89";"";"361265";"UO_0000065";"12.56";"0.24";"2.55";"6.18";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107317";"";"None";"510.64";"1";"4.54";"BDBM203631";"COc1ccccc1C1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)CC1";"IC50";"'='";"13.0";"nM";"7.89";"";"361112";"UO_0000065";"15.44";"0.28";"3.35";"8.29";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3961880";"";"None";"487.63";"0";"3.99";"BDBM203691";"O=c1[nH]c(C2CCN(c3ccccn3)CC2)nc(NC2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"180.0";"nM";"6.75";"";"361165";"UO_0000065";"13.83";"0.26";"2.75";"6.82";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3403438";"";"None";"370.41";"0";"0.13";"19";"Cn1c(-c2cnc(N)nc2N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)nc2ccccc21";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3403446";"";"None";"399.48";"0";"1.36";"27";"Nc1ncc(-c2ncc(-c3ccccc3)s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4112772";"";"None";"386.48";"0";"1.61";"BDBM203760";"O=c1[nH]c(NCCO)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"450.0";"nM";"6.35";"";"361234";"UO_0000065";"16.42";"0.32";"4.74";"5.52";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4461516";"";"None";"434.50";"0";"2.40";"36";"CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(C(N)=O)CC3)cc2O1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"16.75";"0.31";"4.88";"6.33";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3586511";"";"None";"481.54";"0";"0.95";"33";"Cc1ccc(-n2nc(N3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"18.06";"0.35";"7.75";"6.66";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3634505";"";"None";"425.44";"0";"2.86";"35";"Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCNC4)nc23)c(C(F)(F)F)n1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"21.38";"0.43";"6.24";"9.40";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634508";"";"None";"389.41";"0";"2.42";"38";"Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCNC4)nn23)c(C(F)F)n1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"23.23";"0.44";"6.63";"10.25";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4251324";"";"None";"436.58";"0";"4.54";"30";"O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4233340";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4229420";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";""
"CHEMBL3948951";"";"None";"514.59";"1";"3.11";"BDBM188972";"COC(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1";"IC50";"'<'";"1000.0";"nM";"";"";"338827";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3634501";"";"None";"440.40";"0";"2.58";"31";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CC(F)(F)CC[C@@H]4N)nn23)c(C(F)F)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.35";"0.38";"5.94";"7.40";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634511";"";"None";"404.43";"0";"2.21";"41";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCCNC4)nn23)c(C(F)F)n1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"22.64";"0.43";"6.94";"9.05";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3970676";"";"None";"479.57";"0";"2.61";"BDBM188777";"Cc1ccc(-n2nc(C3CCCN(S(C)(=O)=O)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338632";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3601186";"";"None";"490.59";"0";"3.23";"19";"Cc1cc(Nc2ncc(-c3nc(-c4ccccc4)cs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"14.32";"0.27";"3.80";"5.16";"0";"CHEMBL3603426";"Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL4550702";"";"None";"406.39";"0";"3.15";"9";"Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"17.70";"0.35";"4.04";"9.33";"0";"CHEMBL4479732";"Inhibition of full-length recombinant human His-tagged IRAK4 expressed in baculovirus expression system by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL407821";"";"None";"364.47";"0";"4.45";"2k";"O=C(Nc1ccc(N2CCCCC2)cc1)c1csc(-c2cccnc2)n1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"15.42";"0.30";"1.17";"9.67";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4070214";"";"None";"337.43";"0";"2.56";"2";"N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c2c1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"21.74";"0.40";"4.78";"9.91";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL1232515";"";"None";"426.55";"0";"3.22";"SCH-1473759";"CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"18.98";"0.37";"4.88";"7.55";"0";"CHEMBL1272500";"Inhibition of IRK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268847";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";""
"CHEMBL4539647";"";"None";"473.59";"0";"2.87";"6";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)cc34)CC2)CC1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"19.00";"0.35";"6.13";"7.83";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4455718";"";"None";"394.48";"0";"2.61";"4";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"18.84";"0.35";"4.82";"7.87";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3920277";"";"None";"483.62";"0";"4.99";"BDBM188938";"Cc1ccc(-n2nc(C3CCN(C4CCCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338793";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3947284";"";"None";"549.71";"2";"3.76";"BDBM203301";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(N2CCN(CCN3CCOCC3)CC2)o1";"IC50";"'='";"22.1";"nM";"7.66";"";"360863";"UO_0000065";"13.93";"0.27";"3.90";"7.11";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4059465";"";"None";"417.47";"0";"2.56";"35";"CNC(=O)c1cnc(Nc2ccc(C#N)cc2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"12.90";"0.24";"2.83";"4.13";"0";"CHEMBL4047625";"Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3634510";"";"None";"404.43";"0";"2.21";"40";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCCNC4)nc23)c(C(F)F)n1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"23.98";"0.46";"7.49";"9.59";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3356117";"";"None";"484.98";"0";"2.86";"4";"CC(=O)c1ccc(N2CCN(C(=O)CN3CC[C@@H](C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3376481";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351461";"1";"Scientific Literature";"J Med Chem";"2014";"None";""
"CHEMBL3601072";"";"None";"493.59";"1";"2.47";"3";"CN(C)c1ccc(Nc2ncc(-c3nc4cnccc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"17.01";"0.33";"5.93";"6.02";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601198";"";"None";"372.45";"0";"1.45";"32";"Nc1ccc(-c2nc3ccccc3s2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"9510.0";"nM";"5.02";"";"";"UO_0000065";"13.48";"0.26";"3.57";"4.03";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601191";"";"None";"502.58";"1";"2.69";"25";"CC(C)n1ccc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc1=O";"IC50";"'='";"155.0";"nM";"6.81";"";"";"UO_0000065";"13.55";"0.25";"4.12";"4.68";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601190";"";"None";"500.56";"1";"2.89";"23";"OC[C@H]1C[C@@H](Nc2nc(Nc3ccnc(OC4CC4)c3)ncc2-c2ccc3ccccc3n2)[C@H](O)[C@@H]1O";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"14.70";"0.27";"4.47";"5.05";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601080";"";"None";"465.54";"1";"2.11";"11";"Cc1cc(Nc2ncc(-c3nc4ccncc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.01";"0.33";"5.81";"5.31";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3955046";"";"None";"556.65";"1";"3.78";"BDBM189120";"COc1ccc([S+]([O-])N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)cn1";"IC50";"'<'";"1000.0";"nM";"";"";"338978";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3601070";"";"None";"502.58";"1";"3.13";"24";"CC(C)Oc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"15.06";"0.28";"4.44";"5.20";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3896654";"";"None";"464.93";"0";"2.49";"BDBM188055";"CC[C@@H](CO)Nc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.1";"nM";"8.39";"";"337721";"UO_0000065";"18.04";"0.36";"5.90";"6.70";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109051";"";"None";"470.60";"0";"1.42";"BDBM203805";"NCCNc1cccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc12";"IC50";"'='";"16.0";"nM";"7.80";"";"361279";"UO_0000065";"16.57";"0.32";"6.38";"5.85";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3933904";"";"None";"443.46";"0";"2.30";"BDBM188049";"C[C@H](F)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.1";"nM";"8.39";"";"337715";"UO_0000065";"18.91";"0.36";"6.09";"6.51";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4077215";"";"None";"287.41";"0";"2.81";"11";"CCc1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"27.44";"0.51";"5.08";"13.87";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4087806";"";"None";"410.45";"0";"2.83";"36";"CNC(=O)c1cnc(Nc2ccc(F)cc2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"14.34";"0.27";"3.06";"5.53";"0";"CHEMBL4047625";"Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4085735";"";"None";"301.44";"0";"3.37";"12";"CC(C)c1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"25.01";"0.47";"4.17";"13.26";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4110138";"";"None";"433.56";"0";"2.29";"BDBM203606";"CN(C)[C@@H]1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1";"IC50";"'='";"62.0";"nM";"7.21";"";"361087";"UO_0000065";"16.62";"0.31";"4.92";"8.08";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4745378";"";"None";"461.52";"0";"3.52";"4";"CCNC(=O)c1cnc(Nc2ccc3c(c2)C(C)(C)OC3=O)nc1N[C@H](CO)c1ccccc1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"14.56";"0.27";"3.20";"5.36";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL3957438";"";"None";"406.90";"0";"3.79";"BDBM206218";"CC[C@@H](CO)Nc1ncc2scc(C(=O)Nc3cc(Cl)ccc3OC)c2n1";"IC50";"'='";"2226.0";"nM";"5.65";"";"364889";"UO_0000065";"13.89";"0.29";"1.86";"5.87";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3964751";"";"None";"419.53";"0";"1.90";"BDBM203559";"CN1CCN(c2nc(NC3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)CC1";"IC50";"'='";"97.0";"nM";"7.01";"";"361039";"UO_0000065";"16.72";"0.31";"5.11";"7.86";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108237";"";"None";"430.48";"0";"1.84";"BDBM187441";"CC(C)(O)CNc1cc(-n2ccc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"13.6";"nM";"7.87";"";"337177";"UO_0000065";"18.27";"0.35";"6.03";"6.28";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108910";"";"None";"453.52";"0";"3.39";"BDBM187664";"CCOC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"3.7";"nM";"8.43";"";"337349";"UO_0000065";"18.59";"0.35";"5.04";"7.16";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3942281";"";"None";"414.43";"0";"2.86";"BDBM187666";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(O)cn1";"IC50";"'='";"15.5";"nM";"7.81";"";"337351";"UO_0000065";"18.84";"0.34";"4.95";"5.51";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4779593";"";"None";"828.97";"2";"2.16";"17";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)NCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)c12";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"6.41";"0.12";"3.15";"2.54";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL4791281";"";"None";"768.92";"2";"2.91";"20";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)NCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)c12";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL3973052";"";"None";"483.54";"0";"2.99";"BDBM187670";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(N2CCOCC2)cn1";"IC50";"'='";"8.4";"nM";"8.08";"";"337355";"UO_0000065";"16.70";"0.31";"5.09";"6.03";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3910861";"";"None";"474.57";"0";"2.93";"BDBM187667";"CNC(=O)C[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"19.5";"nM";"7.71";"";"337352";"UO_0000065";"16.25";"0.30";"4.78";"5.60";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3931566";"";"None";"348.79";"0";"4.30";"BDBM206187";"O=C(Nc1cc(Cl)ccc1-c1ccccc1)c1cnn2cccnc12";"IC50";"'='";"534.0";"nM";"6.27";"";"364858";"UO_0000065";"17.98";"0.34";"1.97";"10.58";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4108780";"";"None";"460.46";"0";"2.26";"BDBM203612";"O=c1[nH]c(N2CC(O)(C(F)(F)F)C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"18.0";"nM";"7.75";"";"361093";"UO_0000065";"16.82";"0.32";"5.48";"7.29";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3952252";"";"None";"494.56";"0";"3.48";"BDBM189047";"COc1ncccc1CN1CC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)C1";"IC50";"'<'";"100.0";"nM";"";"";"338902";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3937694";"";"None";"364.79";"0";"4.01";"BDBM206212";"O=C(Nc1cc(Cl)ccc1-c1cccc(O)c1)c1cnn2cccnc12";"IC50";"'='";"2047.0";"nM";"5.69";"";"364883";"UO_0000065";"15.59";"0.30";"1.68";"7.15";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3906006";"";"None";"425.45";"0";"3.03";"BDBM189060";"Cc1ccc(-n2nc(-c3ccnc(CO)c3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338918";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3926861";"";"None";"364.79";"0";"4.01";"BDBM206181";"O=C(Nc1cc(Cl)ccc1-c1ccc(O)cc1)c1cnn2cccnc12";"IC50";"'='";"477.0";"nM";"6.32";"";"364852";"UO_0000065";"17.33";"0.33";"2.31";"7.95";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3945308";"";"None";"480.59";"1";"6.57";"BDBM203296";"Cc1oc(-c2cnc(Nc3ccc4ncsc4c3)cc2NC(C)C)nc1NC(=O)OC(C)(C)C";"IC50";"'='";"875.0";"nM";"6.06";"";"360858";"UO_0000065";"12.61";"0.24";"-0.51";"5.30";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3936227";"";"None";"543.66";"1";"3.42";"BDBM189117";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cn(C)c(C)n4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338975";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3590479";"";"None";"404.43";"0";"2.33";"26";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)F)n1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"23.98";"0.46";"7.37";"8.42";"1";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3622511";"";"None";"417.49";"0";"0.63";"11";"CN(C)c1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"15.11";"0.30";"5.68";"4.69";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3622188";"";"None";"420.52";"0";"1.28";"10";"CSc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"352.0";"nM";"6.45";"";"";"UO_0000065";"15.35";"0.31";"5.17";"4.91";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3950976";"";"None";"380.79";"0";"4.13";"BDBM206217";"O=C(Nc1cc(Cl)ccc1Oc1ccc(O)cc1)c1cnn2cccnc12";"IC50";"'='";"2221.0";"nM";"5.65";"";"364888";"UO_0000065";"14.85";"0.29";"1.52";"6.37";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3622518";"";"None";"412.52";"0";"2.05";"19";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"18.72";"0.36";"5.67";"8.11";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3941139";"";"None";"400.87";"0";"2.13";"BDBM206125";"NC(O)C1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"53.0";"nM";"7.28";"";"364796";"UO_0000065";"18.15";"0.35";"5.15";"6.69";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3953652";"";"None";"448.53";"0";"2.23";"BDBM187712";"CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NCC1CC1C(C)(C)O";"IC50";"'='";"13.5";"nM";"7.87";"";"337397";"UO_0000065";"17.55";"0.33";"5.64";"5.08";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110250";"";"None";"423.45";"0";"2.10";"BDBM187575";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CC1";"IC50";"'='";"2.9";"nM";"8.54";"";"337274";"UO_0000065";"20.16";"0.38";"6.44";"6.63";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4093910";"";"None";"399.52";"0";"3.61";"28";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@H](CO)CC(C)C";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"18.27";"0.36";"3.69";"7.36";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4075333";"";"None";"329.45";"0";"3.09";"18b";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCO4)c23)CC1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"17.97";"0.34";"2.83";"8.96";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3943272";"";"None";"358.40";"0";"3.97";"BDBM206254";"COc1cc(-c2ccccc2)c(C)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"5941.0";"nM";"5.23";"";"364925";"UO_0000065";"14.58";"0.26";"1.26";"7.63";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3979646";"";"None";"391.44";"0";"2.03";"BDBM188024";"CCCCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1COC1";"IC50";"'='";"7.8";"nM";"8.11";"";"337693";"UO_0000065";"20.71";"0.38";"6.08";"6.89";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3934570";"";"None";"482.55";"0";"3.84";"BDBM188966";"Cc1ccc(-n2nc(C3CCN(Cc4ncco4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338821";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3931740";"";"None";"464.53";"0";"3.47";"BDBM189048";"Cc1ccc(-n2nc(C3CN(Cc4cccnc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338903";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4093475";"";"None";"259.36";"0";"2.24";"10";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]ccc23)CC1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"22.57";"0.42";"3.61";"10.30";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4081502";"";"None";"329.45";"0";"2.75";"19a";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOC4)c23)CC1";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"19.02";"0.36";"3.52";"9.49";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3906519";"";"None";"509.66";"2";"5.38";"BDBM188991";"Cc1ccc(-n2nc(C3CCN(C4CC5(CCCC5)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338846";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3894958";"";"None";"417.45";"0";"2.87";"BDBM188821";"O=C(Nc1cc(C2CNC2)nn1-c1ccc(C2CC2)cc1F)c1cnn2cccnc12";"IC50";"'<'";"100.0";"nM";"";"";"338676";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3892984";"";"None";"390.90";"0";"4.45";"BDBM206173";"CCCN(C)c1ncc2scc(C(=O)Nc3cc(Cl)ccc3OC)c2n1";"IC50";"'='";"436.0";"nM";"6.36";"";"364844";"UO_0000065";"16.27";"0.33";"1.91";"9.44";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4109195";"";"None";"443.53";"1";"1.53";"BDBM203463";"O=c1[nH]c(NC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"20.0";"nM";"7.70";"";"360924";"UO_0000065";"17.36";"0.34";"6.17";"5.37";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3943689";"";"None";"486.58";"0";"3.23";"BDBM188998";"Cc1ccc(-n2nc(C3CCN(C4CCCOC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338853";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3897697";"";"None";"300.75";"0";"3.20";"BDBM206241";"CCc1ccc(Cl)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"3796.0";"nM";"5.42";"";"364912";"UO_0000065";"18.02";"0.35";"2.22";"9.14";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3893767";"";"None";"362.77";"0";"1.37";"BDBM206224";"O=C(Nc1cc(Cl)ccc1OC[C@@H](O)CO)c1cnn2cccnc12";"IC50";"'='";"2311.0";"nM";"5.64";"";"364895";"UO_0000065";"15.54";"0.31";"4.27";"5.17";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3901110";"";"None";"526.65";"1";"3.67";"BDBM188948";"Cc1ccc(-n2nc(C3CCN(C(C)C(=O)N4CCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338803";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3947203";"";"None";"529.63";"1";"3.11";"BDBM189107";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cn(C)cn4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338965";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3938253";"";"None";"430.52";"0";"3.10";"BDBM188918";"Cc1ccc(-n2nc(C3CCC(CN)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338773";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2022711";"";"None";"560.66";"2";"4.51";"56";"Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4F)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1";"IC50";"'='";"1219.0";"nM";"5.91";"";"";"UO_0000065";"10.55";"0.20";"1.40";"5.01";"0";"CHEMBL2024840";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021851";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL4109253";"";"None";"500.97";"1";"3.83";"BDBM187815";"CC(C)n1cc(Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"3.5";"nM";"8.46";"";"337492";"UO_0000065";"16.88";"0.33";"4.63";"6.89";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL255272";"";"None";"293.37";"0";"2.58";"9";"c1cc(NC2CCNCC2)nc(-n2cnc3ccccc32)c1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"24.39";"0.44";"4.57";"13.06";"1";"CHEMBL956501";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL255098";"";"None";"294.36";"0";"1.96";"1";"c1ccn2c(-c3ccnc(NC4CCNCC4)n3)cnc2c1";"IC50";"'='";"216.0";"nM";"6.67";"";"";"UO_0000065";"22.64";"0.41";"4.71";"9.93";"1";"CHEMBL956501";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL5094876";"";"None";"495.59";"0";"3.61";"4";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(C(=O)N4CCCC4)c3)ncc2-c2cccnc2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"16.14";"0.30";"4.39";"6.34";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL4088438";"";"None";"462.62";"0";"2.15";"26";"CS(=O)(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"14.96";"0.30";"4.77";"6.69";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4089379";"";"None";"343.48";"0";"3.14";"15";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOCC4)c23)CC1";"IC50";"'='";"6.166";"nM";"8.21";"";"";"UO_0000065";"23.90";"0.45";"5.07";"12.43";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3904543";"";"None";"496.37";"0";"3.41";"BDBM188838";"COc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338693";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3914020";"";"None";"509.57";"1";"2.98";"BDBM188756";"O=C(Nc1cc(C2CCN(S(=O)(=O)C3CC3)CC2)nn1-c1ccc(F)cc1)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338611";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5091019";"";"None";"528.59";"1";"3.59";"23";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(C(=O)N4CCOCC4)c3)ncc2-c2cccc(F)c2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"14.86";"0.28";"4.26";"6.41";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL3897604";"";"None";"522.61";"1";"4.26";"BDBM188961";"COc1ccc(CN2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)cn1";"IC50";"'<'";"1000.0";"nM";"";"";"338816";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113046";"";"None";"464.64";"0";"4.23";"BDBM203762";"O=c1[nH]c(N2CCC3CCCCC3C2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"330.0";"nM";"6.48";"";"361236";"UO_0000065";"13.95";"0.27";"2.25";"7.54";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111300";"";"None";"424.57";"0";"3.59";"BDBM203763";"CC1CCCCN1c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"280.0";"nM";"6.55";"";"361237";"UO_0000065";"15.43";"0.30";"2.96";"7.62";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3912863";"";"None";"456.55";"0";"3.60";"BDBM189008";"Cc1ccc(-n2nc(C3CCN(C4CCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338863";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109087";"";"None";"424.57";"0";"3.02";"BDBM203675";"CN1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"690.0";"nM";"6.16";"";"361149";"UO_0000065";"14.51";"0.28";"3.14";"7.17";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109565";"";"None";"427.53";"0";"1.68";"BDBM203655";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1csc(-n2cccc2)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"361137";"UO_0000065";"18.53";"0.36";"6.24";"7.91";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115220";"";"None";"381.44";"0";"0.70";"BDBM203666";"N#Cc1ccnc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)c1";"IC50";"'='";"5621.0";"nM";"5.25";"";"361145";"UO_0000065";"13.76";"0.26";"4.55";"4.41";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109570";"";"None";"467.60";"0";"2.73";"BDBM203689";"CNC(=O)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"361163";"UO_0000065";"14.33";"0.28";"3.97";"5.82";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113079";"";"None";"476.61";"0";"3.38";"BDBM203759";"CN(c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1)[C@H](CO)c1ccccc1";"IC50";"'='";"250.0";"nM";"6.60";"";"361233";"UO_0000065";"13.85";"0.27";"3.22";"6.22";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4070214";"";"None";"337.43";"0";"2.56";"23";"N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c2c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"24.17";"0.45";"5.59";"11.01";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4483477";"";"None";"490.57";"0";"1.91";"17";"Cn1c(N2CCOCC2)nc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc21";"IC50";"'='";"97.0";"nM";"7.01";"";"";"UO_0000065";"14.30";"0.27";"5.10";"6.20";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4085735";"";"None";"301.44";"0";"3.37";"12";"CC(C)c1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"27.54";"0.52";"4.93";"14.60";"1";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3353206";"";"None";"325.33";"0";"0.57";"37";"Cn1cc(-c2cccc(C(=O)Nc3cn(C)nc3C(N)=O)n2)cn1";"IC50";"'='";"138.0";"nM";"6.86";"";"";"UO_0000065";"21.09";"0.39";"6.29";"5.68";"0";"CHEMBL4427853";"Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL4536303";"";"None";"435.49";"0";"2.07";"28";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CCOCC4)c3)n2)c(C(N)=O)n1";"IC50";"'='";"478.0";"nM";"6.32";"";"";"UO_0000065";"14.51";"0.27";"4.25";"4.61";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4518357";"";"None";"504.60";"1";"1.70";"16";"CN(C)[C@H]1CN(C(=O)c2nn(C)cc2NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)C[C@@H]1O";"IC50";"'='";"533.0";"nM";"6.27";"";"";"UO_0000065";"12.43";"0.23";"4.57";"4.88";"0";"CHEMBL4427853";"Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL4446042";"";"None";"391.44";"0";"2.05";"8";"Cn1ncc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c1C(N)=O";"IC50";"'='";"2725.0";"nM";"5.57";"";"";"UO_0000065";"14.22";"0.26";"3.51";"4.35";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4466893";"";"None";"502.62";"1";"3.02";"14";"CN1CCCC(CNC(=O)c2nn(C)cc2NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)C1";"IC50";"'='";"261.0";"nM";"6.58";"";"";"UO_0000065";"13.10";"0.24";"3.56";"5.62";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4750612";"";"None";"436.43";"0";"4.26";"17";"CCOc1cc(NC(=O)c2cccc(C(F)(F)F)n2)cc2cn(CCC(C)(C)O)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4776639";"";"None";"407.40";"0";"3.45";"20";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)cc(N)c2n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4456105";"";"None";"391.44";"0";"2.05";"3";"Cn1cc(NC(=O)c2cc(-c3ccnc(NCC4CC4)c3)ccn2)c(C(N)=O)n1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4782731";"";"None";"463.50";"0";"4.27";"3";"CCN(CC)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(C(C)(C)O)cc2n1";"IC50";"'='";"514.0";"nM";"6.29";"";"";"UO_0000065";"13.57";"0.26";"2.02";"7.55";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4777409";"";"None";"533.59";"2";"3.41";"21";"CCC1(O)CCCN(c2nc3nc(N4CCOCC4)oc3cc2NC(=O)c2coc(-c3ccnc(C)c3)n2)C1";"IC50";"'='";"6.5";"nM";"8.19";"";"";"UO_0000065";"15.34";"0.29";"4.78";"5.73";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4452936";"";"None";"489.50";"0";"3.83";"35";"CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(C(O)C(F)(F)F)CC3)cc2O1";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"14.81";"0.28";"3.42";"7.88";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4763127";"";"None";"417.39";"0";"3.74";"19";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)cc(C#N)c2n1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"13.89";"0.26";"2.06";"5.58";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4747510";"";"None";"419.41";"0";"3.64";"24";"COc1cc(NC(=O)c2cccc(C(F)(F)F)n2)cc2cn(C3CCNCC3)nc12";"IC50";"'='";"375.0";"nM";"6.43";"";"";"UO_0000065";"15.32";"0.29";"2.79";"7.93";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4779374";"";"None";"511.53";"1";"3.14";"8";"CCS(=O)(=O)N1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C(C)(C)O)cc3n2)C1";"IC50";"'='";"256.0";"nM";"6.59";"";"";"UO_0000065";"12.89";"0.26";"3.45";"5.61";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4068127";"";"None";"422.49";"0";"2.70";"37";"CNC(=O)c1cnc(Nc2ccc(OC)cc2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"13.72";"0.26";"3.10";"5.01";"0";"CHEMBL4047625";"Inhibition of IRAK4 in human PBMC assessed as reduction in LTA-stimulated IL6 production pretreated for 30 mins followed by LTA stimulation after 5 hrs by ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4448950";"";"None";"936.19";"3";"6.49";"3";"COc1cc2c(OC[C@@H]3CCC(=O)N3)ncc(C#CCCCCCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)c2cc1C(N)=O";"IC50";"'='";"0.099";"nM";"10.00";"";"";"UO_0000065";"10.69";"0.20";"3.51";"4.65";"0";"CHEMBL4361896";"Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359855";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";""
"CHEMBL4462890";"";"None";"757.75";"2";"0.88";"4";"COc1cc2c(OC[C@@H]3CCC(=O)N3)ncc(C#CCOCCOCCOCCOc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)c2cc1C(N)=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4361896";"Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359855";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";""
"CHEMBL4282348";"";"None";"467.62";"0";"2.38";"32";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H]5CC[C@H](C(N)=O)CC5)c34)CC2)CC1";"IC50";"'='";"1659.59";"nM";"5.78";"";"";"UO_0000065";"12.36";"0.23";"3.40";"5.31";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3634614";"";"None";"379.43";"0";"1.27";"47";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C#N)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"23.72";"0.44";"7.73";"6.48";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634616";"";"None";"396.48";"0";"2.23";"49";"Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C#N)n1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"23.70";"0.46";"7.17";"6.99";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4290222";"";"None";"426.57";"0";"2.51";"31";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"416.87";"nM";"6.38";"";"";"UO_0000065";"14.96";"0.28";"3.87";"8.51";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4778668";"";"None";"846.00";"2";"2.69";"10";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCOCCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)c12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL3403455";"";"None";"478.58";"0";"3.02";"36";"Cc1cc(Nc2ncc(-c3nc4ccccc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"12.54";"0.24";"2.98";"4.40";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4286802";"";"None";"385.51";"0";"2.68";"29";"c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)ccn2n1";"IC50";"'='";"361.0";"nM";"6.44";"";"";"UO_0000065";"16.71";"0.31";"3.76";"10.08";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3904350";"";"None";"332.75";"0";"2.65";"BDBM206229";"COc1cc(OC)c(NC(=O)c2cnn3cccnc23)cc1Cl";"IC50";"'='";"2738.0";"nM";"5.56";"";"364900";"UO_0000065";"16.72";"0.33";"2.91";"7.15";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3960624";"";"None";"399.41";"0";"3.44";"BDBM189065";"Cc1ccc(-n2nc(-c3conc3C)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338923";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL2381601";"";"None";"384.87";"0";"2.83";"8e";"NC(=O)c1cnc(N[C@H]2CC[C@H](N)CC2)c2nc(-c3ccc(Cl)cc3)cn12";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"15.13";"0.29";"2.99";"5.23";"0";"CHEMBL2383896";"Inhibition of human IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2380230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";""
"CHEMBL4288305";"";"None";"400.53";"0";"2.96";"35";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1";"IC50";"'='";"359.0";"nM";"6.45";"";"";"UO_0000065";"16.09";"0.30";"3.48";"8.59";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL5088588";"";"None";"512.59";"1";"4.35";"14";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(C(=O)N4CCCC4)c3)ncc2-c2ccccc2F)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"16.38";"0.30";"4.05";"7.42";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL4060699";"";"None";"307.40";"0";"2.93";"16";"N#Cc1ccc2ncnc(N[C@H]3CC[C@H](N4CCC4)CC3)c2c1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"24.25";"0.44";"4.53";"11.50";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4067181";"";"None";"442.56";"0";"2.96";"27";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.26";"0.36";"5.56";"8.91";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4080574";"";"None";"426.57";"0";"2.74";"24";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"20.39";"0.38";"5.96";"10.07";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4276955";"";"None";"301.44";"0";"3.30";"17";"CC(C)n1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c21";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"23.76";"0.44";"3.86";"15.57";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4072239";"";"None";"318.38";"0";"3.54";"1";"NC(=O)c1cnc(Nc2ccccc2)cc1NCc1ccccc1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"18.04";"0.33";"2.20";"7.18";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4745104";"";"None";"448.53";"0";"3.44";"12";"Cc1cc(-c2nc(C(=O)Nc3cc4cn(CCN(C)C)nc4cc3C(C)(C)O)co2)ccn1";"IC50";"'='";"7.7";"nM";"8.11";"";"";"UO_0000065";"18.09";"0.34";"4.67";"7.42";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4648225";"";"None";"385.49";"0";"3.37";"8";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCCO";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4101649";"";"None";"338.38";"0";"3.93";"8";"CN(C)[C@H]1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"23.78";"0.46";"4.12";"19.60";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4790546";"";"None";"477.49";"0";"3.70";"15";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)cc(N3CCOCC3)c2n1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL3361252";"";"None";"316.47";"0";"3.46";"1";"CN(C)[C@H]1CC[C@H](Nc2ncnc3sc4c(c23)CCC4)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"21.66";"0.43";"3.39";"16.70";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4087063";"";"None";"402.56";"0";"3.59";"34";"c1nc(S[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"18.52";"0.36";"3.87";"11.78";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4079194";"";"None";"409.53";"0";"3.38";"36";"N#Cc1cnc2[nH]cc(C3CCOCC3)c2c1N[C@H]1CC[C@H](N2CCOCC2)CC1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"15.93";"0.30";"3.14";"7.57";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4797475";"";"None";"422.41";"0";"3.87";"16";"COc1cc(NC(=O)c2cccc(C(F)(F)F)n2)cc2cn(CCC(C)(C)O)nc12";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"16.47";"0.32";"3.09";"7.80";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL3735448";"";"None";"516.55";"2";"5.06";"1";"CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2-c1ccc(CCCO)cc1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"13.21";"0.25";"1.76";"5.00";"0";"CHEMBL3737182";"Inhibition of recombinant full length IRAK-4 (unknown origin) using the biotinylated substrate RRRVTSPARRS by chemiluminescent ELISA";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3734693";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL1650545";"";"None";"452.92";"0";"3.47";"18";"Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)C3)ns2)n1.Cl";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"14.41";"0.28";"2.53";"6.89";"0";"CHEMBL1656203";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1649074";"1";"Scientific Literature";"J Med Chem";"2011";"None";""
"CHEMBL4106933";"";"None";"427.48";"0";"2.38";"BDBM187608";"CC(C)Nc1cc(-n2ccc(-c3ccnnc3)n2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"13.1";"nM";"7.88";"";"337303";"UO_0000065";"18.44";"0.35";"5.50";"6.69";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108168";"";"None";"507.57";"1";"2.55";"BDBM187927";"CC(=O)N1CCC(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"337602";"UO_0000065";"15.95";"0.30";"5.55";"5.95";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106997";"";"None";"592.58";"1";"3.13";"BDBM187999";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1CCN(C(=O)c2ccc(F)cc2F)C1";"IC50";"'='";"9.6";"nM";"8.02";"";"337670";"UO_0000065";"13.53";"0.25";"4.89";"5.38";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106902";"";"None";"510.53";"1";"1.78";"BDBM188004";"CCOC(=O)N1CC(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1";"IC50";"'='";"6.8";"nM";"8.17";"";"337675";"UO_0000065";"16.00";"0.30";"6.39";"5.16";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113687";"";"None";"526.61";"1";"2.73";"BDBM187977";"CC(C)Nc1cc(-n2ccc3cc(CNC(=O)C4CCOC4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"10.5";"nM";"7.98";"";"337652";"UO_0000065";"15.15";"0.29";"5.25";"6.12";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4524886";"";"None";"448.53";"0";"2.22";"44";"CN1CCC2(CC1)Cc1cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc1O2";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"14.80";"0.27";"4.42";"7.88";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3947682";"";"None";"434.54";"0";"4.05";"BDBM187414";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCCOC(C)(C)C";"IC50";"'='";"5.5";"nM";"8.26";"";"337150";"UO_0000065";"19.01";"0.35";"4.21";"7.88";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3931002";"";"None";"460.54";"0";"1.62";"BDBM187924";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCC(=O)N1CCN(C)CC1";"IC50";"'='";"2.3";"nM";"8.64";"";"337599";"UO_0000065";"18.76";"0.35";"7.02";"7.25";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4288305";"";"None";"400.53";"0";"2.96";"35";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"18.68";"0.35";"4.52";"9.98";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4280559";"";"None";"443.55";"0";"1.82";"36";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"15.45";"0.29";"5.03";"5.80";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4280559";"";"None";"443.55";"0";"1.82";"36";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1";"IC50";"'='";"138.04";"nM";"6.86";"";"";"UO_0000065";"15.47";"0.29";"5.04";"5.81";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4290202";"";"None";"457.58";"0";"2.08";"37";"CNC(=O)C[C@@H](C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCN(C(=O)OC)CC4)CC3)c12";"IC50";"'='";"207.0";"nM";"6.68";"";"";"UO_0000065";"14.61";"0.28";"4.60";"6.42";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4764582";"";"None";"433.43";"0";"3.98";"23";"COc1cc(NC(=O)c2cccc(C(F)(F)F)n2)cc2cn(C3CCN(C)CC3)nc12";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"19.02";"0.36";"4.26";"11.41";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL3965205";"";"None";"453.48";"0";"1.73";"BDBM188007";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CCOC1";"IC50";"'='";"8.7";"nM";"8.06";"";"337677";"UO_0000065";"17.77";"0.33";"6.33";"5.84";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111056";"";"None";"453.48";"0";"1.73";"BDBM188005";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1CCOC1";"IC50";"'='";"10.6";"nM";"7.97";"";"337680";"UO_0000065";"17.59";"0.33";"6.24";"5.78";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4063689";"";"None";"273.38";"0";"2.55";"13";"Cc1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"4.571";"nM";"8.34";"";"";"UO_0000065";"30.51";"0.57";"5.79";"14.67";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4106870";"";"None";"466.52";"0";"2.72";"BDBM187402";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCOCC1";"IC50";"'='";"1.0";"nM";"9.00";"";"337138";"UO_0000065";"19.29";"0.36";"6.28";"7.19";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114476";"";"None";"525.55";"1";"3.66";"BDBM187869";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cc(-c2ccccc2)n[nH]1";"IC50";"'='";"3.6";"nM";"8.44";"";"337546";"UO_0000065";"16.07";"0.30";"4.78";"5.36";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4752190";"";"None";"1091.39";"None";"None";"8";"Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCCOCC(=O)N2CCN([C@H]3CC[C@@H](Nc4ncnn5ccc(C(C)C)c45)CC3)CC2)C(C)(C)C)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL3958762";"";"None";"378.82";"0";"3.79";"BDBM206155";"O=C(Nc1cc(Cl)ccc1-c1ccc(CO)cc1)c1cnn2cccnc12";"IC50";"'='";"218.0";"nM";"6.66";"";"364826";"UO_0000065";"17.58";"0.34";"2.87";"8.38";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3980247";"";"None";"511.67";"2";"5.48";"BDBM188990";"Cc1ccc(-n2nc(C3CCN(C4CC(C(C)(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338845";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3343052";"";"None";"457.45";"0";"2.64";"24c";"COc1ccc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc1-c1c[nH]c(=O)[nH]c1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380801";"Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351874";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";""
"CHEMBL3966782";"";"None";"522.59";"1";"2.18";"BDBM188854";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cc(NC=O)cnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338709";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3961746";"";"None";"546.64";"1";"4.10";"BDBM189029";"Cc1ccc(-n2nc(C3CCCN(Cc4cccc5c4CNC5=O)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338884";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4746921";"";"None";"410.37";"0";"4.00";"18";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)cc(F)c2n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4528699";"";"None";"378.48";"0";"2.39";"3";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1";"IC50";"'='";"122.0";"nM";"6.91";"";"";"UO_0000065";"18.27";"0.34";"4.52";"8.12";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4641886";"";"None";"414.49";"0";"3.13";"19";"CC(C)Nc1cc(Nc2ccn3nccc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"5.2";"nM";"8.28";"";"";"UO_0000065";"19.99";"0.38";"5.15";"8.00";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4632511";"";"None";"383.52";"0";"4.79";"7";"CCCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL3898528";"";"None";"403.45";"0";"1.28";"BDBM188931";"Cc1ccc(-n2nc(N3CCNCC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338786";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106466";"";"None";"459.60";"0";"2.68";"BDBM203627";"CN1CCC2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4ccc5ccccc5n4)c(=O)[nH]3)C2C1";"IC50";"'='";"851.0";"nM";"6.07";"";"361108";"UO_0000065";"13.21";"0.24";"3.39";"6.81";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3982323";"";"None";"420.52";"0";"2.33";"BDBM203723";"CN1CCCC(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2ccc3ccccc3n2)C1";"IC50";"'='";"720.0";"nM";"6.14";"";"361197";"UO_0000065";"14.61";"0.27";"3.81";"7.11";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4647594";"";"None";"427.57";"0";"4.39";"13";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NC[C@@H](C)C(C)(C)O";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"12.95";"0.25";"1.15";"5.58";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4641886";"";"None";"414.49";"0";"3.13";"19";"CC(C)Nc1cc(Nc2ccn3nccc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"15.41";"0.29";"3.26";"6.17";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4642013";"";"None";"429.52";"0";"3.85";"12";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"15.46";"0.30";"2.79";"6.69";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL3634379";"";"None";"421.43";"0";"3.02";"24";"Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)(F)F)n1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"17.46";"0.33";"4.34";"7.19";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4438027";"";"None";"463.54";"0";"1.56";"40";"CNC(=O)CN1CCN(c2cc3c(cc2NC(=O)c2cnn4cccnc24)CC(C)(C)O3)CC1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"15.58";"0.29";"5.66";"6.94";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4643371";"";"None";"445.56";"0";"4.40";"16";"Cc1nc2ccc(Nc3cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn3)cc2s1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"12.95";"0.25";"1.37";"5.82";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4464832";"";"None";"451.56";"0";"2.87";"21";"CN(C)c1nc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc2s1";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"16.11";"0.31";"4.41";"7.36";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4096246";"";"None";"458.57";"0";"3.36";"7";"CN1CCC(NC(=O)c2ccc(Nc3cc(NCc4ccccc4)c(C(N)=O)cn3)cc2)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3622518";"";"None";"412.52";"0";"2.05";"19";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"13.03";"0.25";"3.33";"5.65";"0";"CHEMBL3625715";"Inhibition of IRAK4 in human PBMC assessed as reduction of TLR 7/8 agonist R848-induced TNFalpha production treated 30 mins before R848 stimulation measured after 5 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4648225";"";"None";"385.49";"0";"3.37";"8";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCCO";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"13.39";"0.26";"1.79";"5.20";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL3897856";"";"None";"417.47";"0";"2.64";"BDBM188742";"COc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338597";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3931431";"";"None";"421.89";"0";"3.29";"BDBM188743";"O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(Cl)cc1)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338598";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3917340";"";"None";"411.44";"0";"3.31";"BDBM203298";"CC(C)Nc1cc(Nc2ccc(C#N)cc2)ncc1-c1nnc(NC[C@@H](F)CO)o1";"IC50";"'='";"22.9";"nM";"7.64";"";"360860";"UO_0000065";"18.57";"0.35";"4.33";"5.79";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3894436";"";"None";"465.54";"0";"2.22";"BDBM188815";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338670";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112464";"";"None";"466.92";"0";"3.47";"BDBM188068";"CC[C@@H](F)CNc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"9.3";"nM";"8.03";"";"337734";"UO_0000065";"17.20";"0.34";"4.56";"7.65";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4789200";"";"None";"535.56";"2";"4.88";"17";"CC1(C)OC(=O)c2ccc(Nc3ncc(-c4nc(-c5ccncc5)no4)c(N[C@H](CO)c4ccccc4)n3)cc21";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"10.77";"0.20";"0.89";"3.89";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4060298";"";"None";"361.41";"0";"2.64";"6";"NC(=O)c1ccc(Nc2cc(NCc3ccccc3)c(C(N)=O)cn2)cc1";"IC50";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"17.51";"0.32";"3.69";"5.14";"0";"CHEMBL4047622";"Inhibition of IRAK4 (unknown origin) using fluorescent labelled IPTSPITTTYFFFKKK peptide as substrate after 60 mins by caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL4108187";"";"None";"418.45";"0";"2.42";"BDBM187531";"C[C@H](CF)Nc1cc(-n2ccc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.3";"nM";"8.48";"";"337250";"UO_0000065";"20.27";"0.39";"6.06";"8.08";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3958335";"";"None";"400.87";"0";"3.63";"BDBM206257";"Cc1ccn2ncc(C(=O)Nc3cc(Cl)ccc3OC3CCC(O)CC3)c2n1";"IC50";"'='";"6561.0";"nM";"5.18";"";"364928";"UO_0000065";"12.93";"0.25";"1.55";"5.84";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3926919";"";"None";"408.47";"0";"4.45";"BDBM188868";"Cc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338723";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3982787";"";"None";"507.58";"1";"2.51";"BDBM188824";"CC(=O)c1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338679";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3929903";"";"None";"372.81";"0";"2.93";"BDBM206170";"O=C(Nc1cc(Cl)ccc1OC1CCC(O)C1)c1cnn2cccnc12";"IC50";"'='";"361.0";"nM";"6.44";"";"364841";"UO_0000065";"17.28";"0.34";"3.51";"7.26";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4112226";"";"None";"466.56";"0";"3.98";"BDBM187911";"CC(C)CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"5.9";"nM";"8.23";"";"337586";"UO_0000065";"17.64";"0.33";"4.25";"7.10";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3894173";"";"None";"393.45";"0";"2.01";"BDBM187768";"CCCCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H](C)CO";"IC50";"'='";"6.5";"nM";"8.19";"";"337453";"UO_0000065";"20.81";"0.39";"6.18";"6.36";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3975532";"";"None";"365.42";"0";"2.90";"BDBM206162";"O=C(Nc1ccc2ncccc2c1)c1csc2cnc(NCCO)nc12";"IC50";"'='";"300.0";"nM";"6.52";"";"364833";"UO_0000065";"17.85";"0.34";"3.62";"6.52";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4075955";"";"None";"449.54";"0";"3.30";"1";"CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"18.53";"0.36";"5.03";"6.97";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4793398";"";"None";"390.40";"0";"1.58";"3";"Cn1cc(NC(=O)c2cnc3ccc(N4CCC[C@@H](N)C4)nn23)c(C(F)F)n1";"IC50";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"20.65";"0.39";"6.48";"7.58";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL500069";"";"None";"293.37";"0";"2.79";"11";"c1cc(NC2CCNCC2)nc(-c2n[nH]c3ccccc23)c1";"IC50";"'='";"456.0";"nM";"6.34";"";"";"UO_0000065";"21.61";"0.39";"3.55";"9.66";"0";"CHEMBL956501";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4582179";"";"None";"989.27";"3";"6.20";"7";"CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)CCCCCCCCCCC#Cc2cnc(OC[C@@H]3CCC(=O)N3)c3cc(OC)c(C(N)=O)cc23)C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C1CCCCC1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"7.76";"0.15";"1.48";"3.44";"0";"CHEMBL4361896";"Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359855";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";""
"CHEMBL4459066";"";"None";"369.39";"0";"-0.78";"1";"Cn1cc(NC(=O)c2cnn3ccc(N4CCNCC4)nc23)c(C(N)=O)n1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"20.09";"0.38";"8.20";"5.48";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3963886";"";"None";"482.55";"0";"3.44";"BDBM187719";"CC(=O)Nc1ccc(CCNC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)cc1";"IC50";"'='";"1.6";"nM";"8.80";"";"337404";"UO_0000065";"18.23";"0.33";"5.36";"6.39";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4276946";"";"None";"284.15";"0";"3.41";"3a";"CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4259087";"Inhibition of untagged IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4257503";"1";"Scientific Literature";"Medchemcomm";"2018";"None";""
"CHEMBL3634380";"";"None";"439.47";"0";"3.38";"25";"Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)(F)F)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"20.48";"0.41";"5.62";"8.13";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3622513";"";"None";"429.50";"0";"0.77";"13";"O=c1[nH]c(N2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"16.70";"0.33";"6.40";"5.33";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3622512";"";"None";"443.53";"0";"1.16";"12";"O=c1[nH]c(N2CCCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"16.03";"0.31";"5.95";"5.28";"0";"CHEMBL3625601";"Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL3622532";"";"None";"494.58";"1";"2.32";"5";"Cc1cc(Nc2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)cc(C)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.15";"0.27";"4.68";"4.48";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4754408";"";"None";"457.63";"0";"4.42";"45";"CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc3sc(-c4cncs4)cc3c2NC(C)C)CC1";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"18.42";"0.37";"4.01";"8.78";"0";"CHEMBL4739586";"Inhibition of IRAK4 (unknown origin) using IPTSPITTTYFFFKKK peptide as substrate in presence of ATP measured after 60 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4732264";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 1.0 hr"
"CHEMBL4647567";"";"None";"411.53";"0";"3.90";"10";"CC(C)(O)CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"14.69";"0.28";"2.15";"6.10";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4648202";"";"None";"449.53";"0";"4.39";"14";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCC(F)(F)C(C)(C)O";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"12.35";"0.24";"1.16";"5.60";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4649875";"";"None";"413.55";"0";"4.15";"9";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCCC(C)(C)O";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"14.41";"0.28";"1.81";"6.01";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL380009";"";"None";"283.25";"0";"2.07";"15";"O=C(Nc1nc2cc[nH]cc-2n1)c1cccc([N+](=O)[O-])c1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"15.97";"0.29";"2.45";"3.97";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3913349";"";"None";"386.84";"0";"2.24";"BDBM206227";"O=C(Nc1cc(Cl)ccc1N1CCCC(CO)C1)c1cnn2nccnc12";"IC50";"'='";"2465.0";"nM";"5.61";"";"364898";"UO_0000065";"14.50";"0.28";"3.37";"5.86";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3984346";"";"None";"494.65";"1";"5.29";"BDBM203293";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nc(C(=O)NCC2CCCO2)cs1";"IC50";"'='";"24.0";"nM";"7.62";"";"360855";"UO_0000065";"15.40";"0.31";"2.33";"7.54";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3893606";"";"None";"500.58";"1";"4.38";"BDBM187618";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@](F)(c2ccnn2C)CC1";"IC50";"'='";"3.3";"nM";"8.48";"";"337309";"UO_0000065";"16.94";"0.31";"4.10";"7.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4294631";"";"None";"301.44";"0";"3.14";"20";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"42.66";"nM";"7.37";"";"";"UO_0000065";"24.45";"0.46";"4.23";"16.21";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4282348";"";"None";"467.62";"0";"2.38";"32";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H]5CC[C@H](C(N)=O)CC5)c34)CC2)CC1";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"15.20";"0.29";"4.73";"6.53";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4556866";"";"None";"490.57";"1";"2.48";"11";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)nc34)CC2)CC1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"14.92";"0.28";"4.84";"5.34";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4113092";"";"None";"451.55";"0";"3.57";"BDBM187551";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)NC(C)C";"IC50";"'='";"4.1";"nM";"8.39";"";"337264";"UO_0000065";"18.57";"0.35";"4.82";"7.79";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115019";"";"None";"540.91";"1";"3.81";"BDBM187811";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1Nc1cnn(CC(F)(F)F)c1";"IC50";"'='";"1.9";"nM";"8.72";"";"337488";"UO_0000065";"16.12";"0.32";"4.91";"7.10";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3950656";"";"None";"401.47";"0";"2.70";"5";"NCC1CCN(c2cc3ncccc3cc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"18.40";"0.34";"4.69";"7.28";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4515682";"";"None";"477.53";"0";"2.17";"19";"O=C(Nc1cc2oc(N3CCOCC3)nc2cc1N1CCC(CO)CC1)c1cnn2cccnc12";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"15.12";"0.28";"5.05";"5.96";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4474636";"";"None";"493.59";"0";"2.64";"20";"O=C(Nc1cc2sc(N3CCOCC3)nc2cc1N1CCC(CO)CC1)c1cnn2cccnc12";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"16.40";"0.32";"5.46";"7.49";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3590476";"";"None";"398.47";"0";"1.54";"16";"COCc1nn(C)cc1NC(=O)c1cnn2ccc(N[C@@H]3CCCC[C@@H]3N)nc12";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"20.63";"0.39";"6.68";"6.61";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4582624";"";"None";"504.60";"2";"2.68";"13";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"14.54";"0.27";"4.66";"5.35";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4438228";"";"None";"532.65";"2";"3.41";"15";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C(C)(C)C#N)nc34)CC2)CC1";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"13.44";"0.25";"3.75";"5.22";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4548760";"";"None";"518.63";"2";"3.24";"14";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C(C)C#N)nc34)CC2)CC1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"13.28";"0.25";"3.65";"5.02";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3601192";"";"None";"472.55";"0";"2.96";"26";"Cc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"15.36";"0.28";"4.30";"5.33";"0";"CHEMBL3603426";"Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL3634378";"";"None";"422.42";"0";"2.42";"23";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)(F)F)n1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"17.51";"0.34";"4.98";"6.42";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4109711";"";"None";"534.64";"1";"2.34";"BDBM203811";"O=c1[nH]c(N2CCC(c3ccccn3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"12.1";"nM";"7.92";"";"360991";"UO_0000065";"14.81";"0.28";"5.58";"5.37";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109175";"";"None";"536.64";"2";"-0.36";"BDBM203475";"CS(=O)(=O)N1CCN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"225.0";"nM";"6.65";"";"361000";"UO_0000065";"12.39";"0.25";"7.01";"3.87";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3634506";"";"None";"390.40";"0";"1.82";"36";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCNC4)nc23)c(C(F)F)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"21.83";"0.42";"6.70";"8.42";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634510";"";"None";"404.43";"0";"2.21";"40";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCCNC4)nc23)c(C(F)F)n1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"19.04";"0.36";"5.49";"7.61";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634511";"";"None";"404.43";"0";"2.21";"41";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCCNC4)nn23)c(C(F)F)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"19.89";"0.38";"5.84";"7.95";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3393607";"";"None";"493.57";"0";"4.59";"THZ-2-118";"CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2ccc(Nc3nccc(-c4cccnc4)n3)cc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731592";"Inhibition of wild-type human partial length IRAK4 (M1 to S460 residues) expressed in mammalian expression system by Kinomescan method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725474";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4569547";"";"None";"392.46";"0";"2.10";"34";"CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCNCC3)cc2O1";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"18.48";"0.34";"5.15";"8.65";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL5083561";"";"None";"878.07";"3";"5.52";"Degrader-4";"COc1cc(N2CCC(OCC(=O)N[C@H](C(=O)N3C[C@@H](O)C[C@H]3C(=O)N[C@@H](C)c3ccc(-c4scnc4C)cc3)C(C)(C)C)CC2)ccc1NC(=O)c1cccc(-c2ccn[nH]2)n1";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"7.40";"0.14";"0.97";"3.18";"0";"CHEMBL5029479";"Inhibition of full length human N-terminal GST-fusion tagged IRAK4 expressed in baculovirus expression system using FAM-labelled peptide as substrate preincubated for 10 mins followed by substrate addition and further incubated for 1 hr in presence of ATP at Km concentration by caliper mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5029152";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.167 hr"
"CHEMBL3353211";"";"None";"463.57";"0";"3.00";"45";"Cn1cc(-c2cccc(-c3ncc(-c4cnn([C@@H]5CCCN(S(C)(=O)=O)C5)c4)cn3)c2)cn1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372371";"Inhibition of IRAK1 (unknown origin) assessed as reduction in biotin tagged phosphorylated peptide substrate1";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4782804";"";"None";"452.47";"0";"4.10";"1; JH-X-119-01";"C=CC(=O)Nc1cccc(C(=O)Nc2ccc(NC(=O)c3cccc(-c4ccn[nH]4)n3)cc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731588";"Inhibition of IRAK4 (unknown origin) using methylcoumarin-labeled peptide as substrate in presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725474";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3634378";"";"None";"422.42";"0";"2.42";"23";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)(F)F)n1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"20.59";"0.40";"6.28";"7.55";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4294035";"";"None";"276.41";"0";"2.98";"7";"CN(C)[C@H]1CC[C@H](Nc2ncnc3cscc23)CC1";"IC50";"'='";"804.0";"nM";"6.09";"";"";"UO_0000065";"22.05";"0.44";"3.11";"14.85";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4294035";"";"None";"276.41";"0";"2.98";"7";"CN(C)[C@H]1CC[C@H](Nc2ncnc3cscc23)CC1";"IC50";"'='";"812.83";"nM";"6.09";"";"";"UO_0000065";"22.03";"0.44";"3.11";"14.84";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL1739550";"";"None";"394.51";"0";"3.61";"12";"Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"18.38";"0.35";"3.64";"8.33";"0";"CHEMBL2024840";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2021851";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";""
"CHEMBL4785986";"";"None";"383.42";"0";"-0.02";"16";"Cn1cc(NC(=O)c2cnc3ccc(N[C@@H]4CCCNC4)nn23)c(C(N)=O)n1";"IC50";"'='";"12.5";"nM";"7.90";"";"";"UO_0000065";"20.61";"0.39";"7.92";"5.48";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL5085200";"";"None";"531.61";"1";"4.01";"31";"CN1CCN(c2cc(F)cc(Nc3ncc(-c4cccc(F)c4)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c2)CC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"14.57";"0.27";"3.73";"7.79";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL3981674";"";"None";"406.45";"0";"1.68";"BDBM206121";"O=C1Cc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc2N1";"IC50";"'='";"49.0";"nM";"7.31";"";"364792";"UO_0000065";"17.98";"0.33";"5.63";"6.53";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3958291";"";"None";"464.53";"0";"3.47";"BDBM189043";"Cc1ccc(-n2nc(C3CN(Cc4ccncc4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338898";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4294023";"";"None";"343.48";"0";"2.91";"28";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCOCC4)CC3)c12";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"22.70";"0.43";"4.89";"14.25";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3969158";"";"None";"540.65";"1";"3.91";"BDBM189089";"Cc1ccc(-n2nc(C3CCN([S+]([O-])Cc4ccncc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338947";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3955114";"";"None";"455.57";"0";"4.07";"BDBM188955";"Cc1ccc(-n2nc(C3CCN(CC4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338810";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3890971";"";"None";"429.86";"0";"2.42";"BDBM206154";"NC(=O)c1cnc2c(C(=O)Nc3cc(Cl)ccc3O[C@H]3CC[C@@H](O)CC3)cnn2c1";"IC50";"'='";"203.0";"nM";"6.69";"";"364825";"UO_0000065";"15.57";"0.30";"4.27";"5.08";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3601071";"";"None";"465.54";"1";"2.11";"2";"Cc1cc(Nc2ncc(-c3nc4cnccc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.31";"0.35";"6.41";"5.71";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL5073141";"";"None";"482.52";"0";"4.77";"32";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(-c4cnco4)c3)ncc2-c2cccc(F)c2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"15.75";"0.29";"2.83";"6.39";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL4747690";"";"None";"796.97";"2";"3.69";"21";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)NCCCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)c12";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"7.01";"0.13";"1.90";"2.93";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL3590486";"";"None";"405.41";"0";"2.37";"26";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4O)nc23)c(C(F)F)n1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"20.71";"0.40";"6.03";"7.68";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3590489";"";"None";"458.40";"0";"2.66";"29";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC(F)(F)[C@@H]4N)nc23)c(C(F)(F)F)n1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"16.66";"0.33";"4.98";"6.63";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4109670";"";"None";"457.49";"0";"2.69";"BDBM188070";"CC(F)CCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"6.1";"nM";"8.21";"";"337736";"UO_0000065";"17.96";"0.34";"5.52";"6.38";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3946151";"";"None";"482.55";"0";"2.70";"BDBM187689";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(c2ncccn2)CC1";"IC50";"'='";"15.7";"nM";"7.80";"";"337374";"UO_0000065";"16.17";"0.30";"5.10";"5.67";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3971885";"";"None";"315.76";"0";"2.70";"BDBM206195";"CN(C)c1ccc(Cl)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"739.0";"nM";"6.13";"";"364866";"UO_0000065";"19.42";"0.38";"3.43";"9.81";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3985685";"";"None";"451.49";"0";"3.50";"BDBM189079";"CNC(=O)c1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338937";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3947045";"";"None";"400.85";"0";"4.47";"BDBM206202";"Cc1ncoc1COc1ccc(Cl)cc1NC(=O)c1csc2cncnc12";"IC50";"'='";"1050.0";"nM";"5.98";"";"364873";"UO_0000065";"14.92";"0.30";"1.51";"6.63";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4107384";"";"None";"469.52";"0";"1.95";"BDBM188035";"CC(C)[C@@H](CO)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"13.0";"nM";"7.89";"";"337701";"UO_0000065";"16.80";"0.32";"5.94";"5.29";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108811";"";"None";"401.45";"0";"1.87";"BDBM187580";"CC(C)Nc1cc(-n2ncc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"6.2";"nM";"8.21";"";"337279";"UO_0000065";"20.44";"0.39";"6.34";"6.96";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5075213";"";"None";"863.06";"2";"4.49";"Degrader-1";"COc1cc(N2CCN(CCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)CC2)ccc1NC(=O)c1cccc(-c2cc[nH]n2)n1";"IC50";"'='";"368.0";"nM";"6.43";"";"";"UO_0000065";"7.46";"0.14";"1.94";"3.25";"0";"CHEMBL5029479";"Inhibition of full length human N-terminal GST-fusion tagged IRAK4 expressed in baculovirus expression system using FAM-labelled peptide as substrate preincubated for 10 mins followed by substrate addition and further incubated for 1 hr in presence of ATP at Km concentration by caliper mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5029152";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.167 hr"
"CHEMBL4110610";"";"None";"471.51";"0";"3.08";"BDBM188066";"CC(C)(F)CCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"5.3";"nM";"8.28";"";"337732";"UO_0000065";"17.55";"0.33";"5.20";"6.43";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3917215";"";"None";"585.69";"1";"4.40";"BDBM189103";"COc1ccc([S+]([O-])N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)c(OC)c1";"IC50";"'<'";"1000.0";"nM";"";"";"338961";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3936975";"";"None";"495.55";"0";"2.87";"BDBM189051";"COc1ncc(CN2CC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)C2)cn1";"IC50";"'<'";"1000.0";"nM";"";"";"338906";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111135";"";"None";"413.50";"0";"2.31";"BDBM203511";"O=c1[nH]c(NC2CCC2)nc(N[C@@H]2CC[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"2261.0";"nM";"5.65";"";"360971";"UO_0000065";"13.65";"0.27";"3.34";"4.58";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108994";"";"None";"465.41";"0";"2.50";"BDBM187583";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCC(F)(F)F";"IC50";"'='";"11.9";"nM";"7.92";"";"337282";"UO_0000065";"17.03";"0.33";"5.42";"6.15";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3634383";"";"None";"421.48";"0";"3.30";"29";"Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)F)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"20.22";"0.40";"5.22";"7.70";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL5075301";"";"None";"484.56";"0";"3.80";"10";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(C(=O)N4CCCC4)c3)ncc2-c2ccoc2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"17.95";"0.33";"4.90";"6.88";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL5085979";"";"None";"494.60";"0";"4.21";"12";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(C(=O)N4CCCC4)c3)ncc2-c2ccccc2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"16.17";"0.30";"3.79";"7.06";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL5079990";"";"None";"500.63";"1";"4.27";"11";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(C(=O)N4CCCC4)c3)ncc2-c2ccsc2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"16.58";"0.31";"4.03";"7.33";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL4109283";"";"None";"522.08";"1";"4.19";"BDBM203593";"O=c1[nH]c(N2CCN(c3ccccc3Cl)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"27.0";"nM";"7.57";"";"361074";"UO_0000065";"14.50";"0.29";"3.38";"8.49";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114946";"";"None";"517.66";"1";"2.94";"BDBM203602";"Cc1cnc(C)c(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)n1";"IC50";"'='";"22.0";"nM";"7.66";"";"361083";"UO_0000065";"14.79";"0.28";"4.72";"6.66";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110735";"";"None";"465.53";"0";"2.42";"BDBM187947";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(N)C1";"IC50";"'='";"3.4";"nM";"8.47";"";"337623";"UO_0000065";"18.19";"0.34";"6.05";"5.97";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110735";"";"None";"465.53";"0";"2.42";"BDBM187947";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC(N)C1";"IC50";"'='";"3.0";"nM";"8.52";"";"337625";"UO_0000065";"18.31";"0.34";"6.10";"6.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622530";"";"None";"426.55";"0";"2.44";"BDBM203567";"C[C@@H]1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1";"IC50";"'='";"114.0";"nM";"6.94";"";"361047";"UO_0000065";"16.28";"0.32";"4.50";"7.30";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113859";"";"None";"526.66";"1";"4.13";"BDBM187969";"CC(C)CCC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"3.5";"nM";"8.46";"";"337644";"UO_0000065";"16.06";"0.30";"4.33";"6.98";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3980604";"";"None";"420.48";"0";"1.86";"BDBM188023";"CC(C)CCNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC1COC1";"IC50";"'='";"3.4";"nM";"8.47";"";"337692";"UO_0000065";"20.14";"0.37";"6.61";"5.89";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4763746";"";"None";"892.12";"2";"3.69";"24";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CCN6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)N(C)C7=O)C8=O)CC6)CC5)CC4)CC3)c12";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL3590471";"";"None";"383.42";"0";"0.11";"11";"Cn1cc(NC(=O)c2cnn3ccc(NC4CCCC4N)nc23)c(C(N)=O)n1";"IC50";"'='";"95.0";"nM";"7.02";"";"";"UO_0000065";"18.31";"0.34";"6.91";"4.44";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3403437";"";"None";"357.37";"0";"0.38";"18";"Nc1ncc(-c2nc3ccccc3o2)c(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"'='";"2570.0";"nM";"5.59";"";"";"UO_0000065";"15.64";"0.29";"5.21";"3.71";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3353194";"";"None";"401.45";"0";"2.15";"27";"CC(C)Nc1cc(Nc2ncc(C#N)cn2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"20.61";"0.39";"6.13";"6.09";"0";"CHEMBL3380182";"Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4788568";"";"None";"384.53";"0";"2.97";"3";"CC(=O)N1CCN([C@H]2CC[C@@H](Nc3ncnc4[nH]cc(C(C)C)c34)CC2)CC1";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"15.80";"0.30";"3.11";"7.88";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL4753038";"";"None";"890.05";"2";"2.71";"11";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCOCCOCCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)c12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL3894869";"";"None";"429.48";"0";"3.96";"BDBM188736";"Cc1ccc(-n2nc(C3CCC(=NO)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338591";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3935941";"";"None";"412.46";"0";"2.51";"BDBM188746";"N#Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338601";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3942404";"";"None";"471.44";"0";"3.53";"BDBM188747";"O=C(Nc1cc(C2CCNCC2)nn1-c1ccc(OC(F)(F)F)cc1)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338602";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3951041";"";"None";"521.60";"1";"2.85";"BDBM188758";"COc1ccc(-n2nc(C3CCN(S(=O)(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338613";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3979995";"";"None";"533.66";"1";"3.93";"BDBM188759";"Cc1ccc(-n2nc(C3CCN(S(=O)(=O)C4CCCC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338614";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586494";"";"None";"415.50";"0";"3.28";"16";"Cc1ccc(-n2nc(C3CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"16.42";"0.30";"3.54";"8.49";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4647567";"";"None";"411.53";"0";"3.90";"10";"CC(C)(O)CCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC1CC1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"15.89";"0.31";"2.64";"6.59";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4648202";"";"None";"449.53";"0";"4.39";"14";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1C(=O)NCC(F)(F)C(C)(C)O";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"13.89";"0.28";"1.85";"6.30";"0";"CHEMBL4625631";"Inhibition of IRAK4 in human PBMC assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PBMC";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"CHEMBL3308021";""
"CHEMBL4644871";"";"None";"369.49";"0";"4.40";"6";"CCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4643371";"";"None";"445.56";"0";"4.40";"16";"Cc1nc2ccc(Nc3cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn3)cc2s1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"11.04";"0.22";"0.52";"4.96";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3590437";"";"None";"344.34";"0";"-0.85";"9";"Cn1cc(NC(=O)c2cnn3ccc(OCCN)nc23)c(C(N)=O)n1";"IC50";"'='";"9200.0";"nM";"5.04";"";"";"UO_0000065";"14.63";"0.28";"5.89";"3.24";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL2385543";"";"None";"561.09";"2";"6.82";"2n";"O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1-c1cccnc1";"IC50";"'='";"26000.0";"nM";"4.58";"";"";"UO_0000065";"8.17";"0.15";"-2.23";"7.44";"0";"CHEMBL2389956";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384992";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";""
"CHEMBL3586502";"";"None";"505.60";"1";"3.18";"BDBM188787";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338642";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4649636";"";"None";"416.46";"0";"3.02";"18";"CC(C)Nc1cc(Nc2ccc3nonc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"16.03";"0.30";"3.66";"5.33";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4290222";"";"None";"426.57";"0";"2.51";"31";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"93.33";"nM";"7.03";"";"";"UO_0000065";"16.48";"0.31";"4.52";"9.37";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4107116";"";"None";"440.48";"0";"1.93";"BDBM188044";"CCCNc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.6";"nM";"8.59";"";"337710";"UO_0000065";"19.49";"0.37";"6.66";"5.55";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3929267";"";"None";"471.58";"1";"2.30";"BDBM203508";"CC(C)(O)[C@H]1C[C@@H](Nc2nc(NC3CCC3)[nH]c(=O)c2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"65.0";"nM";"7.19";"";"360968";"UO_0000065";"15.24";"0.30";"4.89";"5.01";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3634615";"";"None";"378.44";"0";"1.87";"48";"Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C#N)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"20.93";"0.39";"6.05";"6.28";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4109711";"";"None";"534.64";"1";"2.34";"BDBM203811";"O=c1[nH]c(N2CCC(c3ccccn3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"36.0";"nM";"7.44";"";"361001";"UO_0000065";"13.92";"0.27";"5.10";"5.05";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3933431";"";"None";"494.54";"0";"1.51";"BDBM188899";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C=O)cn3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338754";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622525";"";"None";"428.52";"0";"1.02";"26";"O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CNC[C@H](O)C2)c1-c1nc2ccccc2s1";"IC50";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"16.50";"0.32";"6.05";"6.13";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3403451";"";"None";"455.58";"0";"3.01";"32";"OC[C@H]1C[C@@H](Nc2nc(NC3CCCCC3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"3012000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3651966";"";"None";"440.47";"1";"5.04";"8; PIM447";"C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3750402";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745712";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3314140";"";"None";"404.90";"0";"4.86";"13a";"Clc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3369599";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351352";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";""
"CHEMBL4293607";"";"None";"427.55";"0";"1.60";"33";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc([C@H](C)CC(N)=O)c34)CC2)CC1";"IC50";"'='";"141.25";"nM";"6.85";"";"";"UO_0000065";"16.02";"0.30";"5.25";"6.29";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL5087312";"";"None";"512.59";"1";"4.35";"16";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(C(=O)N4CCCC4)c3)ncc2-c2ccc(F)cc2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"15.06";"0.28";"3.37";"6.82";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL3586499";"";"None";"479.57";"0";"2.61";"21";"Cc1cccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)c1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"11.84";"0.23";"3.07";"4.96";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3634503";"";"None";"408.39";"0";"1.90";"33";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCNC4)nn23)c(C(F)(F)F)n1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"21.30";"0.41";"6.80";"8.60";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4094760";"";"None";"385.51";"0";"2.91";"2";"c1nc(N[C@H]2CC[C@@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"16.20";"0.30";"3.33";"8.29";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL3590477";"";"None";"379.43";"0";"1.27";"46";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C#N)n1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"23.98";"0.44";"7.83";"6.55";"1";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634504";"";"None";"407.40";"0";"2.50";"34";"Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCNC4)nn23)c(C(F)(F)F)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.09";"0.42";"6.50";"10.19";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634507";"";"None";"390.40";"0";"1.82";"37";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCNC4)nn23)c(C(F)F)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"23.05";"0.44";"7.18";"8.90";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4794821";"";"None";"376.37";"0";"1.43";"7";"Cn1cc(NC(=O)c2cnc3ccc(N[C@@H]4CCNC4)nn23)c(C(F)F)n1";"IC50";"'='";"7.7";"nM";"8.11";"";"";"UO_0000065";"21.56";"0.41";"6.68";"8.02";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4784487";"";"None";"390.40";"0";"1.58";"1";"Cn1cc(NC(=O)c2cnn3ccc(N4CCC[C@@H](N)C4)nc23)c(C(F)F)n1";"IC50";"'='";"9.3";"nM";"8.03";"";"";"UO_0000065";"20.57";"0.39";"6.45";"7.55";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3590477";"";"None";"379.43";"0";"1.27";"46";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C#N)n1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"20.88";"0.39";"6.65";"5.70";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634382";"";"None";"403.44";"0";"2.94";"28";"Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCC[C@@H]4N)nn23)c(C(F)F)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"22.31";"0.42";"6.06";"8.80";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634504";"";"None";"407.40";"0";"2.50";"34";"Cn1cc(NC(=O)c2ccc3ccc(N[C@@H]4CCCNC4)nn23)c(C(F)(F)F)n1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"19.07";"0.37";"5.27";"8.80";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3634507";"";"None";"390.40";"0";"1.82";"37";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCNC4)nn23)c(C(F)F)n1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"19.52";"0.37";"5.80";"7.53";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL259375";"";"None";"295.37";"0";"3.77";"2g";"Cc1cccc(NC(=O)c2csc(-c3cccnc3)n2)c1";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"18.01";"0.35";"1.55";"9.69";"0";"CHEMBL936449";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143094";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";""
"CHEMBL4110998";"";"None";"505.45";"1";"2.46";"BDBM187637";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)OP(=O)(O)O";"IC50";"'='";"14.7";"nM";"7.83";"";"337326";"UO_0000065";"15.50";"0.31";"5.37";"4.47";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108464";"";"None";"509.52";"1";"2.83";"BDBM187825";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CCCF)c1";"IC50";"'='";"2.4";"nM";"8.62";"";"337502";"UO_0000065";"16.92";"0.32";"5.79";"5.88";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3955569";"";"None";"448.53";"0";"1.96";"BDBM187651";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCCN1CCOCC1";"IC50";"'='";"16.3";"nM";"7.79";"";"337336";"UO_0000065";"17.36";"0.32";"5.83";"6.44";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115550";"";"None";"478.96";"0";"2.74";"BDBM188060";"CC(C)C(O)CNc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"17.5";"nM";"7.76";"";"337726";"UO_0000065";"16.20";"0.32";"5.02";"6.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3974245";"";"None";"400.51";"0";"1.86";"BDBM203709";"CN(C)CCNc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"1600.0";"nM";"5.80";"";"361183";"UO_0000065";"14.47";"0.28";"3.94";"6.71";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3900478";"";"None";"401.49";"0";"2.07";"BDBM203711";"CCC(CO)Nc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"330.0";"nM";"6.48";"";"361185";"UO_0000065";"16.14";"0.32";"4.41";"6.27";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3983974";"";"None";"387.46";"0";"1.68";"BDBM203714";"CC(O)CNc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"780.0";"nM";"6.11";"";"361188";"UO_0000065";"15.76";"0.31";"4.43";"5.91";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4097418";"";"None";"327.48";"0";"3.90";"17";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCC4)c23)CC1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"23.32";"0.43";"3.74";"13.44";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4747510";"";"None";"419.41";"0";"3.64";"24";"COc1cc(NC(=O)c2cccc(C(F)(F)F)n2)cc2cn(C3CCNCC3)nc12";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"17.61";"0.34";"3.75";"9.11";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4645407";"";"None";"432.53";"0";"3.49";"17";"CC(C)Nc1cc(Nc2ccc3nsnc3c2)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1160.0";"nM";"5.94";"";"";"UO_0000065";"13.72";"0.27";"2.45";"5.30";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4778492";"";"None";"365.40";"0";"0.75";"15";"Cn1cc(NC(=O)c2cnc3ccc(N[C@@H]4CCCNC4)nn23)c(C#N)n1";"IC50";"'='";"40.8";"nM";"7.39";"";"";"UO_0000065";"20.22";"0.37";"6.64";"5.91";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4784830";"";"None";"354.42";"0";"1.19";"17";"Cc1nn(C)cc1NC(=O)c1cnc2ccc(N[C@@H]3CCCNC3)nn12";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4780218";"";"None";"478.48";"0";"2.71";"21";"O=C(Nc1cn(C2CCOCC2)nc1C(F)(F)F)c1cnc2ccc(N[C@@H]3CCCNC3)nn12";"IC50";"'='";"49.7";"nM";"7.30";"";"";"UO_0000065";"15.26";"0.29";"4.59";"6.62";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4798725";"";"None";"390.40";"0";"1.58";"2";"Cn1cc(NC(=O)c2ncn3ccc(N4CCC[C@@H](N)C4)nc23)c(C(F)F)n1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3353185";"";"None";"277.35";"0";"2.38";"18";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(F)c23)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"25.24";"0.48";"4.62";"12.32";"0";"CHEMBL3380178";"Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3586485";"";"None";"454.49";"0";"4.16";"7";"COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)cc1OC";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"16.19";"0.30";"3.20";"7.70";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4799763";"";"None";"404.43";"0";"2.13";"5-Me";"Cc1nc2ccc(N[C@@H]3CCCNC3)nn2c1C(=O)Nc1cn(C)nc1C(F)F";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3634513";"";"None";"388.86";"0";"2.05";"43";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(Cl)n1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"23.14";"0.46";"6.95";"7.82";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3353184";"";"None";"284.37";"0";"2.11";"17";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C#N)c23)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"24.62";"0.46";"4.89";"8.68";"0";"CHEMBL3380178";"Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3353220";"";"None";"408.49";"0";"2.90";"55";"COc1cc2ncccc2cc1NC(=O)c1csc2cnc(N(C)CCN)nc12";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"19.82";"0.38";"5.20";"7.62";"1";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL5082351";"";"None";"397.45";"0";"3.25";"1";"CC(C)Nc1c(C(=O)NC[C@@H](F)C(C)(C)O)cnc2c1[nH]c1cc(C#N)ccc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"21.89";"0.41";"5.45";"7.64";"0";"CHEMBL5042338";"Inhibition of IRAK4 (unknown origin) using FL- IPTSPITTTYFFFKKK peptide as substrate in presence of ATP incubated for 60 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038673";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.0 hr"
"CHEMBL3798011";"";"None";"413.48";"0";"3.76";"14";"C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3804242";"Inhibition of N-terminal GST-tagged human IRAK4 expressed in baculovirus preincubated for 5 mins using myelin basic protein as substrate measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3797131";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";""
"CHEMBL3906601";"";"None";"481.56";"0";"3.58";"BDBM188967";"Cc1ccc(-n2nc(C3CCN(Cc4cn[nH]c4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338822";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3905346";"";"None";"541.66";"1";"3.46";"BDBM188969";"Cc1ccc(-n2nc(C3CCN(C4CN(C(=O)NC(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338824";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3975182";"";"None";"491.62";"0";"3.73";"BDBM189099";"Cc1ccc(-n2nc(C3CCN([S+]([O-])C(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338957";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3892724";"";"None";"403.46";"0";"0.65";"BDBM203719";"O=c1[nH]c(N2CCOCC2)nc(NC(CO)CO)c1-c1nc2ccccc2s1";"IC50";"'='";"110.0";"nM";"6.96";"";"361193";"UO_0000065";"17.25";"0.34";"6.31";"5.63";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3601083";"";"None";"428.52";"0";"1.87";"14";"Cc1cc(Nc2ncc(-c3cscn3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1";"IC50";"'='";"852.0";"nM";"6.07";"";"";"UO_0000065";"14.16";"0.28";"4.20";"4.45";"0";"CHEMBL3603417";"Inhibition of human IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3601185";"";"None";"504.62";"1";"3.54";"18";"Cc1cc(Nc2ncc(-c3nc(-c4ccccc4)cs3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"13.99";"0.27";"3.52";"5.18";"0";"CHEMBL3603426";"Inhibition of IRAK4-dependent TLR4 signaling in human THP1-XBlue cells containing NF-kappaB-inducible SEAP reporter gene assessed as inhibition of LPS-EK-induced TLR4 activation incubated at 37 degC for 1 hr by spectrophotometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3600286";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL4750066";"";"None";"492.50";"0";"4.77";"1";"CCOc1cc2nc(CCC(C)(C)C(=O)OC)n(C)c2cc1NC(=O)c1cccc(C(F)(F)F)n1";"IC50";"'='";"70.7";"nM";"7.15";"";"";"UO_0000065";"14.52";"0.28";"2.38";"7.50";"0";"CHEMBL4724652";"Inhibition of human full length N-terminal His6-tagged recombinant IRAK4 expressed in baculovirus-infected Sf21 cells by Z'-LYTE assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf21";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715903";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4568087";"";"None";"421.53";"0";"2.86";"19";"Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"18.12";"0.35";"4.78";"7.41";"0";"CHEMBL4479732";"Inhibition of full-length recombinant human His-tagged IRAK4 expressed in baculovirus expression system by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL3950439";"";"None";"449.52";"0";"4.72";"BDBM188929";"Cc1ccc(-c2cc(NC(=O)c3cnn4cc(C5CC5)cnc34)n(-c3ccc(C)cn3)n2)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338784";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3935363";"";"None";"387.40";"0";"3.24";"BDBM206176";"COc1cc(C(=O)Nc2ccccc2)ccc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"455.0";"nM";"6.34";"";"364847";"UO_0000065";"16.37";"0.30";"3.10";"6.50";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3954918";"";"None";"318.79";"0";"4.21";"BDBM206237";"COc1ccc(Cl)cc1NC(=O)c1csc2cccnc12";"IC50";"'='";"3461.0";"nM";"5.46";"";"364908";"UO_0000065";"17.13";"0.36";"1.25";"10.66";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3924130";"";"None";"409.47";"0";"2.93";"BDBM206111";"COc1cc2ncccc2cc1NC(=O)c1csc2cnc(N(C)CCO)nc12";"IC50";"'='";"29.0";"nM";"7.54";"";"364782";"UO_0000065";"18.41";"0.35";"4.61";"7.50";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3905205";"";"None";"556.67";"1";"4.27";"BDBM188995";"Cc1ccc(-n2nc(C3CCN(C4CN(C(=O)OC(C)(C)C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338850";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4463887";"";"None";"461.53";"0";"2.16";"17";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)N2CCC(O)C2)n1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4466563";"";"None";"476.59";"0";"2.63";"11";"CN(C)CCCNC(=O)c1nn(C)cc1NC(=O)c1cccc(-c2ccnc(NCC3CC3)c2)n1";"IC50";"'='";"542.0";"nM";"6.27";"";"";"UO_0000065";"13.15";"0.24";"3.64";"5.35";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4467839";"";"None";"391.44";"0";"2.05";"2";"Cn1cc(NC(=O)c2cncc(-c3ccnc(NCC4CC4)c3)c2)c(C(N)=O)n1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"15.22";"0.28";"3.91";"4.66";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3912499";"";"None";"468.48";"1";"5.31";"BDBM188831";"Cc1ccc(-n2nc(C3CCC(C(F)(F)F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338686";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3972673";"";"None";"420.49";"0";"4.17";"BDBM206099";"O=C(Nc1cc2cccnc2cc1O[C@H]1CC[C@H](O)CC1)c1csc2cncnc12";"IC50";"'='";"11.0";"nM";"7.96";"";"364770";"UO_0000065";"18.93";"0.36";"3.79";"8.19";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4434908";"";"None";"460.54";"0";"1.98";"15";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)N2CC(CN)C2)n1";"IC50";"'='";"477.0";"nM";"6.32";"";"";"UO_0000065";"13.73";"0.25";"4.34";"4.82";"0";"CHEMBL4427853";"Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL4109402";"";"None";"483.52";"0";"3.22";"BDBM187599";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(F)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"337298";"UO_0000065";"17.63";"0.33";"5.30";"6.62";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4780605";"";"None";"376.37";"0";"1.06";"12";"Cn1cc(NC(=O)c2cnc3ccc(N4CCNCC4)nn23)c(C(F)F)n1";"IC50";"'='";"65.5";"nM";"7.18";"";"";"UO_0000065";"19.09";"0.36";"6.12";"7.78";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL5084495";"";"None";"501.57";"1";"3.35";"28";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2-c2cccc(F)c2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"15.16";"0.28";"4.25";"6.43";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL4108104";"";"None";"516.52";"1";"3.09";"BDBM187520";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCCC(F)(F)C1O";"IC50";"'='";"5.0";"nM";"8.30";"";"337246";"UO_0000065";"16.07";"0.31";"5.21";"6.10";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5074470";"";"None";"390.49";"0";"3.14";"53";"CC(C)Nc1c(C(=O)NCCC2CCNC2)cnc2c1[nH]c1cc(C#N)ccc12";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"22.33";"0.41";"5.58";"8.26";"0";"CHEMBL5042338";"Inhibition of IRAK4 (unknown origin) using FL- IPTSPITTTYFFFKKK peptide as substrate in presence of ATP incubated for 60 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038673";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.0 hr"
"CHEMBL5088802";"";"None";"400.49";"0";"3.59";"75";"CC(C)Nc1c(-c2cn(C3CCNCC3)nn2)cnc2c1[nH]c1cc(C#N)ccc12";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"22.03";"0.40";"5.23";"8.23";"0";"CHEMBL5042338";"Inhibition of IRAK4 (unknown origin) using FL- IPTSPITTTYFFFKKK peptide as substrate in presence of ATP incubated for 60 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038673";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.0 hr"
"CHEMBL4788995";"";"None";"390.40";"0";"1.58";"10";"Cn1cc(NC(=O)c2cnc3ccc(N4CCC(N)CC4)nn23)c(C(F)F)n1";"IC50";"'='";"80.3";"nM";"7.09";"";"";"UO_0000065";"18.17";"0.35";"5.52";"6.67";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3634513";"";"None";"388.86";"0";"2.05";"43";"Cn1cc(NC(=O)c2ccc3cnc(N[C@@H]4CCCC[C@@H]4N)nn23)c(Cl)n1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"19.51";"0.38";"5.54";"6.59";"0";"CHEMBL3637447";"Inhibition of IRAK4 in human PBMC";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3932684";"";"None";"404.52";"0";"3.14";"BDBM203558";"O=c1[nH]c(N2CCCCC2)nc(NC2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"54.0";"nM";"7.27";"";"361038";"UO_0000065";"17.97";"0.33";"4.13";"8.46";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3933351";"";"None";"425.47";"0";"2.35";"BDBM187646";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@H](F)C(C)(C)O";"IC50";"'='";"10.4";"nM";"7.98";"";"337331";"UO_0000065";"18.76";"0.35";"5.63";"6.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3977923";"";"None";"474.57";"0";"2.88";"BDBM187722";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC1CCN(C(=O)C(C)C)CC1";"IC50";"'='";"18.6";"nM";"7.73";"";"337407";"UO_0000065";"16.29";"0.30";"4.85";"6.00";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3914855";"";"None";"486.62";"0";"4.56";"BDBM187901";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC1CCC(C(C)(O)C2CC2)CC1";"IC50";"'='";"4.6";"nM";"8.34";"";"337576";"UO_0000065";"17.13";"0.32";"3.78";"7.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107855";"";"None";"532.58";"1";"3.42";"BDBM187830";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cnn(C2CCOCC2)c1";"IC50";"'='";"2.4";"nM";"8.62";"";"337507";"UO_0000065";"16.18";"0.30";"5.20";"6.03";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110687";"";"None";"477.57";"0";"4.87";"BDBM187630";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@@H]1CC=C(c2ccncc2)CC1";"IC50";"'='";"5.5";"nM";"8.26";"";"337319";"UO_0000065";"17.30";"0.31";"3.39";"7.61";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109707";"";"None";"466.52";"0";"1.82";"BDBM188107";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(N)C1";"IC50";"'='";"8.5";"nM";"8.07";"";"337771";"UO_0000065";"17.30";"0.32";"6.25";"5.21";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3894635";"";"None";"458.53";"0";"2.30";"BDBM187576";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC2CC2)CC1";"IC50";"'='";"8.3";"nM";"8.08";"";"337275";"UO_0000065";"17.62";"0.32";"5.78";"5.87";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114915";"";"None";"453.52";"0";"2.98";"BDBM188042";"CC(C)(C)CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"5.8";"nM";"8.24";"";"337708";"UO_0000065";"18.16";"0.34";"5.26";"6.40";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110124";"";"None";"533.61";"1";"3.02";"BDBM188093";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC12CC3CC(CC(O)(C3)C1)C2";"IC50";"'='";"2.1";"nM";"8.68";"";"337756";"UO_0000065";"16.26";"0.30";"5.66";"5.82";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108854";"";"None";"485.56";"0";"2.05";"BDBM187636";"CC(C)Nc1cc(-n2ccc3cnc(N4CC[C@@H](O)C4)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.7";"nM";"8.33";"";"337325";"UO_0000065";"17.15";"0.32";"6.28";"6.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106804";"";"None";"454.51";"0";"2.32";"BDBM187742";"CC(C)(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.0";"nM";"9.00";"";"337427";"UO_0000065";"19.80";"0.37";"6.68";"5.82";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110216";"";"None";"488.52";"0";"3.37";"BDBM187470";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(CO)c1";"IC50";"'='";"1.5";"nM";"8.82";"";"337206";"UO_0000065";"18.06";"0.33";"5.45";"6.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3938824";"";"None";"475.55";"0";"2.12";"BDBM187489";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2N[C@@H](C)CO)CC1";"IC50";"'='";"3.3";"nM";"8.48";"";"337224";"UO_0000065";"17.84";"0.33";"6.36";"5.85";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4091434";"";"None";"343.38";"0";"1.64";"31";"CC[C@@H]1CC(=O)N[C@@H]1COc1nccc2cc(C(N)=O)c(OC)cc12";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"27.09";"0.51";"7.66";"8.98";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4093120";"";"None";"347.35";"0";"1.19";"38";"COc1cc2c(OC[C@H]3NC(=O)[C@@H](F)[C@H]3C)nccc2cc1C(N)=O";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"27.42";"0.52";"8.33";"9.20";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3954925";"";"None";"433.52";"0";"3.19";"BDBM187648";"COC1CCC(NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"3.4";"nM";"8.47";"";"337333";"UO_0000065";"19.53";"0.36";"5.28";"7.19";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3981034";"";"None";"443.46";"0";"2.30";"BDBM187537";"C[C@@H](CF)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"5.2";"nM";"8.28";"";"337256";"UO_0000065";"18.68";"0.35";"5.98";"6.43";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113092";"";"None";"451.55";"0";"3.57";"BDBM187551";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)NC(C)C";"IC50";"'='";"2.3";"nM";"8.64";"";"337265";"UO_0000065";"19.13";"0.36";"5.07";"8.02";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3974589";"";"None";"498.59";"0";"2.89";"BDBM188982";"CC(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1";"IC50";"'<'";"1000.0";"nM";"";"";"338837";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3973807";"";"None";"522.63";"1";"2.97";"BDBM187507";"CS(=O)(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CCOCC2)CC1";"IC50";"'='";"3.5";"nM";"8.46";"";"337238";"UO_0000065";"16.18";"0.31";"5.49";"6.08";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3975254";"";"None";"438.46";"0";"1.94";"BDBM187951";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCC(F)C1(O)COC1";"IC50";"'='";"1.8";"nM";"8.74";"";"337627";"UO_0000065";"19.94";"0.37";"6.80";"6.99";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108575";"";"None";"436.49";"0";"3.10";"BDBM187405";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCC1";"IC50";"'='";"1.0";"nM";"9.00";"";"337141";"UO_0000065";"20.62";"0.38";"5.90";"7.77";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3947755";"";"None";"424.48";"0";"2.95";"BDBM187422";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@H](F)C(C)(C)O";"IC50";"'='";"2.6";"nM";"8.59";"";"337158";"UO_0000065";"20.22";"0.38";"5.64";"7.41";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112418";"";"None";"486.53";"0";"2.66";"BDBM188065";"CC(C)(F)CCNc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.8";"nM";"8.32";"";"337731";"UO_0000065";"17.10";"0.32";"5.66";"5.37";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107696";"";"None";"463.94";"0";"3.10";"BDBM187434";"CC(C)(O)CNc1cc(-n2ccc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.1";"nM";"8.68";"";"337170";"UO_0000065";"18.70";"0.37";"5.58";"7.73";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115545";"";"None";"464.46";"0";"2.13";"BDBM188037";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCc1cocn1";"IC50";"'='";"15.2";"nM";"7.82";"";"337703";"UO_0000065";"16.83";"0.31";"5.69";"5.05";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4581832";"";"None";"530.64";"2";"3.16";"16";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C5(C#N)CC5)nc34)CC2)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"14.64";"0.27";"4.61";"5.67";"0";"CHEMBL4323523";"Inhibition of IRAK4 (unknown origin) in presence of 5 mM ATP by enzymatic assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL3897707";"";"None";"396.43";"0";"2.78";"BDBM187550";"CO[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)ccc32)cc1NC(C)C";"IC50";"'='";"8.9";"nM";"8.05";"";"337263";"UO_0000065";"20.31";"0.38";"5.27";"7.68";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3973967";"";"None";"447.50";"0";"2.19";"BDBM188015";"CO[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC2COC2)CC1";"IC50";"'='";"13.4";"nM";"7.87";"";"337684";"UO_0000065";"17.59";"0.33";"5.68";"6.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4290202";"";"None";"457.58";"0";"2.08";"37";"CNC(=O)C[C@@H](C)c1ccn2ncnc(N[C@H]3CC[C@H](N4CCN(C(=O)OC)CC4)CC3)c12";"IC50";"'='";"208.93";"nM";"6.68";"";"";"UO_0000065";"14.60";"0.28";"4.60";"6.42";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3586506";"";"None";"506.59";"1";"2.58";"28";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cn3)n2)CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"15.20";"0.29";"5.12";"6.04";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3586500";"";"None";"465.54";"0";"2.31";"22";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccccc3)n2)CC1";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"14.08";"0.27";"4.24";"5.72";"0";"CHEMBL3588639";"Inhibition of recombinant N-terminal GST-tagged full length human IRAK4 expressed in baculovirus-infected insect Sf9 cells using 5FAM-RKRQGSVRRRVH-COOH as substrate assessed as substrate phosphorylation after 30 mins by immobilized metal ion affinity-based fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585289";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL379985";"";"None";"326.31";"0";"2.19";"40";"O=C(Nc1nc2ccccc2n1CCO)c1cccc([N+](=O)[O-])c1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"19.61";"0.36";"4.21";"5.80";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL4537890";"";"None";"428.47";"0";"0.95";"15";"CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2S1(=O)=O";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"19.00";"0.37";"7.19";"7.46";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4468790";"";"None";"392.42";"0";"1.40";"9";"CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O";"IC50";"'='";"0.38";"nM";"9.42";"";"";"UO_0000065";"24.01";"0.44";"8.02";"10.23";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL210887";"";"None";"340.34";"0";"2.58";"41";"O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"20.05";"0.37";"4.24";"6.19";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL4762381";"";"None";"878.07";"3";"5.52";"Degrader-3; JNJ-1013";"COc1cc(N2CCC(OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)c3ccc(-c4scnc4C)cc3)C(C)(C)C)CC2)ccc1NC(=O)c1cccc(-c2ccn[nH]2)n1";"IC50";"'='";"443.0";"nM";"6.35";"";"";"UO_0000065";"7.24";"0.14";"0.83";"3.11";"0";"CHEMBL5029479";"Inhibition of full length human N-terminal GST-fusion tagged IRAK4 expressed in baculovirus expression system using FAM-labelled peptide as substrate preincubated for 10 mins followed by substrate addition and further incubated for 1 hr in presence of ATP at Km concentration by caliper mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5029152";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.167 hr"
"CHEMBL4109510";"";"None";"381.44";"0";"0.70";"BDBM203665";"N#Cc1cccc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)n1";"IC50";"'='";"167.0";"nM";"6.78";"";"361144";"UO_0000065";"17.77";"0.33";"6.08";"5.70";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3983208";"";"None";"420.52";"0";"1.97";"BDBM203622";"O=c1[nH]c(N2CC[C@H](CO)C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"15.0";"nM";"7.82";"";"361103";"UO_0000065";"18.61";"0.34";"5.85";"7.37";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112080";"";"None";"507.54";"1";"2.97";"BDBM203648";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(C(F)(F)F)cn2)cs1";"IC50";"'='";"2403.0";"nM";"5.62";"";"361129";"UO_0000065";"11.07";"0.22";"2.65";"5.20";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109344";"";"None";"381.44";"0";"0.70";"BDBM203667";"N#Cc1ccc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)nc1";"IC50";"'='";"81.0";"nM";"7.09";"";"361146";"UO_0000065";"18.59";"0.35";"6.39";"5.96";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3976387";"";"None";"434.54";"0";"2.72";"BDBM203727";"O=c1[nH]c(N2CCOCC2)nc(NCCN2CCCCC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"2800.0";"nM";"5.55";"";"361201";"UO_0000065";"12.78";"0.24";"2.83";"6.43";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108838";"";"None";"456.55";"0";"2.70";"BDBM203646";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2cccc(F)c2)cs1";"IC50";"'='";"40.0";"nM";"7.40";"";"361127";"UO_0000065";"16.20";"0.32";"4.70";"7.77";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL380097";"";"None";"323.40";"0";"4.10";"13";"CCCCn1c(NC(=O)c2ccc(OC)cc2)nc2ccccc21";"IC50";"'='";"6500.0";"nM";"5.19";"";"";"UO_0000065";"16.04";"0.30";"1.09";"9.24";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL377259";"";"None";"296.29";"0";"3.03";"19";"Cc1ccc2[nH]c(NC(=O)c3cccc([N+](=O)[O-])c3)nc2c1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"20.58";"0.38";"3.07";"6.04";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL210822";"";"None";"310.31";"0";"3.22";"29";"CCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"18.37";"0.34";"2.48";"6.33";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL210714";"";"None";"362.39";"0";"3.96";"47";"C=CCN(C(=O)c1cccc([N+](=O)[O-])c1)c1nc2ccccc2n1CC=C";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3893544";"";"None";"402.46";"0";"2.54";"BDBM187776";"CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC1C=CCC1";"IC50";"'='";"11.1";"nM";"7.96";"";"337461";"UO_0000065";"19.77";"0.36";"5.41";"5.91";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111627";"";"None";"515.48";"1";"3.71";"BDBM187860";"CC(C)(F)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"2.5";"nM";"8.60";"";"337537";"UO_0000065";"16.69";"0.32";"4.89";"6.81";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4796463";"";"None";"376.37";"0";"1.19";"8";"Cn1cc(NC(=O)c2cnc3ccc(N4CC[C@@H](N)C4)nn23)c(C(F)F)n1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3900811";"";"None";"441.50";"0";"3.22";"BDBM187677";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(N(C)C)nc1";"IC50";"'='";"6.9";"nM";"8.16";"";"337362";"UO_0000065";"18.49";"0.34";"4.94";"6.55";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109750";"";"None";"532.65";"1";"3.59";"BDBM203798";"O=c1[nH]c(N2CCN(c3cccnc3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(F)cc2)cs1";"IC50";"'='";"20.0";"nM";"7.70";"";"361272";"UO_0000065";"14.45";"0.28";"4.11";"7.54";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107529";"";"None";"516.97";"1";"2.89";"BDBM187821";"COCCn1cc(Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"2.6";"nM";"8.59";"";"337498";"UO_0000065";"16.61";"0.33";"5.70";"6.50";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3964003";"";"None";"401.43";"0";"2.23";"BDBM187774";"[C-]#[N+]C1(NC(=O)c2cnc(-n3ncc4cc(C#N)c(N)nc43)cc2NC(C)C)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"337459";"UO_0000065";"20.48";"0.37";"5.99";"5.92";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113086";"";"None";"480.64";"0";"3.18";"BDBM203682";"O=c1[nH]c(C2CCN(C3CCOC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"180.0";"nM";"6.75";"";"361156";"UO_0000065";"14.03";"0.27";"3.56";"7.09";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106474";"";"None";"452.58";"0";"2.92";"BDBM203793";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cccc(C3CC3)c2s1";"IC50";"'='";"4500.0";"nM";"5.35";"";"361267";"UO_0000065";"11.81";"0.23";"2.43";"5.62";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3922141";"";"None";"449.52";"0";"1.73";"BDBM187544";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCNC(=O)C(C)(C)O";"IC50";"'='";"7.5";"nM";"8.12";"";"337261";"UO_0000065";"18.07";"0.34";"6.39";"5.60";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3985083";"";"None";"557.64";"1";"3.22";"BDBM187509";"CS(=O)(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2Nc2cccc(C(N)=O)c2)CC1";"IC50";"'='";"3.9";"nM";"8.41";"";"337240";"UO_0000065";"15.08";"0.29";"5.19";"4.86";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4083655";"";"None";"314.34";"0";"1.60";"26";"COc1cc2c(OC[C@@H]3CCC(=O)N3)cccc2cc1C(N)=O";"IC50";"'='";"37.1";"nM";"7.43";"";"";"UO_0000065";"23.64";"0.44";"5.83";"8.20";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4108791";"";"None";"446.96";"0";"2.70";"BDBM203792";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2cc(Cl)ccc2s1";"IC50";"'='";"8.0";"nM";"8.10";"";"361266";"UO_0000065";"18.12";"0.37";"5.40";"8.51";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107459";"";"None";"437.53";"0";"1.92";"BDBM203797";"N#Cc1ccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc2c1";"IC50";"'='";"5.0";"nM";"8.30";"";"361271";"UO_0000065";"18.97";"0.37";"6.38";"6.98";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3940600";"";"None";"420.52";"0";"2.38";"BDBM203729";"CC1(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2ccc3ccccc3n2)CCCNC1";"IC50";"'='";"130.0";"nM";"6.89";"";"361203";"UO_0000065";"16.38";"0.30";"4.51";"7.24";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113923";"";"None";"488.57";"1";"0.41";"BDBM203520";"Cc1cc2sc(-c3c(N[C@@H]4C[C@H](CO)[C@@H](O)[C@H]4O)nc(N4CCOCC4)[nH]c3=O)nc2c(C)n1";"IC50";"'='";"923.0";"nM";"6.04";"";"360980";"UO_0000065";"12.35";"0.24";"5.62";"3.85";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113207";"";"None";"508.89";"1";"3.64";"BDBM187857";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2cnc3cc(Cl)cnc32)cc1Nc1cnn(C(F)F)c1";"IC50";"'='";"7.8";"nM";"8.11";"";"337534";"UO_0000065";"15.93";"0.32";"4.47";"6.60";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107134";"";"None";"483.51";"0";"3.75";"BDBM187465";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(C#N)c1";"IC50";"'='";"1.7";"nM";"8.77";"";"337201";"UO_0000065";"18.14";"0.33";"5.02";"6.28";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3925452";"";"None";"486.54";"0";"2.36";"BDBM187627";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC1CCC2(CC1)NC(=O)NC2=O";"IC50";"'='";"4.1";"nM";"8.39";"";"337318";"UO_0000065";"17.24";"0.32";"6.03";"5.45";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4472720";"";"None";"483.54";"0";"2.67";"20";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)NCc2ccncn2)n1";"IC50";"'='";"4381.0";"nM";"5.36";"";"";"UO_0000065";"11.08";"0.20";"2.69";"3.84";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4523017";"";"None";"391.44";"0";"2.05";"5";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(N)=O)n1";"IC50";"'='";"169.0";"nM";"6.77";"";"";"UO_0000065";"17.30";"0.32";"4.72";"5.30";"0";"CHEMBL4427853";"Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL4784692";"";"None";"350.33";"0";"1.02";"11";"Cn1cc(NC(=O)c2cnc3ccc(NCCN)nn23)c(C(F)F)n1";"IC50";"'='";"17.5";"nM";"7.76";"";"";"UO_0000065";"22.14";"0.42";"6.74";"6.74";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3590478";"";"None";"422.42";"0";"2.42";"1";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C(F)(F)F)n1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"22.54";"0.43";"7.10";"8.27";"1";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL3621219";"";"None";"459.53";"0";"0.40";"BDBM203487";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"11.0";"nM";"7.96";"";"360947";"UO_0000065";"17.32";"0.34";"7.56";"5.53";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3590492";"";"None";"458.40";"0";"2.66";"32";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CC(F)(F)CC[C@@H]4N)nc23)c(C(F)(F)F)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.59";"0.36";"5.86";"7.40";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL3590485";"";"None";"423.40";"0";"2.45";"25";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4O)nc23)c(C(F)(F)F)n1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"18.13";"0.35";"5.23";"7.02";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4798892";"";"None";"864.04";"2";"4.96";"Degrader-2";"COc1cc(N2CCC(OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)CC2)ccc1NC(=O)c1cccc(-c2ccn[nH]2)n1";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"7.62";"0.15";"1.63";"3.23";"0";"CHEMBL5029479";"Inhibition of full length human N-terminal GST-fusion tagged IRAK4 expressed in baculovirus expression system using FAM-labelled peptide as substrate preincubated for 10 mins followed by substrate addition and further incubated for 1 hr in presence of ATP at Km concentration by caliper mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5029152";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.167 hr"
"CHEMBL4447180";"";"None";"337.34";"0";"0.81";"25";"Cn1cc(NC(=O)c2cccc(-c3ccnc(N)c3)n2)c(C(N)=O)n1";"IC50";"'='";"259.0";"nM";"6.59";"";"";"UO_0000065";"19.53";"0.36";"5.78";"4.64";"0";"CHEMBL4427853";"Inhibition of recombinant N-terminal GST-tagged full-length IRAK4 in human THP1-XBlue cells assessed as decrease in NF-kappaB level preincubated for 1 hr followed by stimulation with LPS for 4 to 5 hrs measured after 30 mins by spectrophotometric analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL4475493";"";"None";"321.34";"0";"1.83";"34";"Cn1cc(NC(=O)c2cccc(-c3ccccc3)n2)c(C(N)=O)n1";"IC50";"'='";"3649.0";"nM";"5.44";"";"";"UO_0000065";"16.92";"0.31";"3.61";"5.28";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4534461";"";"None";"322.33";"0";"1.23";"29";"Cn1cc(NC(=O)c2cccc(-c3cccnc3)n2)c(C(N)=O)n1";"IC50";"'='";"212.0";"nM";"6.67";"";"";"UO_0000065";"20.70";"0.38";"5.44";"5.76";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL4552628";"";"None";"425.89";"0";"3.66";"27";"Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"12.97";"0.27";"1.86";"6.47";"0";"CHEMBL4479732";"Inhibition of full-length recombinant human His-tagged IRAK4 expressed in baculovirus expression system by Z'-LYTE assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477252";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";""
"CHEMBL4545898";"";"None";"545.57";"1";"2.43";"21";"CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(CC(F)F)CC3)cc2C1=O";"IC50";"'='";"0.081";"nM";"10.09";"";"";"UO_0000065";"18.50";"0.35";"7.66";"9.49";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4288305";"";"None";"400.53";"0";"2.96";"35";"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1";"IC50";"'='";"363.08";"nM";"6.44";"";"";"UO_0000065";"16.08";"0.30";"3.48";"8.59";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4570872";"";"None";"471.53";"0";"2.60";"22";"Cn1cc(NC(=O)c2cccc(-c3ccnc(NCC4CC4)c3)n2)c(C(=O)NCc2ncc[nH]2)n1";"IC50";"'='";"1605.0";"nM";"5.79";"";"";"UO_0000065";"12.29";"0.23";"3.19";"4.07";"0";"CHEMBL4427852";"Inhibition of human recombinant N-terminal GST-tagged full-length IRAK4 expressed in baculovirus infected Sf9 insect cells using 5FAM-RKRQGSVRRRVH-COOH as substrate in presence of ATP by IMAP fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4425185";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308860";""
"CHEMBL3948538";"";"None";"425.47";"0";"2.35";"BDBM187563";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.3";"nM";"8.48";"";"337469";"UO_0000065";"19.93";"0.37";"6.13";"6.59";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112374";"";"None";"519.59";"1";"3.51";"BDBM187807";"CC(C)(C)Cn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"2.2";"nM";"8.66";"";"337484";"UO_0000065";"16.66";"0.31";"5.15";"5.91";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112023";"";"None";"425.47";"0";"2.35";"BDBM187789";"CCCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"7.1";"nM";"8.15";"";"337471";"UO_0000065";"19.15";"0.36";"5.80";"6.33";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3919803";"";"None";"420.48";"0";"1.76";"BDBM187661";"CCNC(=O)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"12.4";"nM";"7.91";"";"337346";"UO_0000065";"18.80";"0.35";"6.15";"5.75";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3911840";"";"None";"477.57";"0";"2.44";"BDBM187482";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cncnc43)cc2NC2CCOCC2)CC1";"IC50";"'='";"4.4";"nM";"8.36";"";"337217";"UO_0000065";"17.50";"0.33";"5.92";"6.79";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111058";"";"None";"493.54";"0";"2.39";"BDBM188082";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC12CCC(O)(CC1)C2";"IC50";"'='";"2.8";"nM";"8.55";"";"337745";"UO_0000065";"17.33";"0.32";"6.16";"5.74";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114850";"";"None";"484.50";"0";"3.14";"BDBM187982";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cccc(C#N)c1";"IC50";"'='";"2.6";"nM";"8.59";"";"337654";"UO_0000065";"17.72";"0.33";"5.45";"5.63";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3951199";"";"None";"439.45";"0";"1.34";"BDBM187692";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCC(F)C1(O)COC1";"IC50";"'='";"6.1";"nM";"8.21";"";"337383";"UO_0000065";"18.69";"0.35";"6.87";"5.95";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3943142";"";"None";"442.51";"0";"0.79";"BDBM187668";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCNS(C)(=O)=O";"IC50";"'='";"14.9";"nM";"7.83";"";"337353";"UO_0000065";"17.69";"0.34";"7.04";"5.06";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3907387";"";"None";"406.49";"0";"2.87";"BDBM187752";"CC(C)CCNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC(C)C";"IC50";"'='";"3.5";"nM";"8.46";"";"337437";"UO_0000065";"20.80";"0.38";"5.59";"6.29";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115550";"";"None";"478.96";"0";"2.74";"BDBM188060";"CC(C)C(O)CNc1cc(-n2ncc3cc(Cl)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"18.2";"nM";"7.74";"";"337728";"UO_0000065";"16.16";"0.32";"5.00";"6.18";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3983180";"";"None";"504.60";"1";"1.85";"BDBM187702";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCN(C2COC2)CC1";"IC50";"'='";"8.5";"nM";"8.07";"";"337387";"UO_0000065";"15.99";"0.30";"6.22";"5.71";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3916413";"";"None";"393.45";"0";"2.01";"BDBM187687";"CC(O)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"8.1";"nM";"8.09";"";"337372";"UO_0000065";"20.57";"0.38";"6.08";"6.28";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3898994";"";"None";"475.56";"0";"1.40";"BDBM187691";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(=O)N1CCN(C)CC1";"IC50";"'='";"6.2";"nM";"8.21";"";"337376";"UO_0000065";"17.26";"0.32";"6.81";"6.21";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111861";"";"None";"452.49";"0";"2.33";"BDBM187899";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCOC1";"IC50";"'='";"1.9";"nM";"8.72";"";"337574";"UO_0000065";"19.27";"0.36";"6.39";"6.97";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107752";"";"None";"456.50";"0";"3.29";"BDBM187885";"CC(CCF)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.8";"nM";"8.55";"";"337561";"UO_0000065";"18.74";"0.35";"5.26";"7.38";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114234";"";"None";"506.55";"1";"3.58";"BDBM203642";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2cccc(C(F)(F)F)c2)cs1";"IC50";"'='";"141.0";"nM";"6.85";"";"361123";"UO_0000065";"13.52";"0.27";"3.27";"7.20";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108523";"";"None";"530.57";"2";"2.01";"BDBM187998";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@@H]1CCN(c2ncccn2)C1";"IC50";"'='";"6.8";"nM";"8.17";"";"337669";"UO_0000065";"15.39";"0.29";"6.16";"5.18";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107511";"";"None";"537.58";"1";"2.52";"BDBM187449";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1Nc1cccc(S(N)(=O)=O)c1";"IC50";"'='";"1.9";"nM";"8.72";"";"337550";"UO_0000065";"16.22";"0.31";"6.20";"4.95";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3947682";"";"None";"434.54";"0";"4.05";"BDBM187414";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCCOC(C)(C)C";"IC50";"'='";"5.5";"nM";"8.26";"";"337551";"UO_0000065";"19.01";"0.35";"4.21";"7.88";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113937";"";"None";"416.46";"0";"1.45";"BDBM187613";"CC(C)Nc1cc(-n2cnc3cnc(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.7";"nM";"8.43";"";"337306";"UO_0000065";"20.25";"0.38";"6.98";"5.86";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4632511";"";"None";"383.52";"0";"4.79";"7";"CCCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"21.26";"0.41";"3.36";"10.33";"0";"CHEMBL4625630";"Inhibition of IRAK4 (unknown origin) using FL-IPTSPITTTYFFFKKK peptide and ATP as substrate incubated for 60 mins by fluorescence based caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4634922";"";"None";"433.46";"0";"2.67";"21";"CC(C)Nc1cc(Nc2nc3ccnn3cc2F)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"920.0";"nM";"6.04";"";"";"UO_0000065";"13.93";"0.27";"3.37";"5.18";"0";"CHEMBL4625632";"Inhibition of IRAK4 in human whole blood assessed as inhibition of LTA-induced IL-6 production preincubated for 30 mins followed by LTA-stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622963";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3403452";"";"None";"457.56";"0";"1.86";"33";"OC[C@H]1C[C@@H](Nc2nc(NC3CCOCC3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"1081000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3403453";"";"None";"449.54";"0";"3.01";"34";"OC[C@H]1C[C@@H](Nc2nc(Nc3ccccc3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"42000.0";"nM";"4.38";"";"";"UO_0000065";"9.74";"0.19";"1.37";"3.55";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL3403454";"";"None";"464.55";"0";"2.71";"35";"Cc1cc(Nc2ncc(-c3nc4ccccc4s3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)ccn1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"12.92";"0.25";"3.29";"4.40";"0";"CHEMBL3407004";"Inhibition of N-terminal GST tagged human recombinant full-length IRAK4 expressed in Sf9 insect cells assessed as reduction in substrate phosphorylation using RP7030 peptide substrate and ATP incubated for 30 mins fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400143";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308860";""
"CHEMBL4061493";"";"None";"329.40";"0";"2.25";"14";"CC(C)Oc1cc2c(O[C@@H]3CCCNC3)ccnc2cc1C(N)=O";"IC50";"'='";"146.0";"nM";"6.84";"";"";"UO_0000065";"20.75";"0.39";"4.59";"7.91";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4092338";"";"None";"343.38";"0";"1.78";"20";"CC(C)Oc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O";"IC50";"'='";"4.6";"nM";"8.34";"";"";"UO_0000065";"24.28";"0.46";"6.56";"8.05";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4075552";"";"None";"327.34";"0";"0.86";"44";"COc1cc2c(OC[C@H]3NC(=O)[C@@H]4C[C@H]34)nccc2cc1C(N)=O";"IC50";"'='";"115.0";"nM";"6.94";"";"";"UO_0000065";"21.20";"0.39";"6.08";"6.70";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3353206";"";"None";"325.33";"0";"0.57";"40";"Cn1cc(-c2cccc(C(=O)Nc3cn(C)nc3C(N)=O)n2)cn1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"23.04";"0.43";"6.92";"6.21";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4061801";"";"None";"343.38";"0";"1.49";"37";"COc1cc2c(OC[C@H]3NC(=O)[C@H](C)[C@H]3C)nccc2cc1C(N)=O";"IC50";"'='";"87.1";"nM";"7.06";"";"";"UO_0000065";"20.56";"0.39";"5.57";"6.82";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4084228";"";"None";"341.37";"0";"1.10";"45";"COc1cc2c(OC[C@H]3NC(=O)[C@@H]4[C@@H](C)[C@@H]43)nccc2cc1C(N)=O";"IC50";"'='";"52.1";"nM";"7.28";"";"";"UO_0000065";"21.34";"0.40";"6.18";"7.03";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3920766";"";"None";"413.43";"0";"3.28";"BDBM187781";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)(F)F";"IC50";"'='";"13.0";"nM";"7.89";"";"337466";"UO_0000065";"19.07";"0.36";"4.61";"7.27";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3949690";"";"None";"426.48";"0";"2.87";"BDBM187725";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCc1cccnc1";"IC50";"'='";"4.7";"nM";"8.33";"";"337410";"UO_0000065";"19.53";"0.36";"5.46";"6.86";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115033";"";"None";"467.51";"0";"2.12";"BDBM187577";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCOCC1";"IC50";"'='";"2.2";"nM";"8.66";"";"337276";"UO_0000065";"18.52";"0.35";"6.54";"6.27";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3900682";"";"None";"460.54";"0";"2.54";"BDBM187765";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"1.7";"nM";"8.77";"";"337450";"UO_0000065";"19.04";"0.35";"6.23";"6.37";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4781702";"";"None";"454.49";"0";"4.32";"5";"CCC(=O)Nc1cccc(C(=O)Nc2ccc(NC(=O)c3cccc(-c4ccn[nH]4)n3)cc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731588";"Inhibition of IRAK4 (unknown origin) using methylcoumarin-labeled peptide as substrate in presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725474";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3586505";"";"None";"480.55";"0";"2.01";"BDBM188887";"Cc1ccc(-n2nc(C3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338742";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3930843";"";"None";"285.33";"0";"2.95";"BDBM206256";"COc1ccccc1NC(=O)c1csc2cncnc12";"IC50";"'='";"6559.0";"nM";"5.18";"";"364927";"UO_0000065";"18.17";"0.35";"2.23";"8.08";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3951738";"";"None";"365.44";"0";"1.74";"BDBM206146";"NCC1CCN(c2c(N)cccc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"133.0";"nM";"6.88";"";"364817";"UO_0000065";"18.82";"0.35";"5.14";"6.00";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3948588";"";"None";"512.62";"1";"3.28";"BDBM188983";"CCC(=O)N1CC(N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)C1";"IC50";"'<'";"1000.0";"nM";"";"";"338838";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3901586";"";"None";"419.46";"0";"3.08";"BDBM188802";"Cc1cc(F)ccc1-n1nc(C2CCNCC2)cc1NC(=O)c1cnn2cccnc12";"IC50";"'>'";"1000.0";"nM";"";"";"338657";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3942073";"";"None";"540.53";"1";"4.57";"BDBM189069";"Cc1ccc(-n2nc(-c3ccc(S(C)(=O)=O)cc3C(F)(F)F)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"338927";"UO_0000065";"12.95";"0.25";"2.43";"6.29";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3936270";"";"None";"471.53";"0";"3.31";"BDBM187720";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cnn(C2CCOCC2)c1";"IC50";"'='";"15.9";"nM";"7.80";"";"337405";"UO_0000065";"16.54";"0.30";"4.49";"5.75";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3974236";"";"None";"336.40";"0";"2.55";"BDBM206150";"Nc1cccc(NC(=O)c2cnn3cccnc23)c1N1CCCCC1";"IC50";"'='";"156.0";"nM";"6.81";"";"364821";"UO_0000065";"20.23";"0.37";"4.26";"7.69";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4115098";"";"None";"420.52";"0";"2.37";"BDBM203628";"COC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1";"IC50";"'='";"26.0";"nM";"7.58";"";"361109";"UO_0000065";"18.04";"0.33";"5.22";"7.97";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108677";"";"None";"424.48";"0";"2.95";"BDBM187417";"CCCNc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.1";"nM";"8.68";"";"337153";"UO_0000065";"20.44";"0.38";"5.73";"7.49";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3934549";"";"None";"496.60";"0";"2.05";"BDBM187739";"CCS(=O)(=O)N1CCC(NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"5.9";"nM";"8.23";"";"337424";"UO_0000065";"16.57";"0.32";"6.18";"5.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112814";"";"None";"518.55";"1";"2.06";"BDBM187934";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1CCN(C(=O)CC#N)C1";"IC50";"'='";"2.9";"nM";"8.54";"";"337609";"UO_0000065";"16.46";"0.31";"6.48";"5.34";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3983043";"";"None";"475.56";"0";"2.27";"BDBM187766";"CC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)c(N)nc43)cc2NC(C)C)CC1";"IC50";"'='";"3.8";"nM";"8.42";"";"337451";"UO_0000065";"17.71";"0.33";"6.15";"5.15";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3945800";"";"None";"500.58";"1";"4.38";"BDBM187626";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@@](F)(c2nccn2C)CC1";"IC50";"'='";"1.8";"nM";"8.74";"";"337317";"UO_0000065";"17.47";"0.32";"4.36";"7.71";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3984714";"";"None";"546.64";"1";"4.10";"BDBM189019";"Cc1ccc(-n2nc(C3CCCN(Cc4ccc5c(c4)C(=O)NC5)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338874";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3976077";"";"None";"377.84";"0";"3.76";"BDBM206133";"NCc1ccc(-c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'='";"81.0";"nM";"7.09";"";"364804";"UO_0000065";"18.77";"0.36";"3.33";"8.31";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4112477";"";"None";"554.59";"2";"3.55";"BDBM187892";"CCn1nnnc1-c1ccc(Nc2cc(-n3ccc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cc1";"IC50";"'='";"4.1";"nM";"8.39";"";"337567";"UO_0000065";"15.12";"0.28";"4.84";"5.26";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112067";"";"None";"450.47";"0";"3.41";"BDBM187680";"CC(C)Nc1cc(-n2ncc3cc(C(F)F)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"14.2";"nM";"7.85";"";"337365";"UO_0000065";"17.42";"0.33";"4.44";"7.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3931480";"";"None";"511.59";"1";"3.77";"BDBM187696";"COC1CCN(c2ccc(NC(=O)c3cnc(-n4ncc5cc(C#N)cnc54)cc3NC(C)C)cn2)CC1";"IC50";"'='";"6.8";"nM";"8.17";"";"337381";"UO_0000065";"15.96";"0.29";"4.40";"6.10";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4086053";"";"None";"273.38";"0";"2.55";"8";"Cc1cc2c(N[C@H]3CC[C@H](N(C)C)CC3)ncnc2[nH]1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4113892";"";"None";"514.60";"1";"3.72";"BDBM187965";"CCCOC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"2.8";"nM";"8.55";"";"337640";"UO_0000065";"16.62";"0.32";"4.83";"6.56";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114306";"";"None";"494.57";"0";"3.09";"BDBM187966";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@H]1C[C@H](C(C)(C)O)C1";"IC50";"'='";"1.6";"nM";"8.80";"";"337641";"UO_0000065";"17.78";"0.33";"5.71";"6.46";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115121";"";"None";"478.45";"0";"3.50";"BDBM187884";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NCCC(F)(F)F";"IC50";"'='";"1.8";"nM";"8.74";"";"337559";"UO_0000065";"18.28";"0.35";"5.24";"7.55";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4784448";"";"None";"452.47";"0";"4.10";"4";"C=CC(=O)Nc1cccc(C(=O)Nc2cccc(NC(=O)c3cccc(-c4ccn[nH]4)n3)c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731588";"Inhibition of IRAK4 (unknown origin) using methylcoumarin-labeled peptide as substrate in presence of ATP by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725474";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL3353196";"";"None";"481.61";"0";"3.98";"30";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(C(=O)N2CC[C@H](O)C2)s1";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"17.76";"0.35";"4.57";"7.36";"0";"CHEMBL3380182";"Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3352825";"";"None";"424.48";"0";"3.18";"28";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(Nc2ccc3cnccc3n2)cc1NC1CC1";"IC50";"'='";"5.6";"nM";"8.25";"";"";"UO_0000065";"19.44";"0.36";"5.07";"7.36";"0";"CHEMBL3380182";"Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3955028";"";"None";"268.28";"0";"1.99";"BDBM206258";"COc1ccccc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"7337.0";"nM";"5.13";"";"364929";"UO_0000065";"19.14";"0.35";"3.14";"7.49";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3905240";"";"None";"413.49";"0";"3.19";"BDBM188874";"Cc1ccc(-n2nc(C3=CCN(C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338729";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4079234";"";"None";"316.36";"0";"2.79";"3";"CN(C)[C@H]1CC[C@H](Oc2ncnc3ccc([N+](=O)[O-])cc23)CC1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"22.87";"0.43";"4.45";"8.89";"0";"CHEMBL4022135";"Inhibition of recombinant human full length GST tagged IRAK4 expressed in baculovirus infected Sf9 cells using RP7030 peptide as substrate after 30 mins in presence of ATP by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4020773";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";""
"CHEMBL3925181";"";"None";"443.56";"0";"4.06";"BDBM188739";"Cc1ccc(-n2nc(C3CCC(N(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338594";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3361254";"";"None";"416.55";"0";"2.62";"ND-2110";"NC(=O)C[C@H]1CCc2sc3ncnc(O[C@H]4CC[C@H](N5CCOCC5)CC4)c3c21";"IC50";"'='";"7.5";"nM";"8.12";"";"";"UO_0000065";"19.51";"0.38";"5.50";"8.97";"0";"CHEMBL4331758";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330088";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL4520946";"";"None";"360.39";"0";"2.19";"PF-06650833";"CC[C@@H]1[C@H](F)C(=O)N[C@@H]1COc1cccc2cc(C(N)=O)c(OC)cc12";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"26.91";"0.51";"7.51";"10.70";"0";"CHEMBL4331758";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330088";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";""
"CHEMBL3932601";"";"None";"527.53";"1";"4.93";"BDBM188810";"O=C(Nc1cc(C2CCN(CC(F)(F)F)CC2)nn1-c1ccc(C2CC2)cc1F)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338665";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110098";"";"None";"454.51";"0";"2.31";"BDBM187420";"CC(CCO)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.8";"nM";"8.74";"";"337157";"UO_0000065";"19.24";"0.36";"6.43";"6.43";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL210366";"";"None";"354.37";"0";"3.23";"35";"CCOCCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"16.08";"0.30";"2.47";"5.74";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL208743";"";"None";"380.36";"0";"2.71";"48";"CN(C(=O)c1cccc([N+](=O)[O-])c1)c1nc2ccccc2n1C1CCOC1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL4750822";"";"None";"500.56";"1";"4.94";"13";"CC(C)c1noc(-c2cnc(Nc3ccc4c(c3)C(C)(C)OC4=O)nc2N[C@H](CO)c2ccccc2)n1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4539647";"";"None";"473.59";"0";"2.87";"6";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)cc34)CC2)CC1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"13.51";"0.25";"3.53";"5.56";"0";"CHEMBL4323524";"Inhibition of IRAK4 (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321825";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4109721";"";"None";"382.49";"0";"2.42";"BDBM203737";"O=c1[nH]c(N2CCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"2000.0";"nM";"5.70";"";"361211";"UO_0000065";"14.90";"0.29";"3.28";"6.63";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113183";"";"None";"440.57";"0";"2.42";"BDBM203754";"O=c1[nH]c(N2CCC(CO)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"62.0";"nM";"7.21";"";"361228";"UO_0000065";"16.36";"0.32";"4.79";"6.79";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115050";"";"None";"420.52";"0";"1.97";"BDBM203621";"O=c1[nH]c(N2CC[C@@H](CO)C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"13.0";"nM";"7.89";"";"361102";"UO_0000065";"18.75";"0.35";"5.92";"7.43";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4747796";"";"None";"417.43";"0";"2.35";"6";"Nc1ccc(-c2cccc(C(=O)Nc3cnc4nc(N5CCOCC5)oc4c3)n2)cn1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4672982";"Inhibition of IRAK4 in human THP-1 cells assessed as inhibition of LTA-induced TNF-alpha production preincubated for 60 mins followed by LTA stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4742305";"";"None";"474.53";"0";"3.09";"8";"O=C(Nc1cc2oc(N3CCOCC3)nc2nc1N1CCCCC1)c1cccc(-c2cn[nH]c2)n1";"IC50";"'='";"102.5";"nM";"6.99";"";"";"UO_0000065";"14.73";"0.27";"3.90";"5.58";"0";"CHEMBL4672982";"Inhibition of IRAK4 in human THP-1 cells assessed as inhibition of LTA-induced TNF-alpha production preincubated for 60 mins followed by LTA stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3634613";"";"None";"405.92";"0";"3.01";"45";"Cn1cc(NC(=O)c2csc3ncc(N[C@@H]4CCCC[C@@H]4N)nc23)c(Cl)n1";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"23.46";"0.48";"6.51";"8.60";"0";"CHEMBL3637446";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3632465";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";""
"CHEMBL4111157";"";"None";"502.65";"1";"3.69";"BDBM203633";"Cc1nsc(C2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4ccc5ccccc5n4)c(=O)[nH]3)CC2)n1";"IC50";"'='";"138.0";"nM";"6.86";"";"361114";"UO_0000065";"13.65";"0.26";"3.17";"6.14";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3976860";"";"None";"307.31";"0";"2.47";"14";"COc1cc2cc[nH]c2cc1NC(=O)c1cnn2cccnc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4758114";"";"None";"486.53";"0";"4.38";"12";"CCc1noc(-c2cnc(Nc3ccc4c(c3)C(C)(C)OC4=O)nc2N[C@H](CO)c2ccccc2)n1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"11.97";"0.22";"1.44";"4.30";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4799964";"";"None";"477.50";"0";"2.29";"20";"O=C(Nc1cn(C2CCNCC2)nc1C(F)(F)F)c1cnc2ccc(N[C@@H]3CCCNC3)nn12";"IC50";"'='";"52.2";"nM";"7.28";"";"";"UO_0000065";"15.25";"0.29";"4.99";"6.43";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4791626";"";"None";"435.45";"0";"3.49";"2";"CN(C)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(C(C)(C)O)cc2n1";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"16.67";"0.32";"3.77";"8.72";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4782801";"";"None";"450.46";"0";"4.09";"1";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(C(C)(C)O)cc2n1";"IC50";"'='";"128.0";"nM";"6.89";"";"";"UO_0000065";"15.30";"0.29";"2.80";"6.87";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4782731";"";"None";"463.50";"0";"4.27";"3";"CCN(CC)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(C(C)(C)O)cc2n1";"IC50";"'='";"16.7";"nM";"7.78";"";"";"UO_0000065";"16.78";"0.32";"3.51";"9.34";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4798349";"";"None";"458.44";"0";"3.71";"10";"Cn1nccc1Cn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(C(C)(C)O)cc2n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4761337";"";"None";"461.44";"0";"3.21";"9";"CC(C)(O)c1cc2nn(C[C@@H]3CCC(=O)N3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"13.30";"0.25";"2.93";"5.62";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4780645";"";"None";"435.45";"0";"3.93";"21";"CN(C)c1cc(NC(=O)c2cccc(C(F)(F)F)n2)cc2cn(CCC(C)(C)O)nc12";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4777489";"";"None";"419.41";"0";"3.07";"4";"CC(C)(O)c1cc2nn(C3CNC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"13.96";"0.27";"2.78";"6.36";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL3353217";"";"None";"466.57";"0";"3.46";"51";"O=C1Nc2cn(C3CCOCC3)nc2C(=O)NCCCCCc2cc(ccn2)-c2nc1cs2";"IC50";"'<='";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380177";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4107316";"";"None";"466.52";"0";"2.83";"BDBM187878";"CC(C)(O)/C=C/Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.8";"nM";"8.32";"";"337553";"UO_0000065";"17.83";"0.33";"5.49";"6.11";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4078222";"";"None";"452.60";"0";"3.13";"31";"CN1C(=O)C[C@@H]2CN([C@H]3CC[C@H](Nc4ncnc5[nH]cc(C6CCOCC6)c45)CC3)CC[C@@H]21";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.22";"0.36";"5.57";"10.07";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4063127";"";"None";"327.35";"0";"3.26";"14";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C(F)(F)F)c23)CC1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"20.17";"0.39";"3.34";"11.62";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4763804";"";"None";"1000.28";"None";"None";"12";"Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCNC(=O)CCC(=O)N2CCN([C@H]3CC[C@@H](Nc4ncnn5ccc(C(C)C)c45)CC3)CC2)C(C)(C)C)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL4757434";"";"None";"873.02";"2";"2.18";"18";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)NCCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)c12";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL4744403";"";"None";"384.53";"0";"2.74";"5";"CC(=O)N1CCN([C@H]2CC[C@@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL4097847";"";"None";"276.41";"0";"2.98";"5";"CN(C)[C@H]1CC[C@H](Nc2ncnc3sccc23)CC1";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"19.42";"0.39";"2.39";"13.07";"1";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4777817";"";"None";"982.31";"3";"5.81";"16";"Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCNC(=O)CCC(=O)N2CCN([C@H]3CC[C@@H](Nc4ncnn5ccc(C(C)C)c45)CC3)CC2)C(C)(C)C)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL4749598";"";"None";"475.55";"0";"3.91";"6";"CCCNC(=O)c1cnc(Nc2ccc3c(c2)C(C)(C)OC3=O)nc1N[C@H](CO)c1ccccc1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"14.24";"0.26";"2.86";"5.40";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4080574";"";"None";"426.57";"0";"2.74";"24";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4[nH]cc(C5CCOCC5)c34)CC2)CC1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"16.96";"0.32";"4.50";"8.38";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4075333";"";"None";"329.45";"0";"3.09";"18a";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCCO4)c23)CC1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"19.94";"0.37";"3.48";"9.94";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4081502";"";"None";"329.45";"0";"2.75";"19b";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C4CCOC4)c23)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"24.58";"0.46";"5.35";"12.26";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4741488";"";"None";"491.51";"1";"2.24";"25";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@H](O)C3)co2)ccn1";"IC50";"'='";"24.6";"nM";"7.61";"";"";"UO_0000065";"15.48";"0.29";"5.37";"5.33";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL3353199";"";"None";"515.04";"0";"3.02";"33";"Cc1cc(Nc2ncc(-c3nc4ccccc4s3)c(NC3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1.Cl";"IC50";"'='";"0.32";"nM";"9.49";"";"";"UO_0000065";"19.84";"0.38";"6.47";"6.97";"0";"CHEMBL3380186";"Inhibition of IRAK4 (unknown origin) by fluorescence polarization based kinase assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4778959";"";"None";"555.64";"2";"4.63";"18";"CN1CCC(c2noc(-c3cnc(Nc4ccc5c(c4)C(C)(C)OC5=O)nc3N[C@H](CO)c3ccccc3)n2)CC1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"11.98";"0.22";"2.03";"4.81";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4748045";"";"None";"462.51";"0";"3.95";"10";"CCOC(=O)c1cnc(Nc2ccc3c(c2)C(C)(C)OC3=O)nc1N[C@H](CO)c1ccccc1";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"13.99";"0.26";"2.52";"5.27";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL3353214";"";"None";"507.55";"1";"3.11";"48";"CN(C)C(=O)Cc1ccc2nc(NC(=O)c3cccc(Cn4nc(-c5cccnc5)ccc4=O)c3)[nH]c2c1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372369";"Inhibition of IRAK4 (unknown origin) by radiochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4102501";"";"None";"452.60";"0";"3.13";"30";"CN1C(=O)C[C@H]2CN([C@H]3CC[C@H](Nc4ncnc5[nH]cc(C6CCOCC6)c45)CC3)CC[C@H]21";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"16.30";"0.31";"4.25";"8.54";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3900722";"";"None";"338.70";"0";"3.24";"BDBM206194";"O=C(Nc1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12";"IC50";"'='";"717.0";"nM";"6.14";"";"364865";"UO_0000065";"18.14";"0.36";"2.90";"8.97";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3897287";"";"None";"473.52";"0";"2.94";"BDBM189082";"Cc1ccc(-n2nc(-c3ccc(S(C)(=O)=O)nc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338940";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3960060";"";"None";"386.43";"0";"2.06";"BDBM206200";"COc1cc(C(=O)NCCCO)ccc1NC(=O)c1csc2cncnc12";"IC50";"'='";"833.0";"nM";"6.08";"";"364871";"UO_0000065";"15.73";"0.31";"4.02";"5.36";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3899780";"";"None";"545.59";"1";"4.27";"BDBM189094";"Cc1ccc(-n2nc(C3CCN([S+]([O-])CCC(F)(F)F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338952";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3964132";"";"None";"560.71";"1";"4.45";"BDBM189095";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4sc(C)nc4C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338953";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3937953";"";"None";"384.87";"0";"2.81";"BDBM206235";"CC(N)C1CCN(c2ccc(Cl)cc2NC(=O)c2cnn3cccnc23)C1";"IC50";"'='";"3083.0";"nM";"5.51";"";"364906";"UO_0000065";"14.32";"0.28";"2.70";"6.22";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3937950";"";"None";"531.47";"1";"3.03";"BDBM187854";"CC(C)(O)C(F)(F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"6.6";"nM";"8.18";"";"337531";"UO_0000065";"15.39";"0.29";"5.15";"5.58";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4788562";"";"None";"401.43";"0";"3.37";"2";"O=C(Nc1ccc2nc(N3CCOCC3)oc2c1)c1cccc(-c2cccnc2)n1";"IC50";"'='";"797.0";"nM";"6.10";"";"";"UO_0000065";"15.19";"0.28";"2.73";"6.53";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4790506";"";"None";"489.54";"0";"3.66";"13";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCCCC3)co2)ccn1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"16.96";"0.31";"4.64";"6.77";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4111012";"";"None";"416.46";"0";"2.18";"BDBM187589";"CC(C)Nc1cc(-n2ncc3cc(O)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.1";"nM";"8.51";"";"337288";"UO_0000065";"20.43";"0.39";"6.33";"6.80";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3922475";"";"None";"470.56";"0";"1.57";"BDBM187713";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC(C)NS(C)(=O)=O";"IC50";"'='";"2.4";"nM";"8.62";"";"337399";"UO_0000065";"18.32";"0.36";"7.05";"5.57";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114474";"";"None";"432.93";"0";"4.34";"BDBM187436";"CC(C)Nc1cc(-n2ccc3cc(Cl)ccc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"11.8";"nM";"7.93";"";"337172";"UO_0000065";"18.31";"0.36";"3.59";"10.01";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115626";"";"None";"502.67";"1";"2.74";"BDBM203685";"CCS(=O)(=O)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"550.0";"nM";"6.26";"";"361159";"UO_0000065";"12.45";"0.25";"3.52";"5.21";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3940395";"";"None";"416.51";"0";"0.88";"BDBM203700";"O=c1[nH]c(N2CCOCC2)nc(NCCNCCO)c1-c1nc2ccccc2s1";"IC50";"'='";"640.0";"nM";"6.19";"";"361174";"UO_0000065";"14.87";"0.29";"5.31";"5.37";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114246";"";"None";"412.54";"0";"2.13";"BDBM203639";"CC(C)(C)c1cccc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)n1";"IC50";"'='";"537.0";"nM";"6.27";"";"361120";"UO_0000065";"15.20";"0.29";"4.14";"6.59";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3922099";"";"None";"546.61";"1";"3.45";"BDBM188975";"Cc1ccc(-n2nc(C3CCN(C4CN(C(=O)OCCF)C4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338830";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3970139";"";"None";"378.44";"0";"2.23";"BDBM187775";"CCCNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC(C)C";"IC50";"'='";"11.4";"nM";"7.94";"";"337460";"UO_0000065";"20.99";"0.39";"5.71";"5.90";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3919364";"";"None";"523.61";"1";"3.27";"BDBM188081";"CC(C)(O)[C@H]1CCC[C@@H](Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)C1";"IC50";"'='";"5.6";"nM";"8.25";"";"337744";"UO_0000065";"15.76";"0.30";"4.98";"5.54";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108659";"";"None";"487.49";"0";"3.13";"BDBM188083";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(F)(F)C1";"IC50";"'='";"7.7";"nM";"8.11";"";"337746";"UO_0000065";"16.64";"0.32";"4.98";"6.30";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110840";"";"None";"469.50";"0";"2.83";"BDBM188094";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(F)C1";"IC50";"'='";"1.1";"nM";"8.96";"";"337758";"UO_0000065";"19.08";"0.36";"6.13";"6.96";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110746";"";"None";"438.47";"0";"1.68";"BDBM188100";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)c(N)nc32)cc1NC1CC1";"IC50";"'='";"3.4";"nM";"8.47";"";"337763";"UO_0000065";"19.31";"0.36";"6.79";"5.47";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112023";"";"None";"425.47";"0";"2.35";"BDBM187789";"CCCNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.8";"nM";"8.55";"";"337724";"UO_0000065";"20.10";"0.38";"6.20";"6.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4748082";"";"None";"446.47";"0";"3.55";"16";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3C3CC3)co2)ccn1";"IC50";"'='";"55.4";"nM";"7.26";"";"";"UO_0000065";"16.25";"0.30";"3.71";"6.08";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL3935695";"";"None";"572.68";"2";"4.26";"BDBM203287";"CNC(=O)c1ccc(Nc2cc(Nc3ccc4ncsc4c3)ncc2-c2nnc(C(=O)N3CC[C@@H](O)C3)s2)cc1";"IC50";"'='";"3.2";"nM";"8.49";"";"360848";"UO_0000065";"14.83";"0.29";"4.23";"5.85";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3971525";"";"None";"426.55";"0";"2.44";"BDBM203535";"O=c1[nH]c(N2CCOCC2)nc(NC2CCCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"27.0";"nM";"7.57";"";"361015";"UO_0000065";"17.74";"0.34";"5.13";"7.95";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622513";"";"None";"429.50";"0";"0.77";"BDBM203494";"O=c1[nH]c(N2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"67.0";"nM";"7.17";"";"360954";"UO_0000065";"16.70";"0.33";"6.40";"5.33";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106833";"";"None";"489.52";"0";"1.50";"BDBM203496";"Cc1csc(-c2c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)nc(N3CCC(C(F)(F)F)CC3)[nH]c2=O)n1";"IC50";"'='";"93.6";"nM";"7.03";"";"360956";"UO_0000065";"14.36";"0.29";"5.53";"5.22";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114620";"";"None";"470.56";"1";"-0.03";"BDBM203479";"O=c1[nH]c(N2CC3(CNC3)C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"6.5";"nM";"8.19";"";"360939";"UO_0000065";"17.40";"0.34";"8.22";"5.58";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3906831";"";"None";"471.55";"1";"5.07";"BDBM203303";"CC(C)Nc1cc(Nc2ccc3ncsc3c2)ncc1-c1nnc(-c2cccc(C(N)=O)c2)o1";"IC50";"'='";"564.2";"nM";"6.25";"";"360865";"UO_0000065";"13.25";"0.25";"1.18";"4.74";"0";"CHEMBL3887888";"IRAK4 Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 μL prepared from 15 μL additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LabChip 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886488";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4112534";"";"None";"548.65";"2";"-0.36";"BDBM203477";"CS(=O)(=O)N1CC2(CN(c3nc(N[C@@H]4C[C@H](CO)[C@@H](O)[C@H]4O)c(-c4nc5ccccc5s4)c(=O)[nH]3)C2)C1";"IC50";"'='";"5.6";"nM";"8.25";"";"360937";"UO_0000065";"15.04";"0.30";"8.61";"4.80";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108971";"";"None";"431.52";"1";"1.38";"BDBM203468";"CC(C)Nc1nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"151.0";"nM";"6.82";"";"360928";"UO_0000065";"15.81";"0.31";"5.44";"4.76";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115519";"";"None";"503.56";"1";"1.05";"BDBM203521";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc(-c2ccc(F)cc2)cs1";"IC50";"'='";"5.6";"nM";"8.25";"";"360981";"UO_0000065";"16.39";"0.32";"7.20";"5.74";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112396";"";"None";"535.63";"2";"1.74";"BDBM203807";"O=c1[nH]c(N2CCC(c3cncnc3)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"6.2";"nM";"8.21";"";"360987";"UO_0000065";"15.32";"0.29";"6.47";"5.12";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4781999";"";"None";"422.42";"0";"2.38";"18";"CCn1cc(NC(=O)c2cnc3ccc(N[C@@H]4CCCNC4)nn23)c(C(F)(F)F)n1";"IC50";"'='";"32.3";"nM";"7.49";"";"";"UO_0000065";"17.73";"0.34";"5.11";"7.40";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3967068";"";"None";"420.49";"0";"4.17";"BDBM206094";"O=C(Nc1cc2cccnc2cc1O[C@H]1CC[C@@H](O)CC1)c1csc2cncnc12";"IC50";"'='";"7.0";"nM";"8.15";"";"364764";"UO_0000065";"19.39";"0.37";"3.98";"8.39";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4283453";"";"None";"385.51";"0";"2.74";"27";"CN(C)[C@H]1CC[C@H](Oc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"2340.0";"nM";"5.63";"";"";"UO_0000065";"14.61";"0.27";"2.89";"6.57";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4286802";"";"None";"385.51";"0";"2.68";"29";"c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)ccn2n1";"IC50";"'='";"88.0";"nM";"7.06";"";"";"UO_0000065";"18.30";"0.34";"4.38";"11.04";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4278882";"";"None";"384.53";"0";"2.74";"30";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"19.91";"0.37";"4.92";"11.64";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3964623";"";"None";"505.56";"1";"2.56";"BDBM188925";"[C-]#[N+]c1cnc2c(C(=O)Nc3cc(C4CCN(S(C)(=O)=O)CC4)nn3-c3ccc(C)cn3)cnn2c1";"IC50";"'<'";"100.0";"nM";"";"";"338780";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114884";"";"None";"406.49";"0";"1.72";"BDBM203613";"CC1(O)CN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1";"IC50";"'='";"3147.0";"nM";"5.50";"";"361094";"UO_0000065";"13.54";"0.25";"3.78";"5.18";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4796558";"";"None";"483.53";"1";"1.86";"15";"O=C(Nc1cc2oc(N3CCOCC3)nc2nc1N1CCCCC1)c1coc(N2CC[C@H](O)C2)n1";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"17.46";"0.33";"6.58";"6.34";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4757349";"";"None";"493.50";"0";"3.22";"23";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](F)C3)co2)ccn1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"16.30";"0.31";"4.83";"6.56";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4757094";"";"None";"493.57";"0";"2.27";"12";"O=C(Nc1cc2oc(N3CCOCC3)nc2nc1N1CCCCC1)c1cccc(N2CC[C@H](O)C2)n1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"14.95";"0.28";"5.11";"6.14";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4111716";"";"None";"433.56";"0";"2.29";"BDBM203608";"CN(C)[C@H]1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)C1";"IC50";"'='";"158.0";"nM";"6.80";"";"361089";"UO_0000065";"15.69";"0.29";"4.51";"7.63";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111648";"";"None";"530.68";"1";"1.56";"BDBM203562";"CS(=O)(=O)N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4c(C5CC5)nccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"6.9";"nM";"8.16";"";"361042";"UO_0000065";"15.38";"0.31";"6.60";"5.99";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115332";"";"None";"426.55";"0";"2.44";"BDBM203570";"C[C@@H]1COCCN1c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"1691.0";"nM";"5.77";"";"361050";"UO_0000065";"13.53";"0.26";"3.33";"6.06";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622523";"";"None";"426.55";"0";"2.44";"BDBM203547";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"79.0";"nM";"7.10";"";"361027";"UO_0000065";"16.65";"0.32";"4.66";"7.46";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4551768";"";"None";"415.50";"0";"3.59";"12";"CN(C)c1ccc2cc(NC(=O)c3cnn4cccnc34)c(N3CCCCC3)cc2n1";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"16.87";"0.31";"3.42";"8.91";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4576141";"";"None";"437.50";"0";"2.28";"43";"CC(C)(O)[C@]1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"15.47";"0.29";"4.49";"6.69";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4111164";"";"None";"417.52";"0";"1.70";"BDBM203636";"O=c1[nH]c(N2CC3CC2CN3)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"169.0";"nM";"6.77";"";"361117";"UO_0000065";"16.22";"0.30";"5.07";"6.91";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4784270";"";"None";"404.43";"0";"2.13";"4-Me";"Cc1nn2ccc(N[C@@H]3CCCNC3)nc2c1C(=O)Nc1cn(C)nc1C(F)F";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4767781";"Inhibition of recombinant human His-tagged full length IRAK4 expressed in baculovirus expression system using Ser/Thr07 peptide as substrate incubated for 1 hr by Z'lyte assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4765255";"1";"Scientific Literature";"Eur J Med Chem";"2020";"None";"TIME = 1.0 hr"
"CHEMBL4112884";"";"None";"437.48";"0";"2.49";"BDBM187581";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC1";"IC50";"'='";"4.5";"nM";"8.35";"";"337280";"UO_0000065";"19.08";"0.36";"5.86";"6.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111161";"";"None";"494.64";"0";"4.84";"BDBM203630";"Cc1ccccc1C1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3ccc4ccccc4n3)c(=O)[nH]2)CC1";"IC50";"'='";"17.0";"nM";"7.77";"";"361111";"UO_0000065";"15.71";"0.29";"2.93";"9.04";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4536517";"";"None";"394.23";"0";"1.76";"1";"COc1cc2c(OC[C@@H]3CCC(=O)N3)ncc(Br)c2cc1C(N)=O";"IC50";"'='";"2.1";"nM";"8.68";"";"";"UO_0000065";"22.01";"0.49";"6.92";"8.38";"0";"CHEMBL4361896";"Binding affinity to human IRK4 using myelin basic protein as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359855";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";""
"CHEMBL4459509";"";"None";"377.45";"0";"3.30";"33";"CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCCC3)cc2O1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"18.16";"0.33";"3.55";"9.55";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4077215";"";"None";"287.41";"0";"2.81";"11";"CCc1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"25.05";"0.47";"4.39";"12.67";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4085199";"";"None";"359.36";"0";"1.19";"50";"COc1cc2c(OC[C@H]3NC(=O)[C@@]4(F)[C@@H]3[C@@H]4C)nccc2cc1C(N)=O";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"25.66";"0.48";"8.03";"8.91";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4097089";"";"None";"344.46";"0";"3.10";"23";"CN(C)[C@H]1CC[C@H](Oc2ncnc3[nH]cc(C4CCOCC4)c23)CC1";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"19.02";"0.36";"3.45";"10.36";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL3959468";"";"None";"394.82";"0";"3.92";"BDBM206228";"O=C(Nc1cc(Cl)ccc1OCc1cccc(O)c1)c1cnn2cccnc12";"IC50";"'='";"2626.0";"nM";"5.58";"";"364899";"UO_0000065";"14.13";"0.27";"1.66";"6.29";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4112994";"";"None";"417.47";"0";"-0.51";"BDBM203497";"Cc1cccc(-c2c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)nc(N3CCOCC3)[nH]c2=O)n1";"IC50";"'='";"213.5";"nM";"6.67";"";"360957";"UO_0000065";"15.98";"0.30";"7.18";"4.64";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4292700";"";"None";"384.53";"0";"3.00";"23";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"358.0";"nM";"6.45";"";"";"UO_0000065";"16.76";"0.31";"3.45";"6.45";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4106852";"";"None";"393.47";"1";"0.37";"BDBM203485";"O=c1[nH]c(NC2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nccs1";"IC50";"'='";"1114.0";"nM";"5.95";"";"360945";"UO_0000065";"15.13";"0.30";"5.58";"4.15";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4283453";"";"None";"385.51";"0";"2.74";"27";"CN(C)[C@H]1CC[C@H](Oc2ncnn3ccc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1";"IC50";"'='";"671.0";"nM";"6.17";"";"";"UO_0000065";"16.01";"0.30";"3.43";"7.20";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4112161";"";"None";"414.49";"0";"2.78";"BDBM187591";"Cc1cnc2c(cnn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"7.0";"nM";"8.15";"";"337290";"UO_0000065";"19.67";"0.37";"5.37";"7.77";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4063127";"";"None";"327.35";"0";"3.26";"14";"CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc(C(F)(F)F)c23)CC1";"IC50";"'='";"99.0";"nM";"7.00";"";"";"UO_0000065";"21.40";"0.42";"3.74";"12.32";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4568894";"";"None";"571.60";"1";"2.97";"23";"CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCC(N4CC(F)(F)C4)CC3)cc2C1=O";"IC50";"'='";"0.11";"nM";"9.96";"";"";"UO_0000065";"17.42";"0.33";"6.99";"9.37";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4291706";"";"None";"259.36";"0";"2.01";"11";"CN(C)[C@H]1CC[C@H](Nc2ncnn3cccc23)CC1";"IC50";"'='";"1530.0";"nM";"5.82";"";"";"UO_0000065";"22.42";"0.42";"3.81";"12.79";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4288288";"";"None";"273.38";"0";"2.25";"16";"Cn1ccc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c21";"IC50";"'='";"741.31";"nM";"6.13";"";"";"UO_0000065";"22.42";"0.42";"3.88";"13.33";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4278882";"";"None";"384.53";"0";"2.74";"30";"CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1";"IC50";"'='";"194.98";"nM";"6.71";"";"";"UO_0000065";"17.45";"0.33";"3.97";"10.20";"0";"CHEMBL4266473";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3962169";"";"None";"416.49";"0";"2.86";"BDBM188919";"Cc1ccc(-n2nc(C3CCC(N)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338774";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3905293";"";"None";"395.44";"0";"2.90";"BDBM206132";"COc1cc2ncccc2cc1NC(=O)c1csc2cnc(NCCO)nc12";"IC50";"'='";"76.0";"nM";"7.12";"";"364803";"UO_0000065";"18.00";"0.35";"4.22";"6.52";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4085735";"";"None";"301.44";"0";"3.37";"14";"CC(C)c1c[nH]c2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"4.786";"nM";"8.32";"";"";"UO_0000065";"27.60";"0.52";"4.95";"14.64";"0";"CHEMBL4266468";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4265877";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL3919293";"";"None";"386.84";"0";"3.17";"BDBM206164";"O=C(Nc1cc(Cl)ccc1OC1CCC(CO)C1)c1cnn2cccnc12";"IC50";"'='";"306.0";"nM";"6.51";"";"364835";"UO_0000065";"16.84";"0.33";"3.34";"7.34";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3892251";"";"None";"428.43";"0";"3.98";"BDBM188866";"COc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3cccc(F)c3)n2)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338721";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3972075";"";"None";"538.41";"1";"4.18";"BDBM188852";"COC(=O)N1CCC(c2cc(NC(=O)c3cnn4cc(Br)cnc34)n(-c3ccc(C)cc3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338707";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3891709";"";"None";"396.41";"0";"2.93";"BDBM188871";"Cc1ccc(-n2nc(-c3cncnc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338726";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4069890";"";"None";"357.50";"0";"3.16";"22";"CN(C)[C@H]1CC[C@H](N(C)c2ncnc3[nH]cc(C4CCOCC4)c23)CC1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"18.80";"0.35";"3.56";"11.73";"0";"CHEMBL4026982";"Inhibition of recombinant full length His-tagged human IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate after 240 mins in presence of ATP by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4750630";"";"None";"505.54";"2";"2.63";"19";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(O)CC3)co2)ccn1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"16.73";"0.31";"5.83";"5.92";"0";"CHEMBL4672980";"Inhibition of recombinant full length N-terminal His6-tagged human IRAK4 expressed in baculovirus infected sf9 cells using biotinylated histone H3 as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of ATP by TR-FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 0.5 hr"
"CHEMBL4789126";"";"None";"401.43";"0";"3.37";"1";"O=C(Nc1ccc2nc(N3CCOCC3)oc2c1)c1cccc(-c2ccncc2)n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4672982";"Inhibition of IRAK4 in human THP-1 cells assessed as inhibition of LTA-induced TNF-alpha production preincubated for 60 mins followed by LTA stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL3353195";"";"None";"509.64";"1";"3.46";"29";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(Nc3ccc4ncsc4n3)cc2NC2CCOCC2)CC1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"17.31";"0.33";"5.36";"6.78";"0";"CHEMBL3380182";"Inhibition of IRAK4 (unknown origin) using fluoresceinated peptide and ATP after 60 mins by by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3361258";"";"None";"369.49";"0";"3.23";"16";"CN(C)[C@H]1CC[C@H](Nc2ncnc3sc4ccc(C(N)=O)cc4c23)CC1";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3380178";"Inhibition of N-terminal GST-fused full-length human IRAK4 (1 to 460 amino acids) assessed as reduction in phosphorylated substrates by Caliper assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL3353216";"";"None";"437.46";"0";"2.77";"50";"O=C1Nc2nc3ccccc3n2CCn2cc(cn2)-c2ccc(=O)n(n2)Cc2cccc1c2";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372369";"Inhibition of IRAK4 (unknown origin) by radiochemical assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351266";"1";"Scientific Literature";"J Med Chem";"2015";"None";""
"CHEMBL4781524";"";"None";"407.40";"0";"3.27";"22";"COc1cc(NC(=O)c2cccc(C(F)(F)F)n2)cc2cn(CCN(C)C)nc12";"IC50";"'='";"223.0";"nM";"6.65";"";"";"UO_0000065";"16.33";"0.31";"3.38";"9.20";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4800602";"";"None";"432.45";"0";"4.74";"14";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)cc(C3CC3)c2n1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4746200";"";"None";"499.52";"0";"2.87";"6";"CCS(=O)(=O)NCCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)c(C(C)(C)O)cc2n1";"IC50";"'='";"128.0";"nM";"6.89";"";"";"UO_0000065";"13.80";"0.28";"4.02";"5.46";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4777489";"";"None";"419.41";"0";"3.07";"4";"CC(C)(O)c1cc2nn(C3CNC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1";"IC50";"'='";"10.6";"nM";"7.97";"";"";"UO_0000065";"19.01";"0.36";"4.90";"8.66";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4776639";"";"None";"407.40";"0";"3.45";"20";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)cc(N)c2n1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4069060";"";"None";"304.46";"0";"3.59";"2";"Cc1sc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c2c1C";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"18.40";"0.36";"2.01";"13.65";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4783351";"EMAVUSERTIB";"1.0";"491.51";"1";"2.24";"24; CA-4948";"Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1";"IC50";"'='";"514.0";"nM";"6.29";"";"";"UO_0000065";"12.80";"0.24";"4.05";"4.40";"0";"CHEMBL4672982";"Inhibition of IRAK4 in human THP-1 cells assessed as inhibition of LTA-induced TNF-alpha production preincubated for 60 mins followed by LTA stimulation and measured after 5 hrs by ELISA";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665913";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 1.0 hr"
"CHEMBL5079737";"";"None";"513.58";"1";"3.75";"17";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(C(=O)N4CCCC4)c3)ncc2-c2cncc(F)c2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"16.16";"0.30";"4.55";"6.58";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL4748154";"";"None";"458.48";"0";"3.82";"24";"CC1(C)OC(=O)c2ccc(Nc3ncc(-c4nnco4)c(N[C@H](CO)c4ccccc4)n3)cc21";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"15.77";"0.29";"3.41";"5.34";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL4761884";"";"None";"447.50";"0";"3.13";"3";"CNC(=O)c1cnc(Nc2ccc3c(c2)C(C)(C)OC3=O)nc1N[C@H](CO)c1ccccc1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"16.38";"0.30";"4.20";"5.84";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL3911443";"";"None";"468.49";"0";"1.07";"BDBM187679";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(=O)N[C@@H](C)CO";"IC50";"'='";"13.4";"nM";"7.87";"";"337364";"UO_0000065";"16.80";"0.32";"6.80";"4.99";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5090869";"";"None";"525.66";"1";"4.15";"1";"Cc1cc(Nc2ncc(-c3cccnc3)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc1OCCN1CCCC1";"IC50";"'='";"179.0";"nM";"6.75";"";"";"UO_0000065";"12.84";"0.24";"2.60";"5.70";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL4109280";"";"None";"511.95";"1";"3.16";"BDBM187834";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(Cl)cnc32)cc1Nc1cnn(CCC#N)c1";"IC50";"'='";"2.7";"nM";"8.57";"";"337511";"UO_0000065";"16.74";"0.33";"5.41";"5.85";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111561";"";"None";"463.48";"0";"2.00";"BDBM187844";"Cn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"3.3";"nM";"8.48";"";"337521";"UO_0000065";"18.30";"0.34";"6.48";"5.79";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4110810";"";"None";"439.50";"0";"3.00";"BDBM187650";"COC(C)(C)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"2.8";"nM";"8.55";"";"337335";"UO_0000065";"19.46";"0.37";"5.55";"7.26";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3956425";"";"None";"478.58";"0";"2.95";"BDBM187508";"CS(=O)(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CC2)CC1";"IC50";"'='";"1.7";"nM";"8.77";"";"337239";"UO_0000065";"18.32";"0.35";"5.82";"6.76";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109707";"";"None";"466.52";"0";"1.82";"BDBM188107";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC1CCC(N)C1";"IC50";"'='";"11.7";"nM";"7.93";"";"337770";"UO_0000065";"17.00";"0.32";"6.11";"5.12";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3913330";"";"None";"511.59";"1";"3.77";"BDBM187703";"COC1CCN(c2ccc(NC(=O)c3cnc(-n4ncc5cc(C#N)cnc54)cc3NC(C)C)nc2)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"337388";"UO_0000065";"15.64";"0.29";"4.23";"5.98";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113240";"";"None";"505.50";"1";"2.96";"BDBM188067";"CC(C)(CNc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O)OC(F)F";"IC50";"'='";"14.2";"nM";"7.85";"";"337733";"UO_0000065";"15.52";"0.30";"4.89";"5.69";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109739";"";"None";"442.47";"0";"2.91";"BDBM187744";"CC(C)Nc1cc(-n2ncc3cc(C#N)c(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)F";"IC50";"'='";"1.9";"nM";"8.72";"";"337429";"UO_0000065";"19.71";"0.37";"5.81";"6.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3895880";"";"None";"482.55";"0";"2.56";"BDBM187676";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1ccc(N2CCNCC2)nc1";"IC50";"'='";"5.3";"nM";"8.28";"";"337361";"UO_0000065";"17.15";"0.31";"5.72";"6.05";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3945800";"";"None";"500.58";"1";"4.38";"BDBM187879";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)N[C@H]1CC[C@@](F)(c2nccn2C)CC1";"IC50";"'='";"4.4";"nM";"8.36";"";"337554";"UO_0000065";"16.69";"0.31";"3.98";"7.37";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4779496";"";"None";"472.51";"0";"4.13";"20";"Cc1nnc(-c2cnc(Nc3ccc4c(c3)C(C)(C)OC4=O)nc2N[C@H](CO)c2ccccc2)o1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"15.57";"0.29";"3.23";"5.44";"0";"CHEMBL4689491";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4680358";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";""
"CHEMBL3894977";"";"None";"424.51";"0";"2.30";"BDBM187442";"CC(C)(O)CCNC(=O)c1cnc(-n2ccc3cncnc32)cc1NC1CCOCC1";"IC50";"'='";"6.0";"nM";"8.22";"";"337178";"UO_0000065";"19.37";"0.36";"5.92";"7.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5084123";"";"None";"518.57";"1";"4.09";"30";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cc(F)cc(N4CCOCC4)c3)ncc2-c2cccc(F)c2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"15.27";"0.28";"3.83";"7.52";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL5091192";"";"None";"514.61";"1";"3.26";"27";"CN1CCN(c2cc(Nc3ncc(-c4cccc(F)c4)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)ccn2)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"15.98";"0.30";"4.96";"7.32";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL5094640";"";"None";"513.58";"1";"3.75";"18";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(C(=O)N4CCCC4)c3)ncc2-c2ccnc(F)c2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"16.60";"0.31";"4.77";"6.76";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL3900669";"";"None";"427.53";"0";"2.60";"BDBM203539";"O=c1[nH]c(N2CCOCC2)nc(NC2CCCC(O)C2)c1-c1nc2ccccc2s1";"IC50";"'='";"1803.0";"nM";"5.74";"";"361019";"UO_0000065";"13.44";"0.26";"3.14";"5.56";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4746921";"";"None";"410.37";"0";"4.00";"18";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)cc(F)c2n1";"IC50";"'='";"309.0";"nM";"6.51";"";"";"UO_0000065";"15.86";"0.31";"2.51";"8.13";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4112990";"";"None";"523.07";"1";"3.59";"BDBM203586";"O=c1[nH]c(N2CCN(c3ccc(Cl)cn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"8.0";"nM";"8.10";"";"361067";"UO_0000065";"15.48";"0.31";"4.51";"7.93";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113392";"";"None";"551.72";"1";"4.05";"BDBM203785";"CC(C)(C)OC(=O)N1CC2(CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)C1";"IC50";"'='";"27.0";"nM";"7.57";"";"361259";"UO_0000065";"13.72";"0.27";"3.52";"6.55";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108188";"";"None";"488.47";"0";"2.58";"BDBM187941";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1COCC1(F)F";"IC50";"'='";"3.5";"nM";"8.46";"";"337616";"UO_0000065";"17.31";"0.33";"5.88";"6.76";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109952";"";"None";"523.55";"1";"3.21";"BDBM187813";"CC(C)(F)Cn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"2.4";"nM";"8.62";"";"337490";"UO_0000065";"16.46";"0.31";"5.41";"5.88";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113624";"";"None";"507.53";"2";"2.11";"BDBM187820";"COCCn1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"3.2";"nM";"8.49";"";"337497";"UO_0000065";"16.74";"0.31";"6.38";"5.45";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5087642";"";"None";"383.43";"0";"2.86";"2";"CCNc1c(C(=O)NC[C@@H](F)C(C)(C)O)cnc2c1[nH]c1cc(C#N)ccc12";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"22.94";"0.43";"5.94";"7.73";"0";"CHEMBL5042338";"Inhibition of IRAK4 (unknown origin) using FL- IPTSPITTTYFFFKKK peptide as substrate in presence of ATP incubated for 60 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038673";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.0 hr"
"CHEMBL3889905";"";"None";"430.42";"0";"4.42";"BDBM188768";"Cc1ccc(-c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(F)cc3F)n2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338623";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3970164";"";"None";"420.52";"0";"2.33";"BDBM203728";"O=c1[nH]c(N2CCOCC2)nc(NCCN2CCCC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"4900.0";"nM";"5.31";"";"361206";"UO_0000065";"12.63";"0.23";"2.98";"6.15";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4750612";"";"None";"436.43";"0";"4.26";"17";"CCOc1cc(NC(=O)c2cccc(C(F)(F)F)n2)cc2cn(CCC(C)(C)O)nc12";"IC50";"'='";"202.0";"nM";"6.70";"";"";"UO_0000065";"15.34";"0.29";"2.43";"7.50";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4106577";"";"None";"502.62";"1";"4.43";"BDBM203800";"O=c1[nH]c(N2CCc3ccccc3C2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2ccc(F)cc2)cs1";"IC50";"'='";"5400.0";"nM";"5.27";"";"361275";"UO_0000065";"10.48";"0.20";"0.84";"6.13";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3964745";"";"None";"459.59";"0";"4.78";"BDBM187871";"CC(C)Nc1cc(-n2ccc3cc(C#N)ccc32)ncc1C(=O)N[C@H]1CC[C@H](C(C)(C)O)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"337548";"UO_0000065";"17.41";"0.32";"3.22";"7.77";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111280";"";"None";"513.48";"1";"2.73";"BDBM187799";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)F)c1";"IC50";"'='";"1.3";"nM";"8.89";"";"337481";"UO_0000065";"17.31";"0.33";"6.16";"6.06";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115128";"";"None";"488.62";"0";"3.38";"BDBM203692";"O=c1[nH]c(C2CCN(c3cnccn3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"180.0";"nM";"6.75";"";"361166";"UO_0000065";"13.80";"0.26";"3.36";"6.04";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3971772";"";"None";"385.45";"0";"1.23";"BDBM203699";"N=C(N)CNc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"300.0";"nM";"6.52";"";"361173";"UO_0000065";"16.92";"0.33";"5.29";"4.90";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3957950";"";"None";"441.56";"0";"1.20";"BDBM203705";"O=c1[nH]c(N2CCOCC2)nc(NCCN2CCNCC2)c1-c1nc2ccccc2s1";"IC50";"'='";"55.0";"nM";"7.26";"";"361179";"UO_0000065";"16.44";"0.32";"6.06";"7.38";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3985495";"";"None";"410.48";"0";"0.82";"BDBM203722";"O=c1[nH]c(N2CCOCC2)nc(NCCNCCO)c1-c1ccc2ccccc2n1";"IC50";"'='";"670.0";"nM";"6.17";"";"361196";"UO_0000065";"15.04";"0.28";"5.35";"5.35";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3957399";"";"None";"426.55";"0";"2.29";"BDBM203720";"O=c1[nH]c(N2CCOCC2)nc(NCC2CCNCC2)c1-c1nc2ccccc2s1";"IC50";"'='";"330.0";"nM";"6.48";"";"361194";"UO_0000065";"15.20";"0.30";"4.19";"6.81";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622513";"";"None";"429.50";"0";"0.77";"13";"O=c1[nH]c(N2CCC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"292.0";"nM";"6.54";"";"";"UO_0000065";"15.21";"0.30";"5.76";"4.85";"0";"CHEMBL3625601";"Inhibition of IRAK4-mediated NFkappaB activation in human THP1-XBlue cells assessed as LPS-induced secreted embryonic alkaline phosphatase activity treated 1 hr before LPS challenge measured after 5 hrs by spectrophotometer analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"CHEMBL3307574";""
"CHEMBL4110834";"";"None";"400.46";"0";"2.47";"BDBM187438";"CC(C)Nc1cc(-n2ccc3cncnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"1.1";"nM";"8.96";"";"337174";"UO_0000065";"22.37";"0.42";"6.49";"8.54";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3986991";"";"None";"457.54";"0";"2.90";"BDBM187485";"CNC(=O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC2CC2)CC1";"IC50";"'='";"13.3";"nM";"7.88";"";"337220";"UO_0000065";"17.21";"0.32";"4.98";"6.31";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113871";"";"None";"541.63";"1";"4.21";"BDBM187921";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1NC1CCN(c2ccccc2)CC1";"IC50";"'='";"3.1";"nM";"8.51";"";"337596";"UO_0000065";"15.71";"0.29";"4.30";"7.14";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3900615";"";"None";"386.44";"0";"0.78";"BDBM203698";"NC(=O)CNc1nc(N2CCOCC2)[nH]c(=O)c1-c1nc2ccccc2s1";"IC50";"'='";"3900.0";"nM";"5.41";"";"361172";"UO_0000065";"14.00";"0.27";"4.63";"4.28";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115048";"";"None";"362.46";"0";"0.89";"BDBM203544";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nccs1";"IC50";"'='";"1830.0";"nM";"5.74";"";"361024";"UO_0000065";"15.83";"0.31";"4.85";"6.03";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107665";"";"None";"546.65";"1";"3.94";"BDBM187972";"CC(C)Nc1cc(-n2ccc3cc(CNC(=O)Cc4ccccc4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.2";"nM";"8.66";"";"337647";"UO_0000065";"15.84";"0.30";"4.72";"7.14";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3986782";"";"None";"433.52";"0";"3.05";"BDBM187759";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1CCOCC1";"IC50";"'='";"4.5";"nM";"8.35";"";"337444";"UO_0000065";"19.25";"0.36";"5.30";"7.09";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115268";"";"None";"526.66";"1";"4.13";"BDBM187976";"CC(C)Nc1cc(-n2ccc3cc(CNC(=O)CC(C)(C)C)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.7";"nM";"8.57";"";"337651";"UO_0000065";"16.27";"0.31";"4.44";"7.07";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111891";"";"None";"440.48";"0";"1.69";"BDBM188012";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(N2CCc3cc(C#N)cnc32)cc1NC1COC1";"IC50";"'='";"16.8";"nM";"7.78";"";"337681";"UO_0000065";"17.65";"0.33";"6.08";"6.30";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113269";"";"None";"460.49";"0";"2.12";"BDBM188078";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(O)C1";"IC50";"'='";"17.4";"nM";"7.76";"";"337743";"UO_0000065";"16.85";"0.32";"5.64";"6.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4754306";"";"None";"441.48";"0";"3.55";"11";"CN(C)CCn1cc2cc(NC(=O)c3nc(C(F)(F)F)cs3)c(C(C)(C)O)cc2n1";"IC50";"'='";"34.8";"nM";"7.46";"";"";"UO_0000065";"16.89";"0.34";"3.91";"8.96";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL4109434";"";"None";"531.47";"1";"3.03";"BDBM187810";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1cnn(CC(F)(F)F)c1";"IC50";"'='";"1.7";"nM";"8.77";"";"337487";"UO_0000065";"16.50";"0.32";"5.74";"5.98";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4466517";"";"None";"409.45";"0";"1.50";"4; DHBF-41";"C[C@]1(CO)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"15.48";"0.29";"4.84";"6.26";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4110394";"";"None";"583.71";"1";"3.08";"BDBM203592";"CS(=O)(=O)c1cc(F)ccc1N1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"361073";"UO_0000065";"13.46";"0.27";"4.77";"6.37";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4568867";"";"None";"465.54";"0";"2.26";"22";"O=C(Nc1cc2sc(N3CCOCC3)nc2cc1N1CCOCC1)c1cnn2cccnc12";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"15.29";"0.29";"4.86";"7.33";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4474664";"";"None";"459.45";"0";"3.13";"27";"CC1(C)Cc2cc(NC(=O)c3cnn4cc(OC(F)F)cnc34)c(N3CCOCC3)cc2O1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4518559";"";"None";"423.47";"0";"2.02";"32";"CC1(C)Cc2cc(NC(=O)c3cnn4cc(CO)cnc34)c(N3CCOCC3)cc2O1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"16.96";"0.32";"5.16";"7.09";"0";"CHEMBL4359943";"Inhibition of IRAK4 in human THP1-Xblue-MD2-CD14 cells assessed as reduction in LPS-induced NFkappaB transcription by measuring alkaline phosphatase level preincubated for 1 hr followed by LPS stimulation and measured after 20 hrs by quanti-blue reagent based reporter assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4359811";"1";"Scientific Literature";"J Med Chem";"2019";"None";""
"CHEMBL4064661";"";"None";"343.38";"0";"1.78";"24";"CC(C)Oc1cc2c(OC[C@H]3CCC(=O)N3)nccc2cc1C(N)=O";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"17.69";"0.33";"4.30";"5.87";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4061801";"";"None";"343.38";"0";"1.49";"37";"COc1cc2c(OC[C@H]3NC(=O)[C@H](C)[C@H]3C)nccc2cc1C(N)=O";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"24.56";"0.46";"6.94";"8.14";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4075552";"";"None";"327.34";"0";"0.86";"44";"COc1cc2c(OC[C@H]3NC(=O)[C@@H]4C[C@H]34)nccc2cc1C(N)=O";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"25.41";"0.47";"7.46";"8.03";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4100091";"";"None";"315.33";"0";"1.00";"21";"COc1cc2c(OC[C@@H]3CCC(=O)N3)nccc2cc1C(N)=O";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"25.75";"0.48";"7.12";"7.84";"0";"CHEMBL4015944";"Inhibition of N-terminal His6-tagged human full length IRAK4 preincubated for 20 mins followed by biotinylated-AGAGRDKYKTLRQIR substrate addition in presence of ATP measured after 60 mins by DELFIA method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4064661";"";"None";"343.38";"0";"1.78";"24";"CC(C)Oc1cc2c(OC[C@H]3CCC(=O)N3)nccc2cc1C(N)=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4015947";"Inhibition of IRAK4 in human PBMC assessed as reduction in R848-stimulated TNF alpha production after 3 hrs";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4014327";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL5094956";"";"None";"409.47";"0";"3.39";"4";"CC(C)(O)[C@H](F)CNC(=O)c1cnc2c([nH]c3cc(C#N)ccc32)c1NC1CCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"21.24";"0.40";"5.31";"7.64";"0";"CHEMBL5042338";"Inhibition of IRAK4 (unknown origin) using FL- IPTSPITTTYFFFKKK peptide as substrate in presence of ATP incubated for 60 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038673";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.0 hr"
"CHEMBL4113269";"";"None";"460.49";"0";"2.12";"BDBM188078";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(F)cnc32)cc1NC1CCC(O)C1";"IC50";"'='";"8.9";"nM";"8.05";"";"337742";"UO_0000065";"17.48";"0.33";"5.93";"6.43";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3946848";"";"None";"451.44";"0";"3.22";"BDBM187734";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)Nc1cnn(CC(F)F)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"337419";"UO_0000065";"17.72";"0.33";"4.78";"6.33";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL207464";"";"None";"366.33";"0";"2.68";"38";"O=C(Nc1nc2ccccc2n1C1CCOC1=O)c1cccc([N+](=O)[O-])c1";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"17.09";"0.32";"3.58";"5.38";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL4106963";"";"None";"494.67";"0";"3.57";"BDBM203683";"O=c1[nH]c(C2CCN(C3CCOCC3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"440.0";"nM";"6.36";"";"361157";"UO_0000065";"12.85";"0.25";"2.79";"6.68";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622515";"";"None";"493.54";"0";"1.80";"15";"O=c1[nH]c(N2CCC(F)(F)CC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"135.0";"nM";"6.87";"";"";"UO_0000065";"13.92";"0.28";"5.07";"5.10";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4111171";"";"None";"445.50";"1";"0.37";"BDBM203474";"O=c1[nH]c(NC2COC2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"892.0";"nM";"6.05";"";"360934";"UO_0000065";"13.58";"0.27";"5.68";"3.96";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3977494";"";"None";"432.53";"0";"3.54";"BDBM187944";"CC(C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NCCC1(O)CCCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"337619";"UO_0000065";"20.11";"0.37";"5.16";"7.51";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL197603";"";"None";"621.75";"1";"4.48";"20, A-770041";"COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL863888";"Inhibitory activity against IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148543";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3590477";"";"None";"379.43";"0";"1.27";"17";"Cn1cc(NC(=O)c2cnn3ccc(N[C@@H]4CCCC[C@@H]4N)nc23)c(C#N)n1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"23.98";"0.44";"7.83";"6.55";"0";"CHEMBL3592269";"Inhibition of human IRAK4 assessed as phosphorylation of fluorescent peptide substrate after 30 mins by fluorescent polarization reader";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3588771";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4110754";"";"None";"480.50";"0";"1.43";"BDBM187705";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(=O)N1CCOCC1";"IC50";"'='";"14.7";"nM";"7.83";"";"337390";"UO_0000065";"16.30";"0.31";"6.40";"5.67";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109478";"";"None";"474.54";"0";"2.84";"BDBM203647";"O=c1[nH]c(N2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc(-c2cc(F)ccc2F)cs1";"IC50";"'='";"90.0";"nM";"7.05";"";"361128";"UO_0000065";"14.85";"0.29";"4.21";"7.40";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112383";"";"None";"559.70";"1";"4.11";"BDBM203772";"O=C(NC1CCN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1)OCc1ccccc1";"IC50";"'='";"100.0";"nM";"7.00";"";"361246";"UO_0000065";"12.51";"0.24";"2.89";"5.63";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL377654";"";"None";"327.82";"0";"4.74";"10";"CCCCn1c(NC(=O)c2cccc(Cl)c2)nc2ccccc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"13.80";"0.27";"-0.22";"9.64";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3932139";"";"None";"475.55";"0";"3.51";"BDBM187497";"COC(=O)N[C@H]1CC[C@H](NC(=O)c2cnc(-n3ccc4cc(C#N)cnc43)cc2NC(C)C)CC1";"IC50";"'='";"4.9";"nM";"8.31";"";"337232";"UO_0000065";"17.47";"0.32";"4.80";"6.20";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113026";"";"None";"411.53";"0";"3.10";"BDBM203733";"O=c1[nH]c(C2CCOCC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"380.0";"nM";"6.42";"";"361207";"UO_0000065";"15.60";"0.30";"3.32";"6.98";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4780645";"";"None";"435.45";"0";"3.93";"21";"CN(C)c1cc(NC(=O)c2cccc(C(F)(F)F)n2)cc2cn(CCC(C)(C)O)nc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4678084";"Inhibition of IRAK4 in human THP-1 cells by cell based anti-inflammatory assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"Blood";"THP-1";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL5071152";"";"None";"495.59";"0";"3.61";"13";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(C(=O)N4CCCC4)c3)ncc2-c2ccncc2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"16.14";"0.30";"4.39";"6.34";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL4749646";"";"None";"878.09";"2";"3.35";"23";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CCN6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)CC4)CC3)c12";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"6.67";"0.12";"2.50";"3.32";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL5077968";"";"None";"519.61";"1";"4.08";"20";"N#Cc1ccc(-c2cnc(Nc3cccc(C(=O)N4CCCC4)c3)nc2N[C@H]2[C@@H](C(N)=O)[C@@H]3C=C[C@H]2C3)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"15.48";"0.28";"3.97";"5.87";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL5094391";"";"None";"485.57";"0";"4.11";"25";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3ccnc(N4CCCC4)c3)ncc2-c2cccc(F)c2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"15.41";"0.28";"3.37";"6.86";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL5090193";"";"None";"458.57";"0";"3.42";"9";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(C(=O)N4CCCC4)c3)ncc2C2CC2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"17.93";"0.33";"4.80";"7.26";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL5082986";"";"None";"495.59";"0";"3.61";"3";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3ccc(C(=O)N4CCCC4)cc3)ncc2-c2cccnc2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"15.31";"0.28";"3.98";"6.01";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL3936900";"";"None";"496.55";"0";"1.19";"BDBM188896";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(CO)cn3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338751";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4798668";"";"None";"864.06";"2";"2.96";"22";"CC(C)c1ccn2ncnc(N[C@H]3CC[C@@H](N4CCN(C(=O)CCC(=O)N5CCC(CN6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)CC4)CC3)c12";"IC50";"'='";"5600.0";"nM";"5.25";"";"";"UO_0000065";"6.08";"0.11";"2.29";"2.98";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL3963960";"";"None";"388.44";"0";"2.07";"BDBM188910";"CC1(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(CN)cn3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338765";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5085436";"";"None";"511.63";"1";"3.84";"2";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3ccc(OCCN4CCCC4)cc3)ncc2-c2cccnc2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"103.0";"nM";"6.99";"";"";"UO_0000065";"13.66";"0.25";"3.15";"5.91";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL5087788";"";"None";"541.63";"1";"3.50";"24";"CN1CCN(C(=O)c2cccc(Nc3ncc(-c4cccc(F)c4)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c2)CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"15.33";"0.28";"4.80";"7.13";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL3961723";"";"None";"427.53";"0";"2.60";"BDBM203718";"O=c1[nH]c(N2CCOCC2)nc(NC2CCCCC2O)c1-c1nc2ccccc2s1";"IC50";"'='";"5600.0";"nM";"5.25";"";"361192";"UO_0000065";"12.28";"0.24";"2.65";"5.08";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3908634";"";"None";"469.59";"0";"4.63";"BDBM188789";"CC(C)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338644";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5076447";"";"None";"432.53";"0";"2.85";"8";"Cc1cnc(Nc2cccc(C(=O)N3CCCC3)c2)nc1N[C@H]1[C@@H](C(N)=O)[C@@H]2C=C[C@H]1C2";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"19.70";"0.36";"5.67";"7.53";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL3901086";"";"None";"492.59";"0";"4.52";"BDBM189059";"Cc1ccc(-n2nc(-c3ccnc(CN4CCCCC4)c3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338917";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3921884";"";"None";"590.75";"1";"3.86";"BDBM188985";"Cc1ccc(-n2nc(C3CCN(C4CCC(N(C)S(C)(=O)=O)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338840";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586491";"";"None";"400.49";"0";"4.52";"BDBM188828";"Cc1ccc(-n2nc(C3CCCCC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338683";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3919434";"";"None";"459.53";"0";"3.99";"BDBM189129";"CN1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C4CC4)cc3F)n2)CC1";"IC50";"'<'";"100.0";"nM";"";"";"338987";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5081576";"";"None";"482.52";"0";"4.77";"33";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3ccc(-c4cnco4)cc3)ncc2-c2cccc(F)c2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"15.40";"0.28";"2.66";"6.25";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL3940487";"";"None";"471.57";"0";"3.84";"BDBM188830";"Cc1ccc(-n2nc(C3CCC(C(=O)N(C)C)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338685";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3912320";"";"None";"498.62";"0";"4.31";"BDBM188956";"Cc1ccc(-n2nc(C3CCN(Cc4nccs4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338811";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3920053";"";"None";"435.92";"0";"3.60";"BDBM188799";"Cc1ccc(-n2nc(C3CCNCC3)cc2NC(=O)c2cnn3cccnc23)c(Cl)c1";"IC50";"'<'";"1000.0";"nM";"";"";"338654";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115149";"";"None";"468.49";"0";"1.30";"BDBM187912";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1COC[C@H]1O";"IC50";"'='";"2.2";"nM";"8.66";"";"337587";"UO_0000065";"18.48";"0.35";"7.36";"5.96";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4108427";"";"None";"470.48";"0";"2.28";"BDBM187915";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ccc3cc(C#N)cnc32)cc1N[C@@H]1COC[C@H]1F";"IC50";"'='";"4.9";"nM";"8.31";"";"337591";"UO_0000065";"17.66";"0.33";"6.03";"6.64";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112724";"";"None";"505.50";"1";"2.34";"BDBM187609";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NCC(F)(F)C(C)(C)O";"IC50";"'='";"3.3";"nM";"8.48";"";"337304";"UO_0000065";"16.78";"0.32";"6.14";"5.69";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109831";"";"None";"460.51";"0";"1.27";"BDBM187614";"CC(C)Nc1cc(-n2cnc3cnc(NCCO)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.5";"nM";"8.60";"";"337307";"UO_0000065";"18.68";"0.36";"7.33";"5.73";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106938";"";"None";"416.46";"0";"1.45";"BDBM188045";"CC(C)Nc1cc(-n2ncc3cnc(N)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.9";"nM";"8.41";"";"337711";"UO_0000065";"20.19";"0.38";"6.96";"5.84";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3928721";"";"None";"481.56";"0";"3.58";"BDBM189021";"Cc1ccc(-n2nc(C3CCCN(Cc4ccn[nH]4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338876";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107151";"";"None";"600.17";"1";"3.59";"BDBM203589";"CS(=O)(=O)c1ccc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)c(Cl)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"361070";"UO_0000065";"13.26";"0.27";"4.37";"6.45";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107519";"";"None";"520.62";"1";"1.95";"BDBM203825";"O=c1[nH]c(N2CCC(c3ccccn3)C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"197.0";"nM";"6.71";"";"361005";"UO_0000065";"12.88";"0.25";"4.76";"4.55";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4079819";"";"None";"290.44";"0";"3.28";"4";"Cc1csc2ncnc(N[C@H]3CC[C@H](N(C)C)CC3)c12";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"18.48";"0.37";"2.09";"13.07";"0";"CHEMBL4026983";"Inhibition of IRAK4 in human KARPAS299 cells assessed as reduction in IL-1 stimulated IRAK4 phosphorylation at Thr345/Ser346 residues preincubated for 1 hr followed by IL-1 stimulation for 10 mins by flow cytometry analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024763";"1";"Scientific Literature";"J Med Chem";"2017";"None";""
"CHEMBL4787177";"";"None";"450.46";"0";"4.09";"13";"CC(C)(O)CCn1cc2cc(NC(=O)c3cccc(C(F)(F)F)n3)cc(C(C)(C)O)c2n1";"IC50";"'>'";"2000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4678083";"Inhibition of IRAK4 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2021";"None";""
"CHEMBL3586496";"";"None";"443.51";"0";"3.20";"BDBM188765";"CC(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338620";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3893473";"";"None";"408.48";"0";"4.03";"BDBM206108";"CC(O)CC(C)Oc1cc2ncccc2cc1NC(=O)c1csc2cncnc12";"IC50";"'='";"24.0";"nM";"7.62";"";"364779";"UO_0000065";"18.65";"0.36";"3.59";"7.84";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4109386";"";"None";"484.61";"0";"4.24";"BDBM189007";"Cc1ccc(-n2nc(C3CCN(C4CC[C@@H](C)C4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338862";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3903936";"";"None";"391.46";"0";"4.07";"BDBM206130";"COc1cc2ncccc2cc1NC(=O)c1csc2cnc(NC3CC3)nc12";"IC50";"'='";"74.0";"nM";"7.13";"";"364801";"UO_0000065";"18.22";"0.35";"3.06";"8.01";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3909042";"";"None";"454.49";"0";"3.06";"BDBM189050";"Cc1ccc(-n2nc(C3CN(Cc4ncco4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338905";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3986993";"";"None";"464.53";"0";"3.47";"BDBM189042";"Cc1ccc(-n2nc(C3CN(Cc4ccccn4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338897";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3944185";"";"None";"470.56";"0";"3.53";"BDBM189046";"Cc1ccc(-n2nc(C3CN(Cc4cncs4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338901";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3928107";"";"None";"348.36";"0";"2.64";"BDBM206169";"COc1cc2ccc(CO)cc2cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"358.0";"nM";"6.45";"";"364840";"UO_0000065";"18.50";"0.34";"3.81";"7.26";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3622519";"";"None";"398.49";"0";"1.66";"20";"O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"15.58";"0.30";"4.55";"6.52";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4472406";"";"None";"464.53";"0";"1.94";"18";"CC(C)(O)CCN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O";"IC50";"'='";"0.16";"nM";"9.80";"";"";"UO_0000065";"21.09";"0.39";"7.86";"8.72";"0";"CHEMBL4345131";"Inhibition of IRAK4 in human whole blood assessed as inhibition of R848-induced IL-6 production preincubated for 90 mins followed by R848 stimulation and measured after 3.5 hrs by MSD assay";"B";"BAO_0000221";"tissue-based format";"Homo sapiens";"CHEMBL3638178";"Blood";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342485";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";""
"CHEMBL4107163";"";"None";"443.53";"0";"2.54";"BDBM187631";"CC(C)Nc1cc(-n2ccc3cnc(N(C)C)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"3.4";"nM";"8.47";"";"337320";"UO_0000065";"19.09";"0.36";"5.93";"7.83";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622531";"";"None";"413.50";"0";"1.84";"3";"OC[C@H]1C[C@@H](Nc2nc(NC3CC3)ncc2-c2nc3ccccc3s2)[C@H](O)[C@@H]1O";"IC50";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"15.30";"0.30";"4.49";"5.13";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4114914";"";"None";"513.62";"1";"3.14";"BDBM187729";"CC(C)CC(=O)NCc1cnc2c(cnn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"16.9";"nM";"7.77";"";"337414";"UO_0000065";"15.13";"0.29";"4.63";"5.80";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3942383";"";"None";"434.50";"0";"1.57";"BDBM187654";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCN1CCOCC1";"IC50";"'='";"4.9";"nM";"8.31";"";"337339";"UO_0000065";"19.12";"0.35";"6.74";"6.87";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4109898";"";"None";"509.52";"1";"2.82";"BDBM187835";"CC(F)Cn1cc(Nc2cc(-n3cnc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"2.6";"nM";"8.59";"";"337512";"UO_0000065";"16.85";"0.32";"5.77";"5.86";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3933400";"";"None";"457.49";"0";"2.68";"BDBM187652";"CC(F)[C@H](C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"10.6";"nM";"7.97";"";"337337";"UO_0000065";"17.43";"0.33";"5.29";"6.19";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL388978";"STAUROSPORINE";"None";"466.54";"0";"4.35";"Staurosporine";"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4";"IC50";"'='";"4.51";"nM";"8.35";"";"";"UO_0000065";"17.89";"0.33";"4.00";"12.02";"0";"CHEMBL4720696";"Inhibition of human IRAK4 using MBP as substrate by [gamma-33P]-ATP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715818";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";""
"CHEMBL4112528";"";"None";"474.59";"0";"3.28";"BDBM203748";"O=c1[nH]c(N[C@@H]2c3ccccc3C[C@@H]2O)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"1200.0";"nM";"5.92";"";"361222";"UO_0000065";"12.48";"0.24";"2.64";"5.15";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL208166";"";"None";"364.41";"0";"4.39";"33";"O=C(Nc1nc2ccccc2n1CCC1CCC1)c1cccc([N+](=O)[O-])c1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"15.64";"0.29";"1.31";"6.33";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL4115100";"";"None";"481.53";"0";"2.24";"BDBM187595";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1N[C@H]1CC[C@H](O)CC1";"IC50";"'='";"2.4";"nM";"8.62";"";"337294";"UO_0000065";"17.90";"0.34";"6.38";"5.79";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3946796";"";"None";"456.50";"0";"3.29";"BDBM187471";"CC(F)[C@H](C)Nc1cc(-n2ccc3cc(C#N)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"2.0";"nM";"8.70";"";"337207";"UO_0000065";"19.06";"0.36";"5.41";"7.51";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4762658";"";"None";"1003.28";"None";"None";"6";"Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCC(=O)N2CCN([C@H]3CC[C@@H](Nc4ncnn5ccc(C(C)C)c45)CC3)CC2)C(C)(C)C)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL208561";"";"None";"340.30";"0";"2.51";"21";"COC(=O)c1ccc2[nH]c(NC(=O)c3cccc([N+](=O)[O-])c3)nc2c1";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"13.52";"0.25";"2.09";"3.62";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL4106530";"";"None";"468.58";"0";"3.16";"BDBM203688";"COC(=O)N1CCC(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"270.0";"nM";"6.57";"";"361162";"UO_0000065";"14.02";"0.27";"3.41";"5.85";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4779139";"";"None";"1088.39";"None";"None";"14";"Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCNC(=O)CCC(=O)N2CCN([C@H]3CC[C@@H](Nc4ncnn5ccc(C(C)C)c45)CC3)CC2)C(C)(C)C)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL206991";"";"None";"312.29";"0";"2.73";"20";"COc1ccc2[nH]c(NC(=O)c3cccc([N+](=O)[O-])c3)nc2c1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"18.65";"0.35";"3.09";"5.29";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL3957749";"";"None";"485.55";"0";"3.29";"BDBM188767";"COc1ccc(-n2nc(C3CCN(C(=O)C4CC4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338622";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4114244";"";"None";"536.95";"1";"3.90";"BDBM187826";"CC(F)(F)Cn1cc(Nc2cc(-n3ncc4cc(Cl)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)cn1";"IC50";"'='";"1.9";"nM";"8.72";"";"337503";"UO_0000065";"16.24";"0.32";"4.82";"7.10";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL208709";"";"None";"382.38";"0";"3.15";"37";"CCOC(=O)CCn1c(NC(=O)c2cccc([N+](=O)[O-])c2)nc2ccccc21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"15.69";"0.29";"2.85";"5.16";"0";"CHEMBL870864";"Inhibition of IRAK4";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147720";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";""
"CHEMBL5080176";"";"None";"514.61";"1";"3.26";"29";"CN1CCN(c2ccc(Nc3ncc(-c4cccc(F)c4)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)cn2)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"14.74";"0.27";"4.33";"6.75";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL3622519";"";"None";"398.49";"0";"1.66";"BDBM203529";"O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"620.0";"nM";"6.21";"";"361009";"UO_0000065";"15.58";"0.30";"4.55";"6.52";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3898529";"";"None";"412.52";"0";"2.05";"BDBM203527";"O=c1[nH]c(N2CCOCC2)nc(N[C@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"255.0";"nM";"6.59";"";"361007";"UO_0000065";"15.98";"0.31";"4.54";"6.93";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106733";"";"None";"456.53";"0";"1.50";"BDBM203769";"O=C(O)C1CN(c2nc(N[C@@H]3CCCNC3)c(-c3nc4ccccc4s3)c(=O)[nH]2)CCO1";"IC50";"'='";"250.0";"nM";"6.60";"";"361243";"UO_0000065";"14.46";"0.28";"5.10";"4.98";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111167";"";"None";"506.59";"1";"1.52";"BDBM203817";"O=c1[nH]c(N2CCc3cnccc3C2)nc(N[C@@H]2C[C@H](CO)[C@@H](O)[C@H]2O)c1-c1nc2ccccc2s1";"IC50";"'='";"26.4";"nM";"7.58";"";"360997";"UO_0000065";"14.96";"0.29";"6.06";"5.14";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3943289";"";"None";"484.99";"0";"3.34";"BDBM188019";"CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(Cl)cnc43)cc2NC2COC2)CC1";"IC50";"'='";"6.2";"nM";"8.21";"";"337688";"UO_0000065";"16.92";"0.33";"4.87";"7.19";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3949060";"";"None";"485.56";"0";"2.05";"BDBM187635";"CC(C)Nc1cc(-n2ccc3cnc(N4CC[C@H](O)C4)nc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"4.8";"nM";"8.32";"";"337324";"UO_0000065";"17.13";"0.32";"6.27";"6.48";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3932227";"";"None";"450.59";"0";"4.00";"BDBM187663";"Cc1cnc2c(cnn2-c2cc(NC(C)C)c(C(=O)N[C@H]3CC[C@H](C(C)(C)O)CC3)cn2)c1";"IC50";"'='";"13.6";"nM";"7.87";"";"337348";"UO_0000065";"17.46";"0.33";"3.87";"7.49";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4112163";"";"None";"543.65";"3";"-0.15";"BDBM203822";"NC(=O)CNCC1CCN(c2nc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)c(=O)[nH]2)CC1";"IC50";"'='";"36.7";"nM";"7.43";"";"361002";"UO_0000065";"13.68";"0.27";"7.59";"3.92";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113995";"";"None";"524.70";"1";"2.73";"BDBM203804";"N[C@H]1CCCC[C@H]1Nc1cccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc12";"IC50";"'='";"2.0";"nM";"8.70";"";"361278";"UO_0000065";"16.58";"0.32";"5.97";"6.53";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113432";"";"None";"516.56";"1";"3.88";"BDBM187984";"CC(C)(O)[C@H](F)CNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1Nc1ccc2ncsc2c1";"IC50";"'='";"2.6";"nM";"8.59";"";"337656";"UO_0000065";"16.62";"0.32";"4.71";"6.06";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3975410";"";"None";"483.50";"0";"4.22";"BDBM188775";"Cc1ccc(-n2nc(C3CCN(CC(F)(F)F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338630";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107826";"";"None";"527.65";"1";"3.63";"BDBM187957";"CCN(CC)C(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"13.2";"nM";"7.88";"";"337632";"UO_0000065";"14.93";"0.28";"4.25";"6.33";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115196";"";"None";"556.52";"1";"4.84";"BDBM203595";"O=c1[nH]c(N2CCN(c3ccc(Cl)c(Cl)c3)CC2)nc(N[C@@H]2CCCNC2)c1-c1nc2ccccc2s1";"IC50";"'='";"57.0";"nM";"7.24";"";"361076";"UO_0000065";"13.02";"0.27";"2.40";"8.12";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111862";"";"None";"491.63";"0";"2.27";"BDBM203601";"Cn1cc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)cn1";"IC50";"'='";"20.0";"nM";"7.70";"";"361082";"UO_0000065";"15.66";"0.30";"5.43";"7.20";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586492";"";"None";"402.46";"0";"3.37";"BDBM188780";"Cc1ccc(-n2nc(C3CCOCC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338635";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622522";"";"None";"426.55";"0";"2.57";"23";"NC1CCCC(Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)C1";"IC50";"'='";"258.0";"nM";"6.59";"";"";"UO_0000065";"15.45";"0.30";"4.02";"6.04";"0";"CHEMBL3625600";"Inhibition of IRAK4 (unknown origin) using 5FAM-RKRQGSVRRRVHCCOOH as substrate after 30 mins by IMAP assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621203";"1";"Scientific Literature";"ACS Med Chem Lett";"2015";"None";""
"CHEMBL4108331";"";"None";"524.70";"1";"2.73";"BDBM203802";"N[C@@H]1CCCC[C@@H]1Nc1cccc2sc(-c3c(N[C@@H]4CCCNC4)nc(N4CCOCC4)[nH]c3=O)nc12";"IC50";"'='";"70.0";"nM";"7.16";"";"361277";"UO_0000065";"13.64";"0.26";"4.42";"5.37";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4107848";"";"None";"512.63";"1";"3.74";"BDBM187960";"CC(C)CC(=O)NCc1cnc2c(ccn2-c2cc(NC(C)C)c(C(=O)NC[C@@H](F)C(C)(C)O)cn2)c1";"IC50";"'='";"2.3";"nM";"8.64";"";"337635";"UO_0000065";"16.85";"0.32";"4.90";"7.13";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4111977";"";"None";"446.58";"0";"3.85";"BDBM203756";"CN(Cc1ccccc1)c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1";"IC50";"'='";"310.0";"nM";"6.51";"";"361230";"UO_0000065";"14.57";"0.28";"2.66";"7.57";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113418";"";"None";"402.50";"0";"2.61";"BDBM203610";"O=c1[nH]c(N2CC3CC3C2)nc(N[C@@H]2CCCNC2)c1-c1ccc2ccccc2n1";"IC50";"'='";"34.0";"nM";"7.47";"";"361091";"UO_0000065";"18.56";"0.34";"4.86";"8.69";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4088216";"TP-030-1";"None";"402.45";"0";"2.35";"EUB0000719";"CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21";"IC50";"";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4884734";"IRAK4(IRK4LGF1) Takeda global kinase panel";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4507327";"54";"Donated Chemical Probes - SGC Frankfurt";"";"2021";"None";"Compound concentration None 1.0 µM"
"CHEMBL4107475";"";"None";"554.67";"1";"3.51";"BDBM187975";"CC(C)Nc1cc(-n2ccc3cc(CNC(=O)CC4CCOCC4)cnc32)ncc1C(=O)NC[C@@H](F)C(C)(C)O";"IC50";"'='";"14.0";"nM";"7.85";"";"337650";"UO_0000065";"14.16";"0.27";"4.34";"6.02";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3976033";"";"None";"475.55";"0";"2.56";"BDBM188018";"CC(C)(O)[C@H]1CC[C@H](NC(=O)c2cnc(-n3ncc4cc(C#N)cnc43)cc2NC2COC2)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"337687";"UO_0000065";"17.15";"0.32";"5.59";"5.91";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3952777";"";"None";"389.46";"0";"3.04";"BDBM187751";"CC(C)Nc1cc(-n2ncc3cc(C#N)cnc32)ncc1C(=O)NCCC1CC1";"IC50";"'='";"4.1";"nM";"8.39";"";"337436";"UO_0000065";"21.54";"0.39";"5.35";"7.73";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4115508";"";"None";"518.65";"1";"2.94";"BDBM203583";"COc1ccc(N2CCN(c3nc(N[C@@H]4CCCNC4)c(-c4nc5ccccc5s4)c(=O)[nH]3)CC2)nc1";"IC50";"'='";"5.0";"nM";"8.30";"";"361064";"UO_0000065";"16.01";"0.31";"5.36";"7.46";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106923";"";"None";"376.49";"0";"1.20";"BDBM203537";"Cc1csc(-c2c(N[C@@H]3CCCNC3)nc(N3CCOCC3)[nH]c2=O)n1";"IC50";"'='";"554.0";"nM";"6.26";"";"361017";"UO_0000065";"16.62";"0.33";"5.06";"6.57";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3924274";"";"None";"391.48";"0";"3.28";"BDBM187747";"CC(C)CCNC(=O)c1cnc(-n2ncc3cc(C#N)cnc32)cc1NC(C)C";"IC50";"'='";"4.5";"nM";"8.35";"";"337432";"UO_0000065";"21.32";"0.39";"5.07";"7.69";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4113185";"";"None";"463.48";"0";"2.30";"BDBM187862";"Cc1cc(Nc2cc(-n3ncc4cc(C#N)cnc43)ncc2C(=O)NC[C@@H](F)C(C)(C)O)[nH]n1";"IC50";"'='";"6.2";"nM";"8.21";"";"337539";"UO_0000065";"17.71";"0.33";"5.91";"5.21";"0";"CHEMBL3887118";"Inhibition Assay: The assays were performed in U-bottom 384-well plates. The final assay volume was 30 L prepared from 15 L additions of enzyme and substrates (fluoresceinated peptide and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.2, 10 mM MgCl2, 0.015% Brij 35 and 4 mM DTT). The reaction was initiated by the combination of IRAK4 with substrates and test compounds. The reaction mixture was incubated at room temperature for 60 min. and terminated by adding 45 μL of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP® 3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the fluorescent substrate and phosphorylated product. Inhibition data were calculated by comparison to no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentrations of reagents in the assays are ATP, 500 μM; FL-IPTSPITTTYFFFKKK peptide 1.5 μM; IRAK4, 0.6 nM; and DMSO, 1.6%.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886172";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3622526";"";"None";"426.50";"0";"1.57";"BDBM203532";"O=C1CC[C@@H](Nc2nc(N3CCOCC3)[nH]c(=O)c2-c2nc3ccccc3s2)CN1";"IC50";"'='";"450.0";"nM";"6.35";"";"361012";"UO_0000065";"14.88";"0.29";"4.78";"5.65";"1";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3962227";"";"None";"420.52";"0";"2.38";"BDBM203725";"O=c1[nH]c(N2CCOCC2)nc(NCC2CCCCN2)c1-c1ccc2ccccc2n1";"IC50";"'='";"340.0";"nM";"6.47";"";"361199";"UO_0000065";"15.38";"0.28";"4.09";"6.80";"0";"CHEMBL3887893";"IMAP technology (Molecular Devices): A 20 ul reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 uM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 ul of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LJL BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886492";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5083433";"";"None";"387.49";"0";"4.71";"73";"CC(C)CCn1cc(-c2cnc3c([nH]c4cc(C#N)ccc43)c2NC(C)C)nn1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"22.77";"0.42";"4.11";"9.27";"0";"CHEMBL5042338";"Inhibition of IRAK4 (unknown origin) using FL- IPTSPITTTYFFFKKK peptide as substrate in presence of ATP incubated for 60 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038673";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 1.0 hr"
"CHEMBL256713";"";"None";"379.42";"0";"2.57";"JH-I-25";"COc1cc(N2CCOCC2)ccc1NC(=O)c1cccc(-c2ccn[nH]2)n1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"20.08";"0.37";"5.05";"8.25";"0";"CHEMBL5029479";"Inhibition of full length human N-terminal GST-fusion tagged IRAK4 expressed in baculovirus expression system using FAM-labelled peptide as substrate preincubated for 10 mins followed by substrate addition and further incubated for 1 hr in presence of ATP at Km concentration by caliper mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5029152";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 1.167 hr"
"CHEMBL3926115";"";"None";"461.55";"0";"4.20";"BDBM188803";"Cc1cc(F)ccc1-n1nc(C2CCN(C(C)C)CC2)cc1NC(=O)c1cnn2cccnc12";"IC50";"'<'";"1000.0";"nM";"";"";"338658";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3952093";"";"None";"575.57";"1";"3.74";"BDBM188753";"O=C(Nc1cc(C2CCN(S(=O)(=O)C3CC3)CC2)nn1-c1ccc(OC(F)(F)F)cc1)c1cnn2cccnc12";"IC50";"'>'";"1000.0";"nM";"";"";"338616";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3946284";"";"None";"551.63";"1";"4.16";"BDBM189000";"O=C(Nc1cc(C2CCN(C3CCN(c4ccc(F)cc4)C3)CC2)nn1-c1ccccn1)c1cnn2cccnc12";"IC50";"'<'";"100.0";"nM";"";"";"338855";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3936946";"";"None";"537.42";"1";"2.90";"BDBM188849";"Cc1ccc(-n2nc(C3CCN(CC(N)=O)CC3)cc2NC(=O)c2cnn3cc(Br)cnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338704";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3940589";"";"None";"369.77";"0";"3.20";"BDBM206185";"O=C(Nc1cc(Cl)ccc1OCc1cnco1)c1cnn2cccnc12";"IC50";"'='";"516.0";"nM";"6.29";"";"364856";"UO_0000065";"17.00";"0.33";"3.09";"6.65";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3903575";"";"None";"357.80";"0";"2.47";"BDBM206186";"O=C(Nc1cc(Cl)ccc1N1CCOCC1)c1cnn2cccnc12";"IC50";"'='";"523.0";"nM";"6.28";"";"364857";"UO_0000065";"17.56";"0.34";"3.81";"8.75";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3962215";"";"None";"324.37";"0";"3.43";"BDBM206189";"COc1cc2cc[nH]c2cc1NC(=O)c1csc2cncnc12";"IC50";"'='";"596.0";"nM";"6.22";"";"364860";"UO_0000065";"19.19";"0.37";"2.79";"7.79";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3983691";"";"None";"594.53";"2";"5.68";"BDBM189121";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4c(Cl)cccc4Cl)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"338979";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3894857";"";"None";"540.65";"1";"3.91";"BDBM189123";"Cc1ccc(-n2nc(C3CCN([S+]([O-])Cc4cccnc4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338981";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3970564";"";"None";"594.62";"1";"4.79";"BDBM189125";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccc(C(F)(F)F)n4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338983";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3915971";"";"None";"326.36";"0";"1.92";"BDBM206263";"COc1ccc(CCCO)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"8361.0";"nM";"5.08";"";"364934";"UO_0000065";"15.56";"0.29";"3.16";"5.72";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3950362";"";"None";"491.62";"0";"3.73";"BDBM189092";"CCC[S+]([O-])N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(-c3ccc(C)cc3)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338950";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3945811";"";"None";"555.66";"1";"4.39";"BDBM189098";"COc1ccc([S+]([O-])N2CCC(c3cc(NC(=O)c4cnn5cccnc45)n(-c4ccc(C)cc4)n3)CC2)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338956";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3586511";"";"None";"481.54";"0";"0.95";"BDBM188933";"Cc1ccc(-n2nc(N3CCN(S(C)(=O)=O)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338789";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3918045";"";"None";"357.80";"0";"2.21";"BDBM206182";"O=C(Nc1cc(Cl)ccc1N1CCC(O)C1)c1cnn2cccnc12";"IC50";"'='";"493.0";"nM";"6.31";"";"364853";"UO_0000065";"17.63";"0.34";"4.10";"7.62";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3586486";"";"None";"395.43";"0";"3.54";"BDBM188859";"Cc1ccc(-n2nc(-c3ccncc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338714";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3911353";"";"None";"511.55";"1";"5.00";"BDBM188994";"Cc1ccc(-n2nc(C3CCN(C(C)CC(F)(F)F)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338849";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3937006";"";"None";"392.87";"0";"3.40";"BDBM206213";"COc1ccc(Cl)cc1NC(=O)c1csc2cnc(NCCCO)nc12";"IC50";"'='";"2062.0";"nM";"5.69";"";"364884";"UO_0000065";"14.47";"0.30";"2.29";"5.90";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3971677";"";"None";"575.70";"2";"5.53";"BDBM189088";"Cc1ccc(-n2nc(C3CCN([S+]([O-])c4cccc5ccccc45)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338946";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3902196";"";"None";"477.55";"0";"2.37";"BDBM188818";"Cc1ccc(-n2nc(C3CN(S(=O)(=O)C4CC4)C3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338673";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3969785";"";"None";"509.62";"1";"4.13";"BDBM188999";"Cc1ccc(-n2nc(C3CCN(C4CCC(C#N)CC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338854";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3892202";"";"None";"498.62";"0";"4.31";"BDBM188963";"Cc1ccc(-n2nc(C3CCN(Cc4cncs4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338818";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3890937";"";"None";"498.62";"0";"4.31";"BDBM188965";"Cc1ccc(-n2nc(C3CCN(Cc4cscn4)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338820";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL4106868";"";"None";"478.56";"0";"0.75";"BDBM188873";"Cc1ccc(-n2nc(C3=CCN(S(C)(=O)=O)CC3)cc2NC(=O)C2=c3nccc[n+]3=NC2)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338728";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL5082615";"";"None";"512.59";"1";"4.35";"15";"NC(=O)[C@@H]1[C@H](Nc2nc(Nc3cccc(C(=O)N4CCCC4)c3)ncc2-c2cccc(F)c2)[C@H]2C=C[C@@H]1C2";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"15.53";"0.29";"3.61";"7.03";"0";"CHEMBL5038453";"Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5036378";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";""
"CHEMBL3353208";"";"None";"487.57";"0";"2.17";"BDBM50040856";"Cc1ccc(-n2nc(N3CCN(C4CCOCC4)CC3)cc2NC(=O)c2cnn3cccnc23)nc1";"IC50";"'<'";"100.0";"nM";"";"";"338910";"UO_0000065";"";"";"";"";"1";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3894435";"";"None";"409.45";"0";"3.72";"BDBM188836";"Cc1ccc(-n2nc(-c3ccc(N)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338691";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3920056";"";"None";"469.55";"0";"3.41";"BDBM206092";"NCC1CCN(c2cc(C(=O)Nc3ccccc3)ccc2NC(=O)c2cnn3cccnc23)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"364762";"UO_0000065";"17.89";"0.33";"4.99";"7.14";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3892596";"";"None";"501.57";"1";"3.39";"BDBM189084";"Cc1ccc(-n2nc(-c3ccc(S(=O)(=O)N(C)C)cc3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"100.0";"nM";"";"";"338942";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3982737";"";"None";"378.84";"0";"3.01";"BDBM206219";"COc1ccc(Cl)cc1NC(=O)c1csc2cnc(NCCO)nc12";"IC50";"'='";"2237.0";"nM";"5.65";"";"364890";"UO_0000065";"14.91";"0.31";"2.64";"5.86";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3952668";"";"None";"325.33";"0";"1.95";"BDBM206260";"COc1ccc(NC(C)=O)cc1NC(=O)c1cnn2cccnc12";"IC50";"'='";"7697.0";"nM";"5.11";"";"364931";"UO_0000065";"15.72";"0.29";"3.16";"5.24";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL3892585";"";"None";"371.83";"0";"2.45";"BDBM206193";"O=C(Nc1cc(Cl)ccc1N1CCC(CO)C1)c1cnn2cccnc12";"IC50";"'='";"650.0";"nM";"6.19";"";"364864";"UO_0000065";"16.64";"0.32";"3.74";"7.48";"0";"CHEMBL3887963";"In vitro IRAK-1 and IRAK-4 Assay: Purified recombinant IRAK-4 protein was incubated with 250 uM synthetic peptide(KKARFSRFAGSSPSQSSMVAR) in 30 ul of kinase buffer including (20 mM MOPS pH7.2, 25 mM beta glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT, 50 uM ATP, 20 mM MgCl2, 10 uCi gamma-33P, 0.1% BSA) for the indicated time. For purified recombinant IRAK-1 protein kinase assay, 50 uM ATP was used. A 25 ul aliquot of the reaction mixture was transferred on to p81 phosphocellulose squares (Upstate Biotechnology, Lake Placid, N.Y.). The assay squares were washed three times with 0.75% phosphoric acid and once with acetone. Enzyme activity was measured by determining the bound radioactivity by liquid scintillation counting.";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886519";"37";"BindingDB Database";"";"2016";"None";""
"CHEMBL4754560";"";"None";"940.23";"2";"4.64";"15";"Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCNC(=O)CCC(=O)N2CCN([C@H]3CC[C@@H](Nc4ncnn5ccc(C(C)C)c45)CC3)CC2)C(C)(C)C)cc1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4729447";"Inhibition of recombinant human full-length His-tagged IRAK4 expressed in baculovirus expression system using 5-FAM-IPTSPITTTYFFFKKK-COOH as substrate measured after 240 mins by mobility shift assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725370";"1";"Scientific Literature";"J Med Chem";"2020";"None";"TIME = 4.0 hr"
"CHEMBL3975355";"";"None";"394.46";"0";"2.09";"BDBM188923";"O=C(Nc1cc(C2CCNCC2)nn1-c1nccs1)c1cnn2cccnc12";"IC50";"'<'";"100.0";"nM";"";"";"338778";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3913530";"";"None";"432.51";"0";"0.28";"BDBM188920";"CS(=O)(=O)N1CCC(c2cc(NC(=O)c3cnn4cccnc34)n(CCN)n2)CC1";"IC50";"'<'";"1000.0";"nM";"";"";"338775";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
"CHEMBL3964604";"";"None";"580.67";"1";"4.66";"BDBM189087";"Cc1ccc(-n2nc(C3CCN([S+]([O-])Cc4noc5ccccc45)CC3)cc2NC(=O)c2cnn3cccnc23)cc1";"IC50";"'<'";"1000.0";"nM";"";"";"338945";"UO_0000065";"";"";"";"";"0";"CHEMBL3887430";"Kinase Assay: The kinase activity of IRAK-4 is determined by its ability to catalyze the phosphorylation of a fluorescent polypeptide substrate. The extent of phosphorylation is measured using the IMAP technology (Molecular Devices) where the phosphorylated fluorescent substrate binds to the large M(III)-based nanoparticles which reduces the rotational speed of the substrate and thus increases its fluorescent polarization (FP). 20 μl reaction mixture contains 10 mM TriHCl, pH 7.2, 0.5 nM GST tagged IRAK-4 (SignalChem), 100 nM fluorescent peptide substrate (RP7030, Molecular Devices), 100 μM ATP, 1 mM DTT, 1 mM MgCl2, and 0.01% Tween 20. The reaction is initiated by the addition of ATP. After incubation for 30 minutes at 25° C., 60 μl of Progressive IMAP Reagent (Molecular Devices) is added to stop the reaction. Change in RP7030's FP is determined by a FP reader (Analyst HT, LH, BioSystems).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3778";"Interleukin-1 receptor-associated kinase 4";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886319";"37";"BindingDB Database";"";"2015";"None";""
